Difference between revisions of "LncRNAWiki:Featured"

From LncRNAWiki
Jump to: navigation, search
 
(50 intermediate revisions by one other user not shown)
Line 1: Line 1:
−
<div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;">
 
−
Jump to section in alphabetical order :  [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']]
 
−
</div>
 
−
 
 
{|class="wikitable sortable" style="width:90%;text-align:center"
 
{|class="wikitable sortable" style="width:90%;text-align:center"
 
|-
 
|-
−
!width="50"|Name
+
!width="50"|LncBook ID
−
!width="50"|Transcript ID
+
!width="50"|Symbol
−
!width="50"|Alias
+
!width="50"|Synonyms
−
!width="50"|Description
+
!width="50"|Functional Mechanism
 +
!width="50"|Biological Process
 
!width="50"|Disease
 
!width="50"|Disease
 +
!width="50"|Mesh Ontology
 
|-
 
|-
−
|''21A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289501 HSALNT0289501]
−
|[[NONHSAT128494]]
+
|[[HPVC1]]
−
|ncRNA 21A
+
|PE5L,HPV18E5L
−
|N/A
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''7SK''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289605 HSALNT0289605]
−
|[[NONHSAT113149]]
+
|[[NONHSAT104559]]
−
|"7-3 RNA, K-RNA, 7SK-RNA, 7SK snRNA, RN7SK, ENSG00000202198"
+
|lnc-C9orf53-2:1
−
|"RNA, 7SK small nuclear"
+
|NA
−
|colon adenocarcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''7SL''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199632 HSALNT0199632]
−
|[[lnc-LRR1-1:1]]
+
|[[N4BP2L2-IT2]]
−
|"7S RNA, SRP RNA, 4.5S SRP RNA, 4.5S RNA, RN7SL1 RNA, ENSG00000258486"
+
|CG030
−
|"RNA, 7SL, cytoplasmic 1"
+
|NA
−
|AIDS
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ABALON''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0171094 HSALNT0171094]
−
|[[ABALON]]
+
|[[LINC01150]]
−
|INXS
+
|2G7,TCONS_00019134
−
|apoptotic BCL2L1-antisense long non-coding RNA
+
|NA
−
|renal cell carcinoma
+
|pathogenic process
 +
|Wilms' tumor
 +
|Neoplasms
 
|-
 
|-
−
|''AIRN''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289115 HSALNT0289115]
−
|[[ENST00000609176.1]]
+
|[[LINC01587]]
−
|"AIR, IGF2RAS"
+
|C4orf6,aC1
−
|Antisense of IGF2R non-protein coding RNA
+
|NA
−
|alcoholic liver disease,chronic nonalcoholic liver disease, hepatocelluar carcinoma
+
|pathogenic process
 +
|neuroblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''APOA1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290105 HSALNT0290105]
−
|[[ENST00000444200.1]]
+
|[[NONHSAT115106]]
−
|APOA1 antisense RNA
+
|NONHSAT115106
−
|N/A
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''APTR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289234 HSALNT0289234]
−
|[[NONHSAT121673]]
+
|[[RNF217-AS1]]
−
|Alu-mediated CDKN1A/p21
+
|STL
−
|N/A
+
|NA
−
|liver cirrhosis
+
|pathogenic process
 +
|acute lymphoblastic leukemia
 +
|Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''BANCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0280481 HSALNT0280481]
−
|[[BANCR]]
+
|[[INE2]]
−
|LINC00586
+
|NCRNA00011
−
|BRAF-activated non-protein coding RNA
+
|NA
−
|gastric cancer, Non-small cell lung cancer(NSCLC), Osteosarcoma, Hepatocellular carcinoma, Malignant melanoma, Eosinophilic esophagitis
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BDNF-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289485 HSALNT0289485]
−
|[[ENST00000499008.3]]
+
|[[INE1]]
−
|BDNF antisense RNA
+
|NCRNA00010
−
|"BT2A, BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1, NCRNA00049"
+
|NA
−
|Huntington's disease, psychiatric disease, schizophrenia, obesity
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BLACAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289511 HSALNT0289511]
−
|[[BLACAT1]]
+
|[[LINC01565]]
−
|"linc-UBC1,LINC00912, onco-lncRNA-30"
+
|C3orf27,GR6
−
|bladder cancer associated transcript 1 (non-protein coding)
+
|NA
−
|bladder cancer
+
|pathogenic process
 +
|leukemia
 +
|Neoplasms
 
|-
 
|-
−
|''CAHM''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289068 HSALNT0289068]
−
|[[ENST00000604200.1]]
+
|[[LINC00869]]
−
|LINC00468
+
|KIAA0493
−
|colon adenocarcinoma hypermethylated (non-protein coding)
+
|NA
−
|colorectal neoplasia.
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PTCSC1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289430 HSALNT0289430]
−
|[[NONHSAT129210]]
+
|[[ERC2-IT1]]
−
|AK023948
+
|C1orf1,C3orf51,Po42
−
|papillary thyroid carcinoma susceptibility candidate 1 (non-protein coding)
+
|NA
−
|thyroid carcinoma
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BCYRN1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290394 HSALNT0290394]
−
|[[lnc-EPCAM-1:2]]
+
|[[Lnc-PDIA4-1:1]]
−
|"BC200,BC200a, NCRNA00004, LINC00004"
+
|lnc-PDIA4-1:1
−
|"BCYRN1, brain cytoplasmic RNA 1"
+
|NA
−
|Alzheimer's disease,breast cancer,cervical cancer, lung cancer,oesophagus cancer, ovarian cancer, parotid cancer,tongue cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BPESC1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289195 HSALNT0289195]
−
|[[ENST00000418282.1]]
+
|[[NOP14-AS1]]
−
|NCRNA00187
+
|C4orf10,RES4-24
−
|"blepharophimosis, epicanthus inversus and ptosis, candidate 1 (non-protein coding)"
+
|NA
−
|blepharophimosis syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CYP4A22-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290309 HSALNT0290309]
−
|[[ENST00000444042.2]]
+
|[[NONHSAT022116]]
−
|"Noncoding RNA activating3: ncRNA-a3, ENST00000444042.2, ENSG00000225506"
+
|NONHSAT022116,AF080092,TSU
−
|CYP4A22 antisense RNA 1
+
|NA
−
|_
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CASC8''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289243 HSALNT0289243]
−
|[[ENST00000502056.1]]
+
|[[SMAD5-AS1]]
−
|"LINC00860,CARLo-1"
+
|SMAD5O,DAMS
−
|cancer susceptibility candidate 8 (non-protein coding)
+
|NA
−
|Colorectal Cancer,Lung Cancer
+
|pathogenic process
 +
|malignant hematopoietic
 +
|Cell Physiological Phenomena
 
|-
 
|-
−
|''CCAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289025 HSALNT0289025]
−
|[[NONHSAT129017]]
+
|[[LINC00244]]
−
|"CARLo-5, onco-lncRNA-40"
+
|C7orf4,NCRNA00244
−
|colon cancer associated transcript 1 (non-protein coding)
+
|NA
−
|colorectal cancer,gastric cancer
+
|pathogenic process
 +
|preaxial polydactyly
 +
|NA
 
|-
 
|-
−
|''CCAT2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289017 HSALNT0289017]
−
|[[CCAT2]]
+
|[[KIF25-AS1]]
−
|"NCCP1, LINC00873"
+
|C6orf54,NCRNA00300,HGC6.1.1
−
|colon cancer associated transcript 2 (non-protein coding)
+
|NA
−
|non-small cell lung cancer
+
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''CISTR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289332 HSALNT0289332]
−
|[[NONHSAT028496]]
+
|[[LINC01558]]
−
|"CISTR-ACT, CISTRACT, re52431"
+
|C6orf123,LINC01557,HGC6.2,dJ431P23.4
−
|chondrogenesis-associated transcript
+
|NA
−
|_
+
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''CRNDE''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289438 HSALNT0289438]
−
|[[Lnc-IRX3-4:2]]
+
|[[AFDN-AS1]]
−
|"LOC643911, LINC00180, CRNDEP"
+
|C6orf124,MLLT4-AS1,HGC6.4,dJ431P23.3
−
|colorectal neoplasia differentially expressed (non-protein coding)
+
|NA
−
|colorectal cancer
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CYYR1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289232 HSALNT0289232]
−
|[[ENST00000357401.3]]
+
|[[RFPL3S]]
−
|cysteine and tyrosine rich 1 antisense RNA 1
+
|RFPL3-AS1,RFPL3-A, NCRNA00005
−
|N/A
+
|NA
−
|_
+
|pathogenic process
 +
|opitz syndrome
 +
|NA
 
|-
 
|-
−
|''DALIR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289393 HSALNT0289393]
−
|[[DALIR]]
+
|[[RFPL1S]]
−
|DALI
+
|RFPL1-AS1,RFPL1-A, NCRNA00006
−
|DNMT1-associated long intergenic non-coding RNA
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DANCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289500 HSALNT0289500]
−
|[[NONHSAT096369]]
+
|[[HCG4B]]
−
|differentiation antagonizing non-protein coding RNA
+
|HCG4P6,HCGIV-6,HCGIV.5,HCGIV-06,bCX67J3.3,Em:AB023056.16,bPG309N1.1,bQB90C11.3
−
|"ANCR, AGU2, lncRNA-ANCR"
+
|NA
−
|bone diseases
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DBET''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289894 HSALNT0289894]
−
|[[NONHSAT099821]]
+
|[[LINC00294]]
−
|"DBE-T, DUX4L30"
+
|NA
−
|D4Z4 binding element transcript (non-protein coding)
+
|NA
−
|Pancreatic ductal adenocarcinoma, Facioscapulohumeral muscular dystrophy
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DHFR upstream transcripts''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289345 HSALNT0289345]
−
|[[NONHSAT102417]]
+
|[[LINC00893]]
−
|"DHFR minor transcript 5'-UTR, ENSG00000228716"
+
|NA
−
|N/A
+
|NA
−
|_
+
|pathogenic process
 +
|hunter syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 
|-
 
|-
−
|''DHRS4-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290133 HSALNT0290133]
−
|[[NONHSAT035954]]
+
|[[PCBP3-OT1]]
−
|DHRS4 antisense RNA 1
+
|PCBP3-OT1,FLJ44028
−
|"PRO1488,AS1DHRS4"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DLEU1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289488 HSALNT0289488]
−
|[[NONHSAT033797]]
+
|[[ENST00000418282.1]]
−
|deleted in lymphocytic leukemia 1 (non-protein coding)
+
|NCRNA00187
−
|"LEU1, XTP6, NCRNA00021, LINC00021, BCMS1"
+
|NA
−
|chronic lymphocytic leukemia
+
|pathogenic process
 +
|blepharophimosis syndrome
 +
|Eye Diseases
 
|-
 
|-
−
|''DLEU2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289712 HSALNT0289712]
−
|[[NONHSAT033821]]
+
|[[COPG2IT1]]
−
|deleted in lymphocytic leukemia 2 (non-protein coding)
+
|CIT1,NCRNA00170,COPG2AS
−
|"LEU2, TRIM13OS, NCRNA00022, LINC00022, MIR15AHG"
+
|NA
−
|chronic lymphocytic leukemia, lymphocytic leukemia, myeloma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DISC2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0265040 HSALNT0265040]
−
|[[NONHSAT010191]]
+
|[[LINC00652]]
−
|"DISC1-AS1, DISC1OS, NCRNA00015"
+
|HSPC072
−
|disrupted in schizophrenia 2 (non-protein coding)
+
|NA
−
|affective disorders, Autism spectrum disorder, bipolar disorder, depression, schizophrenia
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''EGOT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289282 HSALNT0289282]
−
|[[NONHSAT087635]]
+
|[[WASIR2]]
−
|"EGO, ""eosinophil granule ontogeny"", NCRNA00190, ""non-protein coding RNA 190"", ENSG00000235947"
+
|NCRNA00286A
−
|Eosinophil granule ontogeny (EGO) RNA
+
|NA
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''EMX2OS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246856 HSALNT0246856]
−
|[[lnc-PDZD8-3:1]]
+
|[[LINC00470]]
−
|"EMX2-AS1, NCRNA00045, ""non-protein coding RNA 45"",ENSG00000229847"
+
|C18orf2
−
|Emx2 opposite strand transcript.
+
|NA
−
|_
+
|pathogenic process
 +
|age-related macular degeneration
 +
|Eye Diseases
 
|-
 
|-
−
|''ERICD''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289507 HSALNT0289507]
−
|[[Lnc-CHRAC1-2:1]]
+
|[[LINC00588]]
−
|"TCONS_00014875, ERIC"
+
|C8orf71,DKFZP434F122
−
|E2F1-regulated inhibitor of cell death (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ESRG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0276604 HSALNT0276604]
−
|[[ENST00000583516.1]]
+
|[[TTC28-AS1]]
−
|HESRG
+
|TTC28AS,TTC28-AS,KIAA1648
−
|embryonic stem cell related (non-protein coding)
+
|NA
−
|embryonal carcinoma, intracranial aneurism
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''Evf2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0237577 HSALNT0237577]
−
|[[lnc-DLX5-3:1]]
+
|[[CDRT7]]
−
|"Evf-2, Dlx6as1, Dlx6os1, ENSG00000231764"
+
|NCRNA00025,LINC00025
−
|_
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''FENDRR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288912 HSALNT0288912]
−
|[[FENDRR]]
+
|[[CDRT8]]
−
|FOXF1 adjacent non-coding developmental regulatory RNA
+
|NA
−
|"lincFOXF1, onco-lncRNA-21"
+
|NA
−
|Heart Failure
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''FIRRE''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275048 HSALNT0275048]
−
|[[ENST00000427391.1]]
+
|[[CECR3]]
−
|firre intergenic repeating RNA element
+
|NA
−
|LINC01200
+
|NA
−
|_
+
|pathogenic process
 +
|cat eye syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 
|-
 
|-
−
|''FOXCUT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288915 HSALNT0288915]
−
|[[Lnc-FOXC1-1:1]],
+
|[[CECR9]]
−
[[NONHSAT106529]]
+
|NA
−
|TCONS_00011636
+
|NA
−
|FOXC1 upstream transcript (non-protein coding)
+
|pathogenic process
−
|esophageal squamous cell carcinoma, basal-like breast cancer
+
|cat eye syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 
|-
 
|-
−
|''FTX''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288998 HSALNT0288998]
−
|[[ENST00000602812.1]]
+
|[[HDHD5-AS1]]
−
|"LINC00182,FLJ33139"
+
|CECR4,CECR5-AS1,NCRNA00017
−
|"FTX transcript, XIST regulator (non-protein coding)"
+
|NA
−
|epatocellular carcinoma, colorectal cancer
+
|pathogenic process
 +
|cat eye syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 
|-
 
|-
−
|''GHET1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288914 HSALNT0288914]
−
|[[GHET1]]
+
|[[CECR5-AS1]]
−
|lncRNA-GHET1
+
|NCRNA00017
−
|gastric carcinoma proliferation enhancing transcript 1
+
|NA
−
|gastric cancer
+
|pathogenic process
 +
|cat eye syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 
|-
 
|-
−
|''GHRLOS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288919 HSALNT0288919]
−
|[[NONHSAT087920]]
+
|[[CLRN1-AS1]]
−
|"NCRNA00068,GHRL-AS1"
+
|CLRN1O,UCRP
−
|ghrelin opposite strand/antisense RNA
+
|NA
−
|obesity, diabetes and cancer
+
|pathogenic process
 +
|usher syndrome type 3
 +
|NA
 
|-
 
|-
−
|''GPR1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289271 HSALNT0289271]
−
|[[NONHSAT076558]]
+
|[[TMEM9B-AS1]]
−
|GPR1AS
+
|C11orf18
−
|GPR1 antisense RNA
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HAGLR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289324 HSALNT0289324]
−
|[[ENST00000416928.2]],
+
|[[LINC01547]]
−
[[NONHSAT075638]]
+
|C21orf69,C21orf67
−
|Mdgt
+
|NA
−
|HOXD antisense growth-associated long non-coding RNA
+
|pathogenic process
−
|neuroblastoma
+
|Down syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''HEIH''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0270409 HSALNT0270409]
−
|[[HEIH]]
+
|[[LINC00029]]
−
|"LINC-HEIH, lncRNA-HEIH, LINC00848, HCCAT2"
+
|C20orf51,NCRNA00029,bA305P22.4
−
|hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA
+
|NA
−
|hepatocelluar carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''JADRR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289336 HSALNT0289336]
−
|[[JADRR]]
+
|[[LINC00529]]
−
|lncRNA-JADE
+
|C8orf8
−
|JADE1 adjacent regulatory RNA
+
|NA
−
|breast cancer
+
|pathogenic process
 +
|keratolytic winter erythema
 +
|NA
 
|-
 
|-
−
|''KANTR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288978 HSALNT0288978]
−
|[[ENST00000604849.1]]
+
|[[FLVCR1-AS1]]
−
|KDM5C adjacent non-coding transcript
+
|FLVCR1-DT,LQK1
−
|Spasm
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC-PINT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0238050 HSALNT0238050]
−
|[[NONHSAT123382]]
+
|[[SMCR2]]
−
|"FLJ43663, PINT, LincRNA-Pint"
+
|NA
−
|"long intergenic non-protein coding RNA, p53 induced transcript"
+
|NA
−
|pancreatic cancer
+
|pathogenic process
 +
|Smith-Magenis syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''LINC00163''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289401 HSALNT0289401]
−
|[[LINC00163]]
+
|[[SMCR5]]
−
|"NLC1-A, NLC1A"
+
|NCRNA00034
−
|long intergenic non-protein coding RNA 163
+
|NA
−
|_
+
|pathogenic process
 +
|Smith-Magenis syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''LINC00312''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290246 HSALNT0290246]
−
|[[NONHSAT087716]]
+
|[[SMCR6]]
−
|"NAG7, NAG-7, ERR10, LMCD1DN, ERR-10"
+
|NA
−
|long intergenic non-protein coding RNA 312
+
|NA
−
|nasopharyngeal carcinoma
+
|pathogenic process
 +
|Smith-Magenis syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''LINC00850''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274626 HSALNT0274626]
−
|[[LINC00850]]
+
|[[LINC00205]]
−
|KUCG1
+
|C21orf86,NCRNA00205,
−
|long intergenic non-protein coding RNA 850
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC01191''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271512 HSALNT0271512]
−
|[[ENST00000412690.1]]
+
|[[C21orf91-OT1]]
−
|"VIN, lnc-ACTR3"
+
|NCRNA00285,D21S2089E
−
|long intergenic non-protein coding RNA 1191
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LSINCT5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0272596 HSALNT0272596]
−
|[[LSINCT5]]
+
|[[LINC00307]]
−
|N/A
+
|NCRNA00307,D21S2091E
−
|long stress-induced non-coding transcript 5
+
|NA
−
|gastric cancer,breast and ovarian cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LUCAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274502 HSALNT0274502]
−
|[[ENST00000511918.1]]
+
|[[TSPEAR-AS2]]
−
|SCAL1
+
|C21orf90
−
|lung cancer associated transcript 1 (non-protein coding)
+
|NA
−
|non-small cell lung cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR22HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274807 HSALNT0274807]
−
|[[ENST00000574306.1]]
+
|[[MCM3AP-AS1]]
−
|"MGC14376, DKFZp686O06159, LOC554202"
+
|C21orf85,MCM3APAS,MCM3AP-AS,FLJ10508,NCRNA00031
−
|MIR22 host gene
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR31HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288888 HSALNT0288888]
−
|[[NONHSAT130385]]
+
|[[B3GALT5-AS1]]
−
|LOC554202
+
|C21orf88
−
|MIR31 host gene
+
|NA
−
|gastric cancer, pancreatic ductal adenocarcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR99AHG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288898 HSALNT0288898]
−
|[[ENST00000602580.1]]
+
|[[BRWD1-AS2]]
−
|MONC
+
|C21orf87,NCRNA00257,BRWD1-IT2
−
|mir-99a-let-7c cluster host gene
+
|NA
−
|myeloid leukemia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR100HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289031 HSALNT0289031]
−
|[[ENST00000531381.1]]
+
|[[LINC00315]]
−
|"AGD1, lncRNA-N2"
+
|C21orf93,NCRNA00315
−
|mir-100-let-7a-2 cluster host gene
+
|NA
−
|myeloid leukemia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR155HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289033 HSALNT0289033]
−
|[[NONHSAT081499]]
+
|[[LINC00334]]
−
|"BIC, NCRNA00172"
+
|C21orf89,NCRNA00334
−
|MIR155 host gene
+
|NA
−
|chronic lymphocytic leukemia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR222HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289322 HSALNT0289322]
−
|[[ENST00000602507.1]]
+
|[[LINC00314]]
−
|Lnc-Ang362
+
|C21orf94,NCRNA00314
−
|MIR222 host gene
+
|NA
−
|Ang II-associated cardiovascular disease
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR503HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271821 HSALNT0271821]
−
|[[ENST00000414769.1]]
+
|[[LINC00308]]
−
|"MGC16121, H19X"
+
|C21orf74,NCRNA00308,PRED16
−
|MIR503 host gene
+
|NA
−
|choriocarcinoma
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MYCNUT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289023 HSALNT0289023]
−
|[[ENST00000433810.1]]
+
|[[LINC00189]]
−
|lncUSMycN
+
|C21orf109,NCRNA00189
−
|MYCN upstream transcript (non-protein coding)
+
|NA
−
|neuroblastoma
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NAMA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289375 HSALNT0289375]
−
|[[ENST00000604258.1]]
+
|[[NCRUPAR]]
−
|N/A
+
|ncR-uPAR,ncRuPAR,NCRNA00193
−
|"non-protein coding RNA, associated with MAP kinase pathway and growth arrest"
+
|transcriptional regulation
−
|papillary thyroid carcinoma
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NRIR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273467 HSALNT0273467]
−
|[[ENST00000414795.1]]
+
|[[DSCR10]]
−
|lncRNA-CMPK2
+
|NA
−
|negative regulator of interferon response (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''OIP5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289480 HSALNT0289480]
−
|[[ENST00000500949.2]]
+
|[[DSCR9]]
−
|"cyrano,LOC729082, linc-NUSAP1-1, OIP5-AS1"
+
|NCRNA00038
−
|OIP5 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''OVAAL''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290051 HSALNT0290051]
−
|[[ENST00000442621.1]]
+
|[[MDS2]]
−
|"LINC01131,OVAL"
+
|NA
−
|ovarian adenocarcinoma amplified long non-coding RNA
+
|NA
−
|ovarian cancer
+
|pathogenic process
 +
|myelodysplastic syndrome
 +
|Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''PACERR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127810 HSALNT0127810]
−
|[[ENST00000608917.1]]
+
|[[ST7-AS2]]
−
|"PACER, PTGS2-AS1"
+
|ST7OT2,ST7AS2
−
|PTGS2 antisense NFKB1 complex-mediated expression regulator RNA
+
|NA
−
|inflammation and cancer
+
|pathogenic process
 +
|autism
 +
|Mental Disorders
 
|-
 
|-
−
|''PART1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127813 HSALNT0127813]
−
|[[ENST00000506884.1]]
+
|[[ST7-OT3]]
−
|"DKFZP586D0823, NCRNA00206"
+
|ST7OT3,NCRNA00026
−
|prostate androgen-regulated transcript 1 (non-protein coding)
+
|NA
−
|prostate carcinogenesis
+
|pathogenic process
 +
|autism
 +
|Mental Disorders
 
|-
 
|-
−
|''PAUPAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290258 HSALNT0290258]
−
|[[NONHSAT018635]]
+
|[[ST7-OT4]]
−
|N/A
+
|NA
−
|PAX6 upstream antisense RNA
+
|NA
−
|_
+
|pathogenic process
 +
|autism
 +
|Mental Disorders
 
|-
 
|-
−
|''PCA3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290257 HSALNT0290257]
−
|[[ENST00000412654.1]]
+
|[[NONHSAT122926]]
−
|"DD3, NCRNA00019, PCAT3"
+
|NONHSAT122926
−
|prostate cancer associated 3 (non-protein coding)
+
|NA
−
|Prostate Cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PCAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289372 HSALNT0289372]
−
|[[ENST00000561978.1]]
+
|[[MIR600HG]]
−
|"PCAT-1, PCA1"
+
|C9orf45,NCRNA00287,GL012,FLJ22161
−
|prostate cancer associated transcript 1 (non-protein coding)
+
|NA
−
|Prostate Cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PCAT4''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013239 HSALNT0013239]
−
|[[ENST00000504263.1]]
+
|[[ATP1A1-AS1]]
−
|"GDEP, PCAN1, PCA4"
+
|C1orf203,ATP1A1OS,MGC16179
−
|prostate cancer associated transcript 4 (non-protein coding)
+
|NA
−
|Prostate Cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PCAT7''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0048563 HSALNT0048563]
−
|[[ENST00000452148.2]]
+
|[[SPATA3-AS1]]
−
|PCAN-R2
+
|NA
−
|prostate cancer associated transcript 7 (non-protein coding)
+
|NA
−
|Prostate Cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PRNCR1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050859 HSALNT0050859]
−
|[[NONHSAT129019]]
+
|[[LINC00852]]
−
|N/A
+
|C3orf42,GHRLOS2,NAG73,GHRL-AS2
−
|prostate cancer associated non-coding RNA 1
+
|NA
−
|Prostate Cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PTCSC2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0069395 HSALNT0069395]
−
|[[ENST00000430058.1]]
+
|[[LINC01096]]
−
|N/A
+
|NA
−
|papillary thyroid carcinoma susceptibility candidate 2 (non-protein coding)
+
|NA
−
|papillary thyroid carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PTCSC3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072367 HSALNT0072367]
−
|[[ENST00000556013.2]]
+
|[[LINC02260]]
−
|N/A
+
|NA
−
|papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding)
+
|NA
−
|psoriasis
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PVT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0077259 HSALNT0077259]
−
|[[ENST00000513868.2]]
+
|[[LINC01091]]
−
|"NCRNA00079, LINC00079, onco-lncRNA-100"
+
|NA
−
|Pvt1 oncogene (non-protein coding)
+
|NA
−
|breast cancer, Burkitt's lymphomas, diabetic nephropathy, Hodgkin's lymphoma, lymphoma, murine plasmacytomas, ovarian cancer, pancreas cancer, prostate cancer,renal cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PWRN1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096480 HSALNT0096480]
−
|[[NONHSAT040920]]
+
|[[SAP30L-AS1]]
−
|NCRNA00198
+
|FLJ38109,GALNT10-AS1
−
|Prader-Willi region non-protein coding RNA 1
+
|NA
−
|Prader-Willi syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PWRN2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0098558 HSALNT0098558]
−
|[[NONHSAT040875]]
+
|[[PRR7-AS1]]
−
|NCRNA00199
+
|NA
−
|Prader-Willi region non-protein coding RNA 2
+
|NA
−
|Prader-Willi syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''RASSF1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0099356 HSALNT0099356]
−
|[[RASSF1-AS1]]
+
|[[LINC01622]]
−
|RASSF1 antisense RNA 1
+
|TCONS_00011202
−
|ANRASSF1
+
|NA
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SCAANT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0113415 HSALNT0113415]
−
|[[SCAANT1]]
+
|[[LINC01312]]
−
|SCA7/ATXN7 antisense RNA 1
+
|MGC34034
−
|ATXN7-AS1
+
|NA
−
|Spinocerebellar ataxia type 7
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SCHLAP1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134652 HSALNT0134652]
−
|[[NONHSAT075852]]
+
|[[EXTL3-AS1]]
−
|SWI/SNF complex antagonist associated with prostate cancer 1 (non-protein coding)
+
|C8orf50
−
|"SChLAP1,PCAT11"
+
|NA
−
|prostate cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SENCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138253 HSALNT0138253]
−
|[[ENST00000526269.2]]
+
|[[C8orf34-AS1]]
−
|smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA
+
|NA
−
|N/A
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TARID''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154876 HSALNT0154876]
−
|[[ENST00000607033.1]]
+
|[[PSMD5-AS1]]
−
|N/A
+
|NA
−
|TCF21 antisense RNA inducing promoter demethylation
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''WFDC21P''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0163228 HSALNT0163228]
−
|[[Lnc-HEATR6-1:4]]
+
|[[LINC01553]]
−
|"WAP four-disulfide core domain 21, pseudogene"
+
|C10orf40,AC023904.2
−
|"LOC645638, lnc-DC, LNCDC"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GAS5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0175689 HSALNT0175689]
−
|[[NONHSAT007663]]
+
|[[LINC00301]]
−
|"SNHG2, ENSG00000234741"
+
|C11orf64,NCRNA00301,MGC39681
−
|_
+
|NA
−
|autoimmune disease, B-cell neoplasms, breast cancer, kidney cancer, lymphoma, prostate cancer, melanoma, systemic lupus erythaematosus
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIAT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247235 HSALNT0247235]
−
|[[lnc-CRYBA4-2:1]]
+
|[[DLGAP1-AS3]]
−
|"FLJ25967, gomafu, LINC00066, lncRNA-MIAT, ""long intergenic non-protein coding RNA 66"", NCRNA00066, ""non-protein coding RNA 66"", Rncr2"
+
|NA
−
|myocardial infarction associated transcript (non-protein coding)
+
|NA
−
|myocardial infarction
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''H19''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0254200 HSALNT0254200]
−
|[[NONHSAT017465]]
+
|[[CIRBP-AS1]]
−
|"Q96MK8,ENSG00000130600"
+
|C19orf23,MGC39338
−
|"H19, imprinted maternally expressed transcript (non-protein coding)"
+
|NA
−
|bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HAR1A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0257335 HSALNT0257335]
−
|[[lnc-BIRC7-2:1]]
+
|[[LINC01785]]
−
|"HAR1F, ENSG00000238820"
+
|NA
−
|highly accelerated region 1A
+
|NA
−
|Alzheimer's disease,Huntington's disease, schizophrenia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HAR1B''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0261582 HSALNT0261582]
−
|[[ENST00000447910.2]]
+
|[[LINC01869]]
−
|"HAR1R, ENSG00000231133"
+
|MGC45922
−
|highly accelerated region 1B
+
|NA
−
|Huntington's disease, schizophrenia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOTAIR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0269743 HSALNT0269743]
−
|[[NONHSAT028508]]
+
|[[LINC01711]]
−
|"Gm16258, Hox antisense intergenic RNA, ENSG00000228630"
+
|MGC4294
−
|Hox antisense intergenic RNA
+
|NA
−
|B-cell neoplasms,breast cancer,cervical cancer,colon cancer,colorectal cancer,endometrial cancer,gastric cancer,hepatocelluar carcinoma,laryngeal squamous cell carcinoma,liver cancer,lung adenocarcinoma,nasopharyngeal carcinoma,non-small cell lung cancer,oesophageal squamous cell carcinoma,oral squamous cell carcinoma,pancreas cancer,rheumatoid arthritis,small cell lung cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOTAIRM1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288468 HSALNT0288468]
−
|[[lnc-EVX1-12:1]]
+
|[[FAM41AY1]]
−
|"HIT06113, HIT92376, linc1548, ENSG00000233429"
+
|FAM41AY
−
|"HOXA transcript antisense RNA, myeloid-specific 1"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOTTIP''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288899 HSALNT0288899]
−
|[[NONHSAT119717]]
+
|[[C5orf66-AS2]]
−
|"HOXA13as, HIT18844, NCRNA00213, ENSG00000243766"
+
|NA
−
|HOXA transcript at the distal tip
+
|NA
−
|hepatocelluar carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOXA11-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288922 HSALNT0288922]
−
|[[NONHSAT119704]]
+
|[[CSTF3-AS1]]
−
|"HOXA cluster antisense RNA 5 (non-protein coding), HOXA-AS5, ""HOXA11 antisense RNA 1 (non-protein coding)"", HOXA11-AS1, HOXA11S, NCRNA00076, ""non-protein coding RNA 76"", ENSG00000240990"
+
|CSTF3-DT
−
|HOXA11 antisense RNA
+
|NA
−
|glioma, ovarian cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOXA-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288923 HSALNT0288923]
−
|[[NONHSAT119676]]
+
|[[CYP1B1-AS1]]
−
|"HOXA3as, ENSG00000253552"
+
|C2orf58,MGC34824
−
|HOXA cluster antisense RNA 2
+
|NA
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOXA-AS3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288957 HSALNT0288957]
−
|[[lnc-EVX1-9:1]]
+
|[[ENTPD3-AS1]]
−
|HOXA6as
+
|FLJ36665
−
|HOXA cluster antisense RNA 3
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HULC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288970 HSALNT0288970]
−
|[[NONHSAT107640]]
+
|[[FAM27E3]]
−
|ENSG00000251164
+
|MGC42630
−
|hepatocellular carcinoma up-regulated long non-coding RNA
+
|NA
−
|hepatocelluar carcinoma, liver cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''IPW''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288972 HSALNT0288972]
−
|[[NONHSAT041063]]
+
|[[FAM41C]]
−
|NCRNA00002
+
|NA
−
|imprinted in Prader-Willi syndrome
+
|NA
−
|Prader-Willi syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''JPX''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288977 HSALNT0288977]
−
|[[lnc-ZCCHC13-1:1]]
+
|[[FLG-AS1]]
−
|"DCBALD06, ENOX, ""expressed neighbor of XIST"", ""just proximal to XIST"", LINC00183"
+
|NA
−
|"JPX transcript, XIST activator (non-protein coding)"
+
|NA
−
|X chromosome inactivatio
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''KCNQ1OT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288983 HSALNT0288983]
−
|[[NONHSAT017524]]
+
|[[GABPB1-IT1]]
−
|"KCNQ1 antisense RNA 2 (non-protein coding), ""KCNQ1 overlapping transcript 1 (non-protein coding)"", KCNQ1-AS2, KvDMR1, KvLQT1-AS, LIT1, NCRNA00012, ""non-protein coding RNA 12"""
+
|FLJ10038
−
|KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)
+
|NA
−
|Beckwith-Wiedemann syndrome,colorectal cancer,hepatocelluar carcinoma,kidney cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''KRASP1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289010 HSALNT0289010]
−
|[[NONHSAT113225]]
+
|[[ILF3-AS1]]
−
|ENSG00000220635
+
|ILF3-DT
−
|KRAS Pseudogene 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''FALEC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289034 HSALNT0289034]
−
|[[ENST00000416894.1]]
+
|[[LINC00347]]
−
|"LINC00568, ""long intergenic non-protein coding RNA 568"", ENSG00000228126.1"
+
|NA
−
|focally amplified long non-coding RNA in epithelial cancer
+
|NA
−
|ovarian cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''lincRNA-ROR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289039 HSALNT0289039]
−
|[[NONHSAT059436]]
+
|[[LINC00466]]
−
|"ROR, lincRNA-ST8SIA3, ENSG00000258609"
+
|NA
−
|"long intergenic non-protein coding RNA, regulator of reprogramming"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LOC100887755''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289040 HSALNT0289040]
−
|[[lnc-SNAI1-1:1]]
+
|[[LINC00471]]
−
|"Noncoding RNA activating7: ncRNA-a7, ENST00000431460.1,ENSG00000231265,TRERNA1"
+
|C2orf52,MGC43122
−
|translation regulatory long non-coding RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TUSC7''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289044 HSALNT0289044]
−
|[[NONHSAT091315]]
+
|[[LINC00526]]
−
|"LINC00902, LOC285194, ENSG00000243197"
+
|C18orf18,MGC17515,HsT959
−
|tumor suppressor candidate 7 (non-protein coding)
+
|NA
−
|colorectal cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''RBM5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289048 HSALNT0289048]
−
|[[NONHSAT089783]]
+
|[[LINC00593]]
−
|"LUCA-15-specific transcript, LUST, ENSG00000003756"
+
|C15orf50,MGC42951
−
|RBM5 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MALAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289050 HSALNT0289050]
−
|[[ENST00000534336.1]]
+
|[[LINC00608]]
−
|"HCN, ""hepcarcin"", LINC00047, ""long intergenic non-protein coding RNA 47"", MALAT-1, mascRNA, ""metastasis associated in lung adenocarcinoma transcript 1"", NCRNA00047, NEAT2, ""non-protein coding RNA 47"", ""nuclear enriched abundant transcript 2"", ""nuclear paraspeckle assembly transcript 2 (non-protein coding)"", PRO1073, ENSG00000251562"
+
|NA
−
|metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)
+
|NA
−
|B-cell neoplasms,bladder cancer,breast cancer, cervial cancer, colon cancer, decreased myogenesis,Diabetes, endometrial cancer, gallbladder cancer, hepatocelluar carcinoma, kidney cancer, laryngeal squamous cell carcinoma, liver cancer, lung cancer, nasopharyngeal carcinoma, neuroblastoma, non-small cell lung cancer, osteosarcoma, pancreas cancer, prostate cancer, small cell lung cancer, uterus cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''mascRNA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289054 HSALNT0289054]
−
|[[lnc-SCYL1-1:5]]
+
|[[LINC00638]]
−
|Malat1
+
|MGC23270
−
|mascRNA (MALAT1-associated small cytoplasmic RNA)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MEG3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289056 HSALNT0289056]
−
|[[NONHSAT039745]]
+
|[[LINC00661]]
−
|"Gtl2, ENSG00000214548"
+
|NA
−
|maternally expressed 3 (non-protein coding)
+
|NA
−
|bladder cancer, breast cancer, chronic myeloid leukemia, colon cancer, gastric cancer, glioma, hepatocelluar carcinoma, heroin abuse, Huntington's disease, kidney cancer, lung cancer, Meningioma, myelodysplastic syndrome, nonfunctioning pituitary adenomas, Pituitary adenoma, prostate cancer, type 1 diabetes
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ncR-PAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289057 HSALNT0289057]
−
|[[NONHSAT102247]]
+
|[[LINC00662]]
−
|"NCRUPAR, ENSG00000225407"
+
|NA
−
|"non-protein coding RNA, upstream of F2R/PAR1"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NDM29''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289062 HSALNT0289062]
−
|[[lnc-C11orf16-1:1]]
+
|[[LINC00692]]
−
|29A
+
|NA
−
|"neuroblastoma differentiation marker 29 (Castelnuovo (2010), Pagano (2007))."
+
|NA
−
|neuroblastoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GNAS-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289064 HSALNT0289064]
−
|[[lnc-CTSZ-5:1]]
+
|[[LINC00705]]
−
|"GNAS antisense, GNAS1AS, NCRNA00075, NESP-AS, NESPAS, ""non-protein coding RNA 75"", SANG, ENSG00000235590"
+
|NA
−
|neuroendocrine secretory protein (Nesp) antisense.
+
|NA
−
|pseudohypoparathyroidism type Ib
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NRON''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289067 HSALNT0289067]
−
|[[NONHSAT134764]]
+
|[[LINC00868]]
−
|ENSG00000253079
+
|C17orf52
−
|"non-protein coding RNA, repressor of NFAT"
+
|NA
−
|AIDS
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NTT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0130693 HSALNT0130693]
−
|[[NONHSAT115106]]
+
|[[LINC00996]]
−
|N/A
+
|NA
−
|noncoding transcript in T cells.
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''OTX2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289101 HSALNT0289101]
−
|[[lnc-C14orf101-5:1]]
+
|[[LINC01252]]
−
|"OTX2OS1, ENSG00000248550"
+
|NA
−
|OTX2 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PANDAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289131 HSALNT0289131]
−
|[[lnc-CDKN1A-1:1]]
+
|[[LINC02135]]
−
|"P21 associated ncRNA DNA damage activated, PANDA antisense RNA, ENSG00000213500, PANDAR"
+
|NA
−
|promoter of CDKN1A antisense DNA damage activated RNA
+
|NA
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PCGEM1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289193 HSALNT0289193]
−
|[[NONHSAT076153]]
+
|[[NIFK-AS1]]
−
|ENSG00000227418; PCAT9; LINC00071; NCRNA00071 lncRNA
+
|NA
−
|Prostate-specific transcript 1
+
|NA
−
|prostate cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00853''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289244 HSALNT0289244]
−
|[[ENST00000429328.2]]
+
|[[SMG7-AS1]]
−
|"PDZK1IP1 antisense RNA 1 (non-protein coding), ""PDZK1IP1 antisense RNA 1 (tail to tail)"", PDZK1IP1-AS1 ,ENSG00000224805"
+
|DKFZP564C196
−
|long intergenic non-protein coding RNA 853
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PRINS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235326 HSALNT0235326]
−
|[[NONHSAT011777]]
+
|[[SNAI3-AS1]]
−
|ENSG00000238115
+
|MGC23284
−
|Psoriasis susceptibility-related RNA Gene Induced by Stress
+
|NA
−
|psoriasis
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PTENP1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0215205 HSALNT0215205]
−
|[[NONHSAT130775]]
+
|[[SNHG10]]
−
|"PTENpg1, PTEN2, ENSG00000237984"
+
|C14orf62,FLJ40557,NCRNA00063,LINC00063
−
|PTEN Pseudogene 1
+
|NA
−
|prostate cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MEG8''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289290 HSALNT0289290]
−
|[[ENST00000553584.1]]
+
|[[ZNF205-AS1]]
−
|"Bsr, ""Imprinted RNA near Meg3/Gtl2"", Irm, LINC00024, ""long intergenic non-protein coding RNA 24"", NCRNA00024, ""non-protein coding RNA 24"", Rian, ""RNA Imprinted and Accumulated in Nucleus"", ENSG00000258399"
+
|MGC3771
−
|Rian: RNA Imprinted and Accumulated in Nucleus;Irm: Imprinted RNA near Meg3/Gtl2;MEG8: Maternally expressed gene 8
+
|NA
−
|Prader-Willi/Angelman syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00599''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289294 HSALNT0289294]
−
|[[lnc-TNKS-1:1]]
+
|[[LINC00260]]
−
|"retinal non-coding RNA 3, Rncr3, ENSG00000253230"
+
|C1orf217,NCRNA00260,MGC5457
−
|"Retinal noncoding RNA 3, long intergenic non-protein coding RNA 599"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''FAS-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289295 HSALNT0289295]
−
|[[NONHSAT015489]]
+
|[[LINC00337]]
−
|"SAF, ENSG00000026103"
+
|C1orf211,NCRNA00337,MGC40168
−
|FAS antisense RNA 1
+
|NA
−
|B-cell lymphoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ATXN8OS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289298 HSALNT0289298]
−
|[[NONHSAT034251]]
+
|[[WAC-AS1]]
−
|"NCRNA00003, ""non-protein coding RNA 3"", ATXN8OS, KLHL1AS, SCA8, ENSG00000230223"
+
|NA
−
|Spinocerebellar ataxia 8 (SCA8) RNA;KLHL1AS: kelch-like 1 (Drosophila) antisense;ATXN8OS: ataxin 8 opposite strand
+
|NA
−
|human spinocerebellar ataxia type 8,Spinocerebellar ataxia type 8
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SNHG1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289299 HSALNT0289299]
−
|[[NONHSAT021826]]
+
|[[LINC00839]]
−
|"UHG, ENSG00000255717"
+
|NA
−
|SNHG1:Small nucleolar RNA host gene 1;UHG: U22 host gene.
+
|NA
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SNHG3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289303 HSALNT0289303]
−
|[[lnc-OR10H5-1:1]]
+
|[[LINC00612]]
−
|"U17HG, linc1343, ENSG00000242125"
+
|C12orf33,MGC40170,FLJ41814
−
|Small nucleolar RNA host gene 3
+
|NA
−
|Alzheimer's disease
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SNHG4''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289312 HSALNT0289312]
−
|[[NONHSAT104072]]
+
|[[LINC00663]]
−
|"U19H, ENSG00000200959"
+
|MGC39821
−
|Small nucleolar RNA host gene 4
+
|NA
−
|myelodysplastic syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SNHG5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289320 HSALNT0289320]
−
|[[NONHSAT054526]]
+
|[[LINC00494]]
−
|"U50HG, ENSG00000203875"
+
|NA
−
|Small nucleolar RNA host gene 5
+
|NA
−
|lymphoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SNHG6''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289330 HSALNT0289330]
−
|[[lnc-TCF24-2:3]]
+
|[[LINC01019]]
−
|"U87HG, ENSG00000245910"
+
|NA
−
|Small nucleolar RNA host gene 6
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SPRY4-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289333 HSALNT0289333]
−
|[[lnc-NDFIP1-3:1]]
+
|[[LINC00265]]
−
|"AK024556, ENSG00000274721"
+
|NCRNA00265,NCRNA00265-1
−
|SPRY4 intronic transcript 1 (non-protein coding)
+
|NA
−
|melanoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SRA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289334 HSALNT0289334]
−
|[[lnc-SRA1-1:1]]
+
|[[LINC00689]]
−
|"SRA1, ENSG00000213523"
+
|NA
−
|Steroid receptor RNA Activator
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TEA-ncRNAs''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289337 HSALNT0289337]
−
|[[NONHSAT035776]]
+
|[[LINC01591]]
−
|ENSG00000251002
+
|NA
−
|T early alpha
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''IFNG-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289340 HSALNT0289340]
−
|[[ENST00000538665.1]]
+
|[[LINC01501]]
−
|"LincR-Ifng-3'AS, NEST, "Theiler's murine encephalomyelitis virus persistence candidate gene 1", Tmevpg1, ENSG00000255733"
+
|NA
−
|IFNG antisense RNA 1
+
|NA
−
|multiple sclerosis
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TncRNA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289346 HSALNT0289346]
−
|[[NONHSAT022116]]
+
|[[LINC01560]]
−
|TSU
+
|CXorf24
−
|TncRNA: trophoblast noncoding RNA; TSU: trophoblast STAT utron (untranslated region of an mRNA).
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TUG1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289352 HSALNT0289352]
−
|[[NONHSAT084827]]
+
|[[LINC01959]]
−
|ENSG00000253352
+
|NA
−
|taurine up-regulated gene 1
+
|NA
−
|B-cell neoplasms, bladder cancer, Huntington's disease, non-small cell lung cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''UCA1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289353 HSALNT0289353]
−
|[[lnc-OR10H5-1:1]]
+
|[[LINC02175]]
−
|"UCA1a, CUDR, UCAT1, LINC00178, NCRNA00178, GCAP2, GUCA1B, GUCA2, RP48, ENSG00000214049"
+
|NA
−
|urothelial cancer associated 1 (non-protein coding)
+
|NA
−
|bladder cancer, oral squamous cell carcinoma, pancreaticobiliary maljunction, squamous carcinoma,  tongue squamous cell carcinomas
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''KCNIP4-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289354 HSALNT0289354]
−
|[[NONHSAT095745]]
+
|[[LINC02209]]
−
|"non coding transcript UM9(5), UM9-5"
+
|FAM183CP
−
|KCNIP4 intronic transcript 1 (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''WT1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289359 HSALNT0289359]
−
|[[lnc-EIF3M-1:1]]
+
|[[LINGO1-AS1]]
−
|"WIT1, ENSG00000183242"
+
|NA
−
|WT1 (Wilms' tumor 1) antisense transcript
+
|NA
−
|gastric cancer, hepatocellular carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''XIST''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289362 HSALNT0289362]
−
|[[NONHSAT137541]]
+
|[[MAFG-AS1]]
−
|ENSG00000229807
+
|MAFG-DT
−
|X inactive-specific transcript
+
|NA
−
|Trisomy 21, bladder cancer, breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ZEB2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289373 HSALNT0289373]
−
|[[NONHSAT074775]]
+
|[[MORF4L2-AS1]]
−
|"Zeb2NAT, ENSG00000238057"
+
|NA
−
|Zeb2 natural antisense transcript
+
|NA
−
|bladder cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ZFAS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289381 HSALNT0289381]
−
|[[NONHSAT080206]]
+
|[[NPHP3-AS1]]
−
|"Znfx1 antisense, 1500012F01Rik, NCRNA00275, ENSG00000177410"
+
|NCRNA00119
−
|ZNFX1 antisense RNA 1
+
|NA
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''Zfhx2as''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289385 HSALNT0289385]
−
|[[ENST00000554403.1]]
+
|[[PAXIP1-AS1]]
−
|"Zfh-5AS, ENSG00000157306"
+
|NA
−
|"zinc finger homeobox 2, antisense"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TMEM161B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289413 HSALNT0289413]
−
|[[lnc-RASA1-3:23]],
+
|[[TOLLIP-AS1]]
−
[[lnc-RASA1-3:25]]
+
|NA
−
|"AK082072,linc-POLR3G-8, ENSG00000247828"
+
|NA
−
|TMEM161B antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 
|-
 
|-
−
|''Alpha 250/ Alpha 280''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289416 HSALNT0289416]
−
|[[NONHSAT104559]],
+
|[[LINC00311]]
−
[[lnc-NDST1-1:2]]
+
|TMEM148,NCRNA00311,MGC22001
−
|N/A
+
|NA
−
|N/A
+
|NA
−
|_
+
|NA
 +
|NA
 
|-
 
|-
−
|''CDKN2B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289422 HSALNT0289422]
−
|[[NONHSAT130421]],
+
|[[ZNF252P-AS1]]
−
[[lnc-C9orf53-2:1]]
+
|C8orf77
−
|"ANRIL, p15AS, ENSG00000240498"
+
|NA
−
|CDKN2B antisense RNA 1
+
|NA
−
|abdominal aortic aneurysm,acute lymphoblastic leukemia,basal cell carcinoma,breast cancer,cardiovascular disease,coronary artery disease,coronary heart disease,Diabetes,endometriosis,Esophageal squamous cell cancer,gastric cancer,glioma,hereditary cutaneous malignant melanoma,intracranial aneurism,ischemic stroke,melanoma,myocardial infarction,nasopharyngeal carcinoma,neural system tumors syndrome,Neurofibromatosis type 1,periodontitis,prostate cancer,
+
|NA
 +
|NA
 
|-
 
|-
−
|''BACE1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289423 HSALNT0289423]
−
|[[NONHSAT024403]],[[lnc-RNF214-1:2]]
+
|[[ZNF436-AS1]]
−
|"BACE1AS,NCRNA00177; FJ573250"
+
|C1orf213,FLJ90508
−
|BACE1 antisense RNA
+
|NA
−
|Alzheimer's disease,
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''Beta-globin transcripts''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289429 HSALNT0289429]
−
|[[NONHSAT017676]],
+
|[[BFSP2-AS1]]
−
[[NONHSAT017675]],
+
|MGC2848
−
[[NONHSAT017674]]
+
|NA
−
|N/A
+
|NA
−
|N/A
+
|NA
−
|_
+
|NA
 
|-
 
|-
−
|''LINC00581''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289432 HSALNT0289432]
−
|[[lnc-PRL-6:2]],
+
|[[CTBP1-DT]]
−
[[lnc-PRL-6:1]]
+
|C4orf42,CTBP1-AS1,CTBP1-DT,MGC21675
−
|"BX118339,Hs.112750, linc-MBOAT1-4: TCONS_00012107, linc-MBOAT1-4: TCONS_00012678"
+
|NA
−
|long intergenic non-protein coding RNA 581
+
|NA
−
|West Syndrome
+
|NA
 +
|NA
 
|-
 
|-
−
|''CAR Intergenic 10''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289436 HSALNT0289436]
−
|[[NONHSAT016928]],
+
|[[EXOC3-AS1]]
−
[[lnc-FANK1-3:1]]
+
|C5orf55
−
|"Intergenic10, CR611911, AK055628"
+
|NA
−
|Chromatin Associated RNA 10
+
|NA
−
|_
+
|NA
 +
|NA
 
|-
 
|-
−
|''DIO3OS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289441 HSALNT0289441]
−
|[[NONHSAT040032]],
+
|[[HCG27]]
−
[[NONHSAT040039]]
+
|bPG299F13.9,bCX101P6.9,bQB115I13.2,FLJ40123
−
|"DIO3-AS1, NCRNA00041, ""non-protein coding RNA 41"", ENSG00000258498"
+
|NA
−
|DIO3 opposite strand/antisense RNA (head to head)
+
|NA
−
|_
+
|NA
 +
|NA
 
|-
 
|-
−
|''PCAT6''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289450 HSALNT0289450]
−
|[[PCAT6]]
+
|[[BAALC-AS2]]
−
|"Noncoding RNA activating2: ncRNA-a2, KDM5B antisense RNA 1 (KDM5B-AS1),, ENSG00000228288"
+
|C8orf56,BAALCOS,MGC39526
−
|N/A
+
|NA
−
|prostate cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00570''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289453 HSALNT0289453]
−
|[[ENST00000417473.2]]
+
|[[FAM87A]]
−
|"KDM5BAS1, ncRNA-a2, onco-lncRNA-96, PCAN-R1, ""prostate cancer-associated noncoding RNA 1"",ENSG00000224177,"
+
|NA
−
|prostate cancer associated transcript 6 (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NEAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289459 HSALNT0289459]
−
|[[ENST00000501122.2]],
+
|[[JMJD1C-AS1]]
−
[[NONHSAT022111]]
+
|NA
−
|"MEN epsilon/beta, VINC, TncRNA, linc1317, ENSG00000245532"
+
|NA
−
|Nuclear enriched abundant transcript 1.
+
|NA
−
|infertility
+
|NA
 +
|NA
 
|-
 
|-
−
|''ST7OT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289465 HSALNT0289465]
−
|[[NONHSAT122926]],
+
|[[ATP2B1-AS1]]
−
[[NONHSAT122918]],
+
|LINC00936
−
[[NONHSAT122914]],
+
|NA
−
[[NONHSAT122932]]
+
|NA
−
|"ST7OT1, ST7OT2, ST7OT3, ST7OT4, ST7AS1, ST7AS2, ST7AS3, ST7AS4, ENSG00000214188"
+
|NA
−
|N/A
+
|NA
−
|_
 
 
|-
 
|-
−
|''snaR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289466 HSALNT0289466]
−
|[[lnc-BSPH1-1:1]],[[lnc-BSPH1-2:1]]
+
|[[CEP83-AS1]]
−
|small NF90-associated RNAs
+
|CEP83-DT
−
|small NF90-associated RNAs
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''Y RNAs''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289470 HSALNT0289470]
−
|[[lnc-PDIA4-1:1]]
+
|[[HEXA-AS1]]
−
|N/A
+
|C15orf34,FLJ13315
−
|N/A
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PR antisense transcripts''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289487 HSALNT0289487]
−
|[[NONHSAT023851]]
+
|[[BIN3-IT1]]
−
|N/A
+
|FLJ14107
−
|N/A
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289490 HSALNT0289490]
 +
|[[CSNK1G2-AS1]]
 +
|C19orf34,MGC39696
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289508 HSALNT0289508]
 +
|[[LINC00634]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''FAM3D-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289510 HSALNT0289510]
−
|[[FAM3D-AS1]]
+
|[[LINC00685]]
−
|lnc-KCTD6-3
+
|CXYorf10,NCRNA00107,PPP2R3B-AS1,OTTHUMT00000055574
−
|FAM3D antisense RNA 1
+
|NA
−
|head and neck squamous cell carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SHANK2-AS3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289515 HSALNT0289515]
 
|[[SHANK2-AS3]]
 
|[[SHANK2-AS3]]
−
|N/A
+
|C11orf76
−
|SHANK2 antisense RNA 3
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''AATBC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290073 HSALNT0290073]
−
|[[AATBC]]
+
|[[NCBP2-AS2]]
−
|N/A
+
|NA
−
|apoptosis associated transcript in bladder cancer
+
|NA
−
|bladder cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ABHD11-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289502 HSALNT0289502]
−
|[[ABHD11-AS1]]
+
|[[NONHSAT095745]]
−
|NCRNA00035
+
|NCRNA00099,UM9-5
−
|ABHD11 antisense RNA 1 (tail to tail)
+
|NA
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ABHD15-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289856 HSALNT0289856]
−
|[[ABHD15-AS1]]
+
|[[GTSCR1]]
−
|"linc-TP53I13, lnc-TP53I13"
+
|NA
−
|ABHD15 antisense RNA 1
+
|NA
−
|cardiometabolic diseases
+
|pathogenic process
 +
|Gilles de la Tourette syndrome
 +
|Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''ACTA2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289325 HSALNT0289325]
−
|[[ACTA2-AS1]]
+
|[[LINC00272]]
−
|"uc001kfo.1, ZXF1"
+
|C1orf120,NCRNA00272,RP1-223H12.3
−
|ACTA2 antisense RNA 1
+
|NA
−
|lung adenocarcinoma
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''ADAMTS9-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288512 HSALNT0288512]
−
|[[ADAMTS9-AS2]]
+
|[[TTTY9B]]
−
|N/A
+
|NCRNA00132
−
|ADAMTS9 antisense RNA 2
+
|NA
−
|glioma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ADORA2A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290155 HSALNT0290155]
−
|[[ADORA2A-AS1]]
+
|[[Prion-associated RNAs]]
−
|FLJ34651
+
|NA
−
|ADORA2A antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|prion disease
 +
|Nervous System Diseases
 
|-
 
|-
−
|''AFAP1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289444 HSALNT0289444]
−
|[[AFAP1-AS1]]
+
|[[BLACE]]
−
|MGC10981
+
|NA
−
|AFAP1 antisense RNA 1
+
|NA
−
|Barrett's esophagus and esophageal adenocarcinoma
+
|pathogenic process
 +
|acute B lymphoblastic leukemias
 +
|Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''AGAP2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060411 HSALNT0060411]
−
|[[AGAP2-AS1]]
+
|[[H1FX-AS1]]
−
|"LOC100130776, PUNISHER"
+
|C3orf47,FLJ34151
−
|AGAP2 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''Alpha 250/Alpha 280''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0186668 HSALNT0186668]
−
|[[NONHSAT104559]],[[lnc-NDST1-1:2]]
+
|[[LINC00477]]
−
|N/A
+
|C12orf67,FLJ32894,FAM191B
−
|N/A
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ANP32A-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275096 HSALNT0275096]
−
|[[ANP32A-IT1]]
+
|[[LINC00528]]
−
|"FLJ11722, HsT18971"
+
|C22orf37,FLJ40542
−
|ANP32A intronic transcript 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ARRDC1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287824 HSALNT0287824]
−
|[[ARRDC1-AS1]]
+
|[[ASMTL-AS1]]
−
|N/A
+
|CXYorf2,NCRNA00105,ASMTLAS,ASMTL-AS,FLJ13330
−
|ARRDC1 antisense RNA 1
+
|NA
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ASAP1-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288887 HSALNT0288887]
−
|[[ASAP1-IT1]]
+
|[[ANP32A-IT1]]
−
|"HSPC054, NCRNA00050, ASAP1IT, ASAP1-IT"
+
|C15orf28,NCRNA00321,FLJ11722,HsT18971
−
|ASAP1 intronic transcript 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ASMTL-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289396 HSALNT0289396]
−
|[[ASMTL-AS1]]
+
|[[RUSC1-AS1]]
−
|FLJ13330
+
|C1orf104,FLJ35976
−
|ASMTL antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ATP1A1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084628 HSALNT0084628]
−
|[[ATP1A1-AS1]]
+
|[[LINC01194]]
−
|MGC16179
+
|CT49,TAG
−
|ATP1A1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|melanoma
 +
|Neoplasms
 
|-
 
|-
−
|''B3GALT5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289468 HSALNT0289468]
−
|[[B3GALT5-AS1]]
+
|[[NONHSAT040032]]
−
|N/A
+
|C14orf134,NCRNA00041,DIO3-AS1,NONHSAT040032,NONHSAT040039,BC111049
−
|B3GALT5 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''B4GALT1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0121060 HSALNT0121060]
−
|[[B4GALT1-AS1]]
+
|[[NPSR1-AS1]]
−
|N/A
+
|AAA1,IMAGE:4827585
−
|B4GALT1 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BAALC-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0074370 HSALNT0074370]
−
|[[BAALC-AS2]]
+
|[[LINC00575]]
−
|MGC39526
+
|C4orf11
−
|BAALC antisense RNA 2
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BCAR4''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137345 HSALNT0137345]
−
|[[BCAR4]]
+
|[[LINC01602]]
−
|N/A
+
|T1560
−
|breast cancer anti-estrogen resistance 4 (non-protein coding)
+
|NA
−
|breast cancer
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BFSP2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289433 HSALNT0289433]
−
|[[BFSP2-AS1]]
+
|[[FAM13A-AS1]]
−
|MGC2848
+
|FAM13A1OS,FAM13AOS,NCRNA00039
−
|BFSP2 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BGLT3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289186 HSALNT0289186]
−
|[[BGLT3]]
+
|[[MIRLET7DHG]]
−
|"LINC01083, BGL3, lncRNA-BGL3"
+
|NA
−
|beta globin locus transcript 3 (non-protein coding)
+
|NA
−
|Bcr-Abl-positive leukemia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BIN3-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0155254 HSALNT0155254]
−
|[[BIN3-IT1]]
+
|[[MIR181A2HG]]
−
|FLJ14107
+
|NA
−
|BIN3 intronic transcript 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BIRC6-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289283 HSALNT0289283]
−
|[[BIRC6-AS1]]
+
|[[WDFY3-AS2]]
−
|N/A
+
|C4orf12,NCRNA00247,FBI4
−
|BIRC6 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BIRC6-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154555 HSALNT0154555]
−
|[[BIRC6-AS2]]
+
|[[PAPPA-AS1]]
−
|megamind
+
|PAPPAS,PAPPA-AS,DIPAS,TAF4B,TAF2C2,TAFII105,NCRNA00156
−
|BIRC6 antisense RNA 2
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0136307 HSALNT0136307]
 +
|[[LINC00293]]
 +
|BEYLA
 +
|NA
 +
|developmental process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030983 HSALNT0030983]
 +
|[[SIX3-AS1]]
 +
|SIX3OS
 +
|NA
 +
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BISPR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211503 HSALNT0211503]
−
|[[BISPR]]
+
|[[Lnc-C14orf101-5:1]]
−
|N/A
+
|OTX2OS1
−
|BST2 interferon stimulated positive regulator (non-protein coding)
+
|NA
−
|_
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BOK-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0063422 HSALNT0063422]
−
|[[BOK-AS1]]
+
|[[LINC01192]]
−
|"NCRNA00151, NAToB"
+
|CT64
−
|BOK antisense RNA 1
+
|NA
−
|testicular cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BRWD1-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217123 HSALNT0217123]
−
|[[BRWD1-AS2]]
+
|[[LINC01193]]
−
|N/A
+
|CT60,LOC348120
−
|BRWD1 antisense RNA 2
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''C1QTNF9B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289664 HSALNT0289664]
 
|[[C1QTNF9B-AS1]]
 
|[[C1QTNF9B-AS1]]
 
|PCOTH
 
|PCOTH
−
|C1QTNF9B antisense RNA 1
+
|NA
 +
|pathogenic process
 
|prostate cancer
 
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''C21orf91-OT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289623 HSALNT0289623]
−
|[[C21orf91-OT1]]
+
|[[ATP6V1G2-DDX39B]]
−
|D21S2089E
+
|NA
−
|C21orf91 overlapping transcript 1
+
|NA
−
|_
+
|pathogenic process
 +
|dilated cardiomyopathy
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''C5orf66-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289498 HSALNT0289498]
−
|[[C5orf66-AS1]]
+
|[[FAM226B]]
−
|"CTC-276P9.1, Epist"
+
|CXorf50B,NCRNA00246B,LINC00246B
−
|C5orf66 antisense RNA 1
+
|NA
−
|esophageal squamous cell carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''C5orf66-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289321 HSALNT0289321]
−
|[[C5orf66-AS2]]
+
|[[LINC00163]]
−
|N/A
+
|C21orf134,NCRNA00163,NLC1-A,NLC1A
−
|C5orf66 antisense RNA 2
+
|NA
−
|_
+
|pathogenic process
 +
|narcolepsy
 +
|Mental Disorders;Nervous System Diseases
 
|-
 
|-
−
|''C8orf34-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289505 HSALNT0289505]
−
|[[C8orf34-AS1]]
+
|[[LINC00165]]
−
|N/A
+
|C21orf135,NCRNA00165,NLC1-B
−
|C8orf34 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CACNA1G-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290297 HSALNT0290297]
−
|[[CACNA1G-AS1]]
+
|[[NONHSAT035776]]
−
|N/A
+
|ENSG00000251002
−
|CACNA1G antisense RNA 1
+
|NA
−
| keloid
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CAPN10-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274212 HSALNT0274212]
−
|[[CAPN10-AS1]]
+
|[[LINC00322]]
−
|locus959
+
|C21orf136,NCRNA00322,FLJ16545
−
|CAPN10 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CARD8-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289741 HSALNT0289741]
−
|[[CARD8-AS1]]
+
|[[NONHSAT102417]]
−
|LOC100505812
+
|DHFR minor transcript 5'-UTR,ENSG00000228716,NONHSAT102417
−
|CARD8 antisense RNA 1
+
|transcriptional regulation
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CARMN''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289527 HSALNT0289527]
−
|[[CARMN]]
+
|[[NONHSAT128494]]
−
|CARMEN
+
|ncRNA 21A,NONHSAT128494
−
|cardiac mesoderm enhancer-associated non-coding RNA
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289409 HSALNT0289409]
 +
|[[TLX1NB]]
 +
|TD1,TDI,APT-B7
 +
|NA
 +
|pathogenic process
 +
|leukemogenesis
 +
|Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''CASC11''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289662 HSALNT0289662]
−
|[[CASC11]]
+
|[[C15orf2]]
−
|"TCONSN/A00014535, LINC00990, CARLo-7"
+
|NA
−
|cancer susceptibility candidate 11 (non-protein coding)
+
|NA
−
|colorectal cancer
+
|pathogenic process
 +
|Angelman syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''CASC15''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290097 HSALNT0290097]
−
|[[CASC15]]
+
|[[NPAP1]]
−
|N/A
+
|NA
−
|cancer susceptibility candidate 15 (non-protein coding)
+
|NA
−
|metastatic melanoma, neuroblastoma
+
|pathogenic process
 +
|Angelman syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''CASC19''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217406 HSALNT0217406]
−
|[[CASC19]]
+
|[[NONHSAT040875]]
−
|CARLo-6
+
|NCRNA00199
−
|cancer susceptibility candidate 19 (non-protein coding)
+
|NA
−
|prostate cancer
+
|pathogenic process
 +
|Prader-Willi syndrome
 +
|Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''CASC2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289227 HSALNT0289227]
−
|[[CASC2]]
+
|[[NONHSAT040920]]
−
|N/A
+
|NCRNA00198
−
|cancer susceptibility candidate 2 (non-protein coding)
+
|NA
−
|colorectal cancer
+
|pathogenic process
 +
|Prader-Willi syndrome
 +
|Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''CASC21''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262816 HSALNT0262816]
−
|[[CASC21]]
+
|[[MIMT1]]
−
|CARLo-2
+
|MIM1,NCRNA00067,LINC00067
−
|cancer susceptibility candidate 21 (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CASC22''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289180 HSALNT0289180]
−
|[[CASC22]]
+
|[[MIR34AHG]]
−
|"TCONSN/A00024290, LincRNA-ENST00000515084"
+
|NA
−
|cancer susceptibility candidate 22 (non-protein coding)
+
|NA
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CASC9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289357 HSALNT0289357]
−
|[[CASC9]]
+
|[[LINC02570]]
−
|"LINC00981, ESCCAL-1"
+
|XXbac-BPG27H4.8
−
|cancer susceptibility candidate 9 (non-protein coding)
+
|NA
−
|predicted esophageal squamous cell carcinoma
+
|pathogenic process
 +
|MHC-associated diseases
 +
|Immune System Diseases
 
|-
 
|-
−
|''CBR3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290177 HSALNT0290177]
−
|[[CBR3-AS1]]
+
|[[RNY1]]
−
|PlncRNA-1
+
|NA
−
|CBR3 antisense RNA 1
+
|NA
−
|esophageal squamous carcinoma cell
+
|pathogenic process
 +
|cervix cancer;prostate cancer;colorectal cancer;bladder cancer;kidney cancer;lung cancer
 +
|Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
 
|-
 
|-
−
|''CCDC18-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289378 HSALNT0289378]
−
|[[CCDC18-AS1]]
+
|[[NKX2-2-AS1]]
−
|ENST00000440778.1
+
|NKX2-2AS
−
|CCDC18 antisense RNA 1
+
|transcriptional regulation
−
|Adolescent Idiopathic Scoliosis
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CCDC26''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290151 HSALNT0290151]
−
|[[CCDC26]]
+
|[[NONHSAT023851]]
−
|"MGC27434, RAM"
+
|FJ515872.1,NONHSAT023851
−
|CCDC26 long non-coding RNA
+
|transcriptional regulation
−
|glioma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CCEPR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289607 HSALNT0289607]
−
|[[CCEPR]]
+
|[[Anti-NOS2A]]
−
|CCHE1
+
|NA
−
|cervical carcinoma expressed PCNA regulatory lncRNA
+
|NA
−
|cervical cancer
+
|pathogenic process
 +
|meningioma;glioblastoma
 +
|Neoplasms;Nervous System Diseases
 
|-
 
|-
−
|''CDKN1A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289687 HSALNT0289687]
 
|[[CDKN1A-AS1]]
 
|[[CDKN1A-AS1]]
 
|p21NAT
 
|p21NAT
−
|CDKN1A antisense RNA 1
+
|transcriptional regulation
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CDR1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0116668 HSALNT0116668]
−
|[[CDR1-AS]]
+
|[[RPS6KA2-AS1]]
−
|"CDR1NAT, ciRS-7, CDR1as"
+
|NA
−
|CDR1 antisense RNA
+
|NA
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CDRT7''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289384 HSALNT0289384]
−
|[[CDRT7]]
+
|[[PAPPA-AS2]]
−
|"NCRNA00025, LINC00025"
+
|AGU1
−
|CMT1A duplicated region transcript 7 (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CDRT8''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262802 HSALNT0262802]
−
|[[CDRT8]]
+
|[[ZIM2-AS1]]
−
|N/A
+
|ZIM2as
−
|CMT1A duplicated region transcript 8
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CECR3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289824 HSALNT0289824]
−
|[[CECR3]]
+
|[[Lnc-DLX5-3:1]]
−
|N/A
+
|Evf-2,Dlx6as1,Dlx6os1,ENSG00000231764, ENST00000430027.2,lnc-DLX5-3:1
−
|"cat eye syndrome chromosome region, candidate 3 (non-protein coding)"
+
|transcriptional regulation
−
|cat eye syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CECR5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289481 HSALNT0289481]
−
|[[CECR5-AS1]]
+
|[[ADORA2A-AS1]]
−
|NCRNA00017
+
|C22orf45,FLJ34651
−
|CECR5 antisense RNA 1
+
|NA
−
|cat eye syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CECR7''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290146 HSALNT0290146]
−
|[[CECR7]]
+
|[[POU5F1P4]]
−
|SAHL1
+
|NA
−
|"cat eye syndrome chromosome region, candidate 7 (non-protein coding)"
+
|NA
−
|cat eye syndrome
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''CECR9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290033 HSALNT0290033]
−
|[[CECR9]]
+
|[[LSINCT1]]
−
|N/A
+
|NA
−
|"cat eye syndrome chromosome region, candidate 9 (non-protein coding)"
+
|NA
−
|cat eye syndrome
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CEP83-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290034 HSALNT0290034]
−
|[[CEP83-AS1]]
+
|[[LSINCT10]]
−
|N/A
+
|NA
−
|CEP83 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CIRBP-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290035 HSALNT0290035]
−
|[[CIRBP-AS1]]
+
|[[LSINCT11]]
−
|MGC39338
+
|NA
−
|CIRBP antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CLRN1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290036 HSALNT0290036]
−
|[[CLRN1-AS1]]
+
|[[LSINCT12]]
−
|UCRP
+
|NA
−
|CLRN1 antisense RNA 1
+
|NA
−
|Usher syndrome type 3
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''COPG2IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290037 HSALNT0290037]
−
|[[COPG2IT1]]
+
|[[LSINCT2]]
−
|"CIT1, NCRNA00170, COPG2AS"
+
|NA
−
|COPG2 imprinted transcript 1 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CPS1-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290038 HSALNT0290038]
−
|[[CPS1-IT1]]
+
|[[LSINCT3]]
−
|"PRO0132, CPS1-IT"
+
|NA
−
|CPS1 intronic transcript 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CSNK1G2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290039 HSALNT0290039]
−
|[[CSNK1G2-AS1]]
+
|[[LSINCT4]]
−
|MGC39696
+
|NA
−
|CSNK1G2 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CSTF3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290041 HSALNT0290041]
−
|[[CSTF3-AS1]]
+
|[[LSINCT6]]
−
|N/A
+
|NA
−
|CSTF3 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CTBP1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290042 HSALNT0290042]
−
|[[CTBP1-AS]]
+
|[[LSINCT7]]
−
|PCAT10
+
|NA
−
|CTBP1 antisense RNA
+
|NA
−
| prostate cancer
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CTBP1-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290043 HSALNT0290043]
−
|[[CTBP1-AS2]]
+
|[[LSINCT8]]
−
|MGC21675
+
|NA
−
|CTBP1 antisense RNA 2 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CYP1B1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290044 HSALNT0290044]
−
|[[CYP1B1-AS1]]
+
|[[LSINCT9]]
−
|MGC34824
+
|NA
−
|CYP1B1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CYP51A1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289676 HSALNT0289676]
−
|[[CYP51A1-AS1]]
+
|[[NONHSAT016928]]
−
|"ENST00000453068, LRRD1-AS1"
+
|FLJ31066,NONHSAT016928,lnc-FANK1-3:1
−
|CYP51A1 antisense RNA 1
+
|transcriptional regulation
−
|renal cell carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DACOR1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290032 HSALNT0290032]
−
|[[DACOR1]]
+
|[[LRRC3DN]]
−
|TCONSN/A00023265
+
|C21orf30,DKFZP434C128
−
|DNMT1-associated colon cancer repressed lncRNA 1
+
|transcriptional regulation
−
|colon cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DANT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266984 HSALNT0266984]
−
|[[DANT1]]
+
|[[SNHG11]]
−
|N/A
+
|C20orf198,LINC00101,NCRNA00101
−
|"DXZ4 associated non-coding transcript 1, proximal"
+
|NA
−
|_
+
|pathogenic process
 +
|obesity
 +
|Nutritional and Metabolic Diseases
 
|-
 
|-
−
|''DANT2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289880 HSALNT0289880]
−
|[[DANT2]]
+
|[[NONHSAT113225]]
−
|N/A
+
|NONHSAT113225,ENSG00000220635
−
|"DXZ4 associated non-coding transcript 2, distal"
+
|ceRNA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DAOA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0006368 HSALNT0006368]
−
|[[DAOA-AS1]]
+
|[[ENST00000444042.2]]
−
|G30
+
|ncRNA-a3
−
|DAOA antisense RNA 1
+
|transcriptional regulation
−
|bipolar illness,schizophrenia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DAPK1-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027470 HSALNT0027470]
−
|[[DAPK1-IT1]]
+
|[[ENST00000417473.2]]
−
|N/A
+
|ncRNA-a5
−
|DAPK1 intronic transcript 1
+
|transcriptional regulation
−
| pancreatic cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DBH-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289066 HSALNT0289066]
−
|[[DBH-AS1]]
+
|[[ENST00000429328.2]]
−
|BPR
+
|PDZK1IP1-AS1,ncRNA-a4
−
|DBH antisense RNA 1
+
|transcriptional regulation
−
|hepatocellular carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DGCR10''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289936 HSALNT0289936]
−
|[[DGCR10]]
+
|[[NONHSAT059436]]
−
|DGS-B
+
|ROR,lincRNA-ST8SIA3,ENSG00000258609,NONHSAT059436
−
|DiGeorge syndrome critical region gene 10 (non-protein coding)
+
|NA
−
|DiGeorge syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DGCR11''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289705 HSALNT0289705]
−
|[[DGCR11]]
+
|[[CHL1-AS2]]
−
|DGS-D
+
|NA
−
|DiGeorge syndrome critical region gene 11 (non-protein coding)
+
|NA
−
|DiGeorge and velo-cardio-facial syndrome
+
|pathogenic process
 +
|adolescent idiopathic scoliosis
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''DGCR12''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076084 HSALNT0076084]
−
|[[DGCR12]]
+
|[[SEC24B-AS1]]
−
|DGS-E
+
|1/2-SBSRNA4
−
|DiGeorge syndrome critical region gene 12 (non-protein coding)
+
|siRNA
−
|DiGeorge and velo-cardio-facial syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DGCR5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290137 HSALNT0290137]
−
|[[DGCR5]]
+
|[[PDZRN3-AS1]]
−
|"NCRNA00037, LINC00037"
+
|NA
−
|DiGeorge syndrome critical region gene 5 (non-protein coding)
+
|NA
−
|DiGeorge syndrome
+
|pathogenic process
 +
|type 2 diabetes
 +
|Nutritional and Metabolic Diseases;Endocrine System Diseases
 
|-
 
|-
−
|''DGCR9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290237 HSALNT0290237]
−
|[[DGCR9]]
+
|[[SCAANT1]]
−
|"DGS-A, POM121L5P"
+
|ATXN7-AS1
−
|DiGeorge syndrome critical region gene 9 (non-protein coding)
+
|transcriptional regulation
−
|DiGeorge syndrome
+
|pathogenic process
 +
|spinocerebellar ataxia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''DIAPH2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289594 HSALNT0289594]
−
|[[DIAPH2-AS1]]
+
|[[AK123790]]
−
|N/A
+
|NA
−
|DIAPH2 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''DISC1FP1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289911 HSALNT0289911]
−
|[[DISC1FP1]]
+
|[[LINC01451]]
−
|N/A
+
|NA
−
|DISC1 fusion partner 1 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''DLG2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290401 HSALNT0290401]
−
|[[DLG2-AS1]]
+
|[[ZNF350-AS1]]
−
|"PSZA11q14, SZ-1"
+
|NA
−
|DLG2 antisense RNA 1
+
|NA
−
|schizophrenia
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''DLGAP1-AS3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289845 HSALNT0289845]
−
|[[DLGAP1-AS3]]
+
|[[GADD45G]]
−
|N/A
+
|NA
−
|DLGAP1 antisense RNA 3
+
|NA
−
|_
+
|pathogenic process
 +
|pituitary adenoma
 +
|Endocrine System Diseases;Neoplasms;Nervous System Diseases
 
|-
 
|-
−
|''DLX6-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289410 HSALNT0289410]
−
|[[DLX6-AS1]]
+
|[[Lnc-RASA1-3:23]]
−
|"FLJ34048, Evf-2"
+
|AK082072,linc-POLR3G-8,ENSG00000247828
−
|DLX6 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DNM3OS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289736 HSALNT0289736]
−
|[[DNM3OS]]
+
|[[DAPK1]]
−
|"MIR199A2HG, DNM3-AS1"
+
|NA
−
|DNM3 opposite strand/antisense RNA
+
|NA
−
|Sézary syndrome
+
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''DRAIC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290048 HSALNT0290048]
−
|[[DRAIC]]
+
|[[MAP3K14]]
−
|N/A
+
|MAP3K14
−
|"downregulated RNA in cancer, inhibitor of cell invasion and migration"
+
|NA
−
|prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma
+
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''DSCR10''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290150 HSALNT0290150]
−
|[[DSCR10]]
+
|[[PPP3CB]]
−
|N/A
+
|NA
−
|Down syndrome critical region 10 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''DSCR9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0151531 HSALNT0151531]
−
|[[DSCR9]]
+
|[[DAPK1-IT1]]
−
|NCRNA00038
+
|NA
−
|Down syndrome critical region 9 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DUBR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288990 HSALNT0288990]
−
|[[DUBR]]
+
|[[GDNF-AS1]]
−
|N/A
+
|GDNFOS
−
|DPPA2 upstream binding RNA
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|Alzheimer's disease
 +
|Mental Disorders;Nervous System Diseases
 
|-
 
|-
−
|''EGFR-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029702 HSALNT0029702]
−
|[[EGFR-AS1]]
+
|[[BIRC6-AS2]]
−
|N/A
+
|megamind
−
|EGFR antisense RNA 1
+
|NA
−
|_
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ELFN1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029692 HSALNT0029692]
−
|[[ELFN1-AS1]]
+
|[[BIRC6-AS1]]
−
|N/A
+
|NA
−
|ELFN1 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ENTPD3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289310 HSALNT0289310]
−
|[[ENTPD3-AS1]]
+
|[[LINC00854]]
−
|FLJ36665
+
|NA
−
|ENTPD3 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''EPB41L4A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290332 HSALNT0290332]
−
|[[EPB41L4A-AS1]]
+
|[[Uc.73]]
−
|TIGA1
+
|NA
−
|EPB41L4A antisense RNA 1
+
|NA
−
|cancer
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''EPB41L4A-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289841 HSALNT0289841]
−
|[[EPB41L4A-AS2]]
+
|[[FR0257520]]
−
|FLJ11235
+
|NA
−
|EPB41L4A antisense RNA 2 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290104 HSALNT0290104]
 +
|[[NRG1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''ERC2-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289689 HSALNT0289689]
−
|[[ERC2-IT1]]
+
|[[CDKN2B-AS11]]
−
|Po42
+
|NA
−
|ERC2 intronic transcript 1
+
|NA
−
|_
+
|pathogenic process;developmental process
 +
|stroke
 +
|Cardiovascular Diseases;Nervous System Diseases
 
|-
 
|-
−
|''ERICH1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289690 HSALNT0289690]
−
|[[ERICH1-AS1]]
+
|[[CDKN2B-AS12]]
−
|N/A
+
|NA
−
|ERICH1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|glioma
 +
|Neoplasms
 
|-
 
|-
−
|''EWSAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289691 HSALNT0289691]
−
|[[EWSAT1]]
+
|[[CDKN2B-AS13]]
−
|FLJ33768
+
|NA
−
|Ewing sarcoma associated transcript 1
+
|NA
−
|Ewing sarcoma
+
|pathogenic process
 +
|plexiform neurofibroma
 +
|Neoplasms;Nervous System Diseases
 
|-
 
|-
−
|''EXOC3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289697 HSALNT0289697]
−
|[[EXOC3-AS1]]
+
|[[CDKN2B-AS7]]
−
|N/A
+
|NA
−
|EXOC3 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|acute lymphoblastic leukemia
 +
|Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''EXTL3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289826 HSALNT0289826]
−
|[[EXTL3-AS1]]
+
|[[FADS1]]
−
|N/A
+
|NA
−
|EXTL3 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lipid metabolism disorder
 +
|Nutritional and Metabolic Diseases
 
|-
 
|-
−
|''F11-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289698 HSALNT0289698]
−
|[[F11-AS1]]
+
|[[CDKN2B-AS8]]
−
|N/A
+
|NA
−
|F11 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|melanoma
 +
|Neoplasms
 
|-
 
|-
−
|''FAM138A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289696 HSALNT0289696]
−
|[[FAM138A]]
+
|[[CDKN2B-AS6]]
−
|F379
+
|NA
−
|family with sequence similarity 138 member A
+
|NA
−
|_
+
|pathogenic process
 +
|neuroblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''FAM138B''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289699 HSALNT0289699]
−
|[[FAM138B]]
+
|[[CDKN2B-AS9]]
−
|F379
+
|NA
−
|family with sequence similarity 138 member B
+
|NA
−
|_
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''FAM138C''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289688 HSALNT0289688]
−
|[[FAM138C]]
+
|[[CDKN2B-AS10]]
−
|F379
+
|NA
−
|family with sequence similarity 138 member C
+
|NA
−
|_
+
|pathogenic process
 +
|stroke
 +
|Cardiovascular Diseases;Nervous System Diseases
 
|-
 
|-
−
|''FAM138D''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288950 HSALNT0288950]
−
|[[FAM138D]]
+
|[[ENST00000456816]]
−
|F379
+
|NA
−
|family with sequence similarity 138 member D
+
|NA
−
|_
+
|pathogenic process
 +
|clear cell renal cell cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''FAM138E''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290021 HSALNT0290021]
−
|[[FAM138E]]
+
|[[LOC389332]]
−
|F379
+
|NA
−
|family with sequence similarity 138 member E
+
|NA
−
|_
+
|pathogenic process
 +
|clear cell renal cell cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''FAM138F''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290306 HSALNT0290306]
−
|[[FAM138F]]
+
|[[TMEM72]]
−
|F379
+
|NA
−
|family with sequence similarity 138 member F
+
|NA
−
|_
+
|pathogenic process
 +
|clear cell renal cell cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''FAM13A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289641 HSALNT0289641]
−
|[[FAM13A-AS1]]
+
|[[BC029135]]
−
|NCRNA00039
+
|NA
−
|FAM13A antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|renal clear cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''FAM201A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290374 HSALNT0290374]
−
|[[FAM201A]]
+
|[[X91348]]
−
|N/A
+
|NA
−
|family with sequence similarity 201 member A
+
|NA
−
|_
+
|pathogenic process
 +
|renal clear cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''FAM215A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289694 HSALNT0289694]
−
|[[FAM215A]]
+
|[[CDKN2B-AS4]]
−
|"APR-2, LINC00530"
+
|NA
−
|family with sequence similarity 215 member A (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|cancer
 +
|Neoplasms
 
|-
 
|-
−
|''FAM222A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289692 HSALNT0289692]
−
|[[FAM222A-AS1]]
+
|[[CDKN2B-AS2]]
−
|N/A
+
|NA
−
|FAM222A antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|coronary heart disease
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''FAM226A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289693 HSALNT0289693]
−
|[[FAM226A]]
+
|[[CDKN2B-AS3]]
−
|MGC34827
+
|NA
−
|family with sequence similarity 226 member A (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|intracranial aneurysm
 +
|Cardiovascular Diseases;Nervous System Diseases
 
|-
 
|-
−
|''FAM226B''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289695 HSALNT0289695]
−
|[[FAM226B]]
+
|[[CDKN2B-AS5]]
−
|N/A
+
|NA
−
|family with sequence similarity 226 member B (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|type 2 diabetes
 +
|Nutritional and Metabolic Diseases;Endocrine System Diseases
 
|-
 
|-
−
|''FAM27E3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290319 HSALNT0290319]
−
|[[FAM27E3]]
+
|[[T-UCRs]]
−
|MGC42630
+
|NA
−
|family with sequence similarity 27 member E3
+
|NA
−
|_
+
|pathogenic process
 +
|neuroblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''FAM41AY1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289530 HSALNT0289530]
−
|[[FAM41AY1]]
+
|[[51A]]
−
|N/A
+
|NA
−
|"family with sequence similarity 41 member A, Y-linked 1"
+
|splicing regulation
−
|_
+
|pathogenic process
 +
|Alzheimer's disease
 +
|Mental Disorders;Nervous System Diseases
 
|-
 
|-
−
|''FAM41C''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290163 HSALNT0290163]
−
|[[FAM41C]]
+
|[[RAB4B-EGLN2]]
−
|N/A
+
|NA
−
|family with sequence similarity 41 member C
+
|NA
−
|_
+
|pathogenic process
 +
|cancer
 +
|Neoplasms
 
|-
 
|-
−
|''FAM66C''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290167 HSALNT0290167]
−
|[[FAM66C]]
+
|[[RERT]]
−
|N/A
+
|NA
−
|family with sequence similarity 66 member C
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''FAM74A3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0265263 HSALNT0265263]
−
|[[FAM74A3]]
+
|[[LINC00237]]
−
|OTTHUMG00000067149
+
|NCRNA00237
−
|family with sequence similarity 74 member A3
+
|NA
−
|_
+
|pathogenic process
 +
|macrocephaly;obesity
 +
|Musculoskeletal Diseases;Pathological Conditions, Signs and Symptoms;Nutritional and Metabolic Diseases;Physiological Phenomena
 
|-
 
|-
−
|''FAM83H-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267186 HSALNT0267186]
−
|[[FAM83H-AS1]]
+
|[[LINC01370]]
−
|onco-lncRNA-3
+
|HI-LNC25,HILNC25
−
|FAM83H antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|type 2 diabetes
 +
|Nutritional and Metabolic Diseases;Endocrine System Diseases
 
|-
 
|-
−
|''FAM87A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289114 HSALNT0289114]
−
|[[FAM87A]]
+
|[[LINC01574]]
−
|N/A
+
|HI-LNC12,TCONS_00009551
−
|family with sequence similarity 87 member A
+
|NA
−
|_
+
|pathogenic process
 +
|type 2 diabetes
 +
|Nutritional and Metabolic Diseases;Endocrine System Diseases
 
|-
 
|-
−
|''FAS-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290159 HSALNT0290159]
−
|[[FAS-AS1]]
+
|[[PTHLH]]
−
|SAF
+
|NA
−
|FAS antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|brachydactyly
 +
|Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 
|-
 
|-
−
|''FGF10-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189394 HSALNT0189394]
−
|[[FGF10-AS1]]
+
|[[NONHSAT028496]]
−
|RP11-473L15.2
+
|CISTR-ACT,CISTRACT,re52431
−
|FGF10 antisense RNA 1
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|brachydactyly
 +
|Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 
|-
 
|-
−
|''FLG-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289862 HSALNT0289862]
−
|[[FLG-AS1]]
+
|[[HELLPAR]]
−
|N/A
+
|LINC-HELLP
−
|FLG antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|HELLP syndrome
 +
|Female Urogenital Diseases and Pregnancy Complications
 
|-
 
|-
−
|''FLVCR1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289904 HSALNT0289904]
−
|[[FLVCR1-AS1]]
+
|[[LINC01125]]
−
|LQK1
+
|NA
−
|FLVCR1 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|uremia
 +
|Male Urogenital Diseases
 
|-
 
|-
−
|''FMR1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289544 HSALNT0289544]
−
|[[FMR1-AS1]]
+
|[[AC002511.1]]
−
|"ASFMR1, FMR4"
+
|LINC01531
−
|FMR1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|enterovirus 71 infection
 +
|Virus Diseases
 
|-
 
|-
−
|''FOXC2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289609 HSALNT0289609]
−
|[[FOXC2-AS1]]
+
|[[AP000688.29]]
−
|ODRUL
+
|AP000688.2
−
|FOXC2 antisense RNA 1
+
|NA
−
|osteosarcoma
+
|pathogenic process
 +
|enterovirus 71 infection
 +
|Virus Diseases
 
|-
 
|-
−
|''FOXG1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289832 HSALNT0289832]
−
|[[FOXG1-AS1]]
+
|[[FFAR2]]
−
|FOXG1-AS
+
|NA
−
|FOXG1 antisense RNA 1 (head to head)
+
|NA
−
|autism spectrum disorders
+
|pathogenic process
 +
|enterovirus 71 infection
 +
|Virus Diseases
 
|-
 
|-
−
|''FRGCA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290222 HSALNT0290222]
−
|[[FRGCA]]
+
|[[RP4-620F22.3]]
−
|LncRNA-AP001631.9
+
|AC099063.2
−
|"FOXM1-regulated, gastric cancer associated"
+
|NA
−
|gastric cancer
+
|pathogenic process
 +
|enterovirus 71 infection
 +
|Virus Diseases
 
|-
 
|-
−
|''GABPB1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290227 HSALNT0290227]
−
|[[GABPB1-AS1]]
+
|[[RP5-843L14.1]]
−
|N/A
+
|LINC01716
−
|GABPB1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|enterovirus 71 infection
 +
|Virus Diseases
 
|-
 
|-
−
|''GACAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287285 HSALNT0287285]
−
|[[ENST00000441383.1]]
+
|[[MAGEA8-AS1]]
−
|"LINC00876, AC096655.1-002"
+
|RP5-869M20.2
−
|gastric cancer associated transcript 1 (non-protein coding)
+
|NA
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GACAT2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289019 HSALNT0289019]
−
|[[ENST00000579368.1]]
+
|[[LHX5-AS1]]
−
|HMlincRNA717
+
|locus4010
−
|gastric cancer associated transcript 2 (non-protein coding)
+
|NA
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GACAT3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288902 HSALNT0288902]
−
|[[ENST00000426539.1]]
+
|[[CAPN10-AS1]]
−
|lncRNA-AC130710
+
|CAPN10-DT,locus959
−
|gastric cancer associated transcript 3 (non-protein coding)
+
|NA
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GAPLINC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289404 HSALNT0289404]
−
|[[GAPLINC]]
+
|[[STAM-AS1]]
−
|TCONSN/A00026238
+
|locus3182
−
|"gastric adenocarcinoma associated, positive CD44 regulator, long intergenic non-coding RNA"
+
|NA
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GAS1RR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0148276 HSALNT0148276]
−
|[[GAS1RR]]
+
|[[PTENP1-AS]]
−
|LncRNA-Hh
+
|PTENpg1-asRNA
−
|GAS1 adjacent regulatory RNA
+
|transcriptional regulation
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GAS6-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289562 HSALNT0289562]
−
|[[GAS6-AS1]]
+
|[[AF116616]]
−
|N/A
+
|NA
−
|GAS6 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 
|-
 
|-
−
|''GAS8-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289589 HSALNT0289589]
−
|[[GAS8-AS1]]
+
|[[AK094838]]
−
|N/A
+
|NA
−
|GAS8 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 
|-
 
|-
−
|''GATA3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289620 HSALNT0289620]
−
|[[GATA3-AS1]]
+
|[[ASLNC00339]]
−
|N/A
+
|NA
−
|GATA3 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 
|-
 
|-
−
|''GATA6-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289629 HSALNT0289629]
−
|[[GATA6-AS1]]
+
|[[BC002350]]
−
|locus5689
+
|NA
−
|GATA6 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 
|-
 
|-
−
|''GDNF-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289651 HSALNT0289651]
−
|[[GDNF-AS1]]
+
|[[BC091525]]
−
|GDNFOS
+
|NA
−
|GDNF antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 
|-
 
|-
−
|''GLIDR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289652 HSALNT0289652]
−
|[[GLIDR]]
+
|[[BE503655]]
−
|"MGC21881, TCONSN/A00015562"
+
|NA
−
|glioblastoma down-regulated RNA
+
|NA
−
| glioblastoma
+
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 
|-
 
|-
−
|''GLIS3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289753 HSALNT0289753]
−
|[[GLIS3-AS1]]
+
|[[ENO1]]
−
|MGC16153
+
|NA
−
|GLIS3 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 
|-
 
|-
−
|''GNG12-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289835 HSALNT0289835]
−
|[[GNG12-AS1]]
+
|[[FKBP10]]
−
|N/A
+
|NA
−
|GNG12 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 
|-
 
|-
−
|''GTSCR1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290064 HSALNT0290064]
−
|[[GTSCR1]]
+
|[[MYHAS]]
−
|N/A
+
|NA
−
|"Gilles de la Tourette syndrome chromosome region, candidate 1 (non-protein coding)"
+
|NA
−
|_
+
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 
|-
 
|-
−
|''H1FX-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289985 HSALNT0289985]
−
|[[H1FX-AS1]]
+
|[[LncRNA-LALR1]]
−
|FLJ34151
+
|NA
−
|H1FX antisense RNA 1
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|liver cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''HAND2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091577 HSALNT0091577]
−
|[[HAND2-AS1]]
+
|[[NR2F1-AS1]]
−
|"DEIN, NBLA00301, FLJ11539"
+
|FLJ42709
−
|HAND2 antisense RNA 1 (head to head)
+
|NA
−
|neuroblastoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HAS2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289709 HSALNT0289709]
−
|[[HAS2-AS1]]
+
|[[CK19]]
−
|"HASNT, NCRNA00077"
+
|NA
−
|HAS2 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''HCCAT5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289943 HSALNT0289943]
−
|[[HCCAT5]]
+
|[[Llme23]]
−
|"HTA, FJ222407"
+
|NA
−
|hepatocellular carcinoma associated transcript 5 (non-protein coding)
+
|NA
−
| hepatocellular carcinoma
+
|pathogenic process
 +
|melanoma
 +
|Neoplasms
 
|-
 
|-
−
|''HCG27''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289553 HSALNT0289553]
−
|[[HCG27]]
+
|[[AC096655.1]]
−
|"bPG299F13.9, bCX101P6.9, bQB115I13.2, FLJ40123"
+
|NA
−
|HLA complex group 27 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''HCG4''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289178 HSALNT0289178]
−
|[[HCG4]]
+
|[[ENST00000602507.1]]
−
|"HCGIV-10, HCGIV.9"
+
|Lnc-Ang362
−
|HLA complex group 4 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|Ang II-associated cardiovascular disease
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''HCG4B''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289261 HSALNT0289261]
−
|[[HCG4B]]
+
|[[STX18-AS1]]
−
|"HCGIV-6, HCGIV.5, HCGIV-06, bCX67J3.3, Em:AB023056.16, bPG309N1.1, bQB90C11.3"
+
|LOC100507266
−
|HLA complex group 4B (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|atrial septal defect
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''HCG9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289849 HSALNT0289849]
−
|[[HCG9]]
+
|[[GHSR]]
−
|"PERB11, HCGIX, HCGIX4, HCGIX-4"
+
|NA
−
|HLA complex group 9 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''HCP5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289210 HSALNT0289210]
−
|[[HCP5]]
+
|[[ENST00000452148.2]]
−
|"D6S2650E, P5-1"
+
|PCAN-R2
−
|HLA complex P5 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''HELLPAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289702 HSALNT0289702]
−
|[[HELLPAR]]
+
|[[CES1P1]]
−
|LINC-HELLP
+
|NA
−
|HELLP associated long non-coding RNA
+
|NA
−
|extravillous trophoblast
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''HEXA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289892 HSALNT0289892]
−
|[[HEXA-AS1]]
+
|[[LINC00210]]
−
|FLJ13315
+
|NA
−
|HEXA antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''HIF1A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290006 HSALNT0290006]
−
|[[HIF1A-AS1]]
+
|[[LOC100506974]]
−
|5'aHIF-1A
+
|NA
−
|HIF1A antisense RNA 1
+
|NA
−
|kidney cancer
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''HIF1A-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290219 HSALNT0290219]
−
|[[HIF1A-AS2]]
+
|[[RP3-508I15.14]]
−
|"3'aHIF-1A, aHIF"
+
|NA
−
|HIF1A antisense RNA 2
+
|NA
−
| kidney cancer
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''HNF1A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290243 HSALNT0290243]
−
|[[HNF1A-AS1]]
+
|[[SLC6A6]]
−
|FLJ38690
+
|NA
−
|HNF1A antisense RNA 1
+
|NA
−
|adenocarcinoma, oesophageal adenocarcinoma
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''HNF4A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290342 HSALNT0290342]
−
|[[HNF4A-AS1]]
+
|[[Uc003bgl.1]]
−
|uc002xlx
+
|NA
−
|HNF4A antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''HORMAD2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289075 HSALNT0289075]
−
|[[HORMAD2-AS1]]
+
|[[LINC00970]]
−
|"MTMR3-AS1, NONHSAG033653"
+
|NA
−
|HORMAD2 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''HPVC1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211868 HSALNT0211868]
−
|[[HPVC1]]
+
|[[SALRNA1]]
−
|"PE5L, HPV18E5L"
+
|SAL-RNA1,XLOC_023166
−
|human papillomavirus (type 18) E5 central sequence-like 1
+
|NA
−
|_
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HTT-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222267 HSALNT0222267]
−
|[[HTT-AS]]
+
|[[SALRNA3]]
−
|HTTAS
+
|SAL-RNA3,XLOC_025918
−
|HTT antisense RNA (head to head)
+
|NA
−
|Huntington's disease
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HYMAI''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222274 HSALNT0222274]
−
|[[HYMAI]]
+
|[[SALRNA2]]
−
|NCRNA00020
+
|SAL-RNA2,XLOC_025931
−
|hydatidiform mole associated and imprinted (non-protein coding)
+
|NA
−
|_
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''IDI2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289428 HSALNT0289428]
−
|[[IDI2-AS1]]
+
|[[NONHSAT076558]]
−
|"HT009, Em:AC022536.4"
+
|GPR1-AS1,GPR1AS
−
|IDI2 antisense RNA 1
+
|transcriptional regulation
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''IGF2-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0226207 HSALNT0226207]
−
|[[IGF2-AS]]
+
|[[LINC00235]]
−
|"PEG8, IGF2-AS1"
+
|NA
−
|IGF2 antisense RNA
+
|NA
−
|hepatocelluar carcinoma,prostate cancer, type 1 diabetes, Wilms' tumor
+
|pathogenic process
 +
|anorexia nervosa
 +
|Mental Disorders
 
|-
 
|-
−
|''ILF3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289526 HSALNT0289526]
−
|[[ILF3-AS1]]
+
|[[1B FGF-antisense transcripts]]
−
|N/A
+
|NA
−
|ILF3 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|endometriosis
 +
|Female Urogenital Diseases and Pregnancy Complications
 
|-
 
|-
−
|''INE1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290171 HSALNT0290171]
−
|[[INE1]]
+
|[[RNA polymerase III-dependent lncRNAs]]
−
|NCRNA00010
+
|NA
−
|inactivation escape 1 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|diffuse cerebral hypomyelination
 +
|NA
 
|-
 
|-
−
|''INE2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290168 HSALNT0290168]
−
|[[INE2]]
+
|[[REST/CoREST-regulated lncRNAs]]
−
|NCRNA00011
+
|NA
−
|inactivation escape 2 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|Huntington disease
 +
|Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''IRAIN''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289606 HSALNT0289606]
−
|[[IRAIN]]
+
|[[Alu lncRNAs]]
−
|IGF1R-AS
+
|NA
−
|IGF1R antisense imprinted non-protein coding RNA
+
|NA
−
|_
+
|pathogenic process
 +
|macular degeneration
 +
|Eye Diseases
 
|-
 
|-
−
|''JMJD1C-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290358 HSALNT0290358]
−
|[[JMJD1C-AS1]]
+
|[[UCH1LAS]]
−
|N/A
+
|NA
−
|JMJD1C antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|Parkinson's disease
 +
|Nervous System Diseases
 
|-
 
|-
−
|''KCNK15-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290244 HSALNT0290244]
−
|[[KCNK15-AS1]]
+
|[[SLC7A2-IT1A/B]]
−
|RP11-445H22.4
+
|NA
−
|KCNK15 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|progressive encephalopathy with severe infantile anorexia
 +
|Nervous System Diseases
 
|-
 
|-
−
|''KCNMB2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289877 HSALNT0289877]
−
|[[KCNMB2-AS1]]
+
|[[Kcna2-AS]]
−
|RP11-385J1.2
+
|NA
−
|KCNMB2 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|neuropathic pain
 +
|Nervous System Diseases
 
|-
 
|-
−
|''KCNQ1DN''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289191 HSALNT0289191]
−
|[[KCNQ1DN]]
+
|[[NCOA7-AS1]]
−
|"BWRT, HSA404617"
+
|NA
−
|KCNQ1 downstream neighbor (non-protein coding)
+
|NA
−
|Wilms' tumor
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''KIAA1614-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290020 HSALNT0290020]
−
|[[KIAA1614-AS1]]
+
|[[LOC389023]]
−
|RP11-46A10.4
+
|NA
−
|KIAA1614 antisense RNA 1
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|psychiatric disease
 +
|Nervous System Diseases
 
|-
 
|-
−
|''KIF25-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0175124 HSALNT0175124]
−
|[[KIF25-AS1]]
+
|[[PTPRJ-AS1]]
−
|HGC6.1.1
+
|NA
−
|KIF25 antisense RNA 1
+
|transcriptional regulation
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LAMP5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289654 HSALNT0289654]
−
|[[LAMP5-AS1]]
+
|[[BM742401]]
−
|N/A
+
|NA
−
|LAMP5 antisense RNA 1
+
|NA
−
|leukemogenesis
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LBX2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289331 HSALNT0289331]
−
|[[LBX2-AS1]]
+
|[[LINC00951]]
−
|N/A
+
|lincRNA-uc003opf.1,FLJ41649
−
|LBX2 antisense RNA 1
+
|NA
−
|renal cell carcinoma
+
|pathogenic process
 +
|esophageal squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LCAL1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290130 HSALNT0290130]
−
|[[LCAL1]]
+
|[[PAWR]]
−
|onco-lncRNA-27
+
|NA
−
|lung cancer associated lncRNA 1
+
|NA
−
| lung cancer
+
|pathogenic process
 +
|acute lymphoblastic leukemia
 +
|Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''LHX5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290264 HSALNT0290264]
−
|[[LHX5-AS1]]
+
|[[T-ALL-R-LncR1]]
−
|locus4010
+
|NA
−
|LHX5 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|acute lymphoblastic leukemia
 +
|Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''LIFR-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289599 HSALNT0289599]
−
|[[LIFR-AS1]]
+
|[[AK130977]]
−
|N/A
+
|NA
−
|LIFR antisense RNA 1
+
|NA
−
|preterm birth
+
|pathogenic process
 +
|malignant pleural mesothelioma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00029''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289625 HSALNT0289625]
−
|[[LINC00029]]
+
|[[AX746718]]
−
|bA305P22.4
+
|NA
−
|long intergenic non-protein coding RNA 29
+
|NA
−
|_
+
|pathogenic process
 +
|malignant pleural mesothelioma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00052''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289738 HSALNT0289738]
−
|[[LINC00052]]
+
|[[DDR2]]
−
|FLJ31461
+
|NA
−
|long intergenic non-protein coding RNA 52
+
|NA
−
|_
+
|pathogenic process
 +
|malignant pleural mesothelioma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00094''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290003 HSALNT0290003]
−
|[[LINC00094]]
+
|[[LOC100131831]]
−
|"FLJ35348, bA374P20.3"
+
|NA
−
|long intergenic non-protein coding RNA 94
+
|NA
−
|_
+
|pathogenic process
 +
|malignant pleural mesothelioma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00114''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290144 HSALNT0290144]
−
|[[LINC00114]]
+
|[[POT1-AS1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 114
+
|NA
−
|_
+
|pathogenic process
 +
|malignant pleural mesothelioma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00115''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290253 HSALNT0290253]
−
|[[LINC00115]]
+
|[[SNORA17B]]
−
|FLJ22639
+
|NA
−
|long intergenic non-protein coding RNA 115
+
|NA
−
|
+
|pathogenic process
 +
|malignant pleural mesothelioma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00152''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0207421 HSALNT0207421]
−
|[[LINC00152]]
+
|[[GAS6-AS1]]
−
|MGC4677
+
|NA
−
|long intergenic non-protein coding RNA 152
+
|NA
−
|gastric cancer
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00160''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289838 HSALNT0289838]
−
|[[LINC00160]]
+
|[[FMR5]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 160
+
|NA
−
|Breast Cancer
+
|pathogenic process
 +
|fragile X syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''LINC00161''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0208907 HSALNT0208907]
−
|[[LINC00161]]
+
|[[FOXG1-AS1]]
−
|N/A
+
|FOXG1-AS
−
|long intergenic non-protein coding RNA 161
+
|NA
−
|_
+
|pathogenic process
 +
|autism spectrum disorder
 +
|Mental Disorders
 
|-
 
|-
−
|''LINC00165''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290263 HSALNT0290263]
−
|[[LINC00165]]
+
|[[SYNGAP1-AS1]]
−
|NLC1-B
+
|SYNGAP1-AS
−
|long intergenic non-protein coding RNA 165
+
|NA
−
| narcolepsy
+
|pathogenic process
 +
|autism spectrum disorder
 +
|Mental Disorders
 
|-
 
|-
−
|''LINC00189''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290176 HSALNT0290176]
−
|[[LINC00189]]
+
|[[RNase MRP]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 189
+
|NA
−
|Breast Cancer
+
|pathogenic process
 +
|cartilage hair hypoplaisia
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00205''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289469 HSALNT0289469]
−
|[[LINC00205]]
+
|[[GABPB1-AS1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 205
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00235''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289009 HSALNT0289009]
−
|[[LINC00235]]
+
|[[IDI2-AS1]]
−
|N/A
+
|C10orf110,IDI2-A,HT009,Em:AC022536.4
−
|long intergenic non-protein coding RNA 235
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00237''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289093 HSALNT0289093]
−
|[[LINC00237]]
+
|[[LINC01184]]
−
|N/A
+
|FLJ33630
−
|long intergenic non-protein coding RNA 237
+
|NA
−
|macrosomia, obesity, macrocephaly, and ocular abnormalities
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00244''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290108 HSALNT0290108]
−
|[[LINC00244]]
+
|[[OGT]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 244
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC00261''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290077 HSALNT0290077]
−
|[[LINC00261]]
+
|[[NcNRFR]]
−
|"bA216C10.1, HCCDR1, TCONSN/A00027846, ALIEN, DEANR1, onco-lncRNA-17"
+
|NA
−
|long intergenic non-protein coding RNA 261
+
|transcriptional regulation
−
|gastric cancer
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC00265''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290337 HSALNT0290337]
−
|[[LINC00265]]
+
|[[Uc001lsz]]
−
|NCRNA00265-1
+
|NA
−
|long intergenic non-protein coding RNA 265
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer;prostate cancer;liver cancer;lung cancer
 +
|Respiratory Tract Diseases;Male Urogenital Diseases;Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC00272''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289087 HSALNT0289087]
−
|[[LINC00272]]
+
|[[LINC01090]]
−
|RP1-223H12.3
+
|NA
−
|long intergenic non-protein coding RNA 272
+
|NA
−
| prostate cancer region
+
|pathogenic process
 +
|post-traumatic stress disorder
 +
|Mental Disorders
 
|-
 
|-
−
|''LINC00293''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289981 HSALNT0289981]
−
|[[LINC00293]]
+
|[[LncRNA-DQ786227]]
−
|BEYLA
+
|NA
−
|long intergenic non-protein coding RNA 293
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00294''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289876 HSALNT0289876]
−
|[[LINC00294]]
+
|[[JADRR]]
−
|N/A
+
|LINC00915,lncRNA-JADE
−
|long intergenic non-protein coding RNA 294
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00299''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290254 HSALNT0290254]
−
|[[LINC00299]]
+
|[[SOX2OT-S1]]
−
|FLJ45673
+
|NA
−
|long intergenic non-protein coding RNA 299
+
|NA
−
|Intellectual and developmental disability
+
|pathogenic process
 +
|esophageal squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00301''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289870 HSALNT0289870]
−
|[[LINC00301]]
+
|[[HOXA13]]
−
|MGC39681
+
|NA
−
|long intergenic non-protein coding RNA 301
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC00302''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0078946 HSALNT0078946]
−
|[[LINC00302]]
+
|[[SMAD1-AS1]]
−
|XP33
+
|ENST00000513542
−
|long intergenic non-protein coding RNA 302
+
|NA
−
|_
+
|pathogenic process
 +
|ventricular septal defects
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00305''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0087329 HSALNT0087329]
−
|[[LINC00305]]
+
|[[FGF10-AS1]]
−
|"MGC39571, HsT1235"
+
|RP11-473L15.2
−
|long intergenic non-protein coding RNA 305
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|ventricular septal defects
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00307''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290318 HSALNT0290318]
−
|[[LINC00307]]
+
|[[TUC339]]
−
|D21S2091E
+
|NA
−
|long intergenic non-protein coding RNA 307
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC00308''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289819 HSALNT0289819]
−
|[[LINC00308]]
+
|[[Lnc-CHRAC1-2:1]]
−
|PRED16
+
|LINC01130,TCONS_00014875,ERIC
−
|long intergenic non-protein coding RNA 308
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|retinoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00310''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289615 HSALNT0289615]
−
|[[LINC00310]]
+
|[[ARA]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 310
+
|NA
−
|_
+
|pathogenic process
 +
|cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00311''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289822 HSALNT0289822]
−
|[[LINC00311]]
+
|[[ESCCAL-5]]
−
|MGC22001
+
|NA
−
|long intergenic non-protein coding RNA 311
+
|NA
−
|_
+
|pathogenic process
 +
|esophageal squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00313''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290074 HSALNT0290074]
−
|[[LINC00313]]
+
|[[NcC11orf49]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 313
+
|NA
−
|lung cancer
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00314''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290076 HSALNT0290076]
−
|[[LINC00314]]
+
|[[NcHDAC5]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 314
+
|NA
−
|_
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00315''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290078 HSALNT0290078]
−
|[[LINC00315]]
+
|[[NcRAB31]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 315
+
|NA
−
|_
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00320''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290080 HSALNT0290080]
−
|[[LINC00320]]
+
|[[NcSRPK1]]
−
|"PRED14, FLJ37539"
+
|NA
−
|long intergenic non-protein coding RNA 320
+
|NA
−
|_
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00322''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018253 HSALNT0018253]
−
|[[LINC00322]]
+
|[[ENST00000442621.1]]
−
|FLJ16545
+
|LINC01131,OVAL
−
|long intergenic non-protein coding RNA 322
+
|NA
−
|_
+
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''LINC00323''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289884 HSALNT0289884]
−
|[[LINC00323]]
+
|[[LALR]]
−
|"PRED42, FLJ37173"
+
|NA
−
|long intergenic non-protein coding RNA 323
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC00324''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289701 HSALNT0289701]
−
|[[LINC00324]]
+
|[[CEACAMP8]]
−
|"FLJ34790, MGC104931"
+
|CEACAMP8
−
|long intergenic non-protein coding RNA 324
+
|NA
−
|_
+
|pathogenic process
 +
|pre-eclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 
|-
 
|-
−
|''LINC00334''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290018 HSALNT0290018]
−
|[[LINC00334]]
+
|[[LOC284100]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 334
+
|NA
−
|_
+
|pathogenic process
 +
|pre-eclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 
|-
 
|-
−
|''LINC00337''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290023 HSALNT0290023]
−
|[[LINC00337]]
+
|[[LOC391533]]
−
|MGC40168
+
|NA
−
|long intergenic non-protein coding RNA 337
+
|NA
−
|_
+
|pathogenic process
 +
|pre-eclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 
|-
 
|-
−
|''LINC00339''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189558 HSALNT0189558]
−
|[[LINC00339]]
+
|[[LINC01154]]
−
|HSPC157
+
|NA
−
|long intergenic non-protein coding RNA 339
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00342''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0196616 HSALNT0196616]
−
|[[LINC00342]]
+
|[[Lnc-DHX37-1:1]]
−
|N/A
+
|BRI3BP-AS1,BRI3BPAS1,Linc1992,TCONS_00020260
−
|long intergenic non-protein coding RNA 342
+
|transcriptional regulation
−
|Non-small cell lung cancer
+
|pathogenic process
 +
|Kawasaki disease
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00346''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289235 HSALNT0289235]
−
|[[LINC00346]]
+
|[[RNF219-AS1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 346
+
|NA
−
|_
+
|pathogenic process
 +
|blood pressure
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00347''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289561 HSALNT0289561]
−
|[[LINC00347]]
+
|[[AF086415]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 347
+
|NA
−
|_
+
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 
|-
 
|-
−
|''LINC00426''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289583 HSALNT0289583]
−
|[[LINC00426]]
+
|[[AK056098]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 426
+
|NA
−
|_
+
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 
|-
 
|-
−
|''LINC00441''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289590 HSALNT0289590]
−
|[[LINC00441]]
+
|[[AK095147]]
−
|ncRNA-RB1
+
|NA
−
|long intergenic non-protein coding RNA 441
+
|NA
−
|_
+
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 
|-
 
|-
−
|''LINC00461''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289600 HSALNT0289600]
−
|[[LINC00461]]
+
|[[AK294004]]
−
|"EyeLinc1, Visc-1a, Visc-1b, Visc-2, LOC645323"
+
|NA
−
|long intergenic non-protein coding RNA 461
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 
|-
 
|-
−
|''LINC00466''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289612 HSALNT0289612]
−
|[[LINC00466]]
+
|[[AP5M1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 466
+
|NA
−
|_
+
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 
|-
 
|-
−
|''LINC00467''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290110 HSALNT0290110]
−
|[[LINC00467]]
+
|[[ORAOV1]]
−
|MGC14801
+
|NA
−
|long intergenic non-protein coding RNA 467
+
|NA
−
|_
+
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 
|-
 
|-
−
|''LINC00470''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290210 HSALNT0290210]
−
|[[LINC00470]]
+
|[[RP1-179N16.3]]
−
|N/A
+
|Z95152.1
−
|long intergenic non-protein coding RNA 470
+
|NA
−
|_
+
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 
|-
 
|-
−
|''LINC00471''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0037026 HSALNT0037026]
−
|[[LINC00471]]
+
|[[LINC01159]]
−
|MGC43122
+
|linc-Brn1b
−
|long intergenic non-protein coding RNA 471
+
|NA
−
|_
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00472''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289014 HSALNT0289014]
−
|[[LINC00472]]
+
|[[ENST00000604849.1]]
−
|"dJ288M22.3, FLJ13189"
+
|KDM5C adjacent non-coding transcript
−
|long intergenic non-protein coding RNA 472
+
|NA
−
|breast cancer
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00473''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289905 HSALNT0289905]
−
|[[LINC00473]]
+
|[[LINC01157]]
−
|bA142J11.1
+
|TCONS_00010378,linc-Enc1
−
|long intergenic non-protein coding RNA 473
+
|NA
−
|lung cancer
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00477''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289460 HSALNT0289460]
−
|[[LINC00477]]
+
|[[ENST00000444200.1]]
−
|"FLJ32894, FAM191B"
+
|NA
−
|long intergenic non-protein coding RNA 477
+
|transcriptional regulation
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00491''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290400 HSALNT0290400]
−
|[[LINC00491]]
+
|[[ZNF300P1]]
−
|BC008363
+
|ZNF300P1
−
|long intergenic non-protein coding RNA 491
+
|NA
−
|pancreatic ductal adenocarcinoma
+
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''LINC00493''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289750 HSALNT0289750]
−
|[[LINC00493]]
+
|[[EEF1A1P9]]
−
|LOC388789
+
|NA
−
|long intergenic non-protein coding RNA 493
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00494''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289796 HSALNT0289796]
−
|[[LINC00494]]
+
|[[ENST00000318333]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 494
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00507''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289797 HSALNT0289797]
−
|[[LINC00507]]
+
|[[ENST00000374520]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 507
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00511''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289800 HSALNT0289800]
−
|[[LINC00511]]
+
|[[ENST00000422362]]
−
|onco-lncRNA-12
+
|NA
−
|long intergenic non-protein coding RNA 511
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00518''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289808 HSALNT0289808]
−
|[[LINC00518]]
+
|[[ENST00000455912]]
−
|MGC40222
+
|NA
−
|long intergenic non-protein coding RNA 518
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00526''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289809 HSALNT0289809]
−
|[[LINC00526]]
+
|[[ENST00000456007]]
−
|"MGC17515, HsT959"
+
|NA
−
|long intergenic non-protein coding RNA 526
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00528''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289810 HSALNT0289810]
−
|[[LINC00528]]
+
|[[ENST00000456185]]
−
|FLJ40542
+
|NA
−
|long intergenic non-protein coding RNA 528
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00529''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289817 HSALNT0289817]
−
|[[LINC00529]]
+
|[[EPOR]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 529
+
|NA
−
| keratolytic winter erythema
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00536''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289913 HSALNT0289913]
−
|[[LINC00536]]
+
|[[LINC01550]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 536
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00538''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290142 HSALNT0290142]
−
|[[LINC00538]]
+
|[[PMS2P5]]
−
|"Yiya, PROX1UT"
+
|NA
−
|long intergenic non-protein coding RNA 538
+
|NA
−
|cancers
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00575''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290269 HSALNT0290269]
−
|[[LINC00575]]
+
|[[TCF7]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 575
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00588''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290345 HSALNT0290345]
−
|[[LINC00588]]
+
|[[Uc003jfz.2]]
−
|DKFZP434F122
+
|NA
−
|long intergenic non-protein coding RNA 588
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00593''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289095 HSALNT0289095]
−
|[[LINC00593]]
+
|[[ENST00000412690.1]]
−
|MGC42951
+
|VIN,lnc-ACTR3
−
|long intergenic non-protein coding RNA 593
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|influenza A virus
 +
|Virus Diseases
 
|-
 
|-
−
|''LINC00598''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288976 HSALNT0288976]
−
|[[LINC00598]]
+
|[[ENST00000427391.1]]
−
|TTL
+
|LINC01200
−
|long intergenic non-protein coding RNA 598
+
|transcriptional regulation
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00608''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289097 HSALNT0289097]
−
|[[LINC00608]]
+
|[[LINC01202]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 608
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00612''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290271 HSALNT0290271]
−
|[[LINC00612]]
+
|[[TCONS_00014512]]
−
|"MGC40170, FLJ41814"
+
|NA
−
|long intergenic non-protein coding RNA 612
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00620''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290272 HSALNT0290272]
−
|[[LINC00620]]
+
|[[TCONS_00014978]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 620
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00623''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290274 HSALNT0290274]
−
|[[LINC00623]]
+
|[[TCONS_00024647]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 623
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00628''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290279 HSALNT0290279]
−
|[[LINC00628]]
+
|[[TCONS_00090092_MEG3]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 628
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00632''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290280 HSALNT0290280]
−
|[[LINC00632]]
+
|[[TCONS_l2_00000179]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 632
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00634''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290283 HSALNT0290283]
−
|[[LINC00634]]
+
|[[TCONS_l2_00004424]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 634
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00635''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290284 HSALNT0290284]
−
|[[LINC00635]]
+
|[[TCONS_l2_00006843]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 635
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00636''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290289 HSALNT0290289]
−
|[[LINC00636]]
+
|[[TCONS_l2_00014091]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 636
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00638''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290291 HSALNT0290291]
−
|[[LINC00638]]
+
|[[TCONS_l2_00018070]]
−
|MGC23270
+
|NA
−
|long intergenic non-protein coding RNA 638
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00649''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290292 HSALNT0290292]
−
|[[LINC00649]]
+
|[[TCONS_l2_00020565]]
−
|TCONSN/A00028768
+
|NA
−
|long intergenic non-protein coding RNA 649
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00652''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290293 HSALNT0290293]
−
|[[LINC00652]]
+
|[[TCONS_l2_00021262]]
−
|HSPC072
+
|NA
−
|long intergenic non-protein coding RNA 652
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00661''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290296 HSALNT0290296]
−
|[[LINC00661]]
+
|[[TCONS_l2_00030560]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 661
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00662''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289927 HSALNT0289927]
−
|[[LINC00662]]
+
|[[LincRNA1611]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 662
+
|NA
−
|_
+
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00663''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290149 HSALNT0290149]
−
|[[LINC00663]]
+
|[[Ppp3ca]]
−
|MGC39821
+
|NA
−
|long intergenic non-protein coding RNA 663
+
|NA
−
|_
+
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00667''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290265 HSALNT0290265]
−
|[[LINC00667]]
+
|[[TC0100223]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 667
+
|NA
−
|_
+
|pathogenic process
 +
|epithelial ovarian cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00668''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290267 HSALNT0290267]
−
|[[LINC00668]]
+
|[[TC0101686]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 668
+
|NA
−
|_
+
|pathogenic process
 +
|epithelial ovarian cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00673''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290268 HSALNT0290268]
−
|[[LINC00673]]
+
|[[TC1500845]]
−
|HI-LNC75
+
|NA
−
|long intergenic non-protein coding RNA 673
+
|NA
−
|type 2 diabetes
+
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''LINC00675''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289318 HSALNT0289318]
−
|[[LINC00675]]
+
|[[LAMP5-AS1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 675
+
|NA
−
|_
+
|pathogenic process
 +
|acute lymphoblastic leukemia
 +
|Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''LINC00682''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234022 HSALNT0234022]
−
|[[LINC00682]]
+
|[[LINC01228]]
−
|N/A
+
|lincRNA-DYNLRB2-2
−
|long intergenic non-protein coding RNA 682
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00685''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0162654 HSALNT0162654]
−
|[[LINC00685]]
+
|[[SGMS1-AS1]]
−
|OTTHUMT00000055574
+
|NA
−
|long intergenic non-protein coding RNA 685
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00689''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289206 HSALNT0289206]
−
|[[LINC00689]]
+
|[[PCAT19]]
−
|N/A
+
|LOC100505495,LINC01190
−
|long intergenic non-protein coding RNA 689
+
|NA
−
|_
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00692''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289521 HSALNT0289521]
−
|[[LINC00692]]
+
|[[ABHD15-AS1]]
−
|N/A
+
|linc-TP53I13,lnc-TP53I13
−
|long intergenic non-protein coding RNA 692
+
|NA
−
|_
+
|pathogenic process
 +
|cardiometabolic disease
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00704''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289100 HSALNT0289100]
−
|[[LINC00704]]
+
|[[LINC01230]]
−
|N/A
+
|linc-DMRT2,lnc-DRMT2,TCONS_00015639
−
|long intergenic non-protein coding RNA 704
+
|NA
−
|breast cancer
+
|pathogenic process
 +
|cardiometabolic disease
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00705''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0249183 HSALNT0249183]
−
|[[LINC00705]]
+
|[[PCAT18]]
−
|N/A
+
|LINC01092
−
|long intergenic non-protein coding RNA 705
+
|NA
−
|breast cancer
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00839''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290029 HSALNT0290029]
−
|[[LINC00839]]
+
|[[LOC728606]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 839
+
|NA
−
|_
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00852''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288956 HSALNT0288956]
−
|[[LINC00852]]
+
|[[ENST00000547963.1]]
−
|"NAG73, GHRL-AS2"
+
|NA
−
|long intergenic non-protein coding RNA 852
+
|NA
−
|_
+
|pathogenic process
 +
|esophageal squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00854''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289802 HSALNT0289802]
−
|[[LINC00854]]
+
|[[ENST00000435885]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 854
+
|NA
−
|_
+
|pathogenic process
 +
|oesophageal squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00857''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0205898 HSALNT0205898]
−
|[[LINC00857]]
+
|[[LINC01232]]
−
|N/A
+
|FLJ41590,TCONS_00021520
−
|long intergenic non-protein coding RNA 857
+
|NA
−
|lung cancer
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00868''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0257311 HSALNT0257311]
−
|[[LINC00868]]
+
|[[LINC01233]]
−
|N/A
+
|XLOC_013014
−
|long intergenic non-protein coding RNA 868
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00869''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183247 HSALNT0183247]
−
|[[LINC00869]]
+
|[[ENST00000526269.2]]
−
|KIAA0493
+
|FLI1-AS1
−
|long intergenic non-protein coding RNA 869
+
|NA
−
|_
+
|pathogenic process
 +
|vascular SMC phenotype
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00880''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289296 HSALNT0289296]
−
|[[LINC00880]]
+
|[[LINC00467]]
−
|N/A
+
|C1orf97,MGC14801
−
|long intergenic non-protein coding RNA 880
+
|NA
−
|_
+
|pathogenic process
 +
|neuroblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00882''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143586 HSALNT0143586]
−
|[[LINC00882]]
+
|[[CASC21]]
−
|N/A
+
|LINC01244,CARLo-2
−
|long intergenic non-protein coding RNA 882
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00887''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288906 HSALNT0288906]
−
|[[LINC00887]]
+
|[[CASC19]]
−
|linc-ATP13A4-8
+
|LINC01245,CARLo-6
−
|long intergenic non-protein coding RNA 887
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00893''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289754 HSALNT0289754]
−
|[[LINC00893]]
+
|[[ENSG00000135253.9]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 893
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00901''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289755 HSALNT0289755]
−
|[[LINC00901]]
+
|[[ENSG00000147753.5]]
−
|"TCONSN/A00005428, BC040587"
+
|NA
−
|long intergenic non-protein coding RNA 901
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00917''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289756 HSALNT0289756]
−
|[[LINC00917]]
+
|[[ENSG00000196096]]
−
|N/A
+
|AC079610.1
−
|long intergenic non-protein coding RNA 917
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00936''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289757 HSALNT0289757]
−
|[[LINC00936]]
+
|[[ENSG00000197251.3]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 936
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00942''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289758 HSALNT0289758]
−
|[[LINC00942]]
+
|[[ENSG00000203325]]
−
|N/A
+
|AL445248.1
−
|long intergenic non-protein coding RNA 942
+
|NA
−
|autism spectrum disorder
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00950''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289759 HSALNT0289759]
−
|[[LINC00950]]
+
|[[ENSG00000206129]]
−
|FP588
+
|AC006305.1
−
|long intergenic non-protein coding RNA 950
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00951''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289760 HSALNT0289760]
−
|[[LINC00951]]
+
|[[ENSG00000215231.3]]
−
|"lincRNA-uc003opf.1, FLJ41649"
+
|NA
−
|long intergenic non-protein coding RNA 951
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00961''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289761 HSALNT0289761]
−
|[[LINC00961]]
+
|[[ENSG00000215374.4]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 961
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00963''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289762 HSALNT0289762]
−
|[[LINC00963]]
+
|[[ENSG00000215808.2]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 963
+
|NA
−
|prostate cancer
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00964''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289763 HSALNT0289763]
−
|[[LINC00964]]
+
|[[ENSG00000226496.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 964
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00970''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289764 HSALNT0289764]
−
|[[LINC00970]]
+
|[[ENSG00000229563.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 970
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00974''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289765 HSALNT0289765]
−
|[[LINC00974]]
+
|[[ENSG00000230133.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 974
+
|NA
−
|hepatocellular carcinoma
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00977''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289766 HSALNT0289766]
−
|[[LINC00977]]
+
|[[ENSG00000230544.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 977
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00982''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289767 HSALNT0289767]
−
|[[LINC00982]]
+
|[[ENSG00000231133.1]]
−
|FLJ42875
+
|NA
−
|long intergenic non-protein coding RNA 982
+
|NA
−
|gastric cancer
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00993''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289768 HSALNT0289768]
−
|[[LINC00993]]
+
|[[ENSG00000231185]]
−
|N/A
+
|AC010317.1
−
|long intergenic non-protein coding RNA 993
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00994''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289769 HSALNT0289769]
−
|[[LINC00994]]
+
|[[ENSG00000232021.2]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 994
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00996''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289770 HSALNT0289770]
−
|[[LINC00996]]
+
|[[ENSG00000232046.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 996
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01016''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289771 HSALNT0289771]
−
|[[LINC01016]]
+
|[[ENSG00000232956.3]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1016
+
|NA
−
|Breast Cancer
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01018''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289772 HSALNT0289772]
−
|[[LINC01018]]
+
|[[ENSG00000233154.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1018
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01019''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289773 HSALNT0289773]
−
|[[LINC01019]]
+
|[[ENSG00000233251]]
−
|N/A
+
|AC007743.1
−
|long intergenic non-protein coding RNA 1019
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01020''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289774 HSALNT0289774]
−
|[[LINC01020]]
+
|[[ENSG00000235285.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1020
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01021''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289775 HSALNT0289775]
−
|[[LINC01021]]
+
|[[ENSG00000237036.3]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1021
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01024''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289776 HSALNT0289776]
−
|[[LINC01024]]
+
|[[ENSG00000237548.1]]
−
|MA-linc1
+
|NA
−
|long intergenic non-protein coding RNA 1024
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01029''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289777 HSALNT0289777]
−
|[[LINC01029]]
+
|[[ENSG00000240453.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1029
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01080''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289778 HSALNT0289778]
−
|[[LINC01080]]
+
|[[ENSG00000241269.1]]
−
|TCONSN/A00021856
+
|NA
−
|long intergenic non-protein coding RNA 1080
+
|NA
−
|Alzheimer's disease ;amnestic mild cognitive impairment
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01081''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289779 HSALNT0289779]
−
|[[LINC01081]]
+
|[[ENSG00000245910.3]]
−
|TCONSN/A00024764
+
|NA
−
|long intergenic non-protein coding RNA 1081
+
|NA
−
|alveolar capillary dysplasia ;misalignment of pulmonary veins
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01082''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289780 HSALNT0289780]
−
|[[LINC01082]]
+
|[[ENSG00000248176]]
−
|TCONSN/A00024492
+
|AC109349.1
−
|long intergenic non-protein coding RNA 1082
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01089''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289781 HSALNT0289781]
−
|[[LINC01089]]
+
|[[ENSG00000249364]]
−
|N/A
+
|AC112206.2
−
|long intergenic non-protein coding RNA 1089
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01090''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289782 HSALNT0289782]
−
|[[LINC01090]]
+
|[[ENSG00000249772]]
−
|N/A
+
|AC026427.1
−
|long intergenic non-protein coding RNA 1090
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01091''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289783 HSALNT0289783]
−
|[[LINC01091]]
+
|[[ENSG00000250195]]
−
|N/A
+
|AC109927.1
−
|long intergenic non-protein coding RNA 1091
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01096''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289784 HSALNT0289784]
−
|[[LINC01096]]
+
|[[ENSG00000250608]]
−
|N/A
+
|AC010210.1
−
|long intergenic non-protein coding RNA 1096
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01105''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289785 HSALNT0289785]
−
|[[LINC01105]]
+
|[[ENSG00000254154]]
−
|"FLJ30594, LOC150622"
+
|AL359075.2
−
|long intergenic non-protein coding RNA 1105
+
|NA
−
|predicted disease-related genes
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01108''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289786 HSALNT0289786]
−
|[[LINC01108]]
+
|[[ENSG00000255471]]
−
|LncRNA-ES1
+
|AP001528.2
−
|long intergenic non-protein coding RNA 1108
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01122''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289787 HSALNT0289787]
−
|[[LINC01122]]
+
|[[ENSG00000256218]]
−
|FLJ30838
+
|AC007848.2
−
|long intergenic non-protein coding RNA 1122
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01133''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289788 HSALNT0289788]
−
|[[LINC01133]]
+
|[[ENSG00000259150.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1133
+
|NA
−
|lung squamous cell cancer
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01139''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289789 HSALNT0289789]
−
|[[LINC01139]]
+
|[[ENSG00000259334.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1139
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01140''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289790 HSALNT0289790]
−
|[[LINC01140]]
+
|[[ENSG00000259484.1]]
−
|FLJ41676
+
|NA
−
|long intergenic non-protein coding RNA 1140
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01150''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289791 HSALNT0289791]
−
|[[LINC01150]]
+
|[[ENSG00000259758.1]]
−
|"2G7, TCONSN/A00019134"
+
|NA
−
|long intergenic non-protein coding RNA 1150
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01152''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289793 HSALNT0289793]
−
|[[LINC01152]]
+
|[[ENSG00000263753.1]]
−
|"TCONSN/A00025128, CMPD"
+
|NA
−
|long intergenic non-protein coding RNA 1152
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01154''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289794 HSALNT0289794]
−
|[[LINC01154]]
+
|[[ENSG00000264772]]
−
|N/A
+
|AC016876.2
−
|long intergenic non-protein coding RNA 1154
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01157''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289795 HSALNT0289795]
−
|[[LINC01157]]
+
|[[ENSG00000266952.1]]
−
|"TCONSN/A00010378, linc-Enc1"
+
|NA
−
|long intergenic non-protein coding RNA 1157
+
|NA
−
|brain development
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01158''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289828 HSALNT0289828]
−
|[[LINC01158]]
+
|[[FAM66B]]
−
|linc-Brn1a
+
|FAM66E
−
|long intergenic non-protein coding RNA 1158
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01159''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289895 HSALNT0289895]
−
|[[LINC01159]]
+
|[[LINC00336]]
−
|linc-Brn1b
+
|C6orf227,NCRNA00336
−
|long intergenic non-protein coding RNA 1159
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01184''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289899 HSALNT0289899]
−
|[[LINC01184]]
+
|[[LINC00929]]
−
|FLJ33630
+
|NA
−
|long intergenic non-protein coding RNA 1184
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01185''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289906 HSALNT0289906]
−
|[[LINC01185]]
+
|[[LINC01204]]
−
|FLJ16341
+
|NA
−
|long intergenic non-protein coding RNA 1185
+
|NA
−
|Psoriasis
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01192''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289912 HSALNT0289912]
−
|[[LINC01192]]
+
|[[LINC01538]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1192
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01193''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289915 HSALNT0289915]
−
|[[LINC01193]]
+
|[[LINC01721]]
−
|LOC348120
+
|NA
−
|long intergenic non-protein coding RNA 1193
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01194''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289916 HSALNT0289916]
−
|[[LINC01194]]
+
|[[LINC01762]]
−
|TAG
+
|NA
−
|long intergenic non-protein coding RNA 1194
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289917 HSALNT0289917]
 +
|[[LINC01798]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01202''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290247 HSALNT0290247]
−
|[[LINC01202]]
+
|[[SMIM2-IT1]]
−
|N/A
+
|C13orf44-IT1
−
|long intergenic non-protein coding RNA 1202
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01207''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290316 HSALNT0290316]
−
|[[LINC01207]]
+
|[[TTTY7]]
−
|N/A
+
|CLONE795723,LINC00129,NCRNA00129A,TTTY7B,TTY7,TTTY7
−
|long intergenic non-protein coding RNA 1207
+
|NA
−
|Lung adenocarcinoma
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01225''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290175 HSALNT0290175]
−
|[[LINC01225]]
+
|[[RNA-a]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1225
+
|transcriptional regulation
−
|hepatocellular carcinoma
+
|pathogenic process
 +
|Opitz-Kaveggia syndrome
 +
|NA
 
|-
 
|-
−
|''LINC01228''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289525 HSALNT0289525]
−
|[[LINC01228]]
+
|[[116HG]]
−
|lincRNA-DYNLRB2-2
+
|NA
−
|long intergenic non-protein coding RNA 1228
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|Prader-Willi syndrome
 +
|Nervous System Diseases
 
|-
 
|-
−
|''LINC01230''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290320 HSALNT0290320]
−
|[[LINC01230]]
+
|[[U1 spliceosomal lncRNA]]
−
|"linc-DMRT2, lnc-DRMT2, TCONSN/A00015639"
+
|NA
−
|long intergenic non-protein coding RNA 1230
+
|NA
−
|_
+
|pathogenic process
 +
|Parkinson's disease
 +
|Nervous System Diseases
 
|-
 
|-
−
|''LINC01232''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289102 HSALNT0289102]
−
|[[LINC01232]]
+
|[[LINC01262]]
−
|"FLJ41590, TCONSN/A00021520"
+
|TCONS_l2_00021807,RP11-462G22.1
−
|long intergenic non-protein coding RNA 1232
+
|ceRNA
−
|_
+
|pathogenic process
 +
|Parkinson's disease
 +
|Nervous System Diseases
 
|-
 
|-
−
|''LINC01233''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289681 HSALNT0289681]
−
|[[LINC01233]]
+
|[[CCAT1-L]]
−
|XLOCN/A013014
+
|NA
−
|long intergenic non-protein coding RNA 1233
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01234''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290062 HSALNT0290062]
−
|[[LINC01234]]
+
|[[MT-LIPCAR]]
−
|onco-lncRNA-32
+
|uc022bqs.1,LIPCAR
−
|long intergenic non-protein coding RNA 1234
+
|NA
−
|oesophageal squamous cell carcinoma
+
|pathogenic process
 +
|heart disease
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01252''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289941 HSALNT0289941]
−
|[[LINC01252]]
+
|[[LIPCAR]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1252
+
|NA
−
|_
+
|pathogenic process
 +
|heart failure
 +
|Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01262''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0200965 HSALNT0200965]
−
|[[LINC01262]]
+
|[[TUSC8]]
−
|"TCONSN/Al2N/A00021807, RP11-462G22.1"
+
|LINC01071,XLOC_010588
−
|long intergenic non-protein coding RNA 1262
+
|NA
−
|Parkinson's disease
+
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''LINC01264''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0161787 HSALNT0161787]
 
|[[LINC01264]]
 
|[[LINC01264]]
 
|RP11-124O11.2
 
|RP11-124O11.2
−
|long intergenic non-protein coding RNA 1264
+
|NA
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01268''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289733 HSALNT0289733]
−
|[[LINC01268]]
+
|[[D4Z4]]
−
|LOC285758
+
|NA
−
|long intergenic non-protein coding RNA 1268
+
|NA
−
|_
+
|pathogenic process;developmental process
 +
|facioscapulohumeral muscular dystrophy
 +
|Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''LINC01296''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289678 HSALNT0289678]
−
|[[LINC01296]]
+
|[[CARL]]
−
|FLJ39632
+
|NA
−
|long intergenic non-protein coding RNA 1296
+
|ceRNA
−
|prognostic biomarker
+
|pathogenic process
 +
|myocardial infarction
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01312''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289923 HSALNT0289923]
−
|[[LINC01312]]
+
|[[Linc-CBR1-2]]
−
|MGC34034
+
|NA
−
|long intergenic non-protein coding RNA 1312
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01317''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0243354 HSALNT0243354]
−
|[[LINC01317]]
+
|[[Lnc-HEATR6-1:4]]
−
|N/A
+
|WAP four-disulfide core domain 21,pseudogene
−
|long intergenic non-protein coding RNA 1317
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|DC dysfunction
 +
|NA
 
|-
 
|-
−
|''LINC01370''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290232 HSALNT0290232]
−
|[[LINC01370]]
+
|[[RUNX1]]
−
|HI-LNC25
+
|NA
−
|long intergenic non-protein coding RNA 1370
+
|NA
−
|_
+
|pathogenic process
 +
|acute myeloid leukemia
 +
|Neoplasms
 
|-
 
|-
−
|''LINC01374''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290234 HSALNT0290234]
−
|[[LINC01374]]
+
|[[RUNXOR]]
−
|TCONSN/A00018278
+
|NA
−
|long intergenic non-protein coding RNA 1374
+
|NA
−
|hepatocellular carcinoma
+
|pathogenic process
 +
|hematopoietic malignancies
 +
|Neoplasms;Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''LINC01405''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289979 HSALNT0289979]
−
|[[LINC01405]]
+
|[[LncRNA-CIR]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1405
+
|NA
−
|_
+
|pathogenic process
 +
|osteoarthritis
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''LINC01411''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290368 HSALNT0290368]
−
|[[LINC01411]]
+
|[[VIM2P]]
−
|RP11-267A15.1
+
|NA
−
|long intergenic non-protein coding RNA 1411
+
|NA
−
|prostate cancer
+
|pathogenic process
 +
|osteoarthritis
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''LINC01420''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289879 HSALNT0289879]
−
|[[LINC01420]]
+
|[[KRAS1P]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1420
+
|NA
−
|_
+
|pathogenic process
 +
|cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LINC01433''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290054 HSALNT0290054]
−
|[[LINC01433]]
+
|[[MINA]]
−
|LOC728228
+
|NA
−
|long intergenic non-protein coding RNA 1433
+
|NA
−
|_
+
|pathogenic process
 +
|esophageal squamous cell cancer;gastric cancer;lung cancer;hepatocelluar cancer
 +
|Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01435''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289270 HSALNT0289270]
−
|[[LINC01435]]
+
|[[TMEM92-AS1]]
−
|"RP11-215N21.1, TCONSN/A00018040"
+
|RP11-893F2.9,lncRNA-508851,TCONS_00025237
−
|long intergenic non-protein coding RNA 1435
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01436''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288900 HSALNT0288900]
−
|[[LINC01436]]
+
|[[ENST00000604200.1]]
−
|AP000688.8
+
|LINC00468
−
|long intergenic non-protein coding RNA 1436
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01468''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289593 HSALNT0289593]
−
|[[LINC01468]]
+
|[[AK123657]]
−
|lnc-MBL2-4
+
|NA
−
|long intergenic non-protein coding RNA 1468
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01478''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289659 HSALNT0289659]
−
|[[LINC01478]]
+
|[[BX648207]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1478
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01501''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289660 HSALNT0289660]
−
|[[LINC01501]]
+
|[[BX649059]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1501
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01503''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289846 HSALNT0289846]
−
|[[LINC01503]]
+
|[[GAS2L3]]
−
|lnc-PPP2R4-5
+
|NA
−
|long intergenic non-protein coding RNA 1503
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01507''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289633 HSALNT0289633]
−
|[[LINC01507]]
+
|[[BC011663]]
−
|XLOCN/A000303
+
|NA
−
|long intergenic non-protein coding RNA 1507
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01511''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289867 HSALNT0289867]
−
|[[LINC01511]]
+
|[[HIV1230]]
−
|RP11-325I22.2
+
|NA
−
|long intergenic non-protein coding RNA 1511
+
|NA
−
|lung adenocarcinoma
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01512''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290045 HSALNT0290045]
−
|[[LINC01512]]
+
|[[M14574]]
−
|"LOC100132354, TCONSN/A00011120, HI-LNC77"
+
|NA
−
|long intergenic non-protein coding RNA 1512
+
|NA
−
|type 2 diabetes
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01513''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290245 HSALNT0290245]
−
|[[LINC01513]]
+
|[[SLCO5A1]]
−
|"RP11-1C1.7, TCONSN/A00009352"
+
|NA
−
|long intergenic non-protein coding RNA 1513
+
|NA
−
|lung adenocarcinoma
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01525''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290326 HSALNT0290326]
−
|[[LINC01525]]
+
|[[Uc.341]]
−
|lnc-MAN1A2-1
+
|NA
−
|long intergenic non-protein coding RNA 1525
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01526''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290344 HSALNT0290344]
−
|[[LINC01526]]
+
|[[Uc003iqu]]
−
|Lnc-FAM46A-1
+
|NA
−
|long intergenic non-protein coding RNA 1526
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01527''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290346 HSALNT0290346]
−
|[[LINC01527]]
+
|[[Uc003tfx]]
−
|lnc-SPRR2D-1
+
|NA
−
|long intergenic non-protein coding RNA 1527
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01537''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289950 HSALNT0289950]
−
|[[LINC01537]]
+
|[[Lnc-AL355149.1-1]]
−
|RP11-169D4.1-001
+
|NA
−
|long intergenic non-protein coding RNA 1537
+
|NA
−
|_
+
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 
|-
 
|-
−
|''LINC01547''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290001 HSALNT0290001]
−
|[[LINC01547]]
+
|[[Lnc-ZNF674-1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1547
+
|NA
−
|_
+
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 
|-
 
|-
−
|''LINC01553''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0286909 HSALNT0286909]
−
|[[LINC01553]]
+
|[[LINC00632]]
−
|AC023904.2
+
|NA
−
|long intergenic non-protein coding RNA 1553
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01558''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289105 HSALNT0289105]
−
|[[LINC01558]]
+
|[[LINC01317]]
−
|"HGC6.2, dJ431P23.4"
+
|NA
−
|long intergenic non-protein coding RNA 1558
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC01559''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234804 HSALNT0234804]
−
|[[LINC01559]]
+
|[[LINC01081]]
−
|FLJ33810
+
|TCONS_00024764
−
|long intergenic non-protein coding RNA 1559
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|alveolar capillary dysplasia
 +
|Respiratory Tract Diseases
 
|-
 
|-
−
|''LINC01560''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289840 HSALNT0289840]
−
|[[LINC01560]]
+
|[[FOSB]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1560
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01562''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289587 HSALNT0289587]
−
|[[LINC01562]]
+
|[[AK093543]]
−
|RP11-296A18.3
+
|NA
−
|long intergenic non-protein coding RNA 1562
+
|NA
−
|intervertebral disc degeneration
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01564''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289732 HSALNT0289732]
−
|[[LINC01564]]
+
|[[D16366]]
−
|TCONSN/A00011314
+
|NA
−
|long intergenic non-protein coding RNA 1564
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01565''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289814 HSALNT0289814]
−
|[[LINC01565]]
+
|[[ENST00000501583]]
−
|GR6
+
|NA
−
|long intergenic non-protein coding RNA 1565
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01574''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289907 HSALNT0289907]
−
|[[LINC01574]]
+
|[[LINC01374]]
−
|"HI-LNC12, TCONSN/A00009551"
+
|TCONS_00018278
−
|long intergenic non-protein coding RNA 1574
+
|NA
−
|type 2 diabetes
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC01587''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0231106 HSALNT0231106]
−
|[[LINC01587]]
+
|[[CASC22]]
−
|aC1
+
|LINC01373,TCONS_00024290,LincRNA-ENST00000515084
−
|long intergenic non-protein coding RNA 1587
+
|NA
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01589''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0058246 HSALNT0058246]
−
|[[LINC01589]]
+
|[[LINC00882]]
−
|"CTA-941F9.9, TCONSN/A00029353"
+
|NA
−
|long intergenic non-protein coding RNA 1589
+
|ceRNA
−
|_
+
|pathogenic process
 +
|airway diseases
 +
|Respiratory Tract Diseases
 
|-
 
|-
−
|''LINC01591''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018288 HSALNT0018288]
−
|[[LINC01591]]
+
|[[KIAA1614-AS1]]
−
|N/A
+
|RP11-46A10.4
−
|long intergenic non-protein coding RNA 1591
+
|ceRNA
−
|_
+
|pathogenic process
 +
|airway smooth muscle (ASM) disease
 +
|Respiratory Tract Diseases
 
|-
 
|-
−
|''LINC01602''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142310 HSALNT0142310]
−
|[[LINC01602]]
+
|[[LINC00536]]
−
|T1560
+
|NA
−
|long intergenic non-protein coding RNA 1602
+
|NA
−
|_
+
|pathogenic process
 +
|trichorhinophalangeal syndrome
 +
|NA
 
|-
 
|-
−
|''LINC01611''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0034200 HSALNT0034200]
−
|[[LINC01611]]
+
|[[LBX2-AS1]]
−
|"RP1-90L14.1, TCONSN/Al2N/A00025430"
+
|NA
−
|long intergenic non-protein coding RNA 1611
+
|NA
−
|_
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01612''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149799 HSALNT0149799]
−
|[[LINC01612]]
+
|[[ENST00000414223]]
−
|"RP11-789C1.1, TCONSN/A00008319"
+
|NA
−
|long intergenic non-protein coding RNA 1612
+
|NA
−
|gastric cancer
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01613''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290012 HSALNT0290012]
−
|[[LINC01613]]
+
|[[LOC105374631]]
−
|n341773
+
|NA
−
|long intergenic non-protein coding RNA 1613
+
|NA
−
|idiopathic pulmonary fibrosis
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01614''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290305 HSALNT0290305]
−
|[[LINC01614]]
+
|[[TMEM179]]
−
|"LCAL4, TCONSN/A00003105"
+
|NA
−
|long intergenic non-protein coding RNA 1614
+
|NA
−
|_
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01616''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290315 HSALNT0290315]
−
|[[LINC01616]]
+
|[[TSPAN8]]
−
|n341006
+
|NA
−
|long intergenic non-protein coding RNA 1616
+
|NA
−
|Alzheimer's disease
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01617''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290334 HSALNT0290334]
−
|[[LINC01617]]
+
|[[Uc001aka.2]]
−
|XLOCN/A006844
+
|NA
−
|long intergenic non-protein coding RNA 1617
+
|NA
−
|_
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01618''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290339 HSALNT0290339]
−
|[[LINC01618]]
+
|[[Uc001vjj.1]]
−
|LOC152578
+
|NA
−
|long intergenic non-protein coding RNA 1618
+
|NA
−
|colorectal cancer
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01622''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290343 HSALNT0290343]
−
|[[LINC01622]]
+
|[[Uc003erl.1]]
−
|TCONSN/A00011202
+
|NA
−
|long intergenic non-protein coding RNA 1622
+
|NA
−
|_
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01627''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290354 HSALNT0290354]
−
|[[LINC01627]]
+
|[[Uc009wkz.1]]
−
|RP11-397D12.4
+
|NA
−
|long intergenic non-protein coding RNA 1627
+
|NA
−
|NSCLC
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01628''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027893 HSALNT0027893]
−
|[[LINC01628]]
+
|[[ENST00000433810.1]]
−
|AC007403.1
+
|MYCNUN,lncUSMycN
−
|long intergenic non-protein coding RNA 1628
+
|NA
−
|_
+
|pathogenic process
 +
|neuroblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC01629''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273205 HSALNT0273205]
−
|[[LINC01629]]
+
|[[LINC01436]]
−
|linc-KIAA1737-2
+
|AP000688.8
−
|long intergenic non-protein coding RNA 1629
+
|NA
−
|_
+
|pathogenic process
 +
|Down syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''LINCMD1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266116 HSALNT0266116]
−
|[[LINCMD1]]
+
|[[MIR663AHG]]
−
|N/A
+
|RP3-410C9.1
−
|"long intergenic non-protein coding RNA, muscle differentiation 1"
+
|NA
−
|Duchenne muscular dystrophy
+
|pathogenic process
 +
|turner syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases
 
|-
 
|-
−
|''LINGO1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289108 HSALNT0289108]
−
|[[LINGO1-AS1]]
+
|[[LINC01435]]
−
|N/A
+
|RP11-215N21.1,TCONS_00018040
−
|LINGO1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LMCD1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289674 HSALNT0289674]
−
|[[LMCD1-AS1]]
+
|[[CADM3-AS1]]
−
|N/A
+
|NA
−
|LMCD1 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|bladder cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289882 HSALNT0289882]
 +
|[[KRT19P3]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|bladder cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''LOH12CR2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290310 HSALNT0290310]
−
|[[LOH12CR2]]
+
|[[TNXA]]
−
|LOH2CR12
+
|NA
−
|"loss of heterozygosity, 12, chromosomal region 2 (non-protein coding)"
+
|NA
−
|tumour suppressor
+
|pathogenic process
 +
|bladder cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''LOXL1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0008750 HSALNT0008750]
−
|[[LOXL1-AS1]]
+
|[[ZRANB2-AS2]]
−
|N/A
+
|NA
−
|LOXL1 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LPP-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289745 HSALNT0289745]
−
|[[LPP-AS2]]
+
|[[DMTF1]]
−
|N/A
+
|NA
−
|LPP antisense RNA 2
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LRP1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290059 HSALNT0290059]
−
|[[LRP1-AS]]
+
|[[MRUL]]
−
|N/A
+
|NA
−
|LRP1 antisense RNA
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LRRC75A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185163 HSALNT0185163]
−
|[[LRRC75A-AS1]]
+
|[[FAM66C]]
−
|MGC40157
+
|NA
−
|LRRC75A antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LUADT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289476 HSALNT0289476]
−
|[[LUADT1]]
+
|[[ENST00000357401.3]]
−
|N/A
+
|NA
−
|lung adenocarcinoma associated transcript 1
+
|NA
−
|lung adenocarcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LUNAR1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289535 HSALNT0289535]
−
|[[LUNAR1]]
+
|[[AA174084]]
−
|N/A
+
|NA
−
|leukemia-associated non-coding IGF1R activator RNA 1
+
|NA
−
|leukemia
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MAFA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266298 HSALNT0266298]
−
|[[MAFA-AS1]]
+
|[[ABALON]]
−
|"RP11-909N17.3, TCONSN/A00014882"
+
|INXS
−
|MAFA antisense RNA 1
+
|splicing regulation
−
|_
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''MAFG-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290370 HSALNT0290370]
−
|[[MAFG-AS1]]
+
|[[VTRNA2-1]]
−
|N/A
+
|CBL-3,CBL3,MIR886,MIRN886,VTRNA2,hsa-mir-886,hvg-5,nc886,svtRNA2-1a
−
|MAFG antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MAFTRR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289619 HSALNT0289619]
−
|[[MAFTRR]]
+
|[[ASK00420]]
−
|linc-MAF-4
+
|NA
−
|MAF transcriptional regulator RNA
+
|NA
−
|_
+
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''MAGEA8-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289749 HSALNT0289749]
−
|[[MAGEA8-AS1]]
+
|[[EBIC]]
−
|RP5-869M20.2
+
|NA
−
|MAGEA8 antisense RNA 1 (head to head)
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''MAPKAPK5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290299 HSALNT0290299]
−
|[[MAPKAPK5-AS1]]
+
|[[TI09485]]
−
|FLJ39616
+
|NA
−
|MAPKAPK5 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''MCM3AP-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290300 HSALNT0290300]
−
|[[MCM3AP-AS1]]
+
|[[TI10124]]
−
|"FLJ10508, NCRNA00031"
+
|NA
−
|MCM3AP antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''MDC1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290301 HSALNT0290301]
−
|[[MDC1-AS1]]
+
|[[TI13831]]
−
|MDC1-AS
+
|NA
−
|MDC1 antisense RNA 1
+
|NA
−
| bladder cancer
+
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''MEF2C-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290302 HSALNT0290302]
−
|[[MEF2C-AS1]]
+
|[[TI18318]]
−
|N/A
+
|NA
−
|MEF2C antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''MEG9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290303 HSALNT0290303]
−
|[[ENST00000553584.1]]
+
|[[TI21327]]
−
|LINC00584
+
|NA
−
|maternally expressed 9 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''MESTIT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290304 HSALNT0290304]
−
|[[MESTIT1]]
+
|[[TI22687]]
−
|"NCRNA00040, MEST-AS1"
+
|NA
−
|"MEST intronic transcript 1, antisense RNA"
+
|NA
−
|_
+
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''MGAT3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290307 HSALNT0290307]
−
|[[MGAT3-AS1]]
+
|[[TMPOP2]]
−
|TapSAKI
+
|NA
−
|MGAT3 antisense RNA 1
+
|transcriptional regulation
−
|acute kidney injury
+
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''MHRT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289570 HSALNT0289570]
−
|[[MHRT]]
+
|[[AK021444]]
−
|Myheart
+
|NA
−
|myosin heavy chain-associated RNA transcript
+
|NA
−
|heart pathological hypertrophy
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MIF-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289601 HSALNT0289601]
−
|[[MIF-AS1]]
+
|[[AK307796]]
−
|LOC284889
+
|NA
−
|MIF antisense RNA 1
+
|NA
−
|malaria susceptibility
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MIMT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289801 HSALNT0289801]
−
|[[MIMT1]]
+
|[[ENST00000425785]]
−
|"MIM1, NCRNA00067, LINC00067"
+
|SEC63P1
−
|MER1 repeat containing imprinted transcript 1 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MINCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289871 HSALNT0289871]
−
|[[ENST00000517411.1]]
+
|[[HOXB-AS3]]
−
|TCONSN/A00015189
+
|NA
−
|MYC-induced long noncoding RNA
+
|NA
−
|Burkitt lymphoma
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MIR137HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290367 HSALNT0290367]
−
|[[MIR137HG]]
+
|[[URHC]]
−
|N/A
+
|NA
−
|MIR137 host gene
+
|NA
−
|schizophrenia
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MIR17HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289085 HSALNT0289085]
−
|[[MIR17HG]]
+
|[[LINC01080]]
−
|"FLJ14178, MIRH1, MIHG1, NCRNA00048, miR-17-92, LINC00048"
+
|TCONS_00021856
−
|miR-17-92a-1 cluster host gene
+
|NA
−
|lymphoma, syndromic developmental defect
+
|pathogenic process
 +
|Alzheimer's disease
 +
|Mental Disorders;Nervous System Diseases
 
|-
 
|-
−
|''MIR181A2HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289751 HSALNT0289751]
−
|[[MIR181A2HG]]
+
|[[EFNA3]]
−
|N/A
+
|NA
−
|MIR181A2 host gene
+
|NA
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''MIR210HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289798 HSALNT0289798]
−
|[[MIR210HG]]
+
|[[ENST00000395084]]
−
|N/A
+
|NA
−
|MIR210 host gene
+
|NA
−
|inflammatory renal epithelial injury
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MIR34AHG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289829 HSALNT0289829]
−
|[[MIR34AHG]]
+
|[[FAM83A-AS1]]
−
|N/A
+
|NA
−
|MIR34A host gene
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MIR4435-2HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290164 HSALNT0290164]
−
|[[MIR4435-2HG]]
+
|[[RAD1]]
−
|"LINC00978, AGD2, AK001796"
+
|NA
−
|MIR4435-2 host gene
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MIR600HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289585 HSALNT0289585]
−
|[[MIR600HG]]
+
|[[AK056988]]
−
|"GL012, FLJ22161"
+
|NA
−
|MIR600 host gene
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MIR663AHG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289638 HSALNT0289638]
−
|[[MIR663AHG]]
+
|[[BC017743]]
−
|RP3-410C9.1
+
|NA
−
|MIR663A host gene
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MIR7-3HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290156 HSALNT0290156]
−
|[[MIR7-3HG]]
+
|[[PRR26]]
−
|"PGSF1, PGSF1a, PGSF1b, Huh7, uc002mbe.2"
+
|C10orf108
−
|MIR7-3 host gene
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MIRLET7BHG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290349 HSALNT0290349]
−
|[[MIRLET7BHG]]
+
|[[Uc003yqb.1]]
−
|linc-Ppara
+
|NA
−
|MIRLET7B host gene
+
|NA
−
|asbestos exposure-related lung cancer
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MIRLET7DHG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289675 HSALNT0289675]
−
|[[MIRLET7DHG]]
+
|[[CAI2]]
−
|N/A
+
|NA
−
|MIRLET7D host gene
+
|NA
−
|_
+
|pathogenic process
 +
|neuroblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''MKRN3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290313 HSALNT0290313]
−
|[[MKRN3-AS1]]
+
|[[TSLC1-AS1]]
−
|"FNZ127, NCRNA00009, ZNF127-AS"
+
|NA
−
|MKRN3 antisense RNA 1
+
|NA
−
|Prader-Willi syndrome ;Angelman syndromes
+
|pathogenic process
 +
|glioma
 +
|Neoplasms
 
|-
 
|-
−
|''MLK7-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013359 HSALNT0013359]
−
|[[MLK7-AS1]]
+
|[[LINC01525]]
−
|N/A
+
|lnc-MAN1A2-1
−
|MLK7 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''MLLT4-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0109106 HSALNT0109106]
−
|[[MLLT4-AS1]]
+
|[[LINC01526]]
−
|"HGC6.4, dJ431P23.3"
+
|Lnc-FAM46A-1
−
|MLLT4 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''MORF4L2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0162774 HSALNT0162774]
−
|[[MORF4L2-AS1]]
+
|[[LINC01468]]
−
|N/A
+
|lnc-MBL2-4
−
|MORF4L2 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''MT-LIPCAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289110 HSALNT0289110]
−
|[[MT-LIPCAR]]
+
|[[LINC01503]]
−
|"uc022bqs.1, LIPCAR"
+
|lnc-PPP2R4-5
−
|mitochondrially encoded long non-coding cardiac associated RNA
+
|NA
−
|heart failure
+
|pathogenic process
 +
|tongue squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''MYCNOS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289968 HSALNT0289968]
−
|[[MYCNOS]]
+
|[[Lnc-MBL2-4:3]]
−
|"NCYM, N-CYM, MYCN-AS1"
+
|NA
−
|MYCN opposite strand
+
|NA
−
|neuroblastoma
+
|pathogenic process
 +
|tongue squamous cell cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289993 HSALNT0289993]
 +
|[[Lnc-STXBP5-1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|tongue squamous cell cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289563 HSALNT0289563]
 +
|[[AF118081]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''N4BP2L2-IT2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289597 HSALNT0289597]
−
|[[N4BP2L2-IT2]]
+
|[[AK124939]]
−
|CG030
+
|NA
−
|N4BPL2 intronic transcript 2
+
|NA
−
|_
+
|pathogenic process
 +
|pulmonary adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''NALT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290153 HSALNT0290153]
−
|[[NALT1]]
+
|[[PRAS]]
−
|TCONSN/Al2N/A00029132
+
|NA
−
|NOTCH1 associated lncRNA in T-cell acute lymphoblastic leukemia 1
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''NBAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290249 HSALNT0290249]
−
|[[NBAT1]]
+
|[[SNAR-A1]]
−
|NBAT-1
+
|NA
−
|neuroblastoma associated transcript 1
+
|NA
−
|Fighting Neuroblastomas ;breast cancer
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''NBR2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289929 HSALNT0289929]
−
|[[NBR2]]
+
|[[LincRNA-BC2]]
−
|NCRNA00192
+
|NA
−
|neighbor of BRCA1 gene 2 (non-protein coding)
+
|NA
 +
|pathogenic process
 
|breast cancer
 
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''NCBP2-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289930 HSALNT0289930]
−
|[[NCBP2-AS2]]
+
|[[LincRNA-BC4]]
−
|N/A
+
|NA
−
|NCBP2 antisense RNA 2 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''NCOA7-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289931 HSALNT0289931]
−
|[[NCOA7-AS1]]
+
|[[LincRNA-BC5]]
−
|N/A
+
|NA
−
|NCOA7 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''NCRUPAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289932 HSALNT0289932]
−
|[[NCRUPAR]]
+
|[[LincRNA-BC8]]
−
|"ncR-uPAR, ncRuPAR, NCRNA00193"
+
|NA
−
|"non-protein coding RNA, upstream of F2R/PAR1"
+
|NA
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''NFIA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0083190 HSALNT0083190]
−
|[[NFIA-AS1]]
+
|[[LINC01511]]
−
|RP5-833A20.1
+
|RP11-325I22.2
−
|NFIA antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NIPBL-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290026 HSALNT0290026]
−
|[[NIPBL-AS1]]
+
|[[LOC440905]]
−
|NIPBL-AS
+
|NA
−
|NIPBL antisense RNA 1 (head to head)
+
|NA
−
| autism spectrum disorders
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NKILA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289552 HSALNT0289552]
−
|[[NKILA]]
+
|[[AC079776.2]]
−
|N/A
+
|NA
−
|NF-kappaB interacting long non-coding RNA
+
|NA
−
| breast cancer
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NKX2-2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289720 HSALNT0289720]
−
|[[NKX2-2-AS1]]
+
|[[CTA-363E6.2]]
−
|NKX2-2AS
+
|NA
−
|NKX2-2 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NOP14-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289901 HSALNT0289901]
−
|[[NOP14-AS1]]
+
|[[LINC00987]]
−
|RES4-24
+
|NA
−
|NOP14 antisense RNA 1
+
|NA
−
|Huntington disease
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290185 HSALNT0290185]
 +
|[[RP11-1C1.7]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NORAD''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290197 HSALNT0290197]
−
|[[NORAD]]
+
|[[RP11-445K13.2]]
−
|N/A
+
|NA
−
|non-coding RNA activated by DNA damage
+
|NA
−
|_
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NPHP3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290199 HSALNT0290199]
−
|[[NPHP3-AS1]]
+
|[[RP11-473M20.11]]
−
|N/A
+
|NA
−
|NPHP3 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NPPA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290213 HSALNT0290213]
−
|[[NPPA-AS1]]
+
|[[RP11-893F2.6]]
−
|N/A
+
|NA
−
|NPPA antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NPSR1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290217 HSALNT0290217]
−
|[[NPSR1-AS1]]
+
|[[RP13-514E23.1]]
−
|"AAA1, IMAGE:4827585"
+
|NA
−
|NPSR1 antisense RNA 1
+
|NA
−
|cardiovascular disease
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NPTN-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290218 HSALNT0290218]
−
|[[NPTN-IT1]]
+
|[[RP1-90D4.3]]
−
|lncRNA-LET
+
|NA
−
|NPTN intronic transcript 1
+
|NA
−
|colorectal cancer; hepatocelluar carcinoma;squamous-cell lung carcinomas
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NR2F1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290220 HSALNT0290220]
−
|[[NR2F1-AS1]]
+
|[[RP4-575N6.5]]
−
|FLJ42709
+
|NA
−
|NR2F1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NRAV''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290226 HSALNT0290226]
−
|[[NRAV]]
+
|[[RP5-826L7.1]]
−
|N/A
+
|NA
−
|negative regulator of antiviral response (non-protein coding)
+
|NA
−
|influenza A virus (IAV) infection
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''OLMALINC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290378 HSALNT0290378]
−
|[[OLMALINC]]
+
|[[XLOC_003286]]
−
|"bA34D15.5, FLJ12974, HI-LNC80"
+
|NA
−
|oligodendrocyte maturation-associated long intergenic non-coding RNA
+
|NA
−
|_
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''PANCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290379 HSALNT0290379]
−
|[[PANCR]]
+
|[[XLOC_003405]]
−
|N/A
+
|NA
−
|PITX2 adjacent non-coding RNA
+
|NA
−
|_
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''PAPPA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290389 HSALNT0290389]
−
|[[PAPPA-AS1]]
+
|[[XLOC_012255]]
−
|"PAPPA-AS, DIPAS, TAF4B, TAF2C2, TAFII105, NCRNA00156"
+
|NA
−
|PAPPA antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''PAPPA-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290056 HSALNT0290056]
−
|[[PAPPA-AS2]]
+
|[[MIR21]]
−
|AGU1
+
|NA
−
|PAPPA antisense RNA 2
+
|NA
−
|stem cell differentiation
+
|pathogenic process
 +
|laryngeal squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''PARTICL''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289621 HSALNT0289621]
−
|[[PARTICL]]
+
|[[ASncmtRNAs]]
−
|PARTICLE
+
|NA
−
|promoter of MAT2A antisense radiation-induced circulating long non-coding RNA
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|cancer
 +
|Neoplasms
 
|-
 
|-
−
|''PAXIP1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289316 HSALNT0289316]
−
|[[PAXIP1-AS1]]
+
|[[LINC01614]]
−
|N/A
+
|LCAL4,TCONS_00003105
−
|PAXIP1 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''PCAT14''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289982 HSALNT0289982]
−
|[[PCAT14]]
+
|[[LncRNA-FER1L4]]
−
|N/A
+
|NA
−
|prostate cancer associated transcript 14 (non-protein coding)
+
|ceRNA
−
|prostate cancer
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''PCAT18''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290016 HSALNT0290016]
−
|[[PCAT18]]
+
|[[LOC283177]]
−
|LINC01092
+
|NA
−
|prostate cancer associated transcript 18 (non-protein coding)
+
|NA
−
| metastatic prostate cancer
+
|pathogenic process
 +
|diffuse large B-cell lymphoma
 +
|Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''PCAT19''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289003 HSALNT0289003]
−
|[[PCAT19]]
+
|[[HORMAD2-AS1]]
−
|LINC01190
+
|MTMR3-AS1,NONHSAG033653
−
|prostate cancer associated transcript 19 (non-protein coding)
+
|NA
−
|prostate cancer
+
|pathogenic process
 +
|type 1 diabetes;bowel disease
 +
|Nutritional and Metabolic Diseases;Endocrine System Diseases;Digestive System Diseases
 
|-
 
|-
−
|''PCAT29''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290372 HSALNT0290372]
−
|[[PCAT29]]
+
|[[WNT4]]
−
|N/A
+
|NA
−
|prostate cancer associated transcript 29 (non-protein coding)
+
|NA
−
|prostate cancer
+
|pathogenic process
 +
|endometriosis
 +
|Female Urogenital Diseases and Pregnancy Complications
 
|-
 
|-
−
|''PCAT5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289540 HSALNT0289540]
−
|[[PCAT5]]
+
|[[AB074278]]
−
|TPCAT-10-36067
+
|NA
−
|prostate cancer associated transcript 5 (non-protein coding)
+
|NA
−
|Prostate Cancer
+
|pathogenic process
 +
|bladder cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''PCBP2-OT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290166 HSALNT0290166]
−
|[[PCBP2-OT1]]
+
|[[RCCRT1]]
−
|TUC338
+
|NA
−
|PCBP2 overlapping transcript 1
+
|NA
−
|hepatocellular carcinoma
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''PCBP3-OT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289043 HSALNT0289043]
−
|[[PCBP3-OT1]]
+
|[[LINC00491]]
−
|FLJ44028
+
|BC008363
−
|PCBP3 overlapping transcript 1
+
|NA
−
|DNA damage
+
|pathogenic process
 +
|pancreatic ductal adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''PCF11-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289858 HSALNT0289858]
−
|[[PCF11-AS1]]
+
|[[H1.3]]
−
|ENST00000602322.1
+
|NA
−
|PCF11 anstisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''PCNA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289896 HSALNT0289896]
−
|[[PCNA-AS1]]
+
|[[LINC00582]]
−
|N/A
+
|NA
−
|PCNA antisense RNA 1
+
|NA
−
|tumor
+
|pathogenic process
 +
|endometrial cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''PEG13''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289301 HSALNT0289301]
−
|[[PEG13]]
+
|[[LINC01537]]
−
|N/A
+
|RP11-169D4.1-001
−
|paternally expressed 13
+
|NA
−
|_
+
|pathogenic process
 +
|laryngeal squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''PEG3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289551 HSALNT0289551]
−
|[[PEG3-AS1]]
+
|[[AC026166.2]]
−
|"APEG3, NCRNA00155"
+
|MTCO1P5
−
|PEG3 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|laryngeal squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''PICSAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290184 HSALNT0290184]
−
|[[PICSAR]]
+
|[[RP11-169D4.1-001]]
−
|"PRED74, NLC1-C"
+
|NA
−
|P38 inhibited cutaneous squamous cell carcinoma associated lincRNA
+
|NA
−
|Cutaneous Squamous Cell Carcinoma
+
|pathogenic process
 +
|laryngeal squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''PINK1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289545 HSALNT0289545]
−
|[[PINK1-AS]]
+
|[[AC006050.3]]
−
|"FLJ00387, PINK1AS, naPINK1"
+
|NA
−
|PINK1 antisense RNA
+
|NA
−
|_
+
|pathogenic process
 +
|lung squamous cell cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''PISRT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289556 HSALNT0289556]
−
|[[PISRT1]]
+
|[[AC138128.1]]
−
|NCRNA00195
+
|NA
−
|polled intersex syndrome regulated transcript 1 (non-protein coding RNA)
+
|NA
−
|blepharophimosis syndrome
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''PRKCQ-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289818 HSALNT0289818]
−
|[[PRKCQ-AS1]]
+
|[[ERCC1]]
−
|ENST00000414894.1
+
|NA
−
|PRKCQ antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''PRR7-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290061 HSALNT0290061]
−
|[[PRR7-AS1]]
+
|[[MT1DP]]
−
|N/A
+
|MT1DP
−
|PRR7 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|liver cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''PSMA3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289578 HSALNT0289578]
−
|[[PSMA3-AS1]]
+
|[[AK023096]]
−
|FLJ31306
+
|NA
−
|PSMA3 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|Wilms’ tumor;uterine leiomyomas
 +
|Neoplasms
 
|-
 
|-
−
|''PSMD5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289112 HSALNT0289112]
−
|[[PSMD5-AS1]]
+
|[[LINC01562]]
−
|N/A
+
|RP11-296A18.3
−
|PSMD5 antisense RNA 1 (head to head)
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|intervertebral disc degeneration
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''PTENP1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289567 HSALNT0289567]
−
|[[PTENP1-AS]]
+
|[[AK000974]]
−
|PTENpg1-asRNA
+
|NA
−
|PTENP1 antisense RNA
+
|NA
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''PTPRJ-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289579 HSALNT0289579]
−
|[[PTPRJ-AS1]]
+
|[[AK024118]]
−
|N/A
+
|NA
−
|PTPRJ antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''PWAR1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289645 HSALNT0289645]
−
|[[PWAR1]]
+
|[[BC040204]]
−
|"PAR1, PAR-1"
+
|NA
−
|Prader Willi/Angelman region RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''PWAR4''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290321 HSALNT0290321]
−
|[[PWAR4]]
+
|[[U79277]]
−
|"PAR4, PAR-4"
+
|NA
−
|Prader Willi/Angelman region RNA 4
+
|NA
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''PWAR5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289869 HSALNT0289869]
−
|[[PWAR5]]
+
|[[HOST2]]
−
|"PAR5, PAR-5"
+
|NA
−
|Prader Willi/Angelman region RNA 5
+
|ceRNA
−
|_
+
|pathogenic process
 +
|epithelial ovarian cancer
 +
|Neoplasms
 
|-
 
|-
−
|''PWARSN''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289368 HSALNT0289368]
−
|[[PWARSN]]
+
|[[MGAT3-AS1]]
−
|"PAR-SN, PARSN"
+
|TapSAKI
−
|"Prader Willi/Angelman region RNA, SNRPN neighbor"
+
|NA
−
|Prader-Willi syndrome
+
|pathogenic process
 +
|acute kidney injury
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289624 HSALNT0289624]
 +
|[[ATXN7L3B]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|spinocerebellar ataxia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''RAD51-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289990 HSALNT0289990]
−
|[[RAD51-AS1]]
+
|[[Lnc-SCA7]]
−
|TODRA
+
|NA
−
|RAD51 antisense RNA 1 (head to head)
+
|ceRNA
−
|_
+
|pathogenic process
 +
|spinocerebellar ataxia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''RFPL1S''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290004 HSALNT0290004]
−
|[[RFPL1S]]
+
|[[LOC100287482]]
−
|"RFPL1-AS, NCRNA00006"
+
|NA
−
|RFPL1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''RGMB-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290383 HSALNT0290383]
−
|[[RGMB-AS1]]
+
|[[XLOC_007697]]
−
|N/A
+
|NA
−
|RGMB antisense RNA 1
+
|NA
−
|non-small cell lung cancer
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''RHPN1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290384 HSALNT0290384]
−
|[[RHPN1-AS1]]
+
|[[XLOC_008559]]
−
|MGC3113
+
|NA
−
|RHPN1 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''RMST''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290385 HSALNT0290385]
−
|[[RMST]]
+
|[[XLOC_009911]]
−
|"NCRMS, NCRNA00054, LINC00054"
+
|NA
−
|rhabdomyosarcoma 2 associated transcript (non-protein coding)
+
|NA
−
|Rhabdomyosarcoma subtypes
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''RNF217-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289813 HSALNT0289813]
−
|[[RNF217-AS1]]
+
|[[ENST00000480739]]
−
|STL
+
|RPL13AP23
−
|RNF217 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''RNF219-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290111 HSALNT0290111]
−
|[[RNF219-AS1]]
+
|[[OS9]]
−
|N/A
+
|NA
−
|RNF219 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''RPL34-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290324 HSALNT0290324]
−
|[[RPL34-AS1]]
+
|[[Uc.283-plus]]
−
|"FLJ37673, RP11-462C24.1"
+
|NA
−
|RPL34 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|glioma
 +
|Neoplasms
 
|-
 
|-
−
|''RPS6KA2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289117 HSALNT0289117]
−
|[[RPS6KA2-AS1]]
+
|[[LINC01611]]
−
|N/A
+
|RP1-90L14.1,TCONS_l2_00025430
−
|RPS6KA2 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|diabetic retinopathy
 +
|Endocrine System Diseases;Male Urogenital Diseases;Cardiovascular Diseases
 
|-
 
|-
−
|''RUSC1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289529 HSALNT0289529]
−
|[[RUSC1-AS1]]
+
|[[2900055J20Rik]]
−
|FLJ35976
+
|2900055J20Rik
−
|RUSC1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|left ventricular hypertrophy
 +
|Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
 
|-
 
|-
−
|''SALRNA1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289792 HSALNT0289792]
−
|[[SALRNA1]]
+
|[[ENSG00000261777]]
−
|"SAL-RNA1, XLOCN/A023166"
+
|AC012184.3
−
|senescence associated long non-coding RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''SALRNA2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289618 HSALNT0289618]
−
|[[SALRNA2]]
+
|[[Asb3]]
−
|"SAL-RNA2, XLOCN/A025931"
+
|NA
−
|senescence associated long non-coding RNA 2
+
|NA
−
|_
+
|pathogenic process
 +
|cardiovascular and renal disease
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''SALRNA3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289703 HSALNT0289703]
−
|[[SALRNA3]]
+
|[[Chac2]]
−
|"SAL-RNA3, XLOCN/A025918"
+
|NA
−
|senescence associated long non-coding RNA 3
+
|NA
−
|_
+
|pathogenic process
 +
|cardiovascular and renal disease
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''SAMD12-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290139 HSALNT0290139]
−
|[[SAMD12-AS1]]
+
|[[Pex11b]]
−
|N/A
+
|NA
−
|SAMD12 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|cardiovascular and renal disease
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''SAMMSON''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290255 HSALNT0290255]
−
|[[SAMMSON]]
+
|[[Sp5]]
−
|N/A
+
|NA
−
|survival associated mitochondrial melanoma specific oncogenic non-coding RNA
+
|NA
−
|Melanoma
+
|pathogenic process
 +
|cardiovascular and renal disease
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''SAP30L-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211639 HSALNT0211639]
−
|[[SAP30L-AS1]]
+
|[[PSMA3-AS1]]
−
|"FLJ38109, GALNT10-AS1"
+
|FLJ31306
−
|SAP30L antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SEC24B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289319 HSALNT0289319]
−
|[[SEC24B-AS1]]
+
|[[LINC00493]]
−
|1/2-SBSRNA4
+
|LOC388789
−
|SEC24B antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SGMS1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288903 HSALNT0288903]
−
|[[SGMS1-AS1]]
+
|[[CARD8-AS1]]
−
|N/A
+
|LOC100505812
−
|SGMS1 antisense RNA 1
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|leukemia and neuroblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''SIRT1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0064729 HSALNT0064729]
−
|[[SIRT1-AS]]
+
|[[KCNMB2-AS1]]
−
|N/A
+
|RP11-385J1.2
−
|SIRT1 antisense RNA
+
|NA
−
|Hepatocellular Carcinoma
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''SMAD1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289548 HSALNT0289548]
−
|[[SMAD1-AS1]]
+
|[[AC013264.2]]
−
|ENST00000513542
+
|NA
−
|SMAD1 antisense RNA 1
+
|NA
−
|Ventricular septal defects
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''SMAD5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289857 HSALNT0289857]
−
|[[SMAD5-AS1]]
+
|[[GUCY1B2]]
−
|DAMS
+
|NA
−
|SMAD5 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''SMCR2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290190 HSALNT0290190]
−
|[[SMCR2]]
+
|[[RP11-385J1.2]]
−
|N/A
+
|NA
−
|"Smith-Magenis syndrome chromosome region, candidate 2 (non-protein coding)"
+
|NA
−
|_
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''SMCR5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290216 HSALNT0290216]
−
|[[SMCR5]]
+
|[[RP1-317E23.3]]
−
|NCRNA00034
+
|NA
−
|"Smith-Magenis syndrome chromosome region, candidate 5 (non-protein coding)"
+
|NA
−
|_
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''SMCR6''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290317 HSALNT0290317]
−
|[[SMCR6]]
+
|[[TUBA4B]]
−
|N/A
+
|NA
−
|"Smith-Magenis syndrome chromosome region, candidate 6 (non-protein coding)"
+
|NA
−
|Smith-Magenis syndrome
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''SMG7-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290375 HSALNT0290375]
−
|[[SMG7-AS1]]
+
|[[XLOC_000371]]
−
|DKFZP564C196
+
|NA
−
|SMG7 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''SNAI3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290397 HSALNT0290397]
−
|[[SNAI3-AS1]]
+
|[[Z82214.3]]
−
|MGC23284
+
|NA
−
|SNAI3 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''SNHG10''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289735 HSALNT0289735]
−
|[[SNHG10]]
+
|[[DALIR]]
−
|"FLJ40557, NCRNA00063, LINC00063"
+
|DALI
−
|small nucleolar RNA host gene 10
+
|transcriptional regulation
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SNHG11''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290376 HSALNT0290376]
−
|[[SNHG11]]
+
|[[XLOC_000620]]
−
|LINC00101
+
|NA
−
|small nucleolar RNA host gene 11
+
|NA
−
|obesity
+
|pathogenic process
 +
|H. pylori-related diseases
 +
|Bacterial Infections and Mycoses
 
|-
 
|-
−
|''SNHG12''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290380 HSALNT0290380]
−
|[[SNHG12]]
+
|[[XLOC_004122]]
−
|"PNAS-123, LINC00100, ASLNC04080"
+
|NA
−
|small nucleolar RNA host gene 12
+
|NA
−
|osteosarcoma
+
|pathogenic process
 +
|H. pylori-related diseases
 +
|Bacterial Infections and Mycoses
 
|-
 
|-
−
|''SNHG14''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290381 HSALNT0290381]
−
|[[SNHG14]]
+
|[[XLOC_004562]]
−
|"NCRNA00214, UBE3A-AS"
+
|NA
−
|small nucleolar RNA host gene 14
+
|NA
−
| Prader-Willi
+
|pathogenic process
 +
|H. pylori-related diseases
 +
|Bacterial Infections and Mycoses
 
|-
 
|-
−
|''SNHG15''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290382 HSALNT0290382]
−
|[[SNHG15]]
+
|[[XLOC_005912]]
−
|"FLJ38860, MYO1GUT, Linc-Myo1g"
+
|NA
−
|small nucleolar RNA host gene 15
+
|NA
−
|hepatocellular carcinoma
+
|pathogenic process
 +
|H. pylori-related diseases
 +
|Bacterial Infections and Mycoses
 
|-
 
|-
−
|''SNHG16''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290391 HSALNT0290391]
−
|[[NONHSAT056039]]
+
|[[XLOC_014388]]
−
|ncRAN
+
|NA
−
|small nucleolar RNA host gene 16
+
|NA
−
|bladder cancer, colorectal cancer
+
|pathogenic process
 +
|H. pylori-related diseases
 +
|Bacterial Infections and Mycoses
 
|-
 
|-
−
|''SNHG20''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290028 HSALNT0290028]
−
|[[SNHG20]]
+
|[[LOC652276]]
−
|"PRO0872, FLJ25582, DKFZp686L05235, SCARNA16HG"
+
|NA
−
|small nucleolar RNA host gene 20
+
|NA
−
|Hepatocellular Carcinoma
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''SNHG7''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290162 HSALNT0290162]
−
|[[SNHG7]]
+
|[[R05532]]
−
|"MGC16037, NCRNA00061"
+
|NA
−
|small nucleolar RNA host gene 7
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''SNHG8''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0098175 HSALNT0098175]
−
|[[SNHG8]]
+
|[[LINC01411]]
−
|"NCRNA00060, LINC00060"
+
|RP11-267A15.1
−
|small nucleolar RNA host gene 8
+
|NA
−
|_
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''SOCS2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290025 HSALNT0290025]
−
|[[SOCS2-AS1]]
+
|[[LOC401317]]
−
|N/A
+
|NA
−
|SOCS2 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 
|-
 
|-
−
|''SOX21-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289726 HSALNT0289726]
−
|[[SOX21-AS1]]
+
|[[CTD-2574D22.4]]
−
|N/A
+
|AC120114.2
−
|SOX21 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|osteoarthritis
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''SOX2-OT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290141 HSALNT0290141]
−
|[[SOX2-OT]]
+
|[[PMS2L2]]
−
|"DKFZp761J1324, NCRNA00043"
+
|NA
−
|SOX2 overlapping transcript
+
|NA
−
|Esophageal squamous cell cancer, Alzheimer's disease,Neurodevelopmental syndromes associated with the SOX2 locus
+
|pathogenic process
 +
|osteoarthritis
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''SPATA3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289974 HSALNT0289974]
−
|[[SPATA3-AS1]]
+
|[[LncRNA-422]]
−
|N/A
+
|NA
−
|SPATA3 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''ST7-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289520 HSALNT0289520]
−
|[[ST7-AS1]]
+
|[[AATBC]]
−
|ST7AS1
+
|NA
−
|ST7 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|bladder cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289311 HSALNT0289311]
 +
|[[LINC00974]]
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''ST7-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0089943 HSALNT0089943]
−
|[[ST7-AS2]]
+
|[[ZBED3-AS1]]
−
|ST7AS2
+
|NA
−
|ST7 antisense RNA 2
+
|NA
−
|_
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ST7-OT3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289116 HSALNT0289116]
−
|[[ST7-OT3]]
+
|[[LINC01589]]
−
|NCRNA00026
+
|CTA-941F9.9,TCONS_00029353
−
|ST7 overlapping transcript 3
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''STAM-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289910 HSALNT0289910]
−
|[[STAM-AS1]]
+
|[[LINC01426]]
−
|locus3182
+
|NA
−
|STAM antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|esophageal squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''STX18-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290341 HSALNT0290341]
−
|[[STX18-AS1]]
+
|[[Uc002yug.2]]
−
|LOC100507266
+
|NA
−
|STX18 antisense RNA 1 (head to head)
+
|splicing regulation
−
|_
+
|pathogenic process
 +
|esophageal squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''TCL6''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290250 HSALNT0290250]
−
|[[TCL6]]
+
|[[SNCG]]
−
|"TCL6e1, TNG2, TNG1"
+
|NA
−
|T-cell leukemia/lymphoma 6 (non-protein coding)
+
|NA
−
|leukemia, lymphoma
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''TDRG1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289996 HSALNT0289996]
−
|[[NONHSAT112472]]
+
|[[Lnc-uc003wbd]]
−
|"LINC00532, lincRNA-NRN/A024015"
+
|NA
−
|testis development related 1 (non-protein coding)
+
|NA
−
|testicular cancer
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''TEX41''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289559 HSALNT0289559]
−
|[[TEX41]]
+
|[[AF085935]]
−
|"DKFZp686O1327, LINC00953"
+
|NA
−
|testis expressed 41 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''TGFB2-OT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290347 HSALNT0290347]
−
|[[TGFB2-OT1]]
+
|[[Uc003wbd]]
−
|FLJ11812
+
|NA
−
|TGFB2 overlapping transcript 1
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''TH2LCRR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290098 HSALNT0290098]
−
|[[TH2LCRR]]
+
|[[NR_001284]]
−
|TH2-LCR
+
|TNXA
−
|T helper type 2 locus control region associated RNA
+
|NA
−
|_
+
|pathogenic process
 +
|chronic thromboembolic pulmonary hypertension
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''THRIL''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290327 HSALNT0290327]
−
|[[Lnc-DHX37-1:1]]
+
|[[Uc.343]]
−
|"Linc1992, TCONSN/A00020260, BRI3BP-AS1"
+
|NA
−
|TNF and HNRNPL related immunoregulatory long non-coding RNA
+
|NA
−
|Kawasaki disease
+
|pathogenic process
 +
|osteoarthritis
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''TINCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289196 HSALNT0289196]
−
|[[ENST00000448587.1]]
+
|[[NRAV]]
−
|"FLJ90734, NCRNA00036, LINC00036, onco-lncRNA-16"
+
|DYNLL1-AS1
−
|tissue differentiation-inducing non-protein coding RNA
+
|transcriptional regulation
−
|squamous cell carcinoma, gastric cancer
+
|pathogenic process
 +
|influenza A virus
 +
|Virus Diseases
 
|-
 
|-
−
|''TLX1NB''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290140 HSALNT0290140]
−
|[[TLX1NB]]
+
|[[PLEC]]
−
|"TD1, TDI, APT-B7"
+
|NA
−
|TLX1 neighbor
+
|NA
−
|_
+
|pathogenic process
 +
|chronic obstructive pulmonary disease
 +
|Respiratory Tract Diseases
 
|-
 
|-
−
|''TMEM92-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290172 HSALNT0290172]
−
|[[TMEM92-AS1]]
+
|[[RNA44121]]
−
|"RP11-893F2.9, lncRNA-508851, TCONSN/A00025237"
+
|NA
−
|TMEM92 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|chronic obstructive pulmonary disease
 +
|Respiratory Tract Diseases
 
|-
 
|-
−
|''TMEM9B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290173 HSALNT0290173]
−
|[[TMEM9B-AS1]]
+
|[[RNA50010]]
−
|N/A
+
|NA
−
|TMEM9B antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|chronic obstructive pulmonary disease
 +
|Respiratory Tract Diseases
 
|-
 
|-
−
|''TOLLIP-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290174 HSALNT0290174]
−
|[[TOLLIP-AS1]]
+
|[[RNA58351]]
−
|N/A
+
|NA
−
|TOLLIP antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|chronic obstructive pulmonary disease
 +
|Respiratory Tract Diseases
 
|-
 
|-
−
|''TP53COR1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289714 HSALNT0289714]
−
|[[TP53COR1]]
+
|[[CR613944]]
−
|"linc-p21, lincRNA-p21, Trp53cor1"
+
|NA
−
|tumor protein p53 pathway corepressor 1 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''TP53TG1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289933 HSALNT0289933]
−
|[[TP53TG1]]
+
|[[LincRNA-CALCA]]
−
|"HN/ARG012D21.9, LINC00096"
+
|NA
−
|TP53 target 1 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''TP73-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290200 HSALNT0290200]
−
|[[TP73-AS1]]
+
|[[RP11-501G6.1]]
−
|PDAM
+
|NA
−
|TP73 antisense RNA 1
+
|NA
−
|esophageal squamous cell carcinoma.
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''TRERNA1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290208 HSALNT0290208]
−
|[[TRERNA1]]
+
|[[RP11-672F9.1]]
−
|"ncRNA-a7, treRNA"
+
|NA
−
|translation regulatory long non-coding RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''TRPM2-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290405 HSALNT0290405]
−
|[[TRPM2-AS]]
+
|[[C14orf132]]
−
|TRPM2-AS1
+
|NA
−
|TRPM2 antisense RNA
+
|NA
−
|cancer
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''TSIX''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289937 HSALNT0289937]
−
|[[TSIX]]
+
|[[LincRNA-TSPAN8]]
−
|"NCRNA00013, XIST-AS1, LINC00013"
+
|NA
−
|"TSIX transcript, XIST antisense RNA"
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''TSPEAR-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290225 HSALNT0290225]
−
|[[TSPEAR-AS2]]
+
|[[RP5-1014O16.1]]
−
|N/A
+
|AC244098.1
−
|TSPEAR antisense RNA 2
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''TTC28-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290275 HSALNT0290275]
−
|[[TTC28-AS1]]
+
|[[TCONS_00026102]]
−
|KIAA1648
+
|NA
−
|TTC28 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|atrial fibrillation
 +
|Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
 
|-
 
|-
−
|''TTTY15''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290277 HSALNT0290277]
−
|[[TTTY15]]
+
|[[TCONS_00032546]]
−
|"DKFZP434I143, NCRNA00138"
+
|NA
−
|"testis-specific transcript, Y-linked 15 (non-protein coding)"
+
|NA
−
|prostate cancer sample
+
|pathogenic process
 +
|atrial fibrillation
 +
|Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
 
|-
 
|-
−
|''TTTY17A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289037 HSALNT0289037]
−
|[[TTTY17A]]
+
|[[LINC00441]]
−
|NCRNA00140
+
|RB1-DT,ncRNA-RB1
−
|"testis-specific transcript, Y-linked 17A (non-protein coding)"
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TTTY3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289661 HSALNT0289661]
−
|[[TTTY3]]
+
|[[C1401f132]]
−
|"TTY3, TTTY3A, LINC00121"
+
|NA
−
|"testis-specific transcript, Y-linked 3 (non-protein coding)"
+
|NA
−
|_
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''TTTY4''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289141 HSALNT0289141]
−
|[[TTTY4]]
+
|[[LINC02365]]
−
|"TTY4, TTTY4A, LINC00123"
+
|LVCAT8
−
|"testis-specific transcript, Y-linked 4 (non-protein coding)"
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TTTY5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288885 HSALNT0288885]
−
|[[TTTY5]]
+
|[[ADGRD1-AS1]]
−
|"TTY5, LINC00126"
+
|LACAT8
−
|"testis-specific transcript, Y-linked 5 (non-protein coding)"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TTTY6''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289142 HSALNT0289142]
−
|[[TTTY6]]
+
|[[LINC02475]]
−
|"TTY6, TTTY6A, LINC00127"
+
|LVCAT1
−
|"testis-specific transcript, Y-linked 6 (non-protein coding)"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TTTY9B''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289542 HSALNT0289542]
−
|[[TTTY9B]]
+
|[[Abhd11os]]
−
|NCRNA00132
+
|NA
−
|"testis-specific transcript, Y-linked 9B (non-protein coding)"
+
|NA
−
|_
+
|pathogenic process
 +
|neurodegenerative diseases
 +
|Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288895 HSALNT0288895]
 +
|[[BISPR]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|virus infection
 +
|Virus Diseases
 
|-
 
|-
−
|''TUNAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0233975 HSALNT0233975]
−
|[[TUNAR]]
+
|[[MAFTRR]]
−
|"TUNA, HI-LNC78"
+
|linc-MAF-4
−
|TCL1 upstream neural differentiation-associated RNA
+
|transcriptional regulation
−
|type 2 diabetes
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TUSC8''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290058 HSALNT0290058]
−
|[[TUSC8]]
+
|[[MRAK052686]]
−
|XLOCN/A010588
+
|NA
−
|tumor suppressor candidate 8 (non-protein coding)
+
|NA
−
|cervical cancer
+
|pathogenic process
 +
|nonalcoholic fatty liver disease
 +
|Digestive System Diseases
 
|-
 
|-
−
|''UMODL1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290221 HSALNT0290221]
−
|[[UMODL1-AS1]]
+
|[[RP4-583P15.10]]
−
|FLJ33471
+
|AL121845.1
−
|UMODL1 antisense RNA 1
+
|NA
 +
|pathogenic process
 
|breast cancer
 
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''VLDLR-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211341 HSALNT0211341]
−
|[[VLDLR-AS1]]
+
|[[KTN1-AS1]]
−
|N/A
+
|C14orf33,MYCLo-3
−
|VLDLR antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''WAC-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266752 HSALNT0266752]
−
|[[WAC-AS1]]
+
|[[DLGAP4-AS1]]
−
|N/A
+
|CCAT7
−
|WAC antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''WASIR2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289682 HSALNT0289682]
−
|[[WASIR2]]
+
|[[CCAT3]]
−
|N/A
+
|NA
−
|WASH and IL9R antisense RNA 2
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''WDFY3-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289684 HSALNT0289684]
−
|[[WDFY3-AS2]]
+
|[[CCAT8]]
−
|FBI4
+
|NA
−
|WDFY3 antisense RNA 2
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''WSPAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289898 HSALNT0289898]
−
|[[WSPAR]]
+
|[[LINC00659]]
−
|"TCONSN/A00009511-XLOCN/A004555, lncTCF7"
+
|NA
−
|WNT signaling pathway activating non-coding RNA
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''XACT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289627 HSALNT0289627]
−
|[[XACT]]
+
|[[BALR-2]]
−
|N/A
+
|NA
−
|X active specific transcript (non-protein coding)
+
|NA
−
|chromosome inactivation
+
|pathogenic process
 +
|B cell acute lymphoblastic leukemia
 +
|Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''YAM1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289948 HSALNT0289948]
−
|[[YAM1]]
+
|[[Lnc-ACACA-1]]
−
|Yam-1
+
|NA
−
|YY1-associated myogenesis RNA 1
+
|NA
−
|skeletal myogenesis
+
|pathogenic process
 +
|clear cell renal cell cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''ZBED3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289953 HSALNT0289953]
−
|[[ZBED3-AS1]]
+
|[[Lnc-BMP2-2]]
−
|N/A
+
|NA
−
|ZBED3 antisense RNA 1
+
|NA
−
|chondrogenic differentiation
+
|pathogenic process
 +
|clear cell renal cell cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''ZEB1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289955 HSALNT0289955]
−
|[[ZEB1-AS1]]
+
|[[Lnc-CPN2-1]]
−
|N/A
+
|NA
−
|ZEB1 antisense RNA 1
+
|NA
−
|hepatocellular carcinoma,  esophageal squamous cell carcinoma"
+
|pathogenic process
 +
|clear cell renal cell cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''ZFAT-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289958 HSALNT0289958]
−
|[[ZFAT-AS1]]
+
|[[Lnc-FOXG1-2]]
−
|"SAS-ZFAT, NCRNA00070"
+
|NA
−
|ZFAT antisense RNA 1
+
|NA
−
|autoimmune thyroid disease
+
|pathogenic process
 +
|clear cell renal cell cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''ZIM2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289960 HSALNT0289960]
−
|[[ZIM2-AS1]]
+
|[[Lnc-FZD1-2]]
−
|ZIM2as
+
|NA
−
|ZIM2 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|clear cell renal cell cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''ZNF205-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289962 HSALNT0289962]
−
|[[ZNF205-AS1]]
+
|[[Lnc-ITPR2-3]]
−
|MGC3771
+
|NA
−
|ZNF205 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|clear cell renal cell cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''ZNF252P-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289965 HSALNT0289965]
−
|[[ZNF252P-AS1]]
+
|[[Lnc-LCP2-2]]
−
|N/A
+
|NA
−
|ZNF252P antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|clear cell renal cell cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''ZNF436-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289988 HSALNT0289988]
−
|[[ZNF436-AS1]]
+
|[[Lnc-RP3-368B9]]
−
|FLJ90508
+
|NA
−
|ZNF436 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|clear cell renal cell cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''ZNF582-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289991 HSALNT0289991]
−
|[[ZNF582-AS1]]
+
|[[Lnc-SLC30A4-1]]
−
|N/A
+
|NA
−
|ZNF582 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|clear cell renal cell cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''ZNF667-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289992 HSALNT0289992]
−
|[[ZNF667-AS1]]
+
|[[Lnc-SPAM1-6]]
−
|MORT
+
|NA
−
|ZNF667 antisense RNA 1 (head to head)
+
|NA
−
|cancer
+
|pathogenic process
 +
|clear cell renal cell cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''ZRANB2-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289995 HSALNT0289995]
−
|[[ZRANB2-AS2]]
+
|[[Lnc-TTC34-3]]
−
|N/A
+
|NA
−
|ZRANB2 antisense RNA 2 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|clear cell renal cell cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222064 HSALNT0222064]
 +
|[[DRAIC]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|prostate cancer;glioma;cancer;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma
 +
|Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
 
|-
 
|-
−
|''ADAMTS9-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290390 HSALNT0290390]
−
|[[ADAMTS9-AS1]]
+
|[[XLOC_014172]]
−
|N/A
+
|NA
−
|ADAMTS9 antisense RNA 1
+
|NA
−
|epithelial ovarian cancer
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''AFDN-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290014 HSALNT0290014]
−
|[[AFDN-AS1]]
+
|[[LOC149086]]
−
|C6orf124, MLLT4-AS1, HGC6.4, dJ431P23.3
+
|NA
−
|AFDN antisense RNA 1 (head to head)
+
|NA
−
|ovarian cancer
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''ATP2C2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290183 HSALNT0290183]
−
|[[ATP2C2-AS1]]
+
|[[RP11-160H22.5]]
−
|RP11-517C16.2-001
+
|AL121983.2
−
|ATP2C2 antisense RNA 1
+
|NA
−
|Botulinum Toxin Type A
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''ADGRD1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289945 HSALNT0289945]
−
|[[ADGRD1-AS1]]
+
|[[LNC00964-3]]
−
|LACAT8
+
|NA
−
|ADGRD1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''ATP2B1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289616 HSALNT0289616]
−
|[[ATP2B1-AS1]]
+
|[[Arid2-IR]]
−
|N/A
+
|NA
−
|ATP2B1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|renal inflammation
 +
|NA
 
|-
 
|-
−
|''BTG3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289716 HSALNT0289716]
−
|[[BTG3-AS1]]
+
|[[CR619813]]
−
|ASBEL
+
|NA
−
|BTG3 antisense RNA 1
+
|NA
−
|Ovarian carcinoma
+
|pathogenic process
 +
|pancreatic cancer
 +
|Endocrine System Diseases;Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''BRE-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289739 HSALNT0289739]
−
|[[BRE-AS1]]
+
|[[DDX6P1]]
−
|N/A
+
|NA
−
|BRE antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|pancreatic cancer
 +
|Endocrine System Diseases;Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''CCND2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289938 HSALNT0289938]
−
|[[CCND2-AS1]]
+
|[[LincRNA-ZNF532]]
−
|N/A
+
|NA
−
|CCND2 antisense RNA 1
+
|NA
−
|glioma
+
|pathogenic process
 +
|pancreatic cancer
 +
|Endocrine System Diseases;Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''CD44-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290011 HSALNT0290011]
−
|[[CD44-AS1]]
+
|[[LOC105372753]]
−
|RP1-68D18.4
+
|NA
−
|CD44 antisense RNA 1
+
|NA
−
|B cell lymphoma
+
|pathogenic process
 +
|pancreatic cancer
 +
|Endocrine System Diseases;Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''CEBPA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290013 HSALNT0290013]
−
|[[CEBPA-AS1]]
+
|[[LOC105377769]]
−
|N/A
+
|NA
−
|CEBPA antisense RNA 1 (head to head)
+
|NA
−
|Gastric cancer
+
|pathogenic process
 +
|pancreatic cancer
 +
|Endocrine System Diseases;Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''CERNA1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290205 HSALNT0290205]
−
|[[CERNA1]]
+
|[[RP11-58D2.1]]
−
|LOC100129973
+
|NA
−
|competing endogenous lncRNA 1 for miR-4707-5p and miR-4767
+
|NA
−
|cardiovascular disease
+
|pathogenic process
 +
|pancreatic cancer
 +
|Endocrine System Diseases;Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''CERNA2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288946 HSALNT0288946]
−
|[[CERNA2]]
+
|[[ENST00000434223]]
−
|HOST2
+
|NA
−
|competing endogenous lncRNA 2 for microRNA let-7b
+
|NA
−
|Ovarian cancer, Hepatocellular carcinoma
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''CERNA3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288947 HSALNT0288947]
−
|[[CERNA3]]
+
|[[ENST00000442037]]
−
|CTA
+
|NA
−
|competing endogenous lncRNA 3 for miR-645
+
|NA
−
|Osteosarcoma
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''CFLAR-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288953 HSALNT0288953]
−
|[[CFLAR-AS1]]
+
|[[ENST00000540136]]
−
|ALS2CR10
+
|NA
−
|CFLAR antisense RNA 1
+
|NA
−
|hypertrophic scar
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''CLMAT3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290103 HSALNT0290103]
−
|[[CLMAT3]]
+
|[[NR_038125]]
−
|SPARC-AS1
+
|NA
−
|colorectal liver metastasis associated transcript 3
+
|NA
−
|colorectal cancer
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''COL1A2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290136 HSALNT0290136]
−
|[[COL1A2-AS1]]
+
|[[PDLIM3]]
−
|TCONS_00013888, lncRNA8975-1
+
|NA
−
|COL1A2 antisense RNA 1
+
|NA
−
|
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''CSMD2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290335 HSALNT0290335]
−
|[[CSMD2-AS1]]
+
|[[Uc001gch.1]]
−
|ENST00000434181
+
|NA
−
|CSMD2 antisense RNA 1
+
|NA
−
|early-onset preeclampsia
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''CYTOR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290336 HSALNT0290336]
−
|[[CYTOR]]
+
|[[Uc001gzl.3]]
−
|C2orf59, NCRNA00152, LINC00152, MGC4677
+
|NA
−
|cytoskeleton regulator RNA
+
|NA
−
|Breast cancer, Gastric cancer
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''CHMP1B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290351 HSALNT0290351]
−
|[[CHMP1B-AS1]]
+
|[[Uc004bbl.1]]
−
|N/A
+
|NA
−
|CHMP1B antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''CLLU1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290369 HSALNT0290369]
−
|[[CLLU1]]
+
|[[VNN2]]
−
|N/A
+
|NA
−
|chronic lymphocytic leukemia up-regulated 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''DLGAP4-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289577 HSALNT0289577]
−
|[[DLGAP4-AS1]]
+
|[[AK022798]]
−
|CCAT7
+
|NA
−
|DLGAP4 antisense RNA 1
+
|NA
−
|colorectal cancer
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''DM1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289663 HSALNT0289663]
−
|[[DM1-AS]]
+
|[[C1orf74]]
−
|N/A
+
|NA
−
|DM1 locus antisense RNA
+
|NA
−
|Myotonic dystrophy type 1
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''DPYD-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289602 HSALNT0289602]
−
|[[DPYD-AS2]]
+
|[[AKR7L]]
−
|N/A
+
|NA
−
|DPYD antisense RNA 2
+
|NA
−
|Cervical squamous cancers
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''DSCAM-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289711 HSALNT0289711]
−
|[[DSCAM-AS1]]
+
|[[COL3A1]]
−
|M41
+
|NA
−
|DSCAM antisense RNA 1
+
|NA
−
|breast cancer
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''DSCR4''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289878 HSALNT0289878]
−
|[[DSCR4]]
+
|[[KCNE2]]
−
|DCRB
+
|NA
−
|Down syndrome critical region 4
+
|NA
−
|Down syndrome
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''DSCR8''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289636 HSALNT0289636]
−
|[[DSCR8]]
+
|[[BC015134]]
−
|C21orf65, MTAG2, CT25.1a, CT25.1b, MMA-1a, MMA-1b
+
|NA
−
|Down syndrome critical region 8 (non-protein coding)
+
|NA
−
|Down syndrome, melanoma
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''DARS-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289713 HSALNT0289713]
−
|[[DARS-AS1]]
+
|[[CR594506]]
−
|N/A
+
|NA
−
|DARS antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''DCST1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289928 HSALNT0289928]
−
|[[DCST1-AS1]]
+
|[[LincRNA-BBOX1-2]]
−
|RP11-307C12.11
+
|NA
−
|DCST1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''DDN-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271719 HSALNT0271719]
−
|[[DDN-AS1]]
+
|[[LINC00320]]
−
|CAT1507
+
|PRED14,FLJ37539
−
|DDN and PRKAG1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process;developmental process
 +
|cortical white matter
 +
|Nervous System Diseases
 
|-
 
|-
−
|''DDX11-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289823 HSALNT0289823]
−
|[[DDX11-AS1]]
+
|[[EVADR]]
−
|CONCR
+
|NA
−
|DDX11 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|pancreatic cancer;lung cancer;colorectal cancer;rectal cancer
 +
|Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''DINOL''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289952 HSALNT0289952]
−
|[[DINOL]]
+
|[[Lnc-bc060912]]
−
|DINO
+
|NA
−
|damage induced long noncoding RNA
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''DNAJB8-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289613 HSALNT0289613]
−
|[[DNAJB8-AS1]]
+
|[[APF]]
−
|N/A
+
|NA
−
|DNAJB8 antisense RNA 1
+
|ceRNA
−
|_
+
|pathogenic process
 +
|myocardial infarction
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289617 HSALNT0289617]
 +
|[[AS Uchl1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Parkinson's disease
 +
|Nervous System Diseases
 
|-
 
|-
−
|''ELF3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289104 HSALNT0289104]
−
|[[ELF3-AS1]]
+
|[[LINC01296]]
−
|ENST00000415582
+
|FLJ39632
−
|ELF3 antisense RNA 1
+
|NA
−
|Papillary Thyroid Cancer
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''FBXL19-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290403 HSALNT0290403]
−
|[[FBXL19-AS1]]
+
|[[ZXF2]]
−
|NCRNA00095, MGC125469, MGC125470, MGC125472
+
|NA
−
|FBXL19 antisense RNA 1 (head to head)
+
|NA
−
|Colorectal cancer
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''FAM30A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290113 HSALNT0290113]
−
|[[FAM30A]]
+
|[[P14695]]
−
|HSPC053
+
|NA
−
|family with sequence similarity 30 member A
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''FEZF1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290114 HSALNT0290114]
−
|[[FEZF1-AS1]]
+
|[[P16984]]
−
|N/A
+
|NA
−
|FEZF1 antisense RNA 1
+
|NA
−
|Colorectal carcinoma, Gastric cancer
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''FGF14-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290115 HSALNT0290115]
−
|[[FGF14-AS2]]
+
|[[P19780]]
−
|N/A
+
|NA
−
|FGF14 antisense RNA 2
+
|NA
−
|breast cancer
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''FLICR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290116 HSALNT0290116]
−
|[[FLICR]]
+
|[[P23099]]
−
|N/A
+
|NA
−
|FOXP3 regulating long intergenic non-coding RNA
+
|NA
−
|Autoimmune diabetes
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''FLNC-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290117 HSALNT0290117]
−
|[[FLNC-AS1]]
+
|[[P24363]]
−
|N/A
+
|NA
−
|FLNC antisense RNA 1
+
|NA
−
|Cervical squamous cancers
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''FOXD2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290118 HSALNT0290118]
−
|[[FOXD2-AS1]]
+
|[[P28210]]
−
|MGC12982
+
|NA
−
|FOXD2 antisense RNA 1 (head to head)
+
|NA
−
|Lung cancer
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''FOXD3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290120 HSALNT0290120]
−
|[[FOXD3-AS1]]
+
|[[P33863]]
−
|pasFOXD3
+
|NA
−
|FOXD3 antisense RNA 1 (head to head)
+
|NA
−
|glioma
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''FOXP4-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290121 HSALNT0290121]
−
|[[FOXP4-AS1]]
+
|[[P4091]]
−
|N/A
+
|NA
−
|FOXP4 antisense RNA 1
+
|NA
−
|colorectal cancer
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''G2E3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290122 HSALNT0290122]
−
|[[G2E3-AS1]]
+
|[[P6391]]
−
|CAT1647
+
|NA
−
|G2E3 antisense RNA 1
+
|NA
−
|Bladder cancer
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''GCASPC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290123 HSALNT0290123]
−
|[[GCASPC]]
+
|[[P6488]]
−
|TCONS_00011605, RP1-56L9.7-001, lnc-SOD2-1
+
|NA
−
|gall bladder cancer associated suppressor of pyruvate carboxylase lncRNA
+
|NA
−
|gallbladder cancer
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''GABPB1-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290124 HSALNT0290124]
−
|[[GABPB1-IT1]]
+
|[[P700]]
−
|FLJ10038
+
|NA
−
|GABPB1 intronic transcript
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''GPRC5D-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290125 HSALNT0290125]
−
|[[GPRC5D-AS1]]
+
|[[P8611]]
−
|RP11-392P7.6
+
|NA
−
|GPRC5D and HEBP1 antisense RNA 1
+
|NA
−
|Colorectal cancer
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''GSEC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290126 HSALNT0290126]
−
|[[GSEC]]
+
|[[P8725]]
−
|ST3GAL4-AS1, DCPS-AS1, FLJ39051
+
|NA
−
|G-quadruplex forming sequence containing lncRNA
+
|NA
−
|colon cancer
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''HCG11''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290127 HSALNT0290127]
−
|[[HCG11]]
+
|[[P8860]]
−
|bK14H9.3, FLJ14049, FLJ30357
+
|NA
−
|HLA complex group 11 (non-protein coding)
+
|NA
−
|prostate cancer
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''HDAC2-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290128 HSALNT0290128]
−
|[[HDAC2-AS2]]
+
|[[P9745]]
−
|ENST00000421891
+
|NA
−
|HDAC2 and HS3ST5 antisense RNA 2
+
|NA
−
|early-onset preeclampsia
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''HOXC-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289269 HSALNT0289269]
−
|[[HOXC-AS1]]
+
|[[TH2LCRR]]
−
|N/A
+
|TH2-LCR
−
|HOXC cluster antisense RNA 1
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|allergic asthma
 +
|Respiratory Tract Diseases;Immune System Diseases
 
|-
 
|-
−
|''HDHD5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289964 HSALNT0289964]
−
|[[HDHD5-AS1]]
+
|[[Lnc-LCE5A-1]]
−
|CECR4, CECR5-AS1, NCRNA00017
+
|NA
−
|HDHD5 antisense RNA 1
+
|NA
−
|cat eye syndrome
+
|pathogenic process
 +
|laryngeal cancer;head and neck squamous cell cancer
 +
|Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Neoplasms
 
|-
 
|-
−
|''HMMR-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0055198 HSALNT0055198]
−
|[[HMMR-AS1]]
+
|[[FAM3D-AS1]]
−
|N/A
+
|lnc-KCTD6-3
−
|HMMR antisense RNA 1
+
|NA
−
|basal-like breast cancer
+
|pathogenic process
 +
|tongue cancer;pharyngeal cancer;head and neck squamous cell cancer;laryngeal cancer
 +
|Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 
|-
 
|-
−
|''HSD17B3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289843 HSALNT0289843]
−
|[[HSD17B3-AS1]]
+
|[[FRLnc1]]
−
|ENST00000448857
+
|NA
−
|HSD17B3 antisense RNA 1
+
|NA
−
|early-onset preeclampsia
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''IL21R-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0242005 HSALNT0242005]
−
|[[IL21R-AS1]]
+
|[[ENST00000575202]]
−
|N/A
+
|NA
−
|IL21R antisense RNA 1
+
|NA
−
|coronary artery disease
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''INHBA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288952 HSALNT0288952]
−
|[[INHBA-AS1]]
+
|[[ENST00000539009]]
−
|N/A
+
|NA
−
|INHBA antisense RNA 1
+
|NA
−
|Gastric cancer
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''ITFG2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288954 HSALNT0288954]
−
|[[ITFG2-AS1]]
+
|[[ENST00000544591]]
−
|N/A
+
|NA
−
|ITFG2 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''INO80-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289752 HSALNT0289752]
−
|[[INO80-AS1]]
+
|[[EHHADH-AS1]]
−
|ENST00000560178
+
|NA
−
|INO80 antisense RNA 1
+
|NA
−
|early-onset preeclampsia
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''INTS9-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289812 HSALNT0289812]
−
|[[INTS9-AS1]]
+
|[[ENST00000468960]]
−
|ENST00000520055
+
|NA
−
|INTS9 antisense RNA 1
+
|NA
−
|early-onset preeclampsia
+
|pathogenic process
−
|-
 
−
|''KIAA0087''
 
−
|[[KIAA0087]]
 
−
|N/A
 
−
|KIAA0087 lncRNA
 
−
|endometrial carcinoma
 
−
|-
 
−
|''KRT7-AS''
 
−
|[[KRT7-AS]]
 
−
|N/A
 
−
|KRT7 antisense RNA 1
 
−
|gastric cancer
 
−
|-
 
−
|''KTN1-AS1''
 
−
|[[KTN1-AS1]]
 
−
|C14orf33, MYCLo-3
 
−
|KTN1 antisense RNA 1
 
 
|colorectal cancer
 
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LEF1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290276 HSALNT0290276]
−
|[[LEF1-AS1]]
+
|[[TCONS_00026506]]
−
|N/A
+
|NA
−
|LEF1 antisense RNA 1
+
|NA
 +
|pathogenic process
 
|colorectal cancer
 
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LIF-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189952 HSALNT0189952]
−
|[[LIF-AS1]]
+
|[[LRP1-AS]]
−
|Lnc-LIF-AS
+
|NA
−
|LIF antisense RNA 1
+
|transcriptional regulation
−
|Cervical squamous cancers
+
|pathogenic process
 +
|Alzheimer's disease
 +
|Mental Disorders;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0032045 HSALNT0032045]
 +
|[[LINC01122]]
 +
|FLJ30838,AC007092.1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00260''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289565 HSALNT0289565]
−
|[[LINC00260]]
+
|[[AI364715]]
−
|MGC5457
+
|NA
−
|long intergenic non-protein coding RNA 260
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC00513''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289921 HSALNT0289921]
−
|[[LINC00513]]
+
|[[LINC0949]]
−
|AC016831.7
+
|NA
−
|long intergenic non-protein coding RNA 513
+
|NA
−
|_
+
|pathogenic process
 +
|systemic lupus erythematosus
 +
|Immune System Diseases;Skin and Connective Tissue Diseases
 
|-
 
|-
−
|''LINC00665''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289680 HSALNT0289680]
−
|[[LINC00665]]
+
|[[CCAL]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 665
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC00680''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289079 HSALNT0289079]
−
|[[LINC00680]]
+
|[[LINC00993]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 680
+
|NA
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00909''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289811 HSALNT0289811]
−
|[[LINC00909]]
+
|[[ENST00000460164]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 909
+
|NA
−
|_
+
|pathogenic process
 +
|triple-negative breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00969''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290282 HSALNT0290282]
−
|[[LINC00969]]
+
|[[TCONS_l2_00003938]]
−
|ENST00000453324
+
|NA
−
|long intergenic non-protein coding RNA 969
+
|NA
−
|_
+
|pathogenic process
 +
|triple-negative breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01505''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289888 HSALNT0289888]
−
|[[LINC01505]]
+
|[[LGALS3]]
−
|RP11-308N19.1
+
|NA
−
|long intergenic non-protein coding RNA 1505
+
|NA
−
|_
+
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01689''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289963 HSALNT0289963]
−
|[[LINC01689]]
+
|[[Lnc-KCMF1-2:1]]
−
|AP000469.2
+
|NA
−
|long intergenic non-protein coding RNA 1689
+
|NA
−
|_
+
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01711''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289967 HSALNT0289967]
−
|[[LINC01711]]
+
|[[Lnc-LLPH-2:1]]
−
|MGC4294
+
|NA
−
|long intergenic non-protein coding RNA 1711
+
|NA
−
|_
+
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01785''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289971 HSALNT0289971]
−
|[[LINC01785]]
+
|[[Lnc-PLA2R1-1:1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1785
+
|NA
−
|_
+
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01826''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289972 HSALNT0289972]
−
|[[LINC01826]]
+
|[[Lnc-PSD4-1:14]]
−
|lnc-MKI67IP-3
+
|NA
−
|long intergenic non-protein coding RNA 1826
+
|NA
−
|_
+
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01869''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290066 HSALNT0290066]
−
|[[LINC01869]]
+
|[[N335550]]
−
|MGC45922
+
|NA
−
|long intergenic non-protein coding RNA 1869
+
|NA
−
|_
+
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01959''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290070 HSALNT0290070]
−
|[[LINC01959]]
+
|[[N340790]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1959
+
|NA
−
|_
+
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 
|-
 
|-
−
|''LINC02001''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290072 HSALNT0290072]
−
|[[LINC02001]]
+
|[[N386477]]
−
|RP11-1094M14.11
+
|NA
−
|long intergenic non-protein coding RNA 2001
+
|NA
−
|_
+
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 
|-
 
|-
−
|''LINC02135''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290286 HSALNT0290286]
−
|[[LINC02135]]
+
|[[TCONS_l2_00010365]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 2135
+
|NA
−
|_
+
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 
|-
 
|-
−
|''LINC02158''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289118 HSALNT0289118]
−
|[[LINC02158]]
+
|[[LINC01612]]
−
|N/A
+
|RP11-789C1.1,TCONS_00008319
−
|long intergenic non-protein coding RNA 2158
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02175''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289610 HSALNT0289610]
−
|[[LINC02175]]
+
|[[AP001439.2]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 2175
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02179''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289671 HSALNT0289671]
−
|[[LINC02179]]
+
|[[CACNAICAS3]]
−
|RP11-189E14.4
+
|NA
−
|long intergenic non-protein coding RNA 2179
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02209''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289853 HSALNT0289853]
−
|[[LINC02209]]
+
|[[GS1-5L10.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 2209
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02224''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290065 HSALNT0290065]
−
|[[LINC02224]]
+
|[[MYLK-AS1]]
−
|BRCAT107, ENST00000505706
+
|NA
−
|long intergenic non-protein coding RNA 2224
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02232''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290157 HSALNT0290157]
−
|[[LINC02232]]
+
|[[PRSS21]]
−
|RP11-707A18.1
+
|NA
−
|long intergenic non-protein coding RNA 2232
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02233''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290202 HSALNT0290202]
−
|[[LINC02233]]
+
|[[RP11-528G1.2]]
−
|RP11-6C14.1
+
|NA
−
|long intergenic non-protein coding RNA 2233
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02234''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290207 HSALNT0290207]
−
|[[LINC02234]]
+
|[[RP11-643M14.1]]
−
|RP11-455B3.1
+
|NA
−
|long intergenic non-protein coding RNA 2234
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02235''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290209 HSALNT0290209]
−
|[[LINC02235]]
+
|[[RP11-789C1.1]]
−
|RP11-354A14.1
+
|LINC01612
−
|long intergenic non-protein coding RNA 2235
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02236''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290314 HSALNT0290314]
−
|[[LINC02236]]
+
|[[TSNAX-DISC1]]
−
|RP11-332J15.1
+
|NA
−
|long intergenic non-protein coding RNA 2236
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02237''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290386 HSALNT0290386]
−
|[[LINC02237]]
+
|[[XLOC_010235]]
−
|RP11-1101K5.1
+
|NA
−
|long intergenic non-protein coding RNA 2237
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02260''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289558 HSALNT0289558]
−
|[[LINC02260]]
+
|[[AF075041]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 2260
+
|NA
−
|_
+
|pathogenic process
 +
|pancreatic cancer
 +
|Endocrine System Diseases;Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02365''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289564 HSALNT0289564]
−
|[[LINC02365]]
+
|[[AF339813]]
−
|LVCAT8
+
|NA
−
|long intergenic non-protein coding RNA 2365
+
|NA
−
|_
+
|pathogenic process
 +
|pancreatic cancer
 +
|Endocrine System Diseases;Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02475''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289575 HSALNT0289575]
−
|[[LINC02475]]
+
|[[AK022029]]
−
|LVCAT1
+
|NA
−
|long intergenic non-protein coding RNA 2475
+
|NA
−
|_
+
|pathogenic process
 +
|pancreatic cancer
 +
|Endocrine System Diseases;Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02487''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289576 HSALNT0289576]
−
|[[LINC02487]]
+
|[[AK022159]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 2487
+
|NA
−
|_
+
|pathogenic process
 +
|pancreatic cancer
 +
|Endocrine System Diseases;Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02488''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289604 HSALNT0289604]
−
|[[LINC02488]]
+
|[[AL389956]]
−
|CTD-2316B1
+
|NA
−
|long intergenic non-protein coding RNA 2488
+
|NA
−
|_
+
|pathogenic process
 +
|pancreatic cancer
 +
|Endocrine System Diseases;Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02551''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289640 HSALNT0289640]
−
|[[LINC02551]]
+
|[[BC023629]]
−
|RP11-890B15.2
+
|NA
−
|long intergenic non-protein coding RNA 2551
+
|NA
−
|_
+
|pathogenic process
 +
|pancreatic cancer
 +
|Endocrine System Diseases;Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02560''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290096 HSALNT0290096]
−
|[[LINC02560]]
+
|[[NONHSAT125629]]
−
|CTD-2619J13.13
+
|NA
−
|long intergenic non-protein coding RNA 2560
+
|NA
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''LINC02561''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290393 HSALNT0290393]
−
|[[LINC02561]]
+
|[[XR_250621.1]]
−
|RP11-445P17.8
+
|NA
−
|long intergenic non-protein coding RNA 2561
+
|NA
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288951 HSALNT0288951]
 +
|[[ENST00000503938]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|triple-negative breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''LINC-ROR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290085 HSALNT0290085]
−
|[[LINC-ROR]]
+
|[[NONHSAT012762]]
−
|lincRNA-RoR, lincRNA-ST8SIA3, ROR
+
|NA
−
|long intergenic non-protein coding RNA, regulator of reprogramming
+
|NA
−
|_
+
|pathogenic process
 +
|triple-negative breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''LNCPRESS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289151 HSALNT0289151]
−
|[[LNCPRESS1]]
+
|[[LMCD1-AS1]]
−
|lncPRESS1
+
|NA
−
|lncRNA p53 regulated and ESC associated 1
+
|NA
−
|_
+
|pathogenic process
 +
|acute kidney injury
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications
 
|-
 
|-
−
|''LNCPRESS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289926 HSALNT0289926]
−
|[[LNCPRESS2]]
+
|[[Linc-PXN-1]]
−
|lncPRESS2
+
|NA
−
|lncRNA p53 regulated and ESC associated 2
+
|NA
−
|_
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LRRC3DN''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290281 HSALNT0290281]
−
|[[LRRC3DN]]
+
|[[TCONS_l2_00001418]]
−
|DKFZP434C128
+
|NA
−
|LRRC3 downstream neighbor (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LUARIS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290285 HSALNT0290285]
−
|[[LUARIS]]
+
|[[TCONS_l2_00008237]]
−
|lncRNA#32
+
|NA
−
|lncRNA upregulator of antiviral response interferon signaling
+
|NA
−
|_
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LILRB1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290287 HSALNT0290287]
−
|[[LILRB1-AS1]]
+
|[[TCONS_l2_00011130]]
−
|AC009892.10
+
|NA
−
|LILRB1 antisense RNA 1
+
|NA
−
|B cell lymphoma
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00226''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290288 HSALNT0290288]
−
|[[LINC00226]]
+
|[[TCONS_l2_00013175]]
−
|C14orf97, NCRNA00226
+
|NA
−
|long intergenic non-protein coding RNA 226
+
|NA
−
|Pancreatic ductal adenocarcinoma
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00240''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290294 HSALNT0290294]
−
|[[LINC00240]]
+
|[[TCONS_l2_00022611]]
−
|C6orf41, NCRNA00240, bA373D17.1
+
|NA
−
|long intergenic non-protein coding RNA 240
+
|NA
−
|esophageal squamous cell carcinoma
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00365''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290295 HSALNT0290295]
−
|[[LINC00365]]
+
|[[TCONS_l2_00022670]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 365
+
|NA
−
|Esophageal Cancer
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00460''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290352 HSALNT0290352]
−
|[[LINC00460]]
+
|[[Uc004bdv.3]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 460
+
|NA
−
|colorectal cancer
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC00520''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290363 HSALNT0290363]
−
|[[LINC00520]]
+
|[[ULK4P2]]
−
|C14orf34
+
|NA
−
|long intergenic non-protein coding RNA 520
+
|NA
−
|breast cancer
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC00578''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289942 HSALNT0289942]
−
|[[LINC00578]]
+
|[[LK4P2]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 578
+
|NA
−
|major depressive disorder
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC00672''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289538 HSALNT0289538]
−
|[[LINC00672]]
+
|[[AB019562]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 672
+
|NA
−
|Endometrial cancer
+
|pathogenic process
 +
|hypopharyngeal squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00862''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091661 HSALNT0091661]
−
|[[LINC00862]]
+
|[[ENST00000503710]]
−
|C1orf98, SMIM16
+
|NA
−
|long intergenic non-protein coding RNA 862
+
|NA
−
|Cystic Fibrosis
+
|pathogenic process
 +
|endometrial cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''LINC00888''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289806 HSALNT0289806]
−
|[[LINC00888]]
+
|[[ENST00000445734]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 888
+
|NA
−
|Melanoma tumorigenesis
+
|pathogenic process
 +
|endometrial cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''LINC00890''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289807 HSALNT0289807]
−
|[[LINC00890]]
+
|[[ENST00000448093]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 890
+
|NA
−
|Leiomyoma
+
|pathogenic process
 +
|endometrial cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''LINC00998''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289815 HSALNT0289815]
−
|[[LINC00998]]
+
|[[ENST00000502941]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 998
+
|NA
−
|major depressive disorder
+
|pathogenic process
 +
|endometrial cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''LINC01116''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290340 HSALNT0290340]
−
|[[LINC01116]]
+
|[[Uc002nbr.3]]
−
|TALNEC2
+
|NA
−
|long intergenic non-protein coding RNA 1116
+
|NA
−
|Prostate cancer, GBM
+
|pathogenic process
 +
|endometrial cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''LINC01138''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290356 HSALNT0290356]
−
|[[LINC01138]]
+
|[[Uc021re1.1]]
−
|LINC00875, FLJ39739
+
|NA
−
|long intergenic non-protein coding RNA 1138
+
|NA
−
|prostate cancer
+
|pathogenic process
 +
|endometrial cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''LINC01186''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289549 HSALNT0289549]
−
|[[LINC01186]]
+
|[[AC016745.3]]
−
|N/A
+
|AC016745.1
−
|long intergenic non-protein coding RNA 1186
+
|NA
−
|Lung cancer
+
|pathogenic process
 +
|glioma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC01198''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290180 HSALNT0290180]
−
|[[LINC01198]]
+
|[[RP11-128A17.1]]
−
|N/A
+
|AC078909.1
−
|long intergenic non-protein coding RNA 1198
+
|NA
−
|anaplastic gliomas
+
|pathogenic process
 +
|glioma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC01554''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290377 HSALNT0290377]
−
|[[LINC01554]]
+
|[[XLOC_001711]]
−
|C5orf27, FLJ38821, FIS
+
|NA
−
|long intergenic non-protein coding RNA 1554
+
|NA
−
|Esophageal Cancer
+
|pathogenic process
 +
|glioma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC01630''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289975 HSALNT0289975]
−
|[[LINC01630]]
+
|[[LncRNA-AK058003]]
−
|LOC100287225
+
|NA
−
|long intergenic non-protein coding RNA 1630
+
|NA
−
|colorectal cancer
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01671''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289061 HSALNT0289061]
−
|[[LINC01671]]
+
|[[LINC00682]]
−
|BC041455
+
|NA
−
|long intergenic non-protein coding RNA 1671
+
|NA
−
|Breast cancer
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01684''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289305 HSALNT0289305]
−
|[[LINC01684]]
+
|[[LINC01559]]
−
|lnc-JAM2-6
+
|FLJ33810
−
|long intergenic non-protein coding RNA 1684
+
|NA
−
|Nonalcoholic fatty liver disease
+
|pathogenic process
 +
|Huntington disease
 +
|Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''LINC01772''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289854 HSALNT0289854]
−
|[[ENST00000457898.1]]
+
|[[GSTT1-AS1]]
−
|ENSG00000226029
+
|NA
−
|long intergenic non-protein coding RNA 1772
+
|transcriptional regulation
−
|alzheimer's disease, ovarian cancer, pancreatic cancer,gastric cancer
+
|pathogenic process
 +
|mycobacterium tuberculosis infection
 +
|Bacterial Infections and Mycoses
 
|-
 
|-
−
|''LINC01833''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289978 HSALNT0289978]
−
|[[LINC01833]]
+
|[[LncRNA-CD244]]
−
|RP11-89, K21.1
+
|NA
−
|long intergenic non-protein coding RNA 1833
+
|transcriptional regulation
−
|lung adenocarcinoma
+
|pathogenic process
 +
|tuberculosis infection
 +
|Bacterial Infections and Mycoses
 
|-
 
|-
−
|''LINC01844''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289237 HSALNT0289237]
−
|[[LINC01844]]
+
|[[SAMD12-AS1]]
−
|LOC101926975
+
|NA
−
|long intergenic non-protein coding RNA 1844
+
|NA
−
|Hirschsprung Disease
+
|pathogenic process
 +
|neuroblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC01852''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290179 HSALNT0290179]
−
|[[LINC01852]]
+
|[[RP11-119F7.4]]
−
|ENST00000434223
+
|NA
−
|long intergenic non-protein coding RNA 1852
+
|NA
−
|non-small cell lung cancer
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01857''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290278 HSALNT0290278]
−
|[[LINC01857]]
+
|[[TCONS_00068220]]
−
|AC079767.4
+
|NA
−
|long intergenic non-protein coding RNA 1857
+
|NA
−
|Tuberculosis
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01929''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0285573 HSALNT0285573]
−
|[[LINC01929]]
+
|[[DANT1]]
−
|CTD-2171N6.1
+
|NA
−
|long intergenic non-protein coding RNA 1929
+
|transcriptional regulation
−
|Papillary thyroid cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC01930''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288926 HSALNT0288926]
−
|[[LINC01930]]
+
|[[DANT2]]
−
|EU358092
+
|NA
−
|long intergenic non-protein coding RNA 1930
+
|transcriptional regulation
−
|schizophrenia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC01952''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290399 HSALNT0290399]
−
|[[LINC01952]]
+
|[[ZMAT1]]
−
|AC004854.4
+
|NA
−
|long intergenic non-protein coding RNA 1952
+
|NA
−
|recurrent miscarriage
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02055''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289554 HSALNT0289554]
−
|[[LINC02055]]
+
|[[AC100865.1]]
−
|RP1130-1
+
|NA
−
|long intergenic non-protein coding RNA 2055
+
|NA
−
|hepatocellular carcinoma
+
|pathogenic process
 +
|coronary artery disease
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''LINC02081''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289228 HSALNT0289228]
−
|[[LINC02081]]
+
|[[RAD51-AS1]]
−
|CTD-2357A8.3, XLOC_012582
+
|TODRA
−
|long intergenic non-protein coding RNA 2081
+
|transcriptional regulation
−
|Esophageal Cancer, Tuberculosis
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''LINC02098''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289743 HSALNT0289743]
−
|[[LINC02098]]
+
|[[DKFZP434K028]]
−
|RP11-702B10.1
+
|NA
−
|long intergenic non-protein coding RNA 2098
+
|NA
−
|esophageal squamous cell carcinoma
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02099''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289630 HSALNT0289630]
−
|[[LINC02099]]
+
|[[BC002811]]
−
|AC145110.1
+
|NA
−
|long intergenic non-protein coding RNA 2099
+
|NA
−
|Breast cancer
+
|pathogenic process
 +
|astrocytoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC02151''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290387 HSALNT0290387]
−
|[[LINC02151]]
+
|[[XLOC_010967]]
−
|TCONS_00019174
+
|NA
−
|long intergenic non-protein coding RNA 2151
+
|NA
−
|Major Depressive Disorder
+
|pathogenic process
 +
|astrocytoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC02152''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288955 HSALNT0288955]
−
|[[LINC02152]]
+
|[[ENST00000545440]]
−
|ENST00000566208
+
|NA
−
|long intergenic non-protein coding RNA 2152
+
|NA
−
|Major Depressive Disorder
+
|pathogenic process
 +
|pediatric acute myeloid leukemia
 +
|Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''LINC02153''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288981 HSALNT0288981]
−
|[[LINC02153]]
+
|[[FRGCA]]
−
|ENST00000517573
+
|LncRNA-AP001631.9
−
|long intergenic non-protein coding RNA 2153
+
|NA
−
|Major Depressive Disorder
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02154''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289976 HSALNT0289976]
−
|[[LINC02154]]
+
|[[LncRNA-AP001631.9]]
−
|GS1-600G8.5
+
|NA
−
|long intergenic non-protein coding RNA 2154
+
|NA
−
|Esophageal Cancer
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02155''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289686 HSALNT0289686]
−
|[[LINC02155]]
+
|[[CD99P1]]
−
|RP11-705O24.1
+
|NA
−
|long intergenic non-protein coding RNA 2155
+
|ceRNA
−
|Esophageal Cancer
+
|pathogenic process
 +
|idiopathic pulmonary fibrosis
 +
|Respiratory Tract Diseases
 
|-
 
|-
−
|''LINC02156''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289119 HSALNT0289119]
−
|[[LINC02156]]
+
|[[LINC01613]]
−
|RP1-90J4.1
+
|n341773
−
|long intergenic non-protein coding RNA 2156
+
|NA
−
|Esophageal Cancer
+
|pathogenic process
 +
|idiopathic pulmonary fibrosis
 +
|Respiratory Tract Diseases
 
|-
 
|-
−
|''LINC02157''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289844 HSALNT0289844]
−
|[[LINC02157]]
+
|[[FTH1P3]]
−
|RP11-327J17.1
+
|FTH1P3
−
|long intergenic non-protein coding RNA 2157
+
|NA
−
|Esophageal Cancer
+
|pathogenic process
 +
|oral squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LINC02231''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289855 HSALNT0289855]
−
|[[LINC02231]]
+
|[[GTF2IRD2P1]]
−
|RP11-766N7.4
+
|GTF2IRD2P1
−
|long intergenic non-protein coding RNA 2231
+
|NA
−
|Esophageal squamous cell carcinoma
+
|pathogenic process
 +
|oral squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LINC02238''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290135 HSALNT0290135]
−
|[[LINC02238]]
+
|[[PDIA3F]]
−
|RP4-788P17.1
+
|NA
−
|long intergenic non-protein coding RNA 2238
+
|NA
−
|B cell lymphoma
+
|pathogenic process
 +
|oral squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LINC02243''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289329 HSALNT0289329]
−
|[[LINC02243]]
+
|[[LINC00994]]
−
|ENST00000441841
+
|NA
−
|long intergenic non-protein coding RNA 2243
+
|NA
−
|Lung squamous cell carcinoma
+
|pathogenic process
 +
|inflammatory bowel disease
 +
|Digestive System Diseases
 
|-
 
|-
−
|''LINC02245''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289208 HSALNT0289208]
−
|[[LINC02245]]
+
|[[PCAT5]]
−
|lnc-SERTAD2-3
+
|LINC01452,TPCAT-10-36067
−
|long intergenic non-protein coding RNA 2245
+
|NA
−
|epithelial ovarian cancer
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC02246''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0114870 HSALNT0114870]
−
|[[LINC02246]]
+
|[[LUADT1]]
−
|ENST00000418954
+
|NA
−
|long intergenic non-protein coding RNA 2246
+
|transcriptional regulation
−
|early-onset preeclampsia
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''LINC02247''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289154 HSALNT0289154]
−
|[[LINC02247]]
+
|[[LOXL1-AS1]]
−
|ENST00000417135
+
|NA
−
|long intergenic non-protein coding RNA 2247
+
|NA
−
|early-onset preeclampsia
+
|pathogenic process
 +
|exfoliation syndrome
 +
|Eye Diseases
 
|-
 
|-
−
|''LINC02258''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289734 HSALNT0289734]
−
|[[LINC02258]]
+
|[[DACOR1]]
−
|RP11-248E9.5
+
|TCONS_00023265
−
|long intergenic non-protein coding RNA 2258
+
|transcriptional regulation
−
|pneumonia
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC02402''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289060 HSALNT0289060]
−
|[[LINC02402]]
+
|[[LINC00675]]
−
|ENST00000550337.1
+
|NA
−
|long intergenic non-protein coding RNA 2402
+
|NA
−
|Pre-Diabetes, Type 2 Diabetes Mellitus
+
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC02489''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288889 HSALNT0288889]
−
|[[LINC02489]]
+
|[[B4GALT1-AS1]]
−
|CTD-2589M5
+
|NA
−
|long intergenic non-protein coding RNA 2489
+
|transcriptional regulation
−
|Osteosarcoma
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC02490''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289348 HSALNT0289348]
−
|[[LINC02490]]
+
|[[LINC01616]]
−
|RP11-209E8
+
|n341006
−
|long intergenic non-protein coding RNA 2490
+
|NA
−
|Osteosarcoma
+
|pathogenic process
 +
|Alzheimer's disease
 +
|Mental Disorders;Nervous System Diseases
 
|-
 
|-
−
|''LINC02555''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290068 HSALNT0290068]
−
|[[LINC02555]]
+
|[[N336934]]
−
|AC079630.2
+
|NA
−
|long intergenic non-protein coding RNA 2555
+
|NA
−
|Papillary thyroid cancer
+
|pathogenic process
 +
|Alzheimer's disease
 +
|Mental Disorders;Nervous System Diseases
 
|-
 
|-
−
|''LINC02562''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290240 HSALNT0290240]
−
|[[LINC02562]]
+
|[[SIRT1-AS]]
−
|RP11-44F21.5
+
|NA
−
|long intergenic non-protein coding RNA 2562
+
|NA
−
|Squamous cell carcinoma
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINP1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290198 HSALNT0290198]
−
|[[LINP1]]
+
|[[RP11-457M11.2]]
−
|N/A
+
|NA
−
|lncRNA in non-homologous end joining pathway 1
+
|ceRNA
−
|breast cancer
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''LIVAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0150768 HSALNT0150768]
−
|[[LIVAR]]
+
|[[LINC01507]]
−
|lnc18q22.2
+
|XLOC_000303
−
|liver cell viability associated lncRNA
+
|NA
−
|Non-alcoholic steatohepatitis
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LNCSRLR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289903 HSALNT0289903]
−
|[[LNCSRLR]]
+
|[[LINC01057]]
−
|lncRNA-SRLR
+
|NA
−
|lncRNA sorafenib resistance in renal cell carcinoma associated
+
|NA
−
|renal cell carcinoma
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MAGI2-AS3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289914 HSALNT0289914]
−
|[[MAGI2-AS3]]
+
|[[LINC01617]]
−
|ENST00000414797
+
|C8orf23,NCRNA00249,XLOC_006844
−
|MAGI2 antisense RNA 3
+
|NA
−
|early-onset preeclampsia
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MAPT-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290015 HSALNT0290015]
−
|[[MAPT-AS1]]
+
|[[LOC152578]]
−
|N/A
+
|NA
−
|MAPT antisense RNA 1
+
|NA
−
|Parkinson's Disease
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MDS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072252 HSALNT0072252]
−
|[[MDS2]]
+
|[[LINC01618]]
−
|N/A
+
|LOC152578
−
|myelodysplastic syndrome 2 translocation associated
+
|NA
−
|myelodysplastic syndrome
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MEF2C-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0156870 HSALNT0156870]
−
|[[MEF2C-AS2]]
+
|[[NALT1]]
−
|CTC-467M3.1
+
|MIR4674HG,LINC01573,TCONS_l2_00029132
−
|MEF2C antisense RNA 2
+
|transcriptional regulation
−
|B cell lymphoma
+
|pathogenic process
 +
|acute lymphoblastic leukemia
 +
|Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''MELTF-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289083 HSALNT0289083]
−
|[[MELTF-AS1]]
+
|[[MALINC1]]
−
|MFI2-AS1
+
|LINC01024,MA-linc1
−
|MELTF antisense RNA 1
+
|NA
−
|osteosarcoma
+
|pathogenic process
 +
|human breast and lung cancer
 +
|Neoplasms
 
|-
 
|-
−
|''MHENCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289902 HSALNT0289902]
−
|[[MHENCR]]
+
|[[LINC01024]]
−
|N/A
+
|MA-linc1
−
|melanoma highly expressed competing endogenous lncRNA for miR-425 and miR-489
+
|NA
−
|Melanoma
+
|pathogenic process
 +
|osteosarcoma;lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''MIR200CHG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289120 HSALNT0289120]
−
|[[MIR200CHG]]
+
|[[LINC01627]]
−
|U47924.27
+
|RP11-397D12.4
−
|MIR200C and MIR141 host gene
+
|NA
−
|Melanoma tumorigenesis
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''MIR2052HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289121 HSALNT0289121]
−
|[[MIR2052HG]]
+
|[[LINC01628]]
−
|N/A
+
|AC007403.1
−
|MIR2052 host gene
+
|NA
−
|breast cancer
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''MAP3K20-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289820 HSALNT0289820]
−
|[[MAP3K20-AS1]]
+
|[[ERICH1-AS1]]
−
|N/A
+
|NA
−
|MAP3K20 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''MYOSLID''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290193 HSALNT0290193]
−
|[[MYOSLID]]
+
|[[RP11-397D12.4]]
−
|N/A
+
|LINC01627
−
|myocardin-induced smooth muscle lncRNA, inducer of differentiation
+
|NA
−
|_
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''MIR3936HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289122 HSALNT0289122]
−
|[[MIR3936HG]]
+
|[[LINC01629]]
−
|LOC553103, SLC22A5-AS1
+
|linc-KIAA1737-2
−
|MIR3936 host gene
+
|transcriptional regulation
−
|nasopharyngeal carcinoma, gastric cancer
+
|pathogenic process
 +
|hypoxic and inflammatory renal epithelial injury
 +
|NA
 
|-
 
|-
−
|''MIR4422HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290161 HSALNT0290161]
−
|[[MIR4422HG]]
+
|[[PTPRG-AS1]]
−
|RP11-101C11.1
+
|NA
−
|MIR4422 host gene
+
|NA
−
|B cell lymphoma
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''MIR4713HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289980 HSALNT0289980]
−
|[[MIR4713HG]]
+
|[[LncRNA-DLEU1]]
−
|RP11-108K3.1
+
|NA
−
|MIR4713 host gene
+
|ceRNA
−
|Colorectal adenocarcinoma
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''MMP2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289983 HSALNT0289983]
−
|[[MMP2-AS1]]
+
|[[LncRNA-Hh]]
−
|ENST00000569037
+
|NA
−
|MMP2 antisense RNA 1
+
|NA
−
|early-onset preeclampsia
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288986 HSALNT0288986]
 +
|[[GAS1RR]]
 +
|LncRNA-Hh
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''MNX1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288908 HSALNT0288908]
−
|[[MNX1-AS1]]
+
|[[CCDC18-AS1]]
−
|CCAT5, LOC645249
+
|ENST00000440778.1
−
|MNX1 antisense RNA 1 (head to head)
+
|NA
−
|Ovarian Cancer
+
|pathogenic process
 +
|adolescent idiopathic scoliosis
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''MNX1-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289055 HSALNT0289055]
−
|[[MNX1-AS2]]
+
|[[LINC00649]]
−
|ENST00000429228
+
|TCONS_00028768
−
|MNX1 antisense RNA 2
+
|NA
−
|early-onset preeclampsia
+
|pathogenic process
 +
|adolescent idiopathic scoliosis
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''NCF4-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289219 HSALNT0289219]
−
|[[NCF4-AS1]]
+
|[[PRKCQ-AS1]]
−
|CTA-833B7.2
+
|ENST00000414894.1
−
|NCF4 antisense RNA 1
+
|NA
−
|recurrent miscarriage
+
|pathogenic process
 +
|adolescent idiopathic scoliosis
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''NIFK-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290203 HSALNT0290203]
−
|[[NIFK-AS1]]
+
|[[RP11-567G11.1]]
−
|N/A
+
|LINC02041
−
|NIFK antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|pancreatic cancer
 +
|Endocrine System Diseases;Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''NEXN-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289805 HSALNT0289805]
−
|[[NEXN-AS1]]
+
|[[ENST00000438550]]
−
|C1orf118, FLJ90637
+
|RPS24P1
−
|NEXN antisense RNA 1
+
|NA
−
|lung cancer
+
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 
|-
 
|-
−
|''NNT-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290083 HSALNT0290083]
−
|[[NNT-AS1]]
+
|[[NONHSAG011351]]
−
|N/A
+
|NA
−
|NNT antisense RNA 1
+
|NA
−
|colorectal cancer cells
+
|pathogenic process
 +
|type 1 diabetes
 +
|Nutritional and Metabolic Diseases;Endocrine System Diseases
 
|-
 
|-
−
|''PAX8-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290049 HSALNT0290049]
−
|[[PAX8-AS1]]
+
|[[MCHR2-AS1]]
−
|N/A
+
|NA
−
|PAX8 antisense RNA 1
+
|NA
−
|cervical cancer
+
|pathogenic process
 +
|psychiatric disease
 +
|Nervous System Diseases
 
|-
 
|-
−
|''P4HA3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289799 HSALNT0289799]
−
|[[P4HA3-AS1]]
+
|[[ENST00000414355]]
−
|N/A
+
|NA
−
|P4HA3 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|cadmium toxicology
 +
|Disorders of Environmental Origin
 
|-
 
|-
−
|''PCSK6-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290241 HSALNT0290241]
−
|[[PCSK6-AS1]]
+
|[[SKP2]]
−
|N/A
+
|NA
−
|PCSK6 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''PGR-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289837 HSALNT0289837]
−
|[[PGR-AS1]]
+
|[[FLJ90757]]
−
|AT1, AT2, AT3
+
|NA
−
|PGR antisense RNA 1
+
|ceRNA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''POC1B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290017 HSALNT0290017]
−
|[[POC1B-AS1]]
+
|[[LOC283663]]
−
|RP11-734K2.4
+
|NA
−
|POC1B antisense RNA 1
+
|ceRNA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''PPP1R12A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290019 HSALNT0290019]
−
|[[PPP1R12A-AS1]]
+
|[[LOC338651]]
−
|R12A-AS1
+
|NA
−
|PPP1R12A antisense RNA 1
+
|ceRNA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''PRNT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290132 HSALNT0290132]
−
|[[PRNT]]
+
|[[PCATs]]
−
|M8
+
|NA
−
|prion locus lncRNA, testis expressed
+
|NA
−
|_
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''PINCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0086786 HSALNT0086786]
−
|[[PINCR]]
+
|[[EGFLAM-AS1]]
−
|N/A
+
|lncRNA-LOWEG
−
|p53-induced noncoding RNA
+
|NA
−
|Colorectal cancer
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''PLUT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290031 HSALNT0290031]
−
|[[PLUT]]
+
|[[LOWEG]]
−
|PDX1-AS1, PLUTO, HI-LNC71
+
|NA
−
|PDX1 associated lncRNA, upregulator of transcription
+
|NA
−
|Type 2 diabetes
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''PRAL''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289635 HSALNT0289635]
−
|[[PRAL]]
+
|[[BC014579]]
−
|lncRNA-PRAL
+
|NA
−
|p53 regulation associated lncRNA
+
|NA
−
|Hepatocellular carcinoma, Lung Cancer
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''PRKCZ-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289721 HSALNT0289721]
−
|[[PRKCZ-AS1]]
+
|[[CTB-167B5.2]]
−
|RP11-181G12.2
+
|NA
−
|PRKCZ antisense RNA 1
+
|NA
−
|lung adenocarcinoma
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''PRKG1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289863 HSALNT0289863]
−
|[[PRKG1-AS1]]
+
|[[HELLS]]
−
|RP11-573I11.2
+
|NA
−
|PRKG1 antisense RNA 1
+
|NA
−
|rheumatoid arthritis
+
|pathogenic process
 +
|leukemia
 +
|Neoplasms
 
|-
 
|-
−
|''PSMD6-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290195 HSALNT0290195]
−
|[[PSMD6-AS1]]
+
|[[RP11-401P9.4]]
−
|ENST00000462717, lnc00462717
+
|NA
−
|PSMD6 antisense RNA 1
+
|NA
−
|Papillary Thyroid Cancer, GBM
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''PSORS1C3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290252 HSALNT0290252]
−
|[[PSORS1C3]]
+
|[[SNHG19]]
−
|NCRNA00196
+
|NA
−
|psoriasis susceptibility 1 candidate 3 (non-protein coding)
+
|NA
−
|rheumatoid arthritis
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''PSPC1-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289557 HSALNT0289557]
−
|[[PSPC1-AS2]]
+
|[[AF070632]]
−
|RP11-523H24.3
+
|NA
−
|PSPC1 antisense RNA 2
+
|NA
−
|esophageal squamous cell carcinoma
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''RAMP2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289569 HSALNT0289569]
−
|[[RAMP2-AS1]]
+
|[[AK021443]]
−
|N/A
+
|NA
−
|RAMP2 antisense RNA 1
+
|NA
−
|glioblastoma
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''RASGRF2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289728 HSALNT0289728]
−
|[[RASGRF2-AS1]]
+
|[[CTD-3080P12.3]]
−
|CTC-459I6.1
+
|NA
−
|RASGRF2 antisense RNA 1
+
|ceRNA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''RFPL3S''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289987 HSALNT0289987]
−
|[[RFPL3S]]
+
|[[LncRNA-n336928]]
−
|RFPL3-AS, NCRNA00005
+
|NA
−
|RFPL3 antisense
+
|NA
−
|_
+
|pathogenic process
 +
|bladder cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''RNASEH1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289723 HSALNT0289723]
−
|[[RNASEH1-AS1]]
+
|[[CTC-523E23.5]]
−
|LOC100506054
+
|AC008555.2
−
|RNASEH1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|intervertebral disc degeneration
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''SATB2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289724 HSALNT0289724]
−
|[[SATB2-AS1]]
+
|[[CTD-2246P4.1]]
−
|N/A
+
|NA
−
|SATB2 antisense RNA 1
+
|NA
−
|Osteosarcoma
+
|pathogenic process
 +
|intervertebral disc degeneration
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''SKAP1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290055 HSALNT0290055]
−
|[[SKAP1-AS1]]
+
|[[MIR132]]
−
|RP11-456D7.1
+
|MIRN132,miRNA132,mir-132
−
|SKAP1 antisense RNA 1
+
|NA
−
|pneumonia
+
|pathogenic process
 +
|intervertebral disc degeneration
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''SIX3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290189 HSALNT0290189]
−
|[[SIX3-AS1]]
+
|[[RP11-363G2.4]]
−
|SIX3OS
+
|NA
−
|SIX3 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|intervertebral disc degeneration
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''SLC12A9-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290191 HSALNT0290191]
−
|[[SLC12A9-AS1]]
+
|[[RP11-38F22.1]]
−
|RP11-126L15
+
|LINC02424
−
|SLC12A9 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|intervertebral disc degeneration
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''SLC9A3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290223 HSALNT0290223]
−
|[[SLC9A3-AS1]]
+
|[[RP4-639J15.1]]
−
|UC011CLY.2
+
|AC006967.2
−
|SLC9A3 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|intervertebral disc degeneration
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''SMILR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290233 HSALNT0290233]
−
|[[SMILR]]
+
|[[RUNX1-IT1]]
−
|N/A
+
|C21orf96
−
|smooth muscle induced lncRNA, enhancer of proliferation
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''SPRY4-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288943 HSALNT0288943]
−
|[[SPRY4-AS1]]
+
|[[ENST00000415964]]
−
|THCAT68
+
|NA
−
|SPRY4 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|pediatric acute myeloid leukemia
 +
|Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''SLC12A5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290009 HSALNT0290009]
−
|[[SLC12A5-AS1]]
+
|[[LOC101927497]]
−
|RP11-465L10.10
+
|NA
−
|SLC12A5 and MMP9 antisense RNA 1
+
|NA
−
|early-onset preeclampsia
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''SLC16A1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289956 HSALNT0289956]
−
|[[SLC16A1-AS1]]
+
|[[Lnc-CYP4A22-2/3]]
−
|ENST00000421157.1
+
|NA
−
|SLC16A1 antisense RNA 1
+
|NA
−
|Acute myocardial infarction
+
|pathogenic process
 +
|clear cell renal cell cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''SLC25A25-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289999 HSALNT0289999]
−
|[[SLC25A25-AS1]]
+
|[[Lnc-ZNF180-2]]
−
|N/A
+
|NA
−
|SLC25A25 antisense RNA 1
+
|NA
−
|colorectal cancer
+
|pathogenic process
 +
|renal clear cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''SLC5A4-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290086 HSALNT0290086]
−
|[[SLC5A4-AS1]]
+
|[[NONHSAT037832]]
−
|RP1-90G24.10
+
|NA
−
|SLC5A4 antisense RNA 1
+
|NA
−
|gastric cancer
+
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 
|-
 
|-
−
|''SLC7A11-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289658 HSALNT0289658]
−
|[[SLC7A11-AS1]]
+
|[[BX647187]]
−
|ENST00000512786
+
|NA
−
|SLC7A11 antisense RNA 1
+
|NA
−
|early-onset preeclampsia
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''SMIM10L2B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289584 HSALNT0289584]
−
|[[SMIM10L2B-AS1]]
+
|[[AK056155]]
−
|ENST00000453528
+
|NA
−
|SMIM10L2B antisense RNA 1
+
|NA
−
|early-onset preeclampsia
+
|pathogenic process
 +
|Loeys-Dietz syndrome
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''SNHG18''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290057 HSALNT0290057]
−
|[[SNHG18]]
+
|[[MR1]]
−
|N/A
+
|NA
−
|small nucleolar RNA host gene 18
+
|NA
−
|glioma
+
|pathogenic process
 +
|Loeys-Dietz syndrome
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''SNHG26''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289543 HSALNT0289543]
−
|[[SNHG26]]
+
|[[AC002454.1]]
−
|AC005682.5
+
|AC002454.1
−
|small nucleolar RNA host gene 26
+
|NA
−
|Bladder urothelial carcinoma
+
|pathogenic process
 +
|endometriosis
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289909 HSALNT0289909]
 +
|[[LINC01420]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|systemic lupus erythematosus
 +
|Immune System Diseases;Skin and Connective Tissue Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289531 HSALNT0289531]
 +
|[[53BP1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290101 HSALNT0290101]
 +
|[[NR_024118]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis
 +
|Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290239 HSALNT0290239]
 +
|[[SGO1-AS1]]
 +
|SGOL1-AS1
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289293 HSALNT0289293]
 +
|[[ZNF667-AS1]]
 +
|MORT
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289984 HSALNT0289984]
 +
|[[LncRNA-HIF2PUT]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288945 HSALNT0288945]
 +
|[[ENST00000433673]]
 +
|AC068282.1
 +
|NA
 +
|pathogenic process
 +
|polycystic ovary syndrome
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288948 HSALNT0288948]
 +
|[[ENST00000454271]]
 +
|AL021940.1
 +
|NA
 +
|pathogenic process
 +
|polycystic ovary syndrome
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289495 HSALNT0289495]
 +
|[[ENST00000432431]]
 +
|AC023128.1
 +
|NA
 +
|pathogenic process
 +
|polycystic ovary syndrome
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289918 HSALNT0289918]
 +
|[[LINC01828]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|polycystic ovary syndrome
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290388 HSALNT0290388]
 +
|[[XLOC_011402]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|polycystic ovary syndrome
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289873 HSALNT0289873]
 +
|[[ICAM-1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289666 HSALNT0289666]
 +
|[[C5-OT1]]
 +
|C5T1lncRNA
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis
 +
|Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289626 HSALNT0289626]
 +
|[[AX800134]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290338 HSALNT0290338]
 +
|[[Uc001ncr]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290330 HSALNT0290330]
 +
|[[Uc.48+]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|diabetic neuropathic pain
 +
|Male Urogenital Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289098 HSALNT0289098]
 +
|[[LINC01207]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289628 HSALNT0289628]
 +
|[[BALR-6]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|B-lymphoblastic leukemia
 +
|Hemic and Lymphatic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290022 HSALNT0290022]
 +
|[[LOC389641]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289725 HSALNT0289725]
 +
|[[CTD-2541M15]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''SPINT1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289940 HSALNT0289940]
−
|[[SPINT1-AS1]]
+
|[[LINK-A]]
−
|RP11-532F12.5
+
|NA
−
|SPINT1 antisense RNA 1
+
|NA
−
|Melanoma tumorigenesis
+
|pathogenic process
 +
|triple-negative breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''SPON1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290107 HSALNT0290107]
−
|[[SPON1-AS1]]
+
|[[NUTF2P3]]
−
|RP11-21, L19.1
+
|NUTF2P3
−
|SPON1 antisense RNA 1
+
|NA
 +
|pathogenic process
 +
|pancreatic cancer
 +
|Endocrine System Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290095 HSALNT0290095]
 +
|[[NONHSAT123350]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|renal clear cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290362 HSALNT0290362]
 +
|[[UHRF1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290366 HSALNT0290366]
 +
|[[UPAT]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289307 HSALNT0289307]
 +
|[[LINC00324]]
 +
|FLJ34790,MGC104931
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289969 HSALNT0289969]
 +
|[[Lnc-MX1-1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290024 HSALNT0290024]
 +
|[[LOC400891]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289883 HSALNT0289883]
 +
|[[LA16c-313D11.11]]
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|endometrial cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290192 HSALNT0290192]
 +
|[[RP11-395G23.3]]
 +
|AC027031.2
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289581 HSALNT0289581]
 +
|[[AK027294]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290371 HSALNT0290371]
 +
|[[WISP1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0206117 HSALNT0206117]
 +
|[[FGF14-AS2]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290131 HSALNT0290131]
 +
|[[PCAT2]]
 +
|CARLo-4,PCA2,TCONS_00015167
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289528 HSALNT0289528]
 +
|[[2700086A05Rik]]
 +
|2700086A05Rik
 +
|NA
 +
|pathogenic process
 +
|idiopathic pulmonary fibrosis
 +
|Respiratory Tract Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290251 HSALNT0290251]
 +
|[[SNED1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Idiopathic pulmonary fibrosis
 +
|Respiratory Tract Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290333 HSALNT0290333]
 +
|[[Uc.77]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|idiopathic pulmonary fibrosis
 +
|Respiratory Tract Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289816 HSALNT0289816]
 +
|[[ENST00000537266]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289860 HSALNT0289860]
 +
|[[HAGLROS]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289881 HSALNT0289881]
 +
|[[KRT18P55]]
 +
|KRT18P55
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0229266 HSALNT0229266]
 +
|[[IL21R-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|coronary artery disease
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290112 HSALNT0290112]
 +
|[[OTTHUMT00000387022]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|coronary artery disease
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0000551 HSALNT0000551]
 +
|[[PRKCZ-AS1]]
 +
|RP11-181G12.2
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030981 HSALNT0030981]
 +
|[[LINC01833]]
 +
|RP11-89,K21.1
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290214 HSALNT0290214]
 +
|[[RP11-89K21]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0165271 HSALNT0165271]
 +
|[[LINC00857]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290109 HSALNT0290109]
 +
|[[OR3A4]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290046 HSALNT0290046]
 +
|[[MAGI1-IT1]]
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|cardiac hypertrophy
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290242 HSALNT0290242]
 +
|[[SLC26A4-AS1]]
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|cardiac hypertrophy
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289302 HSALNT0289302]
 +
|[[KRT7-AS]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0218672 HSALNT0218672]
 +
|[[LINC01852]]
 +
|ENST00000434223
 +
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290178 HSALNT0290178]
 +
|[[RP11-1008C21.2]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289592 HSALNT0289592]
 +
|[[AK123072]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289573 HSALNT0289573]
 +
|[[AK021954]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|atherosclerosis
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288916 HSALNT0288916]
 +
|[[CERNA1]]
 +
|LOC100129973
 +
|ceRNA
 +
|pathogenic process
 +
|cardiovascular disease
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018525 HSALNT0018525]
 +
|[[LAMC1-AS1]]
 +
|lnc-LAMC2-1:1
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290087 HSALNT0290087]
 +
|[[NONHSAT040387]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|atrial fibrillation
 +
|Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290092 HSALNT0290092]
 +
|[[NONHSAT098586]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|atrial fibrillation
 +
|Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289213 HSALNT0289213]
 +
|[[PCSK6-AS1]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289637 HSALNT0289637]
 +
|[[BC016831]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289874 HSALNT0289874]
 +
|[[IGKV]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290196 HSALNT0290196]
 +
|[[RP11-434D9.1]]
 +
|AC112206.2
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289885 HSALNT0289885]
 +
|[[LCAL6]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289650 HSALNT0289650]
 +
|[[BC088254]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|myocardial hypertrophy
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289596 HSALNT0289596]
 +
|[[AK124454]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289731 HSALNT0289731]
 +
|[[CYP4B1-PS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|diabetic nephropathy
 +
|Endocrine System Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289106 HSALNT0289106]
 +
|[[LINC01405]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290259 HSALNT0290259]
 +
|[[ST8SIA6-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289278 HSALNT0289278]
 +
|[[TRIM52-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289634 HSALNT0289634]
 +
|[[BC012900]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ulcerative colitis
 +
|Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274011 HSALNT0274011]
 +
|[[UMODL1-AS1]]
 +
|FLJ33471
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289454 HSALNT0289454]
 +
|[[ARRDC1-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289456 HSALNT0289456]
 +
|[[FAM74A3]]
 +
|OTTHUMG00000067149
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289834 HSALNT0289834]
 +
|[[FH]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Fumarase deficiency
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289961 HSALNT0289961]
 +
|[[Lnc-HOXC4-3:1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289994 HSALNT0289994]
 +
|[[Lnc-TEAD4-1:1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290270 HSALNT0290270]
 +
|[[TCONS_00003876]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290235 HSALNT0290235]
 +
|[[SARCC]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290360 HSALNT0290360]
 +
|[[Ucoo2kmd.1]]
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289015 HSALNT0289015]
 +
|[[KAZN-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289722 HSALNT0289722]
 +
|[[CTB-89H12.4]]
 +
|AC021078.1
 +
|ceRNA
 +
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289496 HSALNT0289496]
 +
|[[EPB41L4A-AS2]]
 +
|FLJ11235
 +
|NA
 +
|pathogenic process
 +
|lung cancer;breast cancer;kidney cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289146 HSALNT0289146]
 +
|[[LINC02567]]
 +
|ENST00000427806
 +
|NA
 +
|pathogenic process
 +
|attention deficit hyperactivity disorder
 +
|Mental Disorders
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289833 HSALNT0289833]
 +
|[[FGFR3-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289707 HSALNT0289707]
 +
|[[CILinc01]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|osteoarthritis
 +
|Musculoskeletal Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289708 HSALNT0289708]
 +
|[[CILinc02]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|osteoarthritis
 +
|Musculoskeletal Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0286597 HSALNT0286597]
 +
|[[LINC00629]]
 +
|LINC00629AB,LINC00629C,LINC00629D,LINC00629
 +
|NA
 +
|pathogenic process
 +
|choriocarcinoma
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289665 HSALNT0289665]
 +
|[[C2dat1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ischemic brain injury
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289217 HSALNT0289217]
 +
|[[POU6F2-AS2]]
 +
|FLJ12971
 +
|protein localization
 +
|pathogenic process
 +
|oesophageal squamous cell cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289946 HSALNT0289946]
 +
|[[Lnc13]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|celiac disease
 +
|Nutritional and Metabolic Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289729 HSALNT0289729]
 +
|[[CTD903]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290093 HSALNT0290093]
 +
|[[NONHSAT104436]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289550 HSALNT0289550]
 +
|[[AC024560.2]]
 +
|AC024560.1
 +
|NA
 +
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289483 HSALNT0289483]
 +
|[[ENST00000436681]]
 +
|AP000552.1
 +
|NA
 +
|pathogenic process
 +
|congenital heart defect
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289536 HSALNT0289536]
 +
|[[AA584040]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|congenital heart defect
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289537 HSALNT0289537]
 +
|[[AA709223]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|congenital heart defect
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289657 HSALNT0289657]
 +
|[[BX478947]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|congenital heart defect
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247515 HSALNT0247515]
 +
|[[LINC00668]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289719 HSALNT0289719]
 +
|[[CRNDE-h]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142879 HSALNT0142879]
 +
|[[SMILR]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|vascular pathologies
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290396 HSALNT0290396]
 +
|[[Z38]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0197213 HSALNT0197213]
 +
|[[LINC00507]]
 +
|NA
 +
|NA
 +
|developmental process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289086 HSALNT0289086]
 +
|[[LINC01082]]
 +
|TCONSNA00024492
 +
|NA
 +
|pathogenic process
 +
|alveolar capillary dysplasia with misalignment of pulmonary veins
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289094 HSALNT0289094]
 +
|[[LINC01185]]
 +
|FLJ16341
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290160 HSALNT0290160]
 +
|[[PTPRD-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290186 HSALNT0290186]
 +
|[[RP11-254I22.1]]
 +
|MIR583HG
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290204 HSALNT0290204]
 +
|[[RP11-57P19.1]]
 +
|AC009432.1
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290211 HSALNT0290211]
 +
|[[RP11-80H5.7]]
 +
|AL157400.4
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290215 HSALNT0290215]
 +
|[[RP1-223E5.4]]
 +
|AL441883.1
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290224 HSALNT0290224]
 +
|[[RP4-799P18.3]]
 +
|AL122008.4
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289126 HSALNT0289126]
 +
|[[LINC01844]]
 +
|LOC101926975
 +
|NA
 +
|pathogenic process
 +
|hirschsprung disease
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289947 HSALNT0289947]
 +
|[[Lnc34a]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289150 HSALNT0289150]
 +
|[[LINP1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289951 HSALNT0289951]
 +
|[[LncARSR]]
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289392 HSALNT0289392]
 +
|[[RBM15-AS1]]
 +
|AS-RBM15
 +
|translational control
 +
|pathogenic process
 +
|acute megakaryocytic leukemia
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290089 HSALNT0290089]
 +
|[[NONHSAT073641]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|vascular diseases
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290027 HSALNT0290027]
 +
|[[LOC572558]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|bladder cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289582 HSALNT0289582]
 +
|[[AK033210]]
 +
|NA
 +
|NA
 +
|pathogenic process;developmental process
 +
|bronchopulmonary dysplasia
 +
|Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289848 HSALNT0289848]
 +
|[[GClnc1]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289572 HSALNT0289572]
 +
|[[AK021630]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Parkinson's disease
 +
|Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289603 HSALNT0289603]
 +
|[[AL049437]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Parkinson's disease
 +
|Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290007 HSALNT0290007]
 +
|[[LOC100507661]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289084 HSALNT0289084]
 +
|[[LINC01029]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|cognitive functions and neuronal plasticity
 +
|Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290169 HSALNT0290169]
 +
|[[RMEL3]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|melanoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289959 HSALNT0289959]
 +
|[[Lnc-FRG2C-3]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ankylosing spondylitis
 +
|Musculoskeletal Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289966 HSALNT0289966]
 +
|[[Lnc-LIN54-1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ankylosing spondylitis
 +
|Musculoskeletal Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289997 HSALNT0289997]
 +
|[[Lnc-USP50-2]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ankylosing spondylitis
 +
|Musculoskeletal Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290000 HSALNT0290000]
 +
|[[Lnc-ZNF354A-1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ankylosing spondylitis
 +
|Musculoskeletal Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288949 HSALNT0288949]
 +
|[[ENST00000455309]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|primary Sjögren's syndrome
 +
|Immune System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289920 HSALNT0289920]
 +
|[[LINC02384]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|primary Sjögren's syndrome
 +
|Immune System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289998 HSALNT0289998]
 +
|[[Lnc-UTS2D-1:1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|primary Sjögren's syndrome
 +
|Immune System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290067 HSALNT0290067]
 +
|[[N336161]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|primary Sjögren's syndrome
 +
|Immune System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290069 HSALNT0290069]
 +
|[[N340599]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|primary Sjögren's syndrome
 +
|Immune System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290099 HSALNT0290099]
 +
|[[NR_002712]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|primary Sjögren's syndrome
 +
|Immune System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290290 HSALNT0290290]
 +
|[[TCONS_l2_00014794]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|primary Sjögren's syndrome
 +
|Immune System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290170 HSALNT0290170]
 +
|[[RMRP]]
 +
|CHH,NME1R,RRP2,RMRP
 +
|ceRNA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289900 HSALNT0289900]
 +
|[[LINC00961]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289077 HSALNT0289077]
 +
|[[LINC00977]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|primary spontaneous pneumothorax
 +
|Respiratory Tract Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289560 HSALNT0289560]
 +
|[[AF085995]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289566 HSALNT0289566]
 +
|[[AK000053]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289571 HSALNT0289571]
 +
|[[AK021595]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289574 HSALNT0289574]
 +
|[[AK022024]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289595 HSALNT0289595]
 +
|[[AK124307]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289639 HSALNT0289639]
 +
|[[BC020384]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289642 HSALNT0289642]
 +
|[[BC030759]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289715 HSALNT0289715]
 +
|[[CR615992]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289954 HSALNT0289954]
 +
|[[Lnc-CC3]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289614 HSALNT0289614]
 +
|[[APOC1P1-3]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290365 HSALNT0290365]
 +
|[[UNMIBC]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|bladder cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290323 HSALNT0290323]
 +
|[[Uc.167]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ventricular septal defects
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290212 HSALNT0290212]
 +
|[[RP11-838N2.4]]
 +
|GAPLINC
 +
|ceRNA
 +
|pathogenic process
 +
|glioblastoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289109 HSALNT0289109]
 +
|[[LINC01478]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|blood pressure
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289313 HSALNT0289313]
 +
|[[LINC00342]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289677 HSALNT0289677]
 +
|[[CAR10]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289365 HSALNT0289365]
 +
|[[MAPT-AS1]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Parkinson's disease
 +
|Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289679 HSALNT0289679]
 +
|[[CAT104]]
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290260 HSALNT0290260]
 +
|[[STXBP5-AS1]]
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289861 HSALNT0289861]
 +
|[[HAR1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Huntington disease
 +
|Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290359 HSALNT0290359]
 +
|[[UCHL1-AS1]]
 +
|NA
 +
|translational control
 +
|pathogenic process
 +
|Parkinson's disease
 +
|Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290238 HSALNT0290238]
 +
|[[SCAANT1-AS]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|spinocerebellar ataxia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289648 HSALNT0289648]
 +
|[[BC041488]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|bladder cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290188 HSALNT0290188]
 +
|[[RP11-359E19.2]]
 +
|AC022733.1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|bladder cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289851 HSALNT0289851]
 +
|[[GIHCG]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289649 HSALNT0289649]
 +
|[[BC087858]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290353 HSALNT0290353]
 +
|[[Uc004cov.4]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hypertrophic cardiomyopathy
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290357 HSALNT0290357]
 +
|[[Uc022bqu.1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hypertrophic cardiomyopathy
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127837 HSALNT0127837]
 +
|[[CFTR-AS1]]
 +
|BGas
 +
|transcriptional regulation
 +
|pathogenic process
 +
|cystic fibrosis
 +
|Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0046367 HSALNT0046367]
 +
|[[MYOSLID]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|vascular smooth muscle cell (VSMC) contractile phenotype
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290331 HSALNT0290331]
 +
|[[Uc.63]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290106 HSALNT0290106]
 +
|[[Numb]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|uveal melanoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289847 HSALNT0289847]
 +
|[[GCASPC]]
 +
|TCONS_00011605,RP1-56L9.7-001,lnc-SOD2-1
 +
|NA
 +
|pathogenic process
 +
|gallbladder cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289568 HSALNT0289568]
 +
|[[AK001094]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289588 HSALNT0289588]
 +
|[[AK093735]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289631 HSALNT0289631]
 +
|[[BC003519]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290100 HSALNT0290100]
 +
|[[NR_003573]]
 +
|ANXA2P2
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290119 HSALNT0290119]
 +
|[[P2RX7-V3]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|uveal melanoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290308 HSALNT0290308]
 +
|[[TMSB4]]
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|osteoarthritis
 +
|Musculoskeletal Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288928 HSALNT0288928]
 +
|[[DDX11-AS1]]
 +
|CONCR
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290052 HSALNT0290052]
 +
|[[MELOE]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|melanoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290231 HSALNT0290231]
 +
|[[RSU1P2]]
 +
|RSU1P2
 +
|ceRNA
 +
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290165 HSALNT0290165]
 +
|[[RBMY2FP]]
 +
|RBMY2FP
 +
|NA
 +
|NA
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290071 HSALNT0290071]
 +
|[[N375709]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289748 HSALNT0289748]
 +
|[[DUXAP8]]
 +
|DUXAP8
 +
|NA
 +
|NA
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290030 HSALNT0290030]
 +
|[[LOC729966]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290143 HSALNT0290143]
 +
|[[POIR]]
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|periodontitis
 +
|Stomatognathic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0067481 HSALNT0067481]
 +
|[[MELTF-AS1]]
 +
|MFI2-AS1,AC068302.3
 +
|NA
 +
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290053 HSALNT0290053]
 +
|[[MFI2]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289922 HSALNT0289922]
 +
|[[Linc-223]]
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|acute myeloid leukemia
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0014603 HSALNT0014603]
 +
|[[LINC01138]]
 +
|LINC00875,FLJ39739
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290262 HSALNT0290262]
 +
|[[SUZ12P1]]
 +
|SUZ12P1
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290005 HSALNT0290005]
 +
|[[LOC100505976]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|laryngeal squamous cell cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290392 HSALNT0290392]
 +
|[[XLOC_l2_010636]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|laryngeal squamous cell cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0090295 HSALNT0090295]
 +
|[[RASGRF2-AS1]]
 +
|CTC-459I6.1
 +
|NA
 +
|pathogenic process
 +
|sepsis-induced endothelial dysfunction
 +
|Bacterial Infections and Mycoses
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289852 HSALNT0289852]
 +
|[[GPC3-AS1]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189472 HSALNT0189472]
 +
|[[HOXC-AS1]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|atherosclerosis
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289157 HSALNT0289157]
 +
|[[LUARIS]]
 +
|lncRNA#32
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289371 HSALNT0289371]
 +
|[[MIR3936HG]]
 +
|LOC553103,SLC22A5-AS1
 +
|NA
 +
|pathogenic process
 +
|gastric cancer;nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Stomatognathic Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290148 HSALNT0290148]
 +
|[[Ppp1r1b]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|congenital heart defect
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289038 HSALNT0289038]
 +
|[[LINC00460]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290194 HSALNT0290194]
 +
|[[RP1-13P20.6]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290364 HSALNT0290364]
 +
|[[Unigene56159]]
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290355 HSALNT0290355]
 +
|[[Uc009yby.1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289406 HSALNT0289406]
 +
|[[TFAP2A-AS2]]
 +
|HIPSTR
 +
|NA
 +
|developmental process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289704 HSALNT0289704]
 +
|[[Chaer]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|cardiac hypertrophy
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211378 HSALNT0211378]
 +
|[[LINC00520]]
 +
|C14orf34
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0087374 HSALNT0087374]
 +
|[[MRPS30-DT]]
 +
|BRCAT54
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289388 HSALNT0289388]
 +
|[[PPP1R12A-AS1]]
 +
|R12A-AS1
 +
|translational control
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289013 HSALNT0289013]
 +
|[[ITFG2-AS1]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290088 HSALNT0290088]
 +
|[[NONHSAT041499]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|schizophrenia
 +
|Mental Disorders
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290091 HSALNT0290091]
 +
|[[NONHSAT089447]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|schizophrenia
 +
|Mental Disorders
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289970 HSALNT0289970]
 +
|[[Lnc-NKX2-3-1]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|acute lymphoblastic leukemia
 +
|Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289989 HSALNT0289989]
 +
|[[Lnc-RTN4R-1]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|acute lymphoblastic leukemia
 +
|Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289821 HSALNT0289821]
 +
|[[ERL]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Marek's disease
 +
|Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0192459 HSALNT0192459]
 +
|[[LINC02258]]
 +
|RP11-248E9.5
 +
|NA
 +
|pathogenic process
 +
|pneumonia
 +
|Respiratory Tract Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0241871 HSALNT0241871]
 +
|[[SKAP1-AS1]]
 +
|RP11-456D7.1
 +
|NA
 +
|pathogenic process
 +
|pneumonia
 +
|Respiratory Tract Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289439 HSALNT0289439]
 +
|[[DINOL]]
 +
|DINO
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288901 HSALNT0288901]
 +
|[[CAMTA1-DT]]
 +
|lncCAMTA1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|liver cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290328 HSALNT0290328]
 +
|[[Uc.345]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|pancreatic cancer
 +
|Endocrine System Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290060 HSALNT0290060]
 +
|[[MSNP1AS]]
 +
|NA
 +
|translational control
 +
|pathogenic process
 +
|autism spectrum disorder
 +
|Mental Disorders
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289376 HSALNT0289376]
 +
|[[NEXN-AS1]]
 +
|C1orf118,FLJ90637
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183194 HSALNT0183194]
 +
|[[LINC02098]]
 +
|RP11-702B10.1
 +
|NA
 +
|pathogenic process
 +
|esophageal cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0198055 HSALNT0198055]
 +
|[[PSPC1-AS2]]
 +
|RP11-523H24.3
 +
|NA
 +
|pathogenic process
 +
|esophageal cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289155 HSALNT0289155]
 +
|[[LRRC75A-AS1]]
 +
|C17orf45,NCRNA00188,C17orf76-AS1,FAM211A-AS1,MGC40157
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis
 +
|Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289220 HSALNT0289220]
 +
|[[PRKG1-AS1]]
 +
|RP11-573I11.2
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis
 +
|Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289262 HSALNT0289262]
 +
|[[SVIL-AS1]]
 +
|RP11-534G20.3
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis
 +
|Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289281 HSALNT0289281]
 +
|[[VPS33B-DT]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis
 +
|Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289804 HSALNT0289804]
 +
|[[ENST00000438399]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis
 +
|Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290228 HSALNT0290228]
 +
|[[RPKG1-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis
 +
|Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290350 HSALNT0290350]
 +
|[[Uc004afb.1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis
 +
|Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289398 HSALNT0289398]
 +
|[[SLC5A4-AS1]]
 +
|RP1-90G24.10
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289411 HSALNT0289411]
 +
|[[TNFRSF10A-AS1]]
 +
|RP11-1149O23.2
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289727 HSALNT0289727]
 +
|[[CTD-2616J11.14]]
 +
|AC008750.7
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290182 HSALNT0290182]
 +
|[[RP11-150O12.3]]
 +
|AC124067.4
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289730 HSALNT0289730]
 +
|[[CXCL1P1]]
 +
|CXCL1P1
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289803 HSALNT0289803]
 +
|[[ENST00000438347]]
 +
|CCND3P1
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289897 HSALNT0289897]
 +
|[[LINC00601]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289503 HSALNT0289503]
 +
|[[KIAA0087]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289827 HSALNT0289827]
 +
|[[FAM212B-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290010 HSALNT0290010]
 +
|[[LOC102723552]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290181 HSALNT0290181]
 +
|[[RP11-140I24]]
 +
|LINC01568
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290201 HSALNT0290201]
 +
|[[RP11-501O2]]
 +
|LINC02046
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290206 HSALNT0290206]
 +
|[[RP11-600K151]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290084 HSALNT0290084]
 +
|[[NONHSAG051968]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290090 HSALNT0290090]
 +
|[[NONHSAT076747]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290094 HSALNT0290094]
 +
|[[NONHSAT122730]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138768 HSALNT0138768]
 +
|[[MIR2052HG]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289096 HSALNT0289096]
 +
|[[LINC01198]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|glioma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289274 HSALNT0289274]
 +
|[[TPT1-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|glioma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289924 HSALNT0289924]
 +
|[[Linc-cdh4-2]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144641 HSALNT0144641]
 +
|[[LINC02055]]
 +
|RP1130-1
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289737 HSALNT0289737]
 +
|[[DBCCR1]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|bladder cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289547 HSALNT0289547]
 +
|[[AC012065.7]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|chronic lymphocytic leukemia
 +
|Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289229 HSALNT0289229]
 +
|[[RAMP2-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|glioblastoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289591 HSALNT0289591]
 +
|[[AK098081]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289644 HSALNT0289644]
 +
|[[BC037331]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289646 HSALNT0289646]
 +
|[[BC040303]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289717 HSALNT0289717]
 +
|[[CR749831]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289250 HSALNT0289250]
 +
|[[SNHG18]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|glioma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0106140 HSALNT0106140]
 +
|[[FOXP4-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0026202 HSALNT0026202]
 +
|[[RNASEH1-AS1]]
 +
|LOC100506054
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288993 HSALNT0288993]
 +
|[[GSEC]]
 +
|ST3GAL4-AS1,DCPS-AS1,FLJ39051
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060264 HSALNT0060264]
 +
|[[DNAJB8-AS1]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0248137 HSALNT0248137]
 +
|[[CHMP1B-AS1]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021970 HSALNT0021970]
 +
|[[TGFB2-AS1]]
 +
|NR_046268
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0078323 HSALNT0078323]
 +
|[[SLC7A11-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134663 HSALNT0134663]
 +
|[[INTS9-AS1]]
 +
|ENST00000520055
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0231572 HSALNT0231572]
 +
|[[MMP2-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267869 HSALNT0267869]
 +
|[[SLC12A5-AS1]]
 +
|RP11-465L10.10
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288921 HSALNT0288921]
 +
|[[CSMD2-AS1]]
 +
|ENST00000434181
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288997 HSALNT0288997]
 +
|[[HDAC2-AS2]]
 +
|ENST00000421891
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289012 HSALNT0289012]
 +
|[[INO80-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289140 HSALNT0289140]
 +
|[[LINC02247]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289161 HSALNT0289161]
 +
|[[MAGI2-AS3]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289188 HSALNT0289188]
 +
|[[MNX1-AS2]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289245 HSALNT0289245]
 +
|[[SMIM10L2B-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289407 HSALNT0289407]
 +
|[[TGFB3-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289457 HSALNT0289457]
 +
|[[HSD17B3-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289919 HSALNT0289919]
 +
|[[LINC02246]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289288 HSALNT0289288]
 +
|[[ZNF710-AS1]]
 +
|ENST00000558334
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289266 HSALNT0289266]
 +
|[[TDRKH-AS1]]
 +
|RP11-98D18.9
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289128 HSALNT0289128]
 +
|[[LINC01952]]
 +
|AC004854.4
 +
|NA
 +
|pathogenic process
 +
|recurrent miscarriage
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290075 HSALNT0290075]
 +
|[[NCF4-AS1]]
 +
|CTA-833B7.2
 +
|NA
 +
|pathogenic process
 +
|recurrent miscarriage
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289360 HSALNT0289360]
 +
|[[LNCSRLR]]
 +
|lncRNA-SRLR
 +
|transcriptional regulation
 +
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288918 HSALNT0288918]
 +
|[[CFLAR-AS1]]
 +
|ALS2CR10
 +
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289710 HSALNT0289710]
 +
|[[COL1A2-AS1]]
 +
|TCONS_00013888,lncRNA8975-1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hypertrophic scar
 +
|Skin and Connective Tissue Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0075075 HSALNT0075075]
 +
|[[LNCPRESS2]]
 +
|lncPRESS2
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0011289 HSALNT0011289]
 +
|[[LINC01930]]
 +
|EU358092
 +
|NA
 +
|pathogenic process
 +
|schizophrenia
 +
|Mental Disorders
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0097120 HSALNT0097120]
 +
|[[HMMR-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|basal-like breast cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0184498 HSALNT0184498]
 +
|[[CCND2-AS1]]
 +
|CCND2-AS2
 +
|NA
 +
|pathogenic process
 +
|glioma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289045 HSALNT0289045]
 +
|[[LINC00578]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|major depression disorder
 +
|Behavior and Behavior Mechanisms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288884 HSALNT0288884]
 +
|[[ADAMTS9-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|epithelial ovarian cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0080041 HSALNT0080041]
 +
|[[FAM198B-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0103007 HSALNT0103007]
 +
|[[LINC00240]]
 +
|C6orf41,NCRNA00240,bA373D17.1
 +
|ceRNA
 +
|pathogenic process
 +
|esophageal squamous cell cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289071 HSALNT0289071]
 +
|[[LINC00909]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289509 HSALNT0289509]
 +
|[[LINC00680]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0129070 HSALNT0129070]
 +
|[[LINC00513]]
 +
|AC016831.7
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289129 HSALNT0289129]
 +
|[[LINC02001]]
 +
|RP11-1094M14.11
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289215 HSALNT0289215]
 +
|[[POC1B-AS1]]
 +
|RP11-734K2.4
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289241 HSALNT0289241]
 +
|[[SLC12A9-AS1]]
 +
|RP11-126L15.4
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289275 HSALNT0289275]
 +
|[[TRAM2-AS1]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002243 HSALNT0002243]
 +
|[[ENST00000457898.1]]
 +
|ENSG00000226029
 +
|ceRNA
 +
|pathogenic process
 +
|oesophageal cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288941 HSALNT0288941]
 +
|[[ELF3-AS1]]
 +
|ENST00000415582
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289134 HSALNT0289134]
 +
|[[LINC02158]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289350 HSALNT0289350]
 +
|[[LINC01671]]
 +
|BC041455
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289124 HSALNT0289124]
 +
|[[LINC01684]]
 +
|lnc-JAM2-6
 +
|NA
 +
|pathogenic process
 +
|nonalcoholic fatty liver disease
 +
|Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289036 HSALNT0289036]
 +
|[[LINC00365]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|esophageal cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289111 HSALNT0289111]
 +
|[[LINC01554]]
 +
|C5orf27,FLJ38821,FIS
 +
|NA
 +
|pathogenic process
 +
|esophageal cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289132 HSALNT0289132]
 +
|[[LINC02154]]
 +
|GS1-600G8.5
 +
|NA
 +
|pathogenic process
 +
|esophageal cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137721 HSALNT0137721]
 +
|[[LINC02155]]
 +
|RP11-705O24.1
 +
|NA
 +
|pathogenic process
 +
|esophageal cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0225363 HSALNT0225363]
 +
|[[LINC02157]]
 +
|RP11-327J17.1
 +
|NA
 +
|pathogenic process
 +
|esophageal cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289133 HSALNT0289133]
 +
|[[LINC02156]]
 +
|RP1-90J4.1
 +
|NA
 +
|pathogenic process
 +
|esophageal cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0133924 HSALNT0133924]
 +
|[[LINC02153]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|major depression disorder
 +
|Behavior and Behavior Mechanisms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0181656 HSALNT0181656]
 +
|[[LINC02151]]
 +
|TCONS_00019174
 +
|NA
 +
|pathogenic process
 +
|major depression disorder
 +
|Behavior and Behavior Mechanisms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0227367 HSALNT0227367]
 +
|[[LINC02152]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|major depression disorder
 +
|Behavior and Behavior Mechanisms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029246 HSALNT0029246]
 +
|[[BRE-AS1]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289251 HSALNT0289251]
 +
|[[SNHG26]]
 +
|AC005682.5
 +
|NA
 +
|pathogenic process
 +
|bladder urothelial cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0252719 HSALNT0252719]
 +
|[[LIVAR]]
 +
|lnc18q22.2
 +
|NA
 +
|pathogenic process
 +
|nonalcoholic steatohepatiti
 +
|Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289074 HSALNT0289074]
 +
|[[LINC00969]]
 +
|ENST00000453324
 +
|NA
 +
|pathogenic process
 +
|lung squamous cell cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289138 HSALNT0289138]
 +
|[[LINC02243]]
 +
|ENST00000441841
 +
|NA
 +
|pathogenic process
 +
|lung squamous cell cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289399 HSALNT0289399]
 +
|[[SLC9A3-AS1]]
 +
|UC011CLY.2
 +
|NA
 +
|pathogenic process
 +
|lung squamous cell cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288934 HSALNT0288934]
 +
|[[DM1-AS]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|myotonic dystrophy type 1
 +
|Musculoskeletal Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0009014 HSALNT0009014]
 +
|[[LINC02238]]
 +
|RP4-788P17.1
 +
|NA
 +
|pathogenic process
 
|B cell lymphoma
 
|B cell lymphoma
 +
|Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289163 HSALNT0289163]
 +
|[[MEF2C-AS2]]
 +
|CTC-467M3.1
 +
|NA
 +
|pathogenic process
 +
|diffuse large B-cell lymphoma
 +
|Hemic and Lymphatic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289181 HSALNT0289181]
 +
|[[MIR4422HG]]
 +
|RP11-101C11.1
 +
|NA
 +
|pathogenic process
 +
|diffuse large B-cell lymphoma
 +
|Hemic and Lymphatic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289403 HSALNT0289403]
 +
|[[SPON1-AS1]]
 +
|RP11-21,L19.1
 +
|NA
 +
|pathogenic process
 +
|diffuse large B-cell lymphoma
 +
|Hemic and Lymphatic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289461 HSALNT0289461]
 +
|[[CD44-AS1]]
 +
|RP1-68D18.4
 +
|NA
 +
|pathogenic process
 +
|diffuse large B-cell lymphoma
 +
|Hemic and Lymphatic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262277 HSALNT0262277]
 +
|[[LILRB1-AS1]]
 +
|AC009892.10
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0282241 HSALNT0282241]
 +
|[[LINC01186]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289168 HSALNT0289168]
 +
|[[MHENCR]]
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|melanoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072994 HSALNT0072994]
 +
|[[LINC02232]]
 +
|RP11-707A18.1
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0080161 HSALNT0080161]
 +
|[[LINC02233]]
 +
|RP11-6C14.1
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084027 HSALNT0084027]
 +
|[[LINC02236]]
 +
|RP11-332J15.1
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091870 HSALNT0091870]
 +
|[[LINC02234]]
 +
|RP11-455B3.1
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0139521 HSALNT0139521]
 +
|[[LINC02235]]
 +
|RP11-354A14.1
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142040 HSALNT0142040]
 +
|[[LINC02237]]
 +
|RP11-1101K5.1
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289135 HSALNT0289135]
 +
|[[LINC02179]]
 +
|RP11-189E14.4
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289351 HSALNT0289351]
 +
|[[LINC01689]]
 +
|AP000469.2
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289137 HSALNT0289137]
 +
|[[LINC02231]]
 +
|RP11-766N7.4
 +
|NA
 +
|pathogenic process
 +
|Esophageal squamous cell cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0220239 HSALNT0220239]
 +
|[[MIR4713HG]]
 +
|RP11-108K3.1
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288967 HSALNT0288967]
 +
|[[FAM160A1-DT]]
 +
|RP11-610P16.1
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289239 HSALNT0289239]
 +
|[[SATB2-AS1]]
 +
|NA
 +
|translational control
 +
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289512 HSALNT0289512]
 +
|[[LINC01826]]
 +
|lnc-MKI67IP-3
 +
|ceRNA
 +
|pathogenic process
 +
|atherosclerosis
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289024 HSALNT0289024]
 +
|[[LINC00226]]
 +
|C14orf97,NCRNA00226
 +
|NA
 +
|pathogenic process
 +
|pancreatic ductaladenocarcinoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0082192 HSALNT0082192]
 +
|[[F11-AS1]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0219108 HSALNT0219108]
 +
|[[SPINT1-AS1]]
 +
|RP11-532F12.5
 +
|NA
 +
|pathogenic process
 +
|melanoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289177 HSALNT0289177]
 +
|[[MIR200CHG]]
 +
|U47924.27
 +
|NA
 +
|pathogenic process
 +
|melanoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289328 HSALNT0289328]
 +
|[[LINC00888]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|melanoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289309 HSALNT0289309]
 +
|[[LINC00672]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|endometrial cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289198 HSALNT0289198]
 +
|[[P4HA3-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|parkinson's disease
 +
|Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0197312 HSALNT0197312]
 +
|[[TMEM132D-AS1]]
 +
|LOC283352
 +
|NA
 +
|pathogenic process
 +
|human dermal fibroblasts
 +
|Cell Physiological Phenomena
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289472 HSALNT0289472]
 +
|[[ATP2C2-AS1]]
 +
|RP11-517C16.2-001
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0233849 HSALNT0233849]
 +
|[[WWOX-AS1]]
 +
|RP11-190D6.2
 +
|NA
 +
|pathogenic process
 +
|epithelial ovarian cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0128829 HSALNT0128829]
 +
|[[FLNC-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|cervical squamous cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289889 HSALNT0289889]
 +
|[[LIF-AS1]]
 +
|Lnc-LIF-AS
 +
|NA
 +
|pathogenic process
 +
|cervical squamous cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0011283 HSALNT0011283]
 +
|[[DPYD-AS2]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|cervical squamous cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289836 HSALNT0289836]
 +
|[[FLICR]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|autoimmune diabete
 +
|Immune System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289356 HSALNT0289356]
 +
|[[LINC02402]]
 +
|ENST00000550337.1
 +
|NA
 +
|pathogenic process
 +
|diabetes
 +
|Endocrine System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137118 HSALNT0137118]
 +
|[[CERNA3]]
 +
|CTA
 +
|ceRNA
 +
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0090838 HSALNT0090838]
 +
|[[LINC02488]]
 +
|CTD-2316B1
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0174947 HSALNT0174947]
 +
|[[LINC02489]]
 +
|CTD-2589M5
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0220441 HSALNT0220441]
 +
|[[LINC02490]]
 +
|RP11-209E8
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289260 HSALNT0289260]
 +
|[[STK32A-AS1]]
 +
|CTC-255N20
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289143 HSALNT0289143]
 +
|[[LINC02487]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|squamous cell cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0095585 HSALNT0095585]
 +
|[[SPRY4-AS1]]
 +
|THCAT68
 +
|NA
 +
|pathogenic process
 +
|bladder cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288927 HSALNT0288927]
 +
|[[DDN-AS1]]
 +
|CAT1507
 +
|NA
 +
|pathogenic process
 +
|bladder cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0012862 HSALNT0012862]
 +
|[[SLC16A1-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|acute myocardial infarction
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289412 HSALNT0289412]
 +
|[[TNFRSF14-AS1]]
 +
|ENST00000416860.2
 +
|NA
 +
|pathogenic process
 +
|acute myocardial infarction
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0259139 HSALNT0259139]
 +
|[[LINC00665]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0040268 HSALNT0040268]
 +
|[[DARS-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|renal disease
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288913 HSALNT0288913]
 +
|[[CEBPA-AS1]]
 +
|CEBPA-DT
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289011 HSALNT0289011]
 +
|[[INHBA-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288988 HSALNT0288988]
 +
|[[GASAL1]]
 +
|GASL1
 +
|NA
 +
|pathogenic process
 +
|liver cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289127 HSALNT0289127]
 +
|[[LINC01857]]
 +
|AC079767.4
 +
|NA
 +
|pathogenic process
 +
|tuberculosis
 +
|Bacterial Infections and Mycoses
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289091 HSALNT0289091]
 +
|[[LINC01140]]
 +
|FLJ41676
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0281957 HSALNT0281957]
 +
|[[PINCR]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289344 HSALNT0289344]
 +
|[[LINC00890]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|leiomyoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0019828 HSALNT0019828]
 +
|[[LINC00862]]
 +
|C1orf98,SMIM16
 +
|NA
 +
|pathogenic process
 +
|cystic fibrosis
 +
|Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0073790 HSALNT0073790]
 +
|[[LINC02562]]
 +
|RP11-44F21.5
 +
|NA
 +
|pathogenic process
 +
|cystic fibrosis
 +
|Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0263101 HSALNT0263101]
 +
|[[LINC02560]]
 +
|CTD-2619J13.13
 +
|NA
 +
|pathogenic process
 +
|cystic fibrosis
 +
|Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289144 HSALNT0289144]
 +
|[[LINC02551]]
 +
|RP11-890B15.2
 +
|NA
 +
|pathogenic process
 +
|cystic fibrosis
 +
|Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289458 HSALNT0289458]
 +
|[[DDIT4-AS1]]
 +
|RP11-442H21.2
 +
|NA
 +
|pathogenic process
 +
|cystic Fibrosis
 +
|Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288992 HSALNT0288992]
 +
|[[GPRC5D-AS1]]
 +
|RP11-392P7.6
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289386 HSALNT0289386]
 +
|[[PCBP1-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289405 HSALNT0289405]
 +
|[[STARD4-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0201547 HSALNT0201547]
 +
|[[LINC00462]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0207103 HSALNT0207103]
 +
|[[SOX1-OT]]
 +
|LINC00403
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002131 HSALNT0002131]
 +
|[[SLC25A34-AS1]]
 +
|RP11-169K16.4
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289218 HSALNT0289218]
 +
|[[PPP1R26-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289047 HSALNT0289047]
 +
|[[LINC00589]]
 +
|C8orf75,TSLNC8
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289516 HSALNT0289516]
 +
|[[TPM1-AS]]
 +
|TPM1-AS1
 +
|splicing regulation
 +
|pathogenic process
 +
|esophageal cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289314 HSALNT0289314]
 +
|[[LINC01101]]
 +
|FLJ14816
 +
|NA
 +
|pathogenic process
 +
|HPV-induced cervical neoplasia
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289147 HSALNT0289147]
 +
|[[LINC02572]]
 +
|AC079776.2
 +
|NA
 +
|pathogenic process
 +
|epithelial ovarian cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096804 HSALNT0096804]
 +
|[[LINC02202]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289076 HSALNT0289076]
 +
|[[LINC00973]]
 +
|CTD-2021J15.2
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288625 HSALNT0288625]
 +
|[[TTTY10]]
 +
|NCRNA00133
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289323 HSALNT0289323]
 +
|[[LINC00319]]
 +
|C21orf125,NCRNA00319,PRED49,FLJ38036
 +
|ceRNA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0015533 HSALNT0015533]
 +
|[[IL6R-AS1]]
 +
|RP11-350G8.5
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0090330 HSALNT0090330]
 +
|[[CKMT2-AS1]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0012995 HSALNT0012995]
 +
|[[HIPK1-AS1]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289216 HSALNT0289216]
 +
|[[POLH-AS1]]
 +
|RP3-337H4.8
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289276 HSALNT0289276]
 +
|[[TRDN-AS1]]
 +
|HRAT13
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289159 HSALNT0289159]
 +
|[[LY6E-DT]]
 +
|LOC100133669
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288991 HSALNT0288991]
 +
|[[GLIS3-AS1]]
 +
|C9orf70,MGC16153
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288896 HSALNT0288896]
 +
|[[BNC2-AS1]]
 +
|RP11-62F24.2
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289292 HSALNT0289292]
 +
|[[ZNF503-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|age-related macular degeneration
 +
|Eye Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0159506 HSALNT0159506]
 +
|[[VIM-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288882 HSALNT0288882]
 +
|[[ACBD3-AS1]]
 +
|RP11-275I14.4
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289156 HSALNT0289156]
 +
|[[LRRC8C-DT]]
 +
|FLJ27354
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289447 HSALNT0289447]
 +
|[[ELN-AS1]]
 +
|CTB-51J22.1
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076712 HSALNT0076712]
 +
|[[LINC02264]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0093666 HSALNT0093666]
 +
|[[LINC02201]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271685 HSALNT0271685]
 +
|[[LINC02573]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289125 HSALNT0289125]
 +
|[[LINC01816]]
 +
|LOC100133985
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289355 HSALNT0289355]
 +
|[[LINC02381]]
 +
|LOC400043
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289366 HSALNT0289366]
 +
|[[MBNL1-AS1]]
 +
|LOC401093
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289513 HSALNT0289513]
 +
|[[MIR4697HG]]
 +
|LINC00947,LOC283174
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289073 HSALNT0289073]
 +
|[[LINC00968]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0114453 HSALNT0114453]
 +
|[[NMBR-AS1]]
 +
|RP11-137J7.2
 +
|NA
 +
|pathogenic process
 +
|non-melanoma skin cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289300 HSALNT0289300]
 +
|[[LINC01518]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|non-melanoma skin cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0003783 HSALNT0003783]
 +
|[[LINC02574]]
 +
|RP11-288L9.1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|UVB-irradiated KC & non-melanoma skin cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030828 HSALNT0030828]
 +
|[[LINC02580]]
 +
|AC093609.1
 +
|NA
 +
|pathogenic process
 +
|UVB-irradiated KC & non-melanoma skin cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127022 HSALNT0127022]
 +
|[[LINC02577]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|UVB-irradiated KC & non-melanoma skin cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154722 HSALNT0154722]
 +
|[[LINC02578]]
 +
|RP11-127L21.1
 +
|NA
 +
|pathogenic process
 +
|UVB-irradiated KC & non-melanoma skin cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288962 HSALNT0288962]
 +
|[[FAM111A-DT]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|UVB-irradiated KC & non-melanoma skin cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289148 HSALNT0289148]
 +
|[[LINC02575]]
 +
|AP001065.15
 +
|transcriptional regulation
 +
|pathogenic process
 +
|UVB-irradiated KC & non-melanoma skin cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0177212 HSALNT0177212]
 +
|[[RPS6KB2-AS1]]
 +
|AP003419.16
 +
|NA
 +
|pathogenic process
 +
|aging‑associated idiopathic pulmonary fibrosis
 +
|Physiological Phenomena
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289072 HSALNT0289072]
 +
|[[LINC00941]]
 +
|lncRNA-MUF
 +
|ceRNA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289338 HSALNT0289338]
 +
|[[LINC00094]]
 +
|FLJ35348,bA374P20.3
 +
|NA
 +
|pathogenic process
 +
|lung squamous cell cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0114192 HSALNT0114192]
 +
|[[FILNC1]]
 +
|NA
 +
|translational control
 +
|pathogenic process
 +
|renal tumor
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289199 HSALNT0289199]
 +
|[[PARAL1]]
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|obesity
 +
|Pathological Conditions, Signs and Symptoms;Nutritional and Metabolic Diseases;Physiological Phenomena
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0056667 HSALNT0056667]
 +
|[[LINC02027]]
 +
|LOC728290
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289069 HSALNT0289069]
 +
|[[LINC00880]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0252974 HSALNT0252974]
 +
|[[LINC02582]]
 +
|CTD-2354A18.1
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289035 HSALNT0289035]
 +
|[[LINC00364]]
 +
|LncRNA00364
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060981 HSALNT0060981]
 +
|[[NCK1-DT]]
 +
|NCK1-AS1,SLC35G2-AS1
 +
|ceRNA
 +
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288890 HSALNT0288890]
 +
|[[BAALC-AS1]]
 +
|lncFZD6,FZD6-DT
 +
|transcriptional regulation
 +
|pathogenic process
 +
|liver cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0046602 HSALNT0046602]
 +
|[[CPS1-IT1]]
 +
|CPS1-IT,CPS1IT,CPS1IT1,PRO0132
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer;lung cancer;intrahepatic cholangiocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289445 HSALNT0289445]
 +
|[[DLX6-AS1]]
 +
|DLX6-A, DLX6A, Evf-2,NCRNA00212,NCRNA00212,FLJ34048
 +
|transcriptional regulation
 +
|pathogenic process
 +
|split hand/split foot malformation disorder;lung adenocarcinoma
 +
|Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289891 HSALNT0289891]
 +
|[[LINC00114]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289415 HSALNT0289415]
 +
|[[TSIX]]
 +
|LINC00013,NCRNA00013,XIST-A, XIST-AS1,XISTAS
 +
|transcriptional regulation
 +
|pathogenic process
 +
|systemic sclerosis
 +
|Skin and Connective Tissue Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217334 HSALNT0217334]
 +
|[[MKRN3-AS1]]
 +
|ZNF127A, MKRN3A, MKRN3-A,FNZ127,NCRNA00009,ZNF127-AS
 +
|NA
 +
|pathogenic process
 +
|Prader-Willi syndrome
 +
|Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290256 HSALNT0290256]
 +
|[[Lnc-SRA1-1:1]]
 +
|lnc-SRA1-1:1,SRA1,ENSG00000213523
 +
|transcriptional regulation
 +
|pathogenic process
 +
|nonalcoholic fatty liver disease;polycystic ovary syndrome;ovarian cancer;dilated cardiomyopathy;cardiomyopathy;breast cancer;laryngeal squamous cell cancer;uterus cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289442 HSALNT0289442]
 +
|[[HCP5]]
 +
|6S2650E,D6S2650E,P5-1
 +
|NA
 +
|pathogenic process
 +
|AIDS
 +
|Immune System Diseases;Virus Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289284 HSALNT0289284]
 +
|[[Lnc-EIF3M-1:1]]
 +
|WIT1,WIT-1,WT1A, WT1-AS1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|gastric cancer;primary myelofibrosis;hepatocellular cancer;Wilms' tumor;acute myeloid leukemia
 +
|Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289421 HSALNT0289421]
 +
|[[NONHSAT017524]]
 +
|KCNQ1-AS2,KCNQ10T1,Kncq1,KvDMR1,KvLQT1-A, LIT1,NCRNA00012
 +
|transcriptional regulation
 +
|pathogenic process
 +
|prostate cancer;colorectal cancer;hepatocelluar cancer;acute myocardial infarction;kidney cancer;Beckwith-Wiedemann syndrome;breast cancer
 +
|Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0263784 HSALNT0263784]
 +
|[[PCNA-AS1]]
 +
|PCNAA, PCNA-AS
 +
|transcriptional regulation
 +
|pathogenic process
 +
|gastric cancer;hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289524 HSALNT0289524]
 +
|[[HCG9]]
 +
|PERB11,HCGIX,HCGIX4,HCGIX-4
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289264 HSALNT0289264]
 +
|[[TCL6]]
 +
|TCL6e1,TNG2,TNG1
 +
|NA
 +
|pathogenic process;developmental process
 +
|renal cell cancer;leukemia
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289203 HSALNT0289203]
 +
|[[ENST00000412654.1]]
 +
|DD3,NCRNA00019,PCAT3
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289462 HSALNT0289462]
 +
|[[NONHSAT017465]]
 +
|ASM,ASM1,BW, D11S813E,LINC00008,NCRNA00008,WT2
 +
|transcriptional regulation;ceRNA
 +
|developmental process;pathogenic process
 +
|prostate cancer;glioma;cancer;breast cancer;ovarian cancer;Marek's disease;gestational trophoblastic diseases;glioblastoma;non-small cell lung cancer;hyperhomocysteinemia;congenital heart defect;congenital hyperinsulinism;pancreatic cancer;Beckwith-Wiedemann syndrome;endometriosis;trophoblastic tumor;adrenocortical cancer;coronary artery disease;Wiedemann-Beckwith syndrome;bladder cancer;melanoma;myeloproliferative polycythaemia vera;hepatocelluar cancer;meningioma;breast adenocarcinoma;neuroblastoma;embryonal cancer;osteosarcoma;esophageal cancer;kidney cancer;malignant digestive cancer;chronic myeloid leukemia;mullerian aplasia;malignant hematopoiesis;gastric cardia adenocarcinoma;cervical cancer;gallbladder cancer;pheochromocytoma;germ cell tumor;colorectal cancer;hydatidiform mole;Pancreatic ductal adenocarcinoma;pre-eclampsia;atherosclerosis;esophageal squamous cell cancer;calcific aortic valve disease;gastric cancer;osteoarthritis;choriocarcinoma;chronic myeloproliferative disorders;neural tube defects;skin cancer;ulcerative colitis;type 2 diabetes;thyroid cancer;pneumoconiosis;infertility;liver cancer;heart failure;medulloblastoma;laryngeal squamous cell cancer;Silver-Russell syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;growth restriction;Prader-Willi syndrome;diabetic cardiomyopathy;obesity;lung cancer;Parkinson's disease;renal cell cancer;Wilms' tumor
 +
|Nutritional and Metabolic Diseases;Cell Physiological Phenomena;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Physiological Phenomena;Neoplasms;Male Urogenital Diseases;Endocrine System Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Immune System Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Nervous System Diseases;Digestive System Diseases;Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Respiratory Tract Diseases;Occupational Diseases;Otorhinolaryngologic Diseases;Stomatognathic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288932 HSALNT0288932]
 +
|[[NONHSAT033797]]
 +
|BCM, BCMS1,DLB1,LEU1,LEU2,LINC00021,NCRNA00021,XTP6
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;hematopoietic and solid tumors;chronic lymphocytic leukemia;inherited bone marrow failure disorder;lymphoma;breast cancer;head and neck squamous cell cancer
 +
|Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289493 HSALNT0289493]
 +
|[[DBH-AS1]]
 +
|NCRNA00118,BPR
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0088415 HSALNT0088415]
 +
|[[ENST00000506884.1]]
 +
|DKFZP586D0823,NCRNA00206
 +
|NA
 +
|pathogenic process
 +
|prostate cancer;glioblastoma
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289463 HSALNT0289463]
 +
|[[IGF2-AS]]
 +
|IGF2A,PEG8,IGF2-AS1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|liver cancer;type 1 diabetes;prostate cancer;Wilms' tumor;hepatocelluar cancer
 +
|Neoplasms;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0269786 HSALNT0269786]
 +
|[[Lnc-CTSZ-5:1]]
 +
|GNASA, GNAS-A,SANG,NESP-A, NESPA, GNAS1A, NCRNA00075
 +
|transcriptional regulation
 +
|pathogenic process
 +
|non-small cell lung cancer;pseudohypoparathyroidism type Ib
 +
|Musculoskeletal Diseases;Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289252 HSALNT0289252]
 +
|[[NONHSAT054526]]
 +
|C6orf160,MGC16362,bA33E24.2,U50HG,NCRNA00044,LINC00044
 +
|NA
 +
|pathogenic process
 +
|gastric cancer;lymphoma;melanoma
 +
|Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0023827 HSALNT0023827]
 +
|[[NONHSAT010191]]
 +
|DISC1-AS1,DISC1O, NCRNA00015
 +
|transcriptional regulation
 +
|pathogenic process
 +
|bipolar disorder;affective disorder;major depressive affective disorder;schizophrenia;autism spectrum disorder;depression
 +
|Bacterial Infections and Mycoses;Mental Disorders;Behavior and Behavior Mechanisms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0203415 HSALNT0203415]
 +
|[[NONHSAT034251]]
 +
|SCA8,KLHL1A,NCRNA00003
 +
|transcriptional regulation
 +
|pathogenic process
 +
|spinocerebellar ataxia;spinocerebellar ataxia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290312 HSALNT0290312]
 +
|[[TRAF3IP2-AS1]]
 +
|C6UA, C6orf3,NCRNA00248,TRAF3IP2-AS2
 +
|transcriptional regulation
 +
|pathogenic process
 +
|schizophrenia;cocaine abuse
 +
|Chemically-Induced Disorders;Mental Disorders
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289008 HSALNT0289008]
 +
|[[HYMAI]]
 +
|NCRNA00020
 +
|NA
 +
|pathogenic process
 +
|transient neonatal diabetes
 +
|Nutritional and Metabolic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288968 HSALNT0288968]
 +
|[[FAM201A]]
 +
|C9orf122
 +
|NA
 +
|pathogenic process
 +
|leukemia
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288969 HSALNT0288969]
 +
|[[FAM222A-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289484 HSALNT0289484]
 +
|[[FAM226A]]
 +
|CXorf50,NCRNA00246,NCRNA00246A,LINC00246A,MGC34827
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289497 HSALNT0289497]
 +
|[[FAM215A]]
 +
|C17orf88,APR-2,LINC00530
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer;leukemia
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289230 HSALNT0289230]
 +
|[[NONHSAT089783]]
 +
|LUST
 +
|transcriptional regulation
 +
|pathogenic process
 +
|tumor
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002923 HSALNT0002923]
 +
|[[LINC00339]]
 +
|NCRNA00339,HSPC157
 +
|NA
 +
|pathogenic process;developmental process
 +
|Pancreatic ductal adenocarcinoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144027 HSALNT0144027]
 +
|[[ASAP1-IT1]]
 +
|ASAP1-IT,ASAP1IT,ASAP1IT1,DDEF1IT1,HSPC054,NCRNA00050
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289212 HSALNT0289212]
 +
|[[NONHSAT076153]]
 +
|NCRNA00071,LINC00071,PCAT9
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|osteoarthritis;prostate cancer;glioma
 +
|Musculoskeletal Diseases;Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289016 HSALNT0289016]
 +
|[[KCNQ1DN]]
 +
|BWRT,HSA404617
 +
|NA
 +
|pathogenic process
 +
|aging;Wilms' tumor
 +
|Physiological Phenomena;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288933 HSALNT0288933]
 +
|[[NONHSAT033821]]
 +
|DLB2,BCMSUN,RFP2O,LEU2,TRIM13O, NCRNA00022,LINC00022,MIR15AHG
 +
|transcriptional regulation
 +
|pathogenic process
 +
|lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;chronic lymphocytic leukemia;non-small cell lung cancer
 +
|Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217624 HSALNT0217624]
 +
|[[PWAR4]]
 +
|PAR4,PAR-4
 +
|NA
 +
|pathogenic process
 +
|Prader-Willi syndrome and Angelman syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289165 HSALNT0289165]
 +
|[[ENST00000553584.1]]
 +
|SNHG23,SNHG24,NCRNA00024,Irm,Rian,Bsr,LINC00024,AL132709.8,lnc-MGC
 +
|NA
 +
|pathogenic process
 +
|Prader-Willi syndrome and Angelman syndrome;temple syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289482 HSALNT0289482]
 +
|[[CECR7]]
 +
|SAHL1
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer;cat eye syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0074223 HSALNT0074223]
 +
|[[ENST00000504263.1]]
 +
|GDEP,PCAN1,PCA4
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0061175 HSALNT0061175]
 +
|[[PISRT1]]
 +
|NCRNA00195
 +
|transcriptional regulation
 +
|developmental process;pathogenic process
 +
|blepharophimosis syndrome
 +
|Eye Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0190912 HSALNT0190912]
 +
|[[ENST00000538665.1]]
 +
|Tmevpg1,LincR-Ifng-3'A, NEST
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Hashimoto's thyroiditis;primary immune thrombocytopenia;multiple sclerosis;Sjögren syndrome
 +
|Immune System Diseases ;Immune System Diseases;Endocrine System Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0038178 HSALNT0038178]
 +
|[[FAM138B]]
 +
|F379
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0145703 HSALNT0145703]
 +
|[[FAM138C]]
 +
|F379
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288963 HSALNT0288963]
 +
|[[FAM138A]]
 +
|F379
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183947 HSALNT0183947]
 +
|[[FAM138D]]
 +
|F379
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0226092 HSALNT0226092]
 +
|[[FAM138E]]
 +
|F379
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0253925 HSALNT0253925]
 +
|[[FAM138F]]
 +
|F379
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289326 HSALNT0289326]
 +
|[[NONHSAT087716]]
 +
|LOH3CR2A,NCRNA00312,NAG7,NAG-7,ERR10,ERR-10,LMCD1DN
 +
|transcriptional regulation
 +
|pathogenic process
 +
|nasopharyngeal cancer;bladder cancer;non-small cell lung cancer
 +
|Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Stomatognathic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288886 HSALNT0288886]
 +
|[[ENST00000609176.1]]
 +
|AIR,NCRNA00088,IGF2RA, IGF2R-AS1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0254857 HSALNT0254857]
 +
|[[MIR7-3HG]]
 +
|C19orf30,NCRNA00306,LINC00306,PGSF1,PGSF1a,PGSF1b,Huh7,uc002mbe.2
 +
|NA
 +
|pathogenic process
 +
|liver cancer;hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185751 HSALNT0185751]
 +
|[[LOH12CR2]]
 +
|LOH2CR12
 +
|NA
 +
|pathogenic process
 +
|pre-B acute lymphoblastic leukaemia
 +
|Hemic and Lymphatic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289479 HSALNT0289479]
 +
|[[DSCR8]]
 +
|C21orf65,MTAG2,CT25.1a,CT25.1b,MMA-1a,MMA-1b
 +
|NA
 +
|pathogenic process
 +
|Down syndrome;melanoma
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289030 HSALNT0289030]
 +
|[[LINC00313]]
 +
|C21orf84,NCRNA00313,
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289029 HSALNT0289029]
 +
|[[LINC00310]]
 +
|C21orf82,NCRNA00310
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0272435 HSALNT0272435]
 +
|[[LINC00161]]
 +
|C21orf100,NCRNA00161
 +
|ceRNA
 +
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289184 HSALNT0289184]
 +
|[[ENST00000602580.1]]
 +
|C21orf35,FLJ38295,C21orf34,LINC00478,MONC
 +
|NA
 +
|pathogenic process
 +
|myeloid leukemia
 +
|Hemic and Lymphatic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289005 HSALNT0289005]
 +
|[[HOXA11-AS]]
 +
|HOXA11A,HOXA11-AS1,HOXA11, HOXA-AS5,NCRNA00076
 +
|ceRNA
 +
|pathogenic process
 +
|uterine cervix cancer;ovarian cancer;glioma;cervical cancer;gastric cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0193654 HSALNT0193654]
 +
|[[RMST]]
 +
|NCRM, NCRNA00054,LINC00054
 +
|transcriptional regulation
 +
|developmental process;pathogenic process
 +
|breast cancer;rhabdomyosarcoma
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290079 HSALNT0290079]
 +
|[[NONHSAT102247]]
 +
|NCRUPAR,ENSG00000225407
 +
|transcriptional regulation
 +
|developmental process;pathogenic process
 +
|gastric cancer;colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289167 HSALNT0289167]
 +
|[[MESTIT1]]
 +
|MEST-AS1,MEST-IT,MEST-IT1,NCRNA00040,PEG1-AS
 +
|NA
 +
|pathogenic process
 +
|Silver-Russell syndrome
 +
|Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273791 HSALNT0273791]
 +
|[[DSCAM-AS1]]
 +
|M41
 +
|NA
 +
|pathogenic process
 +
|adolescent idiopathic scoliosis;breast cancer
 +
|Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289391 HSALNT0289391]
 +
|[[PWARSN]]
 +
|PAR-SN,PARSN
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127791 HSALNT0127791]
 +
|[[ST7-AS1]]
 +
|ST7OT1,ST7AS1
 +
|NA
 +
|pathogenic process
 +
|glioma;autism
 +
|Mental Disorders;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0206298 HSALNT0206298]
 +
|[[DAOA-AS1]]
 +
|DAOAA, DAOA-A,G30
 +
|NA
 +
|pathogenic process
 +
|panic disorder;schizophrenia;bipolar disorder
 +
|Mental Disorders
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0167060 HSALNT0167060]
 +
|[[OLMALINC]]
 +
|C10orf75,NCRNA00263,LINC00263,bA34D15.5,FLJ12974,HI-LNC80
 +
|NA
 +
|pathogenic process
 +
|type 2 diabetes
 +
|Nutritional and Metabolic Diseases;Endocrine System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0026878 HSALNT0026878]
 +
|[[LINC00299]]
 +
|C2orf46,NCRNA00299,FLJ45673
 +
|NA
 +
|pathogenic process;developmental process
 +
|intellectual and developmental disability;neurodevelopmental disabilities
 +
|Mental Disorders;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289081 HSALNT0289081]
 +
|[[LINC01020]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0101186 HSALNT0101186]
 +
|[[LINC00518]]
 +
|C6orf218,MGC40222
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0083960 HSALNT0083960]
 +
|[[LINC01018]]
 +
|SRHC
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289361 HSALNT0289361]
 +
|[[LPP-AS2]]
 +
|MYCLo-5,MYCLo-6
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143233 HSALNT0143233]
 +
|[[LINC00964]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289364 HSALNT0289364]
 +
|[[MAPKAPK5-AS1]]
 +
|C12orf47,FLJ39616
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289053 HSALNT0289053]
 +
|[[LINC00635]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289327 HSALNT0289327]
 +
|[[LINC00636]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262657 HSALNT0262657]
 +
|[[ZNF582-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289020 HSALNT0289020]
 +
|[[LINC00115]]
 +
|NCRNA00115,FLJ22639
 +
|ceRNA
 +
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289254 HSALNT0289254]
 +
|[[SNHG7]]
 +
|MGC16037,NCRNA00061
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289162 HSALNT0289162]
 +
|[[MAP3K20-AS1]]
 +
|MLK7-AS1
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0145357 HSALNT0145357]
 +
|[[RHPN1-AS1]]
 +
|C8orf51,MGC3113
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289343 HSALNT0289343]
 +
|[[NONHSAT137541]]
 +
|DXS399E,NCRNA00001,DXS1089,swd66,LINC00001
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|non-small cell lung cancer;B-cell acute lymphoblastic leukemia;bladder cancer;testicular germ cell tumor;colorectal cancer;cancer;ovarian cancer;female cancers;renal collecting duct cancer;membranous nephropathy;Trisomy 21;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;Klinefelter's syndrome;glioblastoma;breast cancer;cystic fibrosis
 +
|Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289389 HSALNT0289389]
 +
|[[PRNT]]
 +
|M8
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288942 HSALNT0288942]
 +
|[[Lnc-PDZD8-3:1]]
 +
|NCRNA00045,EMX2-AS1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0200443 HSALNT0200443]
 +
|[[LINC00598]]
 +
|TTL
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289517 HSALNT0289517]
 +
|[[TTTY17A]]
 +
|NCRNA00140
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027901 HSALNT0027901]
 +
|[[MYCNOS]]
 +
|NCYM,N-CYM,MYCN-AS1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|neuroblastoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0047175 HSALNT0047175]
 +
|[[DIRC3]]
 +
|FLJ14199
 +
|NA
 +
|pathogenic process
 +
|familial renal cell cancer;breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289363 HSALNT0289363]
 +
|[[ENST00000534336.1]]
 +
|PRO1073,MALAT-1,NCRNA00047,HCN,NEAT2,LINC00047,mascRNA
 +
|splicing regulation;;translational control;transcriptional regulation;protein localization;ceRNA
 +
|pathogenic process
 +
|prostate cancer;glioma;cancer;breast cancer;ovarian cancer;amyotrophic lateral sclerosis;proliferative vitreoretinopathy;glioblastoma;endometrial stromal sarcoma;oral squamous cell cancer;acute myocardial infarction;hemangioma;pancreatic cancer;endometrioid endometrial cancer;melanoma;tongue squamous cell cancer;HIV;hepatocelluar cancer;bladder cancer;neuroblastoma;lung cancer;nasopharyngeal cancer;osteosarcoma;esophageal cancer;kidney cancer;hepatic steatosis;urothelial cancer;diabetes;triple-negative breast cancer;liver fibrosis;cervical cancer;uterus cancer;gallbladder cancer;decreased myogenesis;esophageal squamous cell cancer;fibrosarcoma;colorectal cancer;Pancreatic ductal adenocarcinoma;pre-eclampsia;retinal neurodegeneration;small cell lung cancer;multiple myeloma;gastric cancer;lung adenocarcinoma;uveal melanoma;epithelial ovarian cancer;TDP-43-associated pathological states;thyroid cancer;congenital microtia;liver cancer;renal clear cell cancer;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;non-small cell lung cancer;pulmonary arterial hypertension;diabetic cardiomyopathy;vulvar squamous cell cancer;hyperglycaemia;papillary thyroid cancer;Parkinson's disease;renal cell cancer;lung cancer brain metastasis
 +
|Eye Diseases;Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Cell Physiological Phenomena;Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Stomatognathic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289744 HSALNT0289744]
 +
|[[DLG2-AS1]]
 +
|DLG2A, DLG2-A,PSZA11q14,SZ-1
 +
|NA
 +
|pathogenic process
 +
|schizophrenia;myotonic dystrophy type 1;heart failure
 +
|Pathological Conditions, Signs and Symptoms;Musculoskeletal Diseases;Mental Disorders;Cardiovascular Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289164 HSALNT0289164]
 +
|[[NONHSAT039745]]
 +
|FP504,GTL2,LINC00023,NCRNA00023,PRO0518,PRO2160,onco-lncRNA-83,prebp1
 +
|translational control;transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|oral squamous cell cancer;phaeochromocytoma;prostate cancer;testicular germ cell tumor;glioma;cancer;osteosarcoma;non-functioning pituitary adenoma;heroin abuse;stroke;non-small cell lung cancer;thrombocytopenic purpura;acute myeloid leukemia;pancreatic cancer;bladder cancer;tongue squamous cell cancer;hepatocelluar cancer;meningioma;drug abuse;liver fibrosis;pancreatic neuroendocrine tumor;esophageal squamous cell cancer;myelodysplastic syndrome;retinoblastoma;chronic myeloid leukemia;type 1 diabetes;breast cancer;cervical cancer;kidney cancer;gallbladder cancer;cholestatic liver injury;colorectal cancer;neuroblastoma;multiple myeloma;gastric cancer;osteoarthritis;lung adenocarcinoma;endometrial cancer;Huntington disease;diabetes;type 2 diabetes;lung cancer;epithelial ovarian cancer;primary myelofibrosis;metabolic syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;vulvar squamous cell cancer;papillary thyroid cancer;renal cell cancer;Wilms' tumor
 +
|Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Immune System Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Chemically-Induced Disorders;Musculoskeletal Diseases;Mental Disorders;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290298 HSALNT0290298]
 +
|[[TERC]]
 +
|DKCA1,PFBMFT2,SCARNA19,TR,TRC3,hTR
 +
|NA
 +
|pathogenic process
 +
|prostate cancer;dyskeratosis congenita;lung squamous cell cancer
 +
|Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288907 HSALNT0288907]
 +
|[[CASC2]]
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|colorectal cancer;gastric cancer;endometrial cancer;lung cancer;renal cell cancer;glioma
 +
|Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0205332 HSALNT0205332]
 +
|[[MIR17HG]]
 +
|C13orf25,MIRHG1,FLJ14178,MIRH1,MIHG1,NCRNA00048,miR-17-92,LINC00048
 +
|NA
 +
|pathogenic process
 +
|diffuse large B-cell lymphoma;syndromic developmental defect;cancer
 +
|Neoplasms;Hemic and Lymphatic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288716 HSALNT0288716]
 +
|[[TTTY6]]
 +
|TTY6,TTTY6A,LINC00127
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288731 HSALNT0288731]
 +
|[[TTTY4]]
 +
|TTY4,TTTY4A,LINC00123
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288815 HSALNT0288815]
 +
|[[TTTY3]]
 +
|TTY3,TTTY3A,LINC00121
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288703 HSALNT0288703]
 +
|[[TTTY5]]
 +
|TTY5,LINC00126
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289255 HSALNT0289255]
 +
|[[SNHG8]]
 +
|NCRNA00060,LINC00060
 +
|NA
 +
|pathogenic process
 +
|gastric cancer;malignant pleural mesothelioma
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289486 HSALNT0289486]
 +
|[[Lnc-EPCAM-1:2]]
 +
|BC200,BC200a,NCRNA00004,LINC00004
 +
|splicing regulation;translational control
 +
|pathogenic process
 +
|aging;lung cancer;glioma;ovarian cancer;esophageal squamous cell cancer;non-small cell lung cancer;esophageal cancer;Alzheimer's disease;tongue cancer;parotid cancer;breast cancer;cervical cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Mental Disorders;Female Urogenital Diseases and Pregnancy Complications;Physiological Phenomena;Endocrine System Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144426 HSALNT0144426]
 +
|[[ZFAT-AS1]]
 +
|ZFATAS,ZFAT-AS,SAS-ZFAT,NCRNA00070
 +
|NA
 +
|pathogenic process
 +
|autoimmune disease
 +
|Immune System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289285 HSALNT0289285]
 +
|[[ZEB1-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer;autoimmune thyroid disease;hepatocelluar cancer
 +
|Immune System Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289185 HSALNT0289185]
 +
|[[MIRLET7BHG]]
 +
|linc-Ppara
 +
|NA
 +
|developmental process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289374 HSALNT0289374]
 +
|[[NBR2]]
 +
|NCRNA00192
 +
|transcriptional regulation
 +
|pathogenic process
 +
|gastric cancer;breast cancer;cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289417 HSALNT0289417]
 +
|[[NONHSAT084827]]
 +
|FLJ20618,NCRNA00080,LINC00080
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|osteosarcoma;prostate cancer;glioma;ovarian cancer;glioblastoma;non-small cell lung cancer;B-cell neoplasms;chronic kidney disease;melanoma;bladder cancer;urothelial cancer of the bladder;esophageal squamous cell cancer;multiple sclerosis;breast cancer;hepatoblastoma;colorectal cancer;multiple myeloma;gastric cancer;Huntington disease;hepatocellular cancer;oesophageal squamous cell cancer;renal cell cancer
 +
|Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288973 HSALNT0288973]
 +
|[[FAS-AS1]]
 +
|FASA, FAS-A,SAF
 +
|transcriptional regulation
 +
|pathogenic process
 +
|ataxia telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Immune System Diseases;Nutritional and Metabolic Diseases;Cardiovascular Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288996 HSALNT0288996]
 +
|[[HAS2-AS1]]
 +
|HAS2A, HAS2-A,HASNT,NCRNA00077
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289390 HSALNT0289390]
 +
|[[PSORS1C3]]
 +
|NCRNA00196
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis;psoriasis
 +
|Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289868 HSALNT0289868]
 +
|[[HLA-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|psoriasis;liver injury;multiple sclerosis;AIDS
 +
|Skin and Connective Tissue Diseases;Immune System Diseases;Virus Diseases;Digestive System Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290154 HSALNT0290154]
 +
|[[NONHSAT011777]]
 +
|NCRNA00074
 +
|transcriptional regulation
 +
|pathogenic process
 +
|psoriasis;prostate cancer
 +
|Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262809 HSALNT0262809]
 +
|[[PEG3-AS1]]
 +
|PEG3AS,PEG3-AS,APEG3,NCRNA00155
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289533 HSALNT0289533]
 +
|[[Lnc-LRR1-1:1]]
 +
|7S RNA,SRP RNA,4.5S SRP RNA,4.5S RNA,RN7SL1 RNA,ENSG00000258486,lnc-LRR1-1:1
 +
|protein localization
 +
|pathogenic process
 +
|AIDS;Leishmaniasis;dermatomyositis;polymyositis
 +
|Skin and Connective Tissue Diseases;Immune System Diseases;Virus Diseases;Musculoskeletal Diseases;Parasitic Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290081 HSALNT0290081]
 +
|[[Lnc-C11orf16-1:1]]
 +
|29A,lnc-C11orf16-1:1
 +
|NA
 +
|pathogenic process
 +
|neuroblastoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289382 HSALNT0289382]
 +
|[[NONHSAT134764]]
 +
|NCRNA00194
 +
|NA
 +
|pathogenic process
 +
|AIDS;Down syndrome;HIV
 +
|Immune System Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases;Virus Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289253 HSALNT0289253]
 +
|[[Lnc-TCF24-2:3]]
 +
|U87HG,HBII-276HG,NCRNA00058
 +
|translational control;ceRNA
 +
|pathogenic process
 +
|hepatocellular cancer;hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289653 HSALNT0289653]
 +
|[[NONHSAT017676]]
 +
|AY195961.1,NONHSAT017674,AY034469.1,NONHSAT017675,AY034470.1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290398 HSALNT0290398]
 +
|[[ENST00000554403.1]]
 +
|Zfh-5AS,ENSG00000157306,ENST00000554403.1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0011306 HSALNT0011306]
 +
|[[MIR137HG]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|schizophrenia;lung cancer;malignant lymphoma
 +
|Respiratory Tract Diseases;Mental Disorders;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289449 HSALNT0289449]
 +
|[[Lnc-EVX1-9:1]]
 +
|HOXA6as
 +
|NA
 +
|pathogenic process
 +
|glioma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289451 HSALNT0289451]
 +
|[[CCDC26]]
 +
|MGC27434,RAM
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hematological malignancies;glioma;acute myeloid leukemia;leukemia;pancreatic cancer;breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Hemic and Lymphatic Diseases;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289893 HSALNT0289893]
 +
|[[LINC00271]]
 +
|C6orf217,NCRNA00271
 +
|NA
 +
|pathogenic process
 +
|type 2 diabetes;schizophrenia
 +
|Nutritional and Metabolic Diseases;Mental Disorders;Endocrine System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288892 HSALNT0288892]
 +
|[[BCAR4]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|osteosarcoma;breast cancer;colorectal cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289890 HSALNT0289890]
 +
|[[LINC00032]]
 +
|C9orf14,NCRNA00032
 +
|NA
 +
|pathogenic process
 +
|narcolepsy;melanoma
 +
|Mental Disorders;Neoplasms;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274572 HSALNT0274572]
 +
|[[PICSAR]]
 +
|C21orf113,LINC00162,NCRNA00162,NLC1-C,NLC1C,PRED74
 +
|transcriptional regulation
 +
|pathogenic process
 +
|testicular embryonal cancer;narcolepsy;cutaneous squamous cell cancer
 +
|Male Urogenital Diseases;Mental Disorders;Neoplasms;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0256354 HSALNT0256354]
 +
|[[Lnc-OR10H5-1:1]]
 +
|CUDR,LINC00178,NCRNA00178,UCAT1,onco-lncRNA-36
 +
|transcriptional regulation;ceRNA
 +
|developmental process;pathogenic process
 +
|oral squamous cell cancer;osteosarcoma;prostate cancer;ovarian cancer;non-small cell lung cancer;acute myocardial infarction;pancreaticobiliary maljunction;pancreatic cancer;melanoma;tongue squamous cell cancer;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;esophageal squamous cell cancer;esophageal cancer;liver cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;urinary bladder;gastric cancer;endometrial cancer;breast cancer;hepatocellular cancer;squamous cell cancer;lung cancer;renal cell cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289475 HSALNT0289475]
 +
|[[Lnc-BIRC7-2:1]]
 +
|HAR1F,NCRNA00064,LINC00064
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Huntington disease;Alzheimer's disease
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Mental Disorders;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288995 HSALNT0288995]
 +
|[[ENST00000447910.2]]
 +
|HAR1R,NCRNA00065,LINC00065
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Huntington disease;hereditary haemorrhagic telangiectasia;Alzheimer's disease
 +
|Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288958 HSALNT0288958]
 +
|[[EPB41L4A-AS1]]
 +
|C5orf26,NCRNA00219,TIGA1
 +
|NA
 +
|pathogenic process
 +
|lung cancer;cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289170 HSALNT0289170]
 +
|[[Lnc-CRYBA4-2:1]]
 +
|C22orf35,FLJ25967,Rncr2,gomafu,NCRNA00066,LINC00066,lncRNA-MIAT
 +
|splicing regulation;ceRNA
 +
|pathogenic process
 +
|prostate cancer;chronic lymphocytic leukemia;cancer;drug abuse;diabetes-induced microvascular dysfunction;schizophrenia;acute myocardial infarction;dilated cardiomyopathy;lung adenocarcinoma;diabetic retinopathy;myocardial infarction;Alzheimer's disease
 +
|Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Chemically-Induced Disorders;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Mental Disorders;Endocrine System Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289007 HSALNT0289007]
 +
|[[NONHSAT107640]]
 +
|NCRNA00078,LINC00078,HCCAT1
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|prostate cancer;glioma;hepatocelluar cancer;osteosarcoma;atherosclerosis;gastric cancer;hepatocellular cancer;esophageal cancer;liver cirrhosis;diffuse large B-cell lymphoma;pancreatic cancer;papillary thyroid cancer;liver cancer;cervical cancer;colorectal cancer
 +
|Neoplasms;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288940 HSALNT0288940]
 +
|[[NONHSAT087635]]
 +
|EGO,NCRNA00190
 +
|NA
 +
|pathogenic process;developmental process
 +
|prostate cancer;breast cancer
 +
|Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289387 HSALNT0289387]
 +
|[[PINK1-AS]]
 +
|PINK1-AS1,FLJ00387,PINK1A, naPINK1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|glucose metabolism disorder;Parkinson's disease;diabetes
 +
|Nutritional and Metabolic Diseases;Endocrine System Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289225 HSALNT0289225]
 +
|[[ENST00000513868.2]]
 +
|NCRNA00079,LINC00079,onco-lncRNA-100,MIR1204HG,PVT
 +
|transcriptional regulation;translational control
 +
|pathogenic process
 +
|murine plasmacytomas;prostate cancer;cancer;ovarian cancer;renal cancer;B-cell lymphoma;non-small cell lung cancer;pancreatic cancer;Hodgkin's lymphoma;asthma;hepatocelluar cancer;bladder cancer;plasmacytoma;cleft lip;acute promyelocytic leukemia;diabetic nephropathy;esophageal cancer;kidney cancer;type 1 diabetes;breast cancer;cervical cancer;diabetic kidney disease;hematological malignancies;colorectal cancer;neuroblastoma;cardiac hypertrophy;multiple myeloma;gastric cancer;lymphoma;type 2 diabetes;thyroid cancer;pleural mesothelioma;lung squamous cell cancer;Burkitt lymphoma;hepatocellular cancer;renal cell cancer
 +
|Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Immune System Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289189 HSALNT0289189]
 +
|[[ENST00000604258.1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246525 HSALNT0246525]
 +
|[[NARF-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0147433 HSALNT0147433]
 +
|[[NONHSAT130421]]
 +
|CDKN2BA,ANRIL,RP11-145E5.4,NCRNA00089,p15A, CDKN2B-A, PCAT12
 +
|siRNA;transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|glaucoma;prostate cancer;glioma;cancer;osteosarcoma;neurofibromatosis;ischemic heart failure;stroke;non-small cell lung cancer;hypertension;intracranial aneurysm;aortic aneurysm;periodontitis;acute lymphoblastic leukemia;Alzheimer's disease;coronary artery disease;melanoma;bladder cancer;abdominal aortic aneurysm;ovarian cancer;esophageal cancer;basal cell cancer;breast cancer;cervical cancer;coronary heart disease;gallbladder cancer;acute myocardial infarction;colorectal cancer;neuroblastoma;peripheral artery disease;esophageal squamous cell cancer;atherosclerosis;leukemia;hereditary cutaneous malignant melanoma;gastric cancer;cardiovascular disease;coronary disease;frailty;diabetes;type 2 diabetes;thyroid cancer;primary open-angle glaucoma;ischemic stroke;plexiform neurofibroma;laryngeal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;myocardial infarction;lung cancer;endometriosis;primary myelofibrosis
 +
|Eye Diseases;Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Mental Disorders;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050854 HSALNT0050854]
 +
|[[NONHSAT087920]]
 +
|NCRNA00068,GHRL-AS1
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288959 HSALNT0288959]
 +
|[[ENST00000583516.1]]
 +
|HESRG
 +
|NA
 +
|pathogenic process
 +
|embryonal cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287173 HSALNT0287173]
 +
|[[FMR1-AS1]]
 +
|FMR1A, FMR1-A,ASFMR1,FMR4
 +
|transcriptional regulation
 +
|pathogenic process
 +
|fragile X syndrome;neurological disorder
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289499 HSALNT0289499]
 +
|[[HCG4]]
 +
|HCGIV-10,HCGIV.9
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288994 HSALNT0288994]
 +
|[[HAND2-AS1]]
 +
|DEIN,NBLA00301,FLJ11539
 +
|NA
 +
|pathogenic process
 +
|neuroblastoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289286 HSALNT0289286]
 +
|[[NONHSAT074775]]
 +
|ZEB2A, ZEB2-A,ZEB2NAT
 +
|splicing regulation
 +
|pathogenic process
 +
|bladder cancer;hepatocellular cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0017702 HSALNT0017702]
 +
|[[NONHSAT007663]]
 +
|SNHG2,NCRNA00030
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|varicose great saphenous veins;prostate cancer;glioma;cancer;ovarian cancer;non-small cell lung cancer;hypertension;pancreatic cancer;B-cell neoplasms;melanoma;head and neck cancer;hepatocelluar cancer;bladder cancer;autoimmune disease;liver fibrosis;kidney cancer;breast cancer;cervical cancer;colorectal cancer;multiple myeloma;gastric cancer;osteoarthritis;endometrial cancer;lymphoma;type 2 diabetes;pleural mesothelioma;hepatocellular cancer;lung adenocarcinoma;lung cancer;renal cell cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Nutritional and Metabolic Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288891 HSALNT0288891]
 +
|[[NONHSAT024403]]
 +
|BACE1A,FJ573250,NCRNA00177,BACE1-AS1
 +
|translational control;transcriptional regulation
 +
|pathogenic process
 +
|ovarian cancer;colorectal cancer;Alzheimer's disease
 +
|Neoplasms;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Nervous System Diseases;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289414 HSALNT0289414]
 +
|[[TRPM2-AS]]
 +
|TRPM2-AS1
 +
|NA
 +
|pathogenic process
 +
|melanoma;prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288935 HSALNT0288935]
 +
|[[DNM3OS]]
 +
|DNM3-AS1,MIR199A2HG
 +
|NA
 +
|pathogenic process
 +
|epithelial ovarian cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288930 HSALNT0288930]
 +
|[[DGCR5]]
 +
|NCRNA00037,LINC00037
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Huntington disease;DiGeorge syndrome;velocardiofacial syndrome;clear cell renal cell cancer
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288893 HSALNT0288893]
 +
|[[ENST00000499008.3]]
 +
|BDNFO,BT2A,BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1,BDNFAS
 +
|siRNA;transcriptional regulation
 +
|developmental process;pathogenic process
 +
|Huntington disease;schizophrenia;psychiatric disease;obesity
 +
|Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nutritional and Metabolic Diseases;Mental Disorders;Physiological Phenomena;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120317 HSALNT0120317]
 +
|[[Lnc-EVX1-12:1]]
 +
|HOXA-AS1,NCRNA00179,HOXA1-AS1
 +
|transcriptional regulation
 +
|pathogenic process;developmental process
 +
|colorectal cancer;Pancreatic ductal adenocarcinoma;promyelocytic leukemia;acute myeloid leukemia;infiltrating ductal cancers ;acute promyelocytic leukemia;leukemia;glioma
 +
|Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290158 HSALNT0290158]
 +
|[[NONHSAT129210]]
 +
|PTCSC,AK023948,NCRNA00197
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289004 HSALNT0289004]
 +
|[[NONHSAT028508]]
 +
|HOXC-AS4,HOXC11-AS1,NCRNA00072
 +
|siRNA;transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|oral squamous cell cancer;prostate cancer;glioma;cancer;breast cancer;osteosarcoma;renal cancer;glioblastoma;non-small cell lung cancer;sarcoma;pancreatic cancer;large B-Cell lymphoma;bladder transitional cell cancer;B-cell neoplasms;melanoma;asthenozoospermia;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;aortic valve calcification;infiltrating ductal cancers ;ovarian cancer;diffuse large B-cell lymphoma;gastrointestinal stromal tumor;atypical teratoid rhabdoid tumor;urothelial cancer;triple-negative breast cancer;gastric cardia adenocarcinoma;cervical cancer;temporomandibular joint osteoarthritis;gallbladder cancer;esophageal squamous cell cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;rheumatoid arthritis;gastric cancer ;pre-eclampsia;acute leukemia;small cell lung cancer;multiple myeloma;gastric cancer;osteoarthritis;LPS-induced sepsis;endometrial cancer;head and neck squamous cell cancer;gastric adenocarcinoma;lung cancer;liver cancer;ischemic stroke;ischemic heart failure;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;papillary thyroid cancer;Parkinson's disease;renal cell cancer;gastrointestinal cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Musculoskeletal Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289192 HSALNT0289192]
 +
|[[ENST00000501122.2]]
 +
|NCRNA00084,TncRNA,MENepsilon/beta,LINC00084,VINC
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|oral squamous cell cancer;glioma;ovarian cancer;amyotrophic lateral sclerosis;paraspeckle disintegration;nasopharyngeal cancer;AIDS;frontotemporal lobar degeneration;prostate cancer;systemic lupus erythematosus;renal syndrome;TDP-43-associated pathological states;HIV;Huntington disease;chronic lymphocytic leukemia;acute promyelocytic leukemia;esophageal squamous cell cancer;multiple sclerosis;breast cancer;intrauterine growth restriction;colorectal cancer;leukemia;gastric cancer;malignant pleural mesothelioma;endometrial cancer;gastric adenocarcinoma;papillary thyroid cancer;infertility;bladder cancer;hepatocellular cancer;non-small cell lung cancer;obesity;lung cancer;Parkinson's disease;laryngeal squamous cell cancer
 +
|Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Nutritional and Metabolic Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Physiological Phenomena;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0095094 HSALNT0095094]
 +
|[[NONHSAT104072]]
 +
|U19H,NCRNA00059
 +
|NA
 +
|pathogenic process
 +
|myelodysplastic syndrome
 +
|Hemic and Lymphatic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0245443 HSALNT0245443]
 +
|[[NONHSAT056039]]
 +
|ncRAN,Nbla12061,Nbla10727
 +
|NA
 +
|pathogenic process
 +
|bladder cancer;bladder cancer;colorectal cancer;neuroblastoma
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288897 HSALNT0288897]
 +
|[[BOK-AS1]]
 +
|BOKA,NCRNA00151,NAToB
 +
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer;testicular cancer;cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289532 HSALNT0289532]
 +
|[[NONHSAT113149]]
 +
|7-3 RNA,K-RNA,7SK-RNA,7SK snRNA,RN7SK,ENSG00000202198,NONHSAT113149
 +
|transcriptional regulation
 +
|developmental process;pathogenic process
 +
|cancer;cardiac hypertrophy;gastric cancer;AIDS;multiple sclerosis;colorectal adenocarcinoma
 +
|Neoplasms;Immune System Diseases;Virus Diseases;Cardiovascular Diseases;Digestive System Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289182 HSALNT0289182]
 +
|[[MIR4435-2HG]]
 +
|MIR4435-1HG,LINC00978,AGD2,AK001796,lncRNA-AWPPH,MORRBID
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289200 HSALNT0289200]
 +
|[[PARTICL]]
 +
|PARTICLE
 +
|transcriptional regulation
 +
|pathogenic process
 +
|low-dose irradiation
 +
|Disorders of Environmental Origin
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289172 HSALNT0289172]
 +
|[[ENST00000517411.1]]
 +
|LINC01604,TCONS_00015189
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|gallbladder cancer;Burkitt lymphoma
 +
|Neoplasms;Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0001792 HSALNT0001792]
 +
|[[NPPA-AS1]]
 +
|NPPAA, NPPA-AS
 +
|splicing regulation
 +
|pathogenic process
 +
|cardiovascular disease
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290230 HSALNT0290230]
 +
|[[RRP1B]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|spinocerebellar ataxia;laryngeal squamous cell cancer;cancer
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289467 HSALNT0289467]
 +
|[[CLLU1]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289173 HSALNT0289173]
 +
|[[ENST00000531381.1]]
 +
|AGD1,lncRNA-N2,linc-NeD125
 +
|NA
 +
|developmental process;pathogenic process
 +
|myeloid leukemia;myopia;cervical cancer;neuroblastoma
 +
|Eye Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Hemic and Lymphatic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0059175 HSALNT0059175]
 +
|[[NONHSAT091315]]
 +
|LINC00902,LSAMP-AS1,LSAMP-AS3,LSAMPAS3,NCRNA00295
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|glioma;Pancreatic ductal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;ischemic heart failure;gastric cancer;hepatocellular cancer;non-small cell lung cancer;acute myeloid leukemia;colorectal cancer
 +
|Respiratory Tract Diseases;Cardiovascular Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289647 HSALNT0289647]
 +
|[[BC040587]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|osteosarcoma;breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0059186 HSALNT0059186]
 +
|[[LINC00901]]
 +
|LSAMP-AS4,TCONS_00005428,BC040587
 +
|NA
 +
|pathogenic process
 +
|osteosarcoma;gastric cancer;breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0233366 HSALNT0233366]
 +
|[[HCCAT5]]
 +
|HTA,FJ222407
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290040 HSALNT0290040]
 +
|[[LSINCT5]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|chronic heart failure;colorectal cancer;ovarian cancer;gastric cancer;lung cancer;breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0179611 HSALNT0179611]
 +
|[[DISC1FP1]]
 +
|Boymaw
 +
|transcriptional regulation
 +
|pathogenic process
 +
|schizophrenia
 +
|Mental Disorders
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217643 HSALNT0217643]
 +
|[[SNHG14]]
 +
|115HG,IC-SNURF-SNRPN,LNCAT,NCRNA00214,U-UBE3A-AT, UBE3A-A, UBE3A-AS1,UBE3AATS
 +
|ceRNA
 +
|pathogenic process
 +
|Angelman syndrome;cerebral infarction;Prader-Willi syndrome
 +
|Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289273 HSALNT0289273]
 +
|[[TP73-AS1]]
 +
|KIAA0495,PDAM
 +
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer;oligodendroglial tumors;non-small cell lung cancer;glioblastoma;multiple myeloma
 +
|Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290311 HSALNT0290311]
 +
|[[TP53COR1]]
 +
|Trp53cor1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|prostate cancer;colorectal cancer;hepatocelluar cancer;atherosclerosis;Burkitt lymphoma;chronic lymphocytic leukemia;B cell lymphoma;lung cancer;cervical cancer
 +
|Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289221 HSALNT0289221]
 +
|[[NONHSAT129019]]
 +
|CARLo-3,PCAT8
 +
|transcriptional regulation
 +
|pathogenic process
 +
|gastric cancer;prostate cancer;glioma;colorectal cancer
 +
|Male Urogenital Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0020131 HSALNT0020131]
 +
|[[PCAT6]]
 +
|KDM5B-AS1,ncRNA-a2,PCAN-R1,KDM5BAS1,onco-lncRNA-96
 +
|transcriptional regulation
 +
|pathogenic process
 +
|prostate cancer;triple-negative breast cancer;lung cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289277 HSALNT0289277]
 +
|[[TRERNA1]]
 +
|LINC00651,ncRNA-a7,treRNA
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0014972 HSALNT0014972]
 +
|[[ENST00000416894.1]]
 +
|LINC00568,ncRNA-a1,FAL1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|ovarian cancer;thyroid cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290008 HSALNT0290008]
 +
|[[Lnc-SNAI1-1:1]]
 +
|Noncoding RNA activating7: ncRNA-a7,ENST00000431460.1,ENSG00000231265,TRERNA1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290248 HSALNT0290248]
 +
|[[Lnc-BSPH1-1:1]]
 +
|EU035784.1,lnc-BSPH1-1:1
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289342 HSALNT0289342]
 +
|[[Lnc-ZCCHC13-1:1]]
 +
|NCRNA00183,ENOX,LINC00183,DCBALD06
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289280 HSALNT0289280]
 +
|[[VLDLR-AS1]]
 +
|lincRNA-VLDLR
 +
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288982 HSALNT0288982]
 +
|[[ENST00000602812.1]]
 +
|NCRNA00182,MIR374AHG,LINC00182,FLJ33139
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocellular cancer;breast cancer;colorectal cancer;hepatocelluar cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091079 HSALNT0091079]
 +
|[[MEF2C-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer;Prader-Willi syndrome and Angelman syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189341 HSALNT0189341]
 +
|[[PCBP2-OT1]]
 +
|TUC338
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer;tongue squamous cell cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290373 HSALNT0290373]
 +
|[[WRAP53]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer;cancer;dyskeratosis congenita
 +
|Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289265 HSALNT0289265]
 +
|[[NONHSAT112472]]
 +
|LINC00532,lincRNA-NRNA024015
 +
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer;gastric cancer;testicular cancer;aplastic anemia
 +
|Male Urogenital Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289175 HSALNT0289175]
 +
|[[NONHSAT081499]]
 +
|MIRHG2,BIC,NCRNA00172
 +
|NA
 +
|pathogenic process
 +
|B-cell chronic lymphocytic leukemia;chronic lymphocytic leukemia;breast cancer;glioma
 +
|Immune System Diseases;Skin and Connective Tissue Diseases;Neoplasms;Hemic and Lymphatic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289051 HSALNT0289051]
 +
|[[LINC00620]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120390 HSALNT0120390]
 +
|[[NONHSAT119717]]
 +
|NCRNA00213,HOXA-AS6,RP1-170O19.3,HOXA13-AS1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hirschsprung disease;colorectal cancer;prostate cancer;tongue squamous cell cancer;Pancreatic ductal adenocarcinoma;osteosarcoma;hepatocelluar cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;pancreatic cancer;lung cancer;glioma
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289287 HSALNT0289287]
 +
|[[NONHSAT080206]]
 +
|C20orf199,NCRNA00275,ZNFX1-AS1,HSUP1,HSUP2
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|gastric cancer;hepatocellular cancer;ductal cancer;colorectal cancer;breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289259 HSALNT0289259]
 +
|[[Lnc-NDFIP1-3:1]]
 +
|SPRIGHTLY
 +
|transcriptional regulation
 +
|pathogenic process
 +
|prostate cancer;melanoma;glioma;esophageal squamous cell cancer;pre-eclampsia;bladder cancer;renal clear cell cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung cancer;breast cancer;cervical cancer;colorectal cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0105595 HSALNT0105595]
 +
|[[Lnc-CDKN1A-1:1]]
 +
|PANDA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|colorectal cancer;cancer;bladder cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;p53-associated pathological states;breast cancer;renal cell cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0068185 HSALNT0068185]
 +
|[[HTT-AS]]
 +
|HTT-AS1,HTTAS
 +
|NA
 +
|pathogenic process
 +
|Huntington disease
 +
|Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0099036 HSALNT0099036]
 +
|[[HEIH]]
 +
|LINC-HEIH,lncRNA-HEIH,LINC00848,HCCAT2
 +
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222533 HSALNT0222533]
 +
|[[NPTN-IT1]]
 +
|lncRNA-LET
 +
|NA
 +
|pathogenic process
 +
|gallbladder cancer;colorectal cancer;hepatocelluar cancer;esophageal squamous cell cancer;lung squamous cell cancer;nasopharyngeal cancer;gastric cancer;hypoxia;squamous cell lung cancer;cervical cancer
 +
|Pathological Conditions, Signs and Symptoms;Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289747 HSALNT0289747]
 +
|[[DQ786243]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|crohn's disease;colorectal cancer;hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289204 HSALNT0289204]
 +
|[[ENST00000561978.1]]
 +
|PCAT-1,PCA1
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|prostate cancer;colorectal cancer;esophageal squamous cell cancer;bladder cancer;hepatocellular cancer;lung cancer
 +
|Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275894 HSALNT0275894]
 +
|[[PCAT14]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211999 HSALNT0211999]
 +
|[[HIF1A-AS2]]
 +
|3'aHIF-1A,aHIF
 +
|translational control
 +
|pathogenic process
 +
|bladder cancer;osteosarcoma;renal cancer;glioblastoma;gastric cancer;acute myocardial infarction;kidney cancer;breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288999 HSALNT0288999]
 +
|[[HIF1A-AS1]]
 +
|5'aHIF-1A,5'aHIF1alpha
 +
|NA
 +
|pathogenic process
 +
|acute myocardial infarction;non-small cell lung cancer;cardiovascular disease;aortic aneurysm;thoracoabdominal aorta aneurysm;kidney cancer
 +
|Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289258 HSALNT0289258]
 +
|[[SOX2-OT]]
 +
|SOX2OT,DKFZp761J1324,NCRNA00043
 +
|transcriptional regulation
 +
|pathogenic process
 +
|colorectal cancer;esophageal squamous cell cancer;lung squamous cell cancer;retinal neurodegeneration;neurodevelopmental syndromes associated with the SOX2 locus;hepatocellular cancer;lung cancer;breast cancer;Alzheimer's disease
 +
|Eye Diseases;Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Mental Disorders;Digestive System Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289700 HSALNT0289700]
 +
|[[CDR1-AS]]
 +
|CDR1NAT,ciRS-7,CDR1as
 +
|ceRNA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289149 HSALNT0289149]
 +
|[[LINCMD1]]
 +
|MIR133BHG,LINC-MD1
 +
|ceRNA
 +
|developmental process;pathogenic process
 +
|Duchenne muscular dystrophy
 +
|Musculoskeletal Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288894 HSALNT0288894]
 +
|[[BGLT3]]
 +
|LINC01083,BGL3,lncRNA-BGL3
 +
|ceRNA
 +
|pathogenic process
 +
|chronic myeloid leukemia
 +
|Neoplasms;Hemic and Lymphatic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289042 HSALNT0289042]
 +
|[[LINC00473]]
 +
|C6orf176,bA142J11.1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|non-small cell lung cancer;renal cell cancer
 +
|Respiratory Tract Diseases;Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0101681 HSALNT0101681]
 +
|[[LINC01108]]
 +
|LncRNA-ES1
 +
|NA
 +
|developmental process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289418 HSALNT0289418]
 +
|[[TUNAR]]
 +
|LINC00617,TUNA,HI-LNC78
 +
|transcriptional regulation
 +
|developmental process;pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289197 HSALNT0289197]
 +
|[[ENST00000500949.2]]
 +
|cyrano,linc-OIP5
 +
|NA
 +
|developmental process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289046 HSALNT0289046]
 +
|[[Lnc-PRL-6:2]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|West Syndrome;West syndrome
 +
|Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289656 HSALNT0289656]
 +
|[[BX118339]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|West syndrome
 +
|Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021726 HSALNT0021726]
 +
|[[LINC00538]]
 +
|Yiya,PROX1UT
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer;cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273249 HSALNT0273249]
 +
|[[CBR3-AS1]]
 +
|PlncRNA-1,PlncRNA1
 +
|ceRNA
 +
|pathogenic process
 +
|esophageal squamous cell cancer;hepatocellular cancer;prostate cancer
 +
|Male Urogenital Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289179 HSALNT0289179]
 +
|[[NONHSAT130385]]
 +
|LOC554202,hsa-lnc-31,LncHIFCAR
 +
|ceRNA
 +
|pathogenic process
 +
|bladder cancer;gastric cancer;breast cancer;colorectal cancer;Pancreatic ductal adenocarcinoma
 +
|Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288925 HSALNT0288925]
 +
|[[NONHSAT096369]]
 +
|KIAA0114,SNHG13,ANCR,AGU2,lncRNA-ANCR
 +
|transcriptional regulation
 +
|developmental process;pathogenic process
 +
|prostate cancer;colorectal cancer;osteosarcoma;bone diseases;postmenopausal osteoporosis;hepatocellular cancer;breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Musculoskeletal Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290329 HSALNT0290329]
 +
|[[Uc.388]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289842 HSALNT0289842]
 +
|[[FR0348383]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289279 HSALNT0289279]
 +
|[[TTTY15]]
 +
|DKFZP434I143,NCRNA00138
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289718 HSALNT0289718]
 +
|[[Lnc-IRX3-4:2]]
 +
|LOC643911,LINC00180,CRNDEP
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|gallbladder cancer;colorectal cancer;ovarian cancer;medulloblastoma;chronic lymphocytic leukemia;renal cell cancer;glioma
 +
|Neoplasms;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289685 HSALNT0289685]
 +
|[[CCND1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|tumor;cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289935 HSALNT0289935]
 +
|[[LincRNA-p21]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|lung cancer;cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290134 HSALNT0290134]
 +
|[[PCNCR1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289492 HSALNT0289492]
 +
|[[NONHSAT099821]]
 +
|DBE-T,DUX4L30
 +
|transcriptional regulation
 +
|developmental process;pathogenic process
 +
|facioscapulohumeral muscular dystrophy
 +
|Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289455 HSALNT0289455]
 +
|[[BANCR]]
 +
|LINC00586
 +
|transcriptional regulation
 +
|pathogenic process
 +
|osteosarcoma ;lung cancer;melanoma;colorectal cancer;osteosarcoma;esophageal squamous cell cancer;bladder cancer;eosinophilic esophagitis;gastric cancer;hepatocellular cancer;non-small cell lung cancer;retinoblastoma;papillary thyroid cancer
 +
|Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0209589 HSALNT0209589]
 +
|[[ENST00000556013.2]]
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|papillary thyroid cancer;thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289103 HSALNT0289103]
 +
|[[LINC01268]]
 +
|LOC285758
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289070 HSALNT0289070]
 +
|[[LINC00887]]
 +
|linc-ATP13A4-8,HEIRCC
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hypoxic and inflammatory renal epithelial injury;renal clear cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288931 HSALNT0288931]
 +
|[[NONHSAT035954]]
 +
|C14orf167,PRO1488,AS1DHRS4
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288974 HSALNT0288974]
 +
|[[FENDRR]]
 +
|FOXF1-AS1,TCONS_00024240,lincFOXF1,onco-lncRNA-21
 +
|transcriptional regulation
 +
|developmental process;pathogenic process
 +
|osteosarcoma;gastric cancer;non-small cell lung cancer;lung cancer
 +
|Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0106473 HSALNT0106473]
 +
|[[LINC01512]]
 +
|LOC100132354,TCONS_00011120,HI-LNC77
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma;type 2 diabetes
 +
|Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Endocrine System Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289059 HSALNT0289059]
 +
|[[LINC00673]]
 +
|HI-LNC75,HILNC75,LUCAIR1,SLNCR,SLNCR1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|pancreatic cancer;type 2 diabetes;non-small cell lung cancer;melanoma;Pancreatic ductal adenocarcinoma
 +
|Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289107 HSALNT0289107]
 +
|[[LINC01433]]
 +
|LOC728228
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143571 HSALNT0143571]
 +
|[[NONHSAT129017]]
 +
|CARLo-5,onco-lncRNA-40
 +
|ceRNA
 +
|pathogenic process
 +
|gallbladder cancer;glioma;hepatocelluar cancer;ovarian cancer;acute myeloid leukemia;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung adenocarcinoma;endometrial cancer;lung cancer;breast cancer;colorectal cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289408 HSALNT0289408]
 +
|[[ENST00000448587.1]]
 +
|ENST00000448587.1,FLJ90734,NCRNA00036,LINC00036,onco-lncRNA-16
 +
|translational control
 +
|pathogenic process;developmental process
 +
|bladder cancer;colorectal cancer;esophageal squamous cell cancer;gastric cancer;skin desease;squamous cell cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289152 HSALNT0289152]
 +
|[[LNCPRESS1]]
 +
|lncPRESS1
 +
|translational control
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289145 HSALNT0289145]
 +
|[[LINC02561]]
 +
|RP11-445P17.8
 +
|NA
 +
|pathogenic process
 +
|cystic fibrosis
 +
|Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289065 HSALNT0289065]
 +
|[[LINC00850]]
 +
|KUCG1
 +
|NA
 +
|pathogenic process
 +
|Duchenne muscular dystrophy
 +
|Musculoskeletal Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289431 HSALNT0289431]
 +
|[[AFAP1-AS1]]
 +
|AFAP1A, AFAP1-A,MGC10981
 +
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;esophageal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;pancreatic cancer;Barrett's Esophagus;lung cancer
 +
|Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289519 HSALNT0289519]
 +
|[[XACT]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0248684 HSALNT0248684]
 +
|[[GATA6-AS1]]
 +
|locus5689,BM742401
 +
|NA
 +
|pathogenic process
 +
|gastric cancer;chronic lymphocytic leukemia
 +
|Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289222 HSALNT0289222]
 +
|[[ENST00000430058.1]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289655 HSALNT0289655]
 +
|[[BTG3-AS1]]
 +
|ASBEL
 +
|translational control
 +
|pathogenic process
 +
|ovarian cancer;colorectal cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289224 HSALNT0289224]
 +
|[[NONHSAT130775]]
 +
|NONHSAT130775,PTENpg1,PTEN2,ENSG00000237984
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|gastric cancer;prostate cancer;renal cell cancer;cancer;hepatocelluar cancer
 +
|Male Urogenital Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290129 HSALNT0290129]
 +
|[[PAN]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Kaposi's sarcoma
 +
|Neoplasms;Virus Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289939 HSALNT0289939]
 +
|[[LINC-ROR]]
 +
|lincRNA-RoR,lincRNA-ST8SIA3,ROR
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|gallbladder cancer;liver cancer;glioma;malignant melanoma;unveal melanoma;breast cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;pancreatic cancer;endometrial cancer;triple-negative breast cancer;colorectal cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Stomatognathic Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290322 HSALNT0290322]
 +
|[[UBE3A-ATS]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Angelman syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091004 HSALNT0091004]
 +
|[[LINC00461]]
 +
|EyeLinc1,Visc-1a,Visc-1b,Visc-2,LOC645323
 +
|NA
 +
|pathogenic process;developmental process
 +
|retinal and visual function
 +
|Eye Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289491 HSALNT0289491]
 +
|[[CTBP1-AS]]
 +
|PCAT10
 +
|transcriptional regulation
 +
|pathogenic process
 +
|chronic hepatitis C;prostate cancer;polycystic ovary syndrome
 +
|Neoplasms;Male Urogenital Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0037401 HSALNT0037401]
 +
|[[ENST00000441383.1]]
 +
|LINC00876,AC096655.1-002
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120344 HSALNT0120344]
 +
|[[NONHSAT119676]]
 +
|HOXA3as
 +
|transcriptional regulation
 +
|pathogenic process
 +
|promyelocytic leukemia;gastric cancer
 +
|Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091313 HSALNT0091313]
 +
|[[ENST00000511918.1]]
 +
|SCAL1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|non-small cell lung cancer;lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289425 HSALNT0289425]
 +
|[[BLACAT1]]
 +
|linc-UBC1,LINC00912,onco-lncRNA-30
 +
|transcriptional regulation
 +
|pathogenic process
 +
|bladder cancer;gastric cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149012 HSALNT0149012]
 +
|[[GLIDR]]
 +
|LINC01172,MGC21881,TCONS_00015562
 +
|NA
 +
|pathogenic process
 +
|glioblastoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217561 HSALNT0217561]
 +
|[[PWAR5]]
 +
|PAR5,PAR-5
 +
|NA
 +
|pathogenic process
 +
|glioblastoma;Prader-Willi syndrome and Angelman syndrome;Prader-Willi syndrome
 +
|Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289272 HSALNT0289272]
 +
|[[TP53TG1]]
 +
|TP53AP1,H_RG012D21.9,LINC00096
 +
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer;ataxia telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Nutritional and Metabolic Diseases;Cardiovascular Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289598 HSALNT0289598]
 +
|[[AK126698]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217598 HSALNT0217598]
 +
|[[NONHSAT041063]]
 +
|NCRNA00002
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Prader-Willi syndrome
 +
|Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143633 HSALNT0143633]
 +
|[[CCAT2]]
 +
|NCCP1,LINC00873
 +
|transcriptional regulation
 +
|pathogenic process
 +
|non-small cell lung cancer;oral squamous cell cancer;colorectal cancer;ovarian cancer;esophageal squamous cell cancer;bladder cancer;small cell lung cancer;gastric cancer;hepatocellular cancer;prostate cancer;cervical squamous cell cancer;lung cancer;breast cancer;cervical cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289026 HSALNT0289026]
 +
|[[LINC00261]]
 +
|C20orf56,NCRNA00261,bA216C10.1,HCCDR1,TCONS_00027846,ALIEN,DEANR1,onco-lncRNA-17
 +
|NA
 +
|pathogenic process
 +
|pancreatic cancer;non-small cell lung cancer;gastric cancer
 +
|Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289078 HSALNT0289078]
 +
|[[LINC00982]]
 +
|FLJ42875
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290082 HSALNT0290082]
 +
|[[NEAT1_2]]
 +
|NEAT1_2
 +
|protein localization
 +
|pathogenic process
 +
|amyotrophic lateral sclerosis
 +
|Nutritional and Metabolic Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288989 HSALNT0288989]
 +
|[[GATA3-AS1]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289427 HSALNT0289427]
 +
|[[GNG12-AS1]]
 +
|NA
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290395 HSALNT0290395]
 +
|[[YAM1]]
 +
|Yam-1
 +
|transcriptional regulation
 +
|pathogenic process;developmental process
 +
|skeletal myogenesis
 +
|Musculoskeletal Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289202 HSALNT0289202]
 +
|[[PAX8-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|malignant pleural mesothelioma;cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0054469 HSALNT0054469]
 +
|[[RASSF1-AS1]]
 +
|ANRASSF1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290261 HSALNT0290261]
 +
|[[SUMO1P3]]
 +
|SUMO1P3
 +
|NA
 +
|pathogenic process
 +
|bladder cancer;gastric cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289002 HSALNT0289002]
 +
|[[HNF1A-AS1]]
 +
|C12orf27,NCRNA00262,FLJ38690,HAS1
 +
|ceRNA
 +
|pathogenic process
 +
|esophageal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;adenocarcinoma;lung adenocarcinoma;pancreatic cancer
 +
|Neoplasms;Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Stomatognathic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289377 HSALNT0289377]
 +
|[[NIPBL-AS1]]
 +
|NIPBL-DT,NIPBL-AS
 +
|NA
 +
|pathogenic process
 +
|autism spectrum disorder
 +
|Mental Disorders
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289249 HSALNT0289249]
 +
|[[SNHG15]]
 +
|C7orf40,FLJ38860,MYO1GUT,Linc-Myo1g
 +
|NA
 +
|pathogenic process
 +
|gastric cancer;hepatocellular cancer;hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235898 HSALNT0235898]
 +
|[[ENST00000574306.1]]
 +
|C17orf91,MGC14376,DKFZp686O06159
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235898 HSALNT0235898]
 +
|[[ENST00000574306.1]]
 +
|C17orf91,MGC14376,DKFZp686O06159
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288984 HSALNT0288984]
 +
|[[ENST00000579368.1]]
 +
|MTCL1-AS1,HMlincRNA717
 +
|NA
 +
|pathogenic process
 +
|pancreatic cancer;non-small cell lung cancer;gastric cancer
 +
|Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289369 HSALNT0289369]
 +
|[[MIF-AS1]]
 +
|LOC284889,MIF-AS
 +
|transcriptional regulation
 +
|pathogenic process
 +
|malaria;nephrolithiasis
 +
|Skin and Connective Tissue Diseases;Male Urogenital Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Parasitic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0129086 HSALNT0129086]
 +
|[[NONHSAT123382]]
 +
|MKLN1-AS1,FLJ43663,PINT,LincRNA-Pint
 +
|transcriptional regulation
 +
|pathogenic process
 +
|colorectal cancer;heart failure
 +
|Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289240 HSALNT0289240]
 +
|[[NONHSAT075852]]
 +
|LINC00913,SChLAP1,PCAT11
 +
|transcriptional regulation
 +
|pathogenic process
 +
|bladder cancer;prostate cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0193241 HSALNT0193241]
 +
|[[SOCS2-AS1]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138824 HSALNT0138824]
 +
|[[CASC9]]
 +
|ESCCAL-1,ESSCAL1,LINC00981
 +
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer;esophageal cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267627 HSALNT0267627]
 +
|[[HNF4A-AS1]]
 +
|uc002xlx
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289194 HSALNT0289194]
 +
|[[NKILA]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|nasopharyngeal cancer;breast cancer;tongue squamous cell cancer
 +
|Skin and Connective Tissue Diseases;Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289304 HSALNT0289304]
 +
|[[LINC00942]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer;autism spectrum disorder
 +
|Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Mental Disorders;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289187 HSALNT0289187]
 +
|[[MNX1-AS1]]
 +
|CCAT5,LOC645249
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer;colorectal cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289518 HSALNT0289518]
 +
|[[VPS9D1-AS1]]
 +
|MYU
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer;colorectal cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290266 HSALNT0290266]
 +
|[[TC0101441]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|epithelial ovarian cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289426 HSALNT0289426]
 +
|[[ERLNC1]]
 +
|TC0101441,ElncRNA1
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290050 HSALNT0290050]
 +
|[[ENST00000416928.2]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0043560 HSALNT0043560]
 +
|[[ENST00000416928.2]]
 +
|HOXD-AS1,Mdgt
 +
|NA
 +
|pathogenic process
 +
|bladder cancer;neuroblastoma
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289092 HSALNT0289092]
 +
|[[LINC01158]]
 +
|PANTR1,linc-Brn1a,linc-POU3F3
 +
|transcriptional regulation
 +
|pathogenic process;developmental process
 +
|esophageal squamous cell cancer;gastric cancer;glioma
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289448 HSALNT0289448]
 +
|[[GHET1]]
 +
|lncRNA-GHET1
 +
|NA
 +
|pathogenic process
 +
|bladder cancer;gastric cancer;colorectal cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289514 HSALNT0289514]
 +
|[[PEG13]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|intellectual disabilities
 +
|Behavior and Behavior Mechanisms;Pathological Conditions, Signs and Symptoms;Mental Disorders;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289183 HSALNT0289183]
 +
|[[ENST00000414769.1]]
 +
|MGC16121,H19X
 +
|NA
 +
|pathogenic process
 +
|choriocarcinoma
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289201 HSALNT0289201]
 +
|[[NONHSAT018635]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process;developmental process
 +
|uveal melanoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288956 HSALNT0288956]
 +
|[[LINC01234]]
 +
|LCAL84,onco-lncRNA-32
 +
|ceRNA
 +
|pathogenic process
 +
|oesophageal squamous cell cancer;breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289021 HSALNT0289021]
 +
|[[CYTOR]]
 +
|C2orf59,NCRNA00152,MGC4677
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|colorectal cancer;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;renal cell cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289706 HSALNT0289706]
 +
|[[CHRF]]
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|cardiac hypertrophy;silicosis
 +
|Respiratory Tract Diseases;Occupational Diseases;Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143635 HSALNT0143635]
 +
|[[ENST00000502056.1]]
 +
|LINC00860,CARLo-1
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143672 HSALNT0143672]
 +
|[[CASC11]]
 +
|TCONS_00014535,LINC00990,CARLo-7,ENST00000518376
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocellular cancer;colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289032 HSALNT0289032]
 +
|[[LINC00323]]
 +
|PRED42,FLJ37173
 +
|NA
 +
|pathogenic process
 +
|breast cancer;hereditary haemorrhagic telangiectasia
 +
|Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0024655 HSALNT0024655]
 +
|[[LINC01139]]
 +
|LINK-A,TCONS_00000027
 +
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289018 HSALNT0289018]
 +
|[[LEF1-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia;colorectal cancer
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247326 HSALNT0247326]
 +
|[[LINC00667]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290145 HSALNT0290145]
 +
|[[POU3F3]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|esophageal squamous cell cancer;glioma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199349 HSALNT0199349]
 +
|[[LINC00426]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|primary Sjögren's syndrome
 +
|Immune System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0155974 HSALNT0155974]
 +
|[[LINC00963]]
 +
|MetaLnc9
 +
|NA
 +
|pathogenic process
 +
|prostate cancer;renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289211 HSALNT0289211]
 +
|[[PCF11-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer;adolescent idiopathic scoliosis
 +
|Musculoskeletal Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289534 HSALNT0289534]
 +
|[[91H]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|osteosarcoma;esophageal squamous cell cancer;breast cancer;colorectal cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289446 HSALNT0289446]
 +
|[[ELFN1-AS1]]
 +
|MYCLo-2
 +
|transcriptional regulation
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288883 HSALNT0288883]
 +
|[[ACTA2-AS1]]
 +
|uc001kfo.1,ZXF1
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289443 HSALNT0289443]
 +
|[[NONHSAT121673]]
 +
|RSBN1L-AS1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|liver fibrosis;glioblastoma
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289986 HSALNT0289986]
 +
|[[LncRNA-MVIH]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer;non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289977 HSALNT0289977]
 +
|[[LncRNA-ATB]]
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|colorectal cancer;hepatocelluar cancer;gastric cancer;pancreatic cancer;renal cell cancer;pneumoconiosis
 +
|Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Occupational Diseases;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289622 HSALNT0289622]
 +
|[[ATB]]
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|prostate cancer;glioma;keloid;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;colorectal cancer
 +
|Pathological Conditions, Signs and Symptoms;Skin and Connective Tissue Diseases;Neoplasms;Tissues;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289586 HSALNT0289586]
 +
|[[AK057054]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0278370 HSALNT0278370]
 +
|[[LINC01315]]
 +
|lnc-C22orf32-1,C22orf32-1
 +
|NA
 +
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0055601 HSALNT0055601]
 +
|[[ADAMTS9-AS2]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer;glioma
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289383 HSALNT0289383]
 +
|[[ENST00000608917.1]]
 +
|PACER,PTGS2-AS1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|osteosarcoma;osteoarthritis;inflammation and cancer
 +
|Musculoskeletal Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289268 HSALNT0289268]
 +
|[[TGFB2-OT1]]
 +
|FLJ11812
 +
|ceRNA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288938 HSALNT0288938]
 +
|[[DUBR]]
 +
|LINC00883
 +
|ceRNA
 +
|pathogenic process
 +
|asthma and chronic obstructive pulmonary disease
 +
|Respiratory Tract Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289440 HSALNT0289440]
 +
|[[Lnc-FOXC1-1:1]]
 +
|LINC01379,TCONS_00011636
 +
|transcriptional regulation
 +
|pathogenic process
 +
|esophageal squamous cell cancer;basal-like breast cancer;oral squamous cell cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288924 HSALNT0288924]
 +
|[[CYP51A1-AS1]]
 +
|ENST00000453068,LRRD1-AS1
 +
|NA
 +
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289395 HSALNT0289395]
 +
|[[RPL34-AS1]]
 +
|FLJ37673,RP11-462C24.1
 +
|NA
 +
|pathogenic process
 +
|gastric cancer;colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289435 HSALNT0289435]
 +
|[[C5orf66-AS1]]
 +
|CTC-276P9.1,Epist
 +
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer;bladder cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289052 HSALNT0289052]
 +
|[[LINC00623]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289831 HSALNT0289831]
 +
|[[FER1L4]]
 +
|FER1L4
 +
|ceRNA
 +
|pathogenic process
 +
|gastric cancer;endometrial cancer;colorectal cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288985 HSALNT0288985]
 +
|[[ENST00000426539.1]]
 +
|LINC01458,lncRNA-AC130710
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer;gastric cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288881 HSALNT0288881]
 +
|[[ABHD11-AS1]]
 +
|WBSCR26,LINC00035,NCRNA00035
 +
|NA
 +
|pathogenic process
 +
|gastric cancer;mutant huntingtin
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0282263 HSALNT0282263]
 +
|[[ZNF674-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289207 HSALNT0289207]
 +
|[[PCAT29]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|prostate cancer;glioma;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma
 +
|Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289672 HSALNT0289672]
 +
|[[CADM1]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289297 HSALNT0289297]
 +
|[[LINC01527]]
 +
|lnc-SPRR2D-1,RP1-13P20.6
 +
|NA
 +
|pathogenic process
 +
|squamous cell cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289158 HSALNT0289158]
 +
|[[LUNAR1]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|diffuse large B-cell lymphoma;T cell acute lymphoblastic leukemia
 +
|Hemic and Lymphatic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289830 HSALNT0289830]
 +
|[[FAR2P-1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma;non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289263 HSALNT0289263]
 +
|[[ENST00000607033.1]]
 +
|EYA4-AS1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|kidney clear cell sarcoma
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0145373 HSALNT0145373]
 +
|[[MAFA-AS1]]
 +
|RP11-909N17.3,TCONS_00014882
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma;non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290229 HSALNT0290229]
 +
|[[RPLP0P2]]
 +
|RPLP0P2
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289291 HSALNT0289291]
 +
|[[ZNF295-AS1]]
 +
|C21orf121,NCRNA00318,PRED87
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma;epithelial ovarian cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084473 HSALNT0084473]
 +
|[[LINC01513]]
 +
|RP11-1C1.7,TCONS_00009352
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289471 HSALNT0289471]
 +
|[[IRAIN]]
 +
|IGF1R-AS
 +
|transcriptional regulation
 +
|pathogenic process
 +
|pancreatic cancer;acute myeloid leukemia;non-small cell lung cancer;breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Endocrine System Diseases;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290402 HSALNT0290402]
 +
|[[ZNRD1-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer;lung cancer;cervical cancer
 +
|Respiratory Tract Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289504 HSALNT0289504]
 +
|[[LCAL1]]
 +
|onco-lncRNA-27
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289169 HSALNT0289169]
 +
|[[MHRT]]
 +
|Myheart
 +
|transcriptional regulation
 +
|pathogenic process
 +
|heart hypertrophy;acute myocardial infarction
 +
|Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289859 HSALNT0289859]
 +
|[[HA117]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hirschsprung disease
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0026673 HSALNT0026673]
 +
|[[ENST00000414795.1]]
 +
|lncRNA-CMPK2
 +
|transcriptional regulation
 +
|pathogenic process
 +
|chronic hepatitis C;HCV
 +
|Digestive System Diseases;Virus Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289887 HSALNT0289887]
 +
|[[LET]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gallbladder cancer;esophageal squamous cell cancer;gastric cancer;nasopharyngeal cancer;renal cell cancer;cervical cancer
 +
|Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Digestive System Diseases;Stomatognathic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0007921 HSALNT0007921]
 +
|[[NFIA-AS1]]
 +
|RP5-833A20.1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|atherosclerosis;glioma
 +
|Cardiovascular Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247156 HSALNT0247156]
 +
|[[GAPLINC]]
 +
|LINC01540,TCONS_00026238,lncRNA-uc002kmd.1
 +
|siRNA
 +
|pathogenic process
 +
|gastric cancer;colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288917 HSALNT0288917]
 +
|[[CERNA2]]
 +
|HOST2,lncRNA-HOST2
 +
|ceRNA
 +
|pathogenic process
 +
|hepatocellular cancer;epithelial ovarian cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289113 HSALNT0289113]
 +
|[[LINC01564]]
 +
|TCONS_00011314
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289088 HSALNT0289088]
 +
|[[LINC01105]]
 +
|FLJ30594,LOC150622
 +
|NA
 +
|pathogenic process
 +
|gastric cancer;leukemia and neuroblastoma
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289464 HSALNT0289464]
 +
|[[AGAP2-AS1]]
 +
|LOC100130776,PUNISHER
 +
|transcriptional regulation
 +
|pathogenic process
 +
|non-small cell lung cancer;glioma;leukemia and neuroblastoma
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288960 HSALNT0288960]
 +
|[[EWSAT1]]
 +
|TMEM84,NCRNA00277,LINC00277,FLJ33768
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Ewing sarcoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289242 HSALNT0289242]
 +
|[[SLC25A25-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289317 HSALNT0289317]
 +
|[[KCNK15-AS1]]
 +
|RP11-445H22.4
 +
|NA
 +
|pathogenic process
 +
|osteoarthritis;breast cancer
 +
|Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289864 HSALNT0289864]
 +
|[[HIF2PUT]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|osteosarcoma;colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289267 HSALNT0289267]
 +
|[[TEX41]]
 +
|DKFZp686O1327,LINC00953
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290361 HSALNT0290361]
 +
|[[UFC1]]
 +
|NA
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|osteoarthritis;hepatocellular cancer
 +
|Musculoskeletal Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289886 HSALNT0289886]
 +
|[[LEIGC]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289367 HSALNT0289367]
 +
|[[MDC1-AS1]]
 +
|MDC1-AS
 +
|NA
 +
|pathogenic process
 +
|bladder cancer;glioma
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289190 HSALNT0289190]
 +
|[[NBAT1]]
 +
|CASC14,NBAT-1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|breast cancer;renal clear cell cancer;neuroblastoma
 +
|Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234826 HSALNT0234826]
 +
|[[LINC00917]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|intervertebral disc degeneration;breast cancer
 +
|Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289419 HSALNT0289419]
 +
|[[LINC00173]]
 +
|NCRNA00173,FLJ42957
 +
|NA
 +
|pathogenic process
 +
|HIV-1-infected;hepatocelluar cancer
 +
|Virus Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290138 HSALNT0290138]
 +
|[[PEG10]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|diffuse large B-cell lymphoma;esophageal cancer
 +
|Neoplasms;Hemic and Lymphatic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289136 HSALNT0289136]
 +
|[[LINC02224]]
 +
|BRCAT107,ENST00000505706
 +
|NA
 +
|pathogenic process
 +
|active tuberculosis
 +
|Bacterial Infections and Mycoses
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289866 HSALNT0289866]
 +
|[[HIT]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|non-small cell lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0003927 HSALNT0003927]
 +
|[[SNHG12]]
 +
|ASLNC04080,C1orf79,LINC00100,NCRNA00100,PNAS-123
 +
|NA
 +
|pathogenic process
 +
|osteosarcoma;endometrial cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289099 HSALNT0289099]
 +
|[[LINC01225]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290047 HSALNT0290047]
 +
|[[MALAT2]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0176345 HSALNT0176345]
 +
|[[NONHSAT021826]]
 +
|LINC00057,NCRNA00057,U22HG,UHG,lncRNA16
 +
|NA
 +
|pathogenic process
 +
|astrocytoma;hepatocellular cancer;non-small cell lung cancer;Parkinson's disease;neuroblastoma
 +
|Respiratory Tract Diseases;Neoplasms;Digestive System Diseases;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0094592 HSALNT0094592]
 +
|[[WSPAR]]
 +
|TCONS_00009511-XLOC_004555,lncTCF7
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocellular cancer;liver cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289308 HSALNT0289308]
 +
|[[LINC00511]]
 +
|onco-lncRNA-12
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289452 HSALNT0289452]
 +
|[[FAM83H-AS1]]
 +
|onco-lncRNA-3
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289041 HSALNT0289041]
 +
|[[LINC00472]]
 +
|C6orf155,dJ288M22.3,FLJ13189
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer;breast cancer
 +
|Skin and Connective Tissue Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Endocrine System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289925 HSALNT0289925]
 +
|[[Linc-ITGB1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gallbladder cancer;breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0016239 HSALNT0016239]
 +
|[[LINC01133]]
 +
|lncRNA-PAGBC
 +
|transcriptional regulation
 +
|pathogenic process
 +
|non-small cell lung cancer;colorectal cancer;lung squamous cell cancer
 +
|Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289489 HSALNT0289489]
 +
|[[CCEPR]]
 +
|CCHE1,lncRNA-CCHE1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocellular cancer;cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289402 HSALNT0289402]
 +
|[[SOX21-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma;oral squamous cell cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288905 HSALNT0288905]
 +
|[[CASC15]]
 +
|LINC00340,lnc-SOX4-1
 +
|NA
 +
|pathogenic process
 +
|basal cell cancer;melanoma;neuroblastoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289555 HSALNT0289555]
 +
|[[AC104699.1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096322 HSALNT0096322]
 +
|[[CLMAT3]]
 +
|SPARC-AS1
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289233 HSALNT0289233]
 +
|[[RGMB-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma;non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289908 HSALNT0289908]
 +
|[[LINC01419]]
 +
|LVCAT7,TCONS_00014497
 +
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289541 HSALNT0289541]
 +
|[[AB209630]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hypopharyngeal squamous cell cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289608 HSALNT0289608]
 +
|[[AOC4P]]
 +
|AOC4P
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer;hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289082 HSALNT0289082]
 +
|[[LINC01021]]
 +
|LINC01021,LOC643401,RP11-46C20.1
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0196121 HSALNT0196121]
 +
|[[LINC01089]]
 +
|LIMT
 +
|NA
 +
|pathogenic process
 +
|breast cancer;astrocytoma
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0123080 HSALNT0123080]
 +
|[[EGFR-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289539 HSALNT0289539]
 +
|[[AB073614]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer;glioma
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0242418 HSALNT0242418]
 +
|[[CACNA1G-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|keloid
 +
|Pathological Conditions, Signs and Symptoms;Skin and Connective Tissue Diseases;Tissues
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0170814 HSALNT0170814]
 +
|[[MIR210HG]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hypoxic and inflammatory stress
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288979 HSALNT0288979]
 +
|[[FOXC2-AS1]]
 +
|ODRUL
 +
|NA
 +
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289022 HSALNT0289022]
 +
|[[LINC00160]]
 +
|C21orf52,NCRNA00160
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0105274 HSALNT0105274]
 +
|[[LINC01016]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288904 HSALNT0288904]
 +
|[[CARMN]]
 +
|MIR143HG,CARMEN
 +
|transcriptional regulation
 +
|pathogenic process
 +
|cardiac differentiation
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289123 HSALNT0289123]
 +
|[[LINC01630]]
 +
|LOC100287225
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288971 HSALNT0288971]
 +
|[[FAM30A]]
 +
|C14orf110,KIAA0125,HSPC053
 +
|NA
 +
|pathogenic process
 +
|gallbladder cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289506 HSALNT0289506]
 +
|[[LINC00346]]
 +
|C13orf29,NCRNA00346
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer;breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289643 HSALNT0289643]
 +
|[[BC032469]]
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|esophageal squamous cell cancer;gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289580 HSALNT0289580]
 +
|[[AK024171]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|intervertebral disc degeneration;gastric cancer
 +
|Musculoskeletal Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290187 HSALNT0290187]
 +
|[[RP11-284N8.3.1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289839 HSALNT0289839]
 +
|[[FMR6]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|fragile X syndrome;fragile X-associated premature ovarian insufficiency
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Female Urogenital Diseases and Pregnancy Complications;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290152 HSALNT0290152]
 +
|[[PRAL]]
 +
|lncRNA-PRAL
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer;lung cancer
 +
|Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289380 HSALNT0289380]
 +
|[[NORAD]]
 +
|LINC00657
 +
|transcriptional regulation;translational control
 +
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0086803 HSALNT0086803]
 +
|[[LIFR-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|preterm
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076183 HSALNT0076183]
 +
|[[PANCR]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|atrial fibrillation
 +
|Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288975 HSALNT0288975]
 +
|[[FEZF1-AS1]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|gastric cancer;colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0238475 HSALNT0238475]
 +
|[[CCDC144NL-AS1]]
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|ovarian cancer;cardiac hypertrophy
 +
|Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Cardiovascular Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290102 HSALNT0290102]
 +
|[[NR_026689]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer;lung cancer
 +
|Respiratory Tract Diseases;Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289522 HSALNT0289522]
 +
|[[ADARB2-AS1]]
 +
|C10orf109,NCRNA00168,bA466B20.1
 +
|NA
 +
|pathogenic process
 +
|breast cancer;pancreatic ductal adenocarcinoma
 +
|Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288936 HSALNT0288936]
 +
|[[DPP10-AS1]]
 +
|BC032913
 +
|NA
 +
|pathogenic process
 +
|breast cancer;colorectal cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289474 HSALNT0289474]
 +
|[[GAS8-AS1]]
 +
|C16orf3
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer;breast cancer
 +
|Skin and Connective Tissue Diseases;Endocrine System Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289063 HSALNT0289063]
 +
|[[LINC00704]]
 +
|LINC00704
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289238 HSALNT0289238]
 +
|[[SAMMSON]]
 +
|LINC01212
 +
|NA
 +
|pathogenic process
 +
|melanoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289027 HSALNT0289027]
 +
|[[LINC00302]]
 +
|C1orf46,NCRNA00302,XP33
 +
|NA
 +
|developmental process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0245543 HSALNT0245543]
 +
|[[SNHG20]]
 +
|C17orf86,NCRNA00338,LINC00338,PRO0872,FLJ25582,DKFZp686L05235,SCARNA16HG
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocellular cancer;colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0015631 HSALNT0015631]
 +
|[[DCST1-AS1]]
 +
|RP11-307C12.11
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149810 HSALNT0149810]
 +
|[[PGM5-AS1]]
 +
|FAM233A,LOC572558
 +
|NA
 +
|pathogenic process
 +
|bladder cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290236 HSALNT0290236]
 +
|[[SBF2-AS1]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290325 HSALNT0290325]
 +
|[[Uc.338]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocellular cancer;lung cancer
 +
|Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290002 HSALNT0290002]
 +
|[[LOC100130476]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer;gastric cardia adenocarcinoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289049 HSALNT0289049]
 +
|[[Lnc-TNKS-1:1]]
 +
|Rncr3
 +
|NA
 +
|pathogenic process
 +
|diabetes
 +
|Endocrine System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0020406 HSALNT0020406]
 +
|[[LINC00628]]
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289478 HSALNT0289478]
 +
|[[DSCR4]]
 +
|DCRB
 +
|NA
 +
|pathogenic process
 +
|Down syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0017675 HSALNT0017675]
 +
|[[GAS5-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|oral submucous fibrosis;non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms;Stomatognathic Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289523 HSALNT0289523]
 +
|[[HCG11]]
 +
|bK14H9.3,FLJ14049,FLJ30357
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134828 HSALNT0134828]
 +
|[[LINC02099]]
 +
|AC145110.1
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis;breast cancer
 +
|Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0209098 HSALNT0209098]
 +
|[[G2E3-AS1]]
 +
|CAT1647
 +
|NA
 +
|pathogenic process
 +
|bladder cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289139 HSALNT0289139]
 +
|[[LINC02245]]
 +
|lnc-SERTAD2-3,AC007386.2
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0008167 HSALNT0008167]
 +
|[[FOXD3-AS1]]
 +
|pasFOXD3
 +
|transcriptional regulation
 +
|pathogenic process
 +
|glioma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289335 HSALNT0289335]
 +
|[[LINC00998]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|major depression disorder
 +
|Behavior and Behavior Mechanisms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289379 HSALNT0289379]
 +
|[[NNT-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0055497 HSALNT0055497]
 +
|[[PSMD6-AS1]]
 +
|ENST00000462717,lnc00462717
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer;glioma
 +
|Endocrine System Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289130 HSALNT0289130]
 +
|[[LINC02081]]
 +
|CTD-2357A8.3,XLOC_012582
 +
|NA
 +
|pathogenic process
 +
|esophageal cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289306 HSALNT0289306]
 +
|[[LINC00052]]
 +
|TMEM83,NCRNA00052,FLJ31461
 +
|ceRNA
 +
|pathogenic process
 +
|hepatocellular cancer;breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199070 HSALNT0199070]
 +
|[[PLUT]]
 +
|PDX1-AS1,PLUTO,HI-LNC71
 +
|transcriptional regulation
 +
|pathogenic process
 +
|type 2 diabetes
 +
|Nutritional and Metabolic Diseases;Endocrine System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289341 HSALNT0289341]
 +
|[[LINC01505]]
 +
|RP11-308N19.1
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289315 HSALNT0289315]
 +
|[[LINC01116]]
 +
|TALNEC2
 +
|transcriptional regulation
 +
|pathogenic process
 +
|prostate cancer;glioblastoma
 +
|Male Urogenital Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0006439 HSALNT0006439]
 +
|[[FOXD2-AS1]]
 +
|MGC12982
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0252387 HSALNT0252387]
 +
|[[LINC00305]]
 +
|C18orf20,NCRNA00305,MGC39571,HsT1235
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289473 HSALNT0289473]
 +
|[[FBXL19-AS1]]
 +
|NCRNA00095,MGC125469,MGC125470,MGC125472
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0187807 HSALNT0187807]
 +
|[[LINC02555]]
 +
|AC079630.2
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0251493 HSALNT0251493]
 +
|[[LINC01929]]
 +
|CTD-2171N6.1
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|Endocrine System Diseases;Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0244776 HSALNT0244776]
 +
|[[LINC01152]]
 +
|TCONS_00025128,CMPD
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0284591 HSALNT0284591]
 +
|[[DIAPH2-AS1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Hodgkin's disease
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289226 HSALNT0289226]
 +
|[[PWAR1]]
 +
|PAR1,PAR-1
 +
|NA
 +
|pathogenic process
 +
|Prader-Willi syndrome and Angelman syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289339 HSALNT0289339]
 +
|[[LINC00950]]
 +
|FP588
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289740 HSALNT0289740]
 +
|[[DGCR12]]
 +
|DGS-E
 +
|NA
 +
|pathogenic process;developmental process
 +
|DiGeorge syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Endocrine System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275220 HSALNT0275220]
 +
|[[DGCR9]]
 +
|DGS-A,POM121L5P
 +
|NA
 +
|pathogenic process
 +
|DiGeorge syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Endocrine System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288929 HSALNT0288929]
 +
|[[DGCR10]]
 +
|DGS-B
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289494 HSALNT0289494]
 +
|[[DGCR11]]
 +
|DGS-D
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267755 HSALNT0267755]
 +
|[[LINC02597]]
 +
|Long intergenic non-protein coding RNA 2597, LOC101929866
 +
|Transcriptional regulation
 +
|Pathogenic process
 +
|Postmenopausal osteoporosis (PMOP)
 +
|Musculoskeletal Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0178412 HSALNT0178412]
 +
|[[UVRAG-DT]]
 +
|UVRAG divergent transcript, LOC100506113
 +
|Transcriptional regulation
 +
|Pathogenic process
 +
|Postmenopausal osteoporosis (PMOP)
 +
|Musculoskeletal Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185540 HSALNT0185540]
 +
|[[LINC02598]]
 +
|Long intergenic non-protein coding RNA 2598, RP11-277P12.9
 +
|_
 +
|Pathogenic process
 +
|Lung squamous cell carcinoma (LUSC)
 +
|Neoplasms; Respiratory Tract Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0278274 HSALNT0278274]
 +
|[[SREBF2-AS1]]
 +
|SREBF2 antisense RNA 1, RP5-821D11.7
 +
|_
 +
|Pathogenic process
 +
|Lung squamous cell carcinoma (LUSC)
 +
|Neoplasms; Respiratory Tract Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021177 HSALNT0021177]
 +
|[[LINC02602]]
 +
|Long intergenic non-protein coding RNA 2602, TCONS_00001798
 +
|_
 +
|Pathogenic process
 +
|Non-small cell lung cancer (NSCLC) 
 +
|Neoplasms; Respiratory Tract Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021052 HSALNT0021052]
 +
|[[MIR205HG]]
 +
|MIR205 host gene, LINC00510
 +
|CeRNA
 +
|Pathogenic process
 +
|Head & neck squamous cell carcinoma (HNSCC)
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0107588 HSALNT0107588]
 +
|[[ZNF451-AS1]]
 +
|ZNF451 regulatory antisense RNA 1, BC032020
 +
|Transcriptional regulation
 +
|Pathogenic process
 +
|Pancreatic ductal adenocarcinoma (PDAC)
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189537 HSALNT0189537]
 +
|[[SCAT2]]
 +
|S-phase cancer associated transcript 2, CBX5-AS1
 +
|_
 +
|Pathogenic process
 +
|Kidney clear cell carcinoma (KIRC)
 +
|Neoplasm
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0107867 HSALNT0107867]
 +
|[[SCAT8]]
 +
|S-phase cancer associated transcript 8, EYS-AS1
 +
|_
 +
|Pathogenic process
 +
|Kidney clear cell carcinoma (KIRC)
 +
|Neoplasm
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0158500 HSALNT0158500]
 +
|[[LINC00707]]
 +
|long intergenic non-protein coding RNA 707
 +
|Transcriptional regulation
 +
|Pathogenic process
 +
|Lung cancer (LC) 
 +
|Neoplasms; Respiratory Tract Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185476 HSALNT0185476]
 +
|[[LINC02470]]
 +
|long intergenic non-protein coding RNA 2470, AC091814.2
 +
|_
 +
|Pathogenic process
 +
|Non-small cell lung cancer (NSCLC) and overian cancer
 +
|Neoplasm
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0068302 HSALNT0068302]
 +
|[[LINC02600]]
 +
|long intergenic non-protein coding RNA 2600, AC141928.1
 +
|_
 +
|Pathogenic process
 +
|Non-small cell lung cancer (NSCLC) and overian cancer
 +
|Neoplasm
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0123915 HSALNT0123915]
 +
|[[LINC02604]]
 +
|long intergenic non-protein coding RNA 2604, lncHERG
 +
|CeRNA
 +
|Pathogenic process
 +
|Glioblastoma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0160932 HSALNT0160932]
 +
|[[MACORIS]]
 +
|macrophage enriched lincRNA repressor of IFN-gamma signaling, MacORIS
 +
|Transcriptional regulation
 +
|_
 +
|Cardiometabolic Diseases
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0171022 HSALNT0171022]
 +
|[[KRTAP5-AS1]]
 +
|KRTAP5-1/KRTAP5-2 antisense RNA 1
 +
|CeRNA
 +
|Pathogenic process
 +
|Gastric Cancer
 +
|Neoplasms; Digestive System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0215076 HSALNT0215076]
 +
|[[GSC-DT]]
 +
|GSC divergent transcript, DIGIT
 +
|_
 +
| Developmental process
 +
|_
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072605 HSALNT0072605]
 +
|[[CHAER1]]
 +
|Cardiac hypertrophy associated epigenetic regulator 1, Chaer
 +
|Translational control
 +
|Pathogenic process
 +
|Cardiac hypertrophy
 +
|Cardiovascular Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027291 HSALNT0027291]
 +
|[[ODC1-DT]]
 +
|ODC1 divergent transcript, lncRNA-MIF
 +
|CeRNA
 +
|Pathogenic process
 +
|Head and neck carcinoma 
 +
|Neoplasm
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0039409 HSALNT0039409]
 +
|[[MAP3K2-DT]]
 +
|MAP3K2 divergent transcript, ENST00000433673
 +
|_
 +
|Pathogenic process
 +
|Polycystic ovary syndrome (PCOS)
 +
|Female Urogenital Diseases and Pregnancy Complications
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0208284 HSALNT0208284]
 +
|[[ZFHX2-AS1]]
 +
|ZFHX2 antisense RNA 1
 +
|Transcriptional regulation
 +
|Developmental process
 +
|_
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0152349 HSALNT0152349]
 +
|[[LINC02603]]
 +
|long intergenic non-protein coding RNA 2603, MIRLET7DHG
 +
|_
 +
|_
 +
|_
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0081596 HSALNT0081596]
 +
|[[TENM3-AS1]]
 +
|TENM3 antisense RNA 1
 +
|_
 +
|_
 +
|_
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0165522 HSALNT0165522]
 +
|[[LINC00858]]
 +
|long intergenic non-protein coding RNA 858, LOC170425, CRCAL-2
 +
|_
 +
|_
 +
|non-small cell lung cancer
 +
| Respiratory Tract Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0281930 HSALNT0281930]
 +
|[[SCAT1]]
 +
|S-phase cancer associated transcript 1 LINC02081, CTD-2357A8.3, XLOC_012582
 +
|_
 +
|_
 +
|esophagal cancer
 +
|Digestive system Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0191750 HSALNT0191750]
 +
|[[LNCOG]]
 +
|lncRNA osteogenesis associated, LINC02407, RP11-54A9.1, lncRNA-OG
 +
|_
 +
|_
 +
|osteogenic differenciation
 +
|Musculoskeletal Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246388 HSALNT0246388]
 +
|[[DCXR-DT]]
 +
|DCXR divergent transcript RP13-650J16.1
 +
|_
 +
|_
 +
|prostate cancer
 +
|Male Urogenital Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0209659 HSALNT0209659]
 +
|[[NKX2-1-AS1]]
 +
|NKX2-1 antisense RNA 1
 +
|_
 +
|_
 +
|lung cancer
 +
| Respiratory Tract Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0038250 HSALNT0038250]
 +
|[[ACTR3-AS1]]
 +
|ACTR3 antisense RNA 1, AC104653.1
 +
|_
 +
|_
 +
|glioblastoma
 +
|Nervous system diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0043145 HSALNT0043145]
 +
|[[ITGA6-AS1]]
 +
|ITGA6 antisense RNA 1, AC078883.3
 +
|_
 +
|_
 +
|glioblastoma
 +
|Nervous system diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0281822 HSALNT0281822]
 +
|[[LINC02601]]
 +
|long intergenic non-protein coding RNA 2601, RP5-1172N10.2
 +
|_
 +
|_
 +
|glioblastoma
 +
|Nervous system diseases
 +
|-
 +
|NA
 +
|[[ZKSCAN7-AS1]]
 +
|ZKSCAN7 ZNF cluster antisense RNA 1, RP11-944L7.4, FLJ12738, ZFP, ZNF167, ZNF448, ZNF64, ZSCAN39
 +
|_
 +
|_
 +
|glioblastoma
 +
|Nervous system diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120721 HSALNT0120721]
 +
|[[GARS-DT ]]
 +
|GARS divergent transcript, AC005154.6, AC005154.1
 +
|_
 +
|_
 +
|heroine addiction
 +
|Nervous system diseases
 +
|-
 +
|NA
 +
|[[GPRACR]]
 +
|GPR107 adjacent cis regulating lncRNA, LncGPR107
 +
|_
 +
|_
 +
|liver cancer
 +
|Digestive system Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0082561 HSALNT0082561]
 +
|[[LINC01060]]
 +
|long intergenic non-protein coding RNA 1060
 +
|_
 +
|_
 +
|pancreatic cancer
 +
|Digestive system Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0058704 HSALNT0058704]
 +
|[[TBILA]]
 +
|TGF-beta induced lncRNA, RP11-757F18.5
 +
|_
 +
|_
 +
|non-small cell lung cancer
 +
| Respiratory Tract Diseases
 +
|-
 +
|NA
 +
|[[UGDH-AS1]]
 +
|UGDH antisense RNA 1
 +
|_
 +
|_
 +
|invertebral disc degeneration
 +
|Musculoskeletal Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0245777 HSALNT0245777]
 +
|[[TNRC6C-AS1]]
 +
|NA
 +
|_
 +
|_
 +
|Thyroid cancer
 +
|Endocrine system Disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0225753 HSALNT0225753]
 +
|[[LINC02244]]
 +
|long intergenic non-protein coding RNA 2244, RP11-20G13.3
 +
|_
 +
|_
 +
|obesity
 +
|Digestive system Diseases
 +
|-
 +
|NA
 +
|[[NKAIN3-IT1]]
 +
|NKAIN3 intronic transcript, LOC643763
 +
|_
 +
|_
 +
|glioblastoma
 +
|Nervous system diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013113 HSALNT0013113]
 +
|[[NGF-AS1]]
 +
|NA
 +
|_
 +
|_
 +
|dysmenorhea
 +
|Female Urogenital Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0031057 HSALNT0031057]
 +
|[[LINC01121]]
 +
|long intergenic non-protein coding RNA 1121, UNQ6975
 +
|_
 +
|_
 +
|pancreatic cancer
 +
|Digestive system Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234176 HSALNT0234176]
 +
|[[ARLNC1]]
 +
|androgen receptor regulated long noncoding RNA 1, LINC02170, PRCAT47
 +
|_
 +
|_
 +
|prostate cancer
 +
|Male Urogenital Diseases
 +
|-
 +
|NA
 +
|[[MPPED2-AS1]]
 +
|MPPED2 antisense RNA 1, RP5-1024C24.1
 +
|_
 +
|_
 +
|thyroid neoplasias
 +
|Endocrine system Disease
 +
|-
 +
|NA
 +
|[[LINC01703]]
 +
|NA
 +
|_
 +
|_
 +
|Hepatocellular carcinoma
 +
|Digestive system Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144162 HSALNT0144162]
 +
|[[HPYR1]]
 +
|Helicobacter pylori responsive 1,  LINC00027
 +
|_
 +
|pathogenic process
 +
|H. pylori infection
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0172266 HSALNT0172266]
 +
|[[LINC00958]]
 +
|long intergenic non-protein coding RNA 958,
 +
|protein localization,transcriptional regulation
 +
|pathogenic process
 +
|bladder cancer, glioma
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0167574 HSALNT0167574]
 +
|[[SH3PXD2A-AS1]]
 +
|SH3PXD2A antisense RNA 1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|colorectal cancer
 +
|_
 +
|-
 +
|NA
 +
|[[SSTR5-AS1]]
 +
|SSTR5 antisense RNA 1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|neuroendocrine prostate cancer
 +
|_
 +
|-
 +
|NA
 +
|[[TSPOAP1-AS1]]
 +
|TSPOAP1, SUPT4H1 and RNF43 antisense RNA 1
 +
|_
 +
|pathogenic process
 +
|breast cancer
 +
|_
 +
|-
 +
|NA
 +
|[[LINC00174]]
 +
|long intergenic non-protein coding RNA 174
 +
|ceRNA
 +
|pathogenic process
 +
|colorectal carcinoma
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0169064 HSALNT0169064]
 +
|[[LINC01561]]
 +
|long intergenic non-protein coding RNA 1561
 +
|ceRNA
 +
|pathogenic process
 +
|breast cancer
 +
|_
 +
|-
 +
|NA
 +
|[[LINC00514]]
 +
|long intergenic non-protein coding RNA 514
 +
|transcriptional regulation
 +
|pathogenic process
 +
|neuroendocrine prostate cancer
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0282164 HSALNT0282164]
 +
|[[LINC02595]]
 +
|long intergenic non-protein coding RNA 2595, AK098783
 +
|_
 +
|pathogenic process
 +
|colorectal cancer
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0197396 HSALNT0197396]
 +
|[[FZD10-AS1]]
 +
|FZD10 antisense divergent transcript
 +
|_
 +
|_
 +
|_
 +
|_
 +
|-
 +
|NA
 +
|[[LINC01567]]
 +
|long intergenic non-protein coding RNA 1567, LOCCS
 +
|transcriptional regulation
 +
|pathogenic process
 +
|colon cancer
 +
|_
 +
|-
 +
|NA
 +
|[[ADPGK-AS1]]
 +
|ADPGK antisense RNA 1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|pancreatic cancer
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0255381 HSALNT0255381]
 +
|[[RAB11B-AS1]]
 +
|RAB11B antisense RNA 1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|osteosarcoma
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0237805 HSALNT0237805]
 +
|[[SNHG29]]
 +
|Small nucleolar RNA host gene 29, LRRC75A-AS1, C17orf76-AS1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|acute myeloid leukemia, rheumatoid arthritis
 +
|_
 +
|-
 +
|NA
 +
|[[SNHG17]]
 +
|small nucleolar RNA host gene 17
 +
|transcriptional regulation
 +
|pathogenic process
 +
|colorectal cancer
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0215138 HSALNT0215138]
 +
|[[DICER1-AS1]]
 +
|DICER1 antisense RNA 1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|osteosarcoma
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0043929 HSALNT0043929]
 +
|[[TTN-AS1]]
 +
|TTN antisense RNA 1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|esophageal squamous cell carcinoma
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0152594 HSALNT0152594]
 +
|[[LINC00092]]
 +
|long intergenic non-protein coding RNA 92
 +
|transcriptional regulation
 +
|pathogenic process
 +
|ovarian cancer
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050704 HSALNT0050704]
 +
|[[THUMPD3-AS1]]
 +
|THUMPD3 antisense RNA 1, SETD5-AS1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Neuron death in stroke
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0205980 HSALNT0205980]
 +
|[[LINC00554]]
 +
|long intergenic non-protein coding RNA 554, lncZic2
 +
|transcriptional regulation
 +
|pathogenic process
 +
|liver cancer
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0141703 HSALNT0141703]
 +
|[[ZFPM2-AS1]]
 +
|ZFPM2 antisense RNA 1, SCAT3
 +
|transcriptional regulation
 +
|pathogenic process
 +
|multiple cancers, gastric carcinogenesis
 +
|_
 +
|-
 +
|NA
 +
|[[HOXB-AS1]]
 +
|HOXB cluster antisense RNA 1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|autosomal dominant polycistic kidney disease
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0167650 HSALNT0167650]
 +
|[[CFAP58-DT]]
 +
|CFAP58 divergent transcript, ITPRIP-1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|innate immune response to viral infection
 +
|_
 +
|-
 +
|NA
 +
|[[FAM230A]]
 +
|family with sequence similarity 230 member A
 +
|_
 +
|_
 +
|_
 +
|_
 +
|-
 +
|NA
 +
|[[CPNE8-AS1]]
 +
|CPNE8 antisense RNA 1, RP11-396F22.1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|cervical cancer
 +
|_
 +
|-
 +
|NA
 +
|[[THORLNC]]
 +
|testis associated oncogenic lncRNA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|melanoma, skin squamous cell carcinoma,osteosarcoma, renal cell carcinoma
 +
|_
 +
|-
 +
|NA
 +
|[[IATPR]]
 +
|ITGB1 adjacent tumor promoting lncRNA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|breast cancer, gallbladder cancer
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0242280 HSALNT0242280]
 +
|[[PICART1]]
 +
|p53 inducible cancer associated RNA transcript 1, AC009720.1, NR_038230, LOC84080
 +
|transcriptional regulation
 +
|pathogenic process
 +
|breast cancer, colorectal cancer, lung cancer
 +
|_
 +
|-
 +
|NA
 +
|[[LINC02599]]
 +
|long intergenic non-protein coding RNA 2599, AC026904.1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|breast cancer
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183231 HSALNT0183231]
 +
|[[ETS1-AS1]]
 +
|ETS1 antisense RNA 1, pancEts-1, Ets-1 promoter-associated noncoding RNA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|gastric cancer, neuroblastoma
 +
|_
 +
|-
 +
|NA
 +
|[[MAPK6-DT]]
 +
|MAPK6 divergent transcript, lncMAPK6
 +
|transcriptional regulation
 +
|pathogenic process
 +
|liver cancer
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0036655 HSALNT0036655]
 +
|[[IL1R1-AS1]]
 +
|IL1R1 antisense RNA 1, AC007271.3
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Oral squamous cell carcinoma, breast cancer
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0001134 HSALNT0001134]
 +
|[[LINC01672]]
 +
|long intergenic non-protein coding RNA 1672, long intergenic non-protein coding RNA 1672
 +
|transcriptional regulation
 +
|pathogenic process
 +
| Esophageal squamous cell carcinoma
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0135857 HSALNT0135857]
 +
|[[SIRLNT]]
 +
|SIRT1 regulating lncRNA tumor promoter, SIRT1 regulating lncRNA tumor promoter,
 +
|ceRNA
 +
|pathogenic process
 +
| Breast cancer
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0135484 HSALNT0135484]
 +
|[[LINC01605]]
 +
|long intergenic non-protein coding RNA 1605, TCONS_00014973, LincDUSP
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Colon Cancer, Bladder cancer
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0184552 HSALNT0184552]
 +
|[[GAU1]]
 +
|GALNT8 antisense upstream 1, GALNT8 divergent transcript
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Neuroblastoma and retinoblastoma
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287294 HSALNT0287294]
 +
|[[LINC00894]]
 +
|long intergenic non-protein coding RNA 894
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Lung adenocarcinoma
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0000250 HSALNT0000250]
 +
|[[LINC02593]]
 +
|long intergenic non-protein coding RNA 2593, AL645608.1
 +
|_
 +
|pathogenic process
 +
|breast cancer, hepatocellular carcinoma
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0241060 HSALNT0241060]
 +
|[[LINC02594]]
 +
|long intergenic non-protein coding RNA 2594, CTC‐501O10.1
 +
|_
 +
|_
 +
|gastric cancer
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0022481 HSALNT0022481]
 +
|[[LINC01705]]
 +
|long intergenic non-protein coding RNA 1705, RP11-400N13.3
 +
|transcriptional regulation
 +
|pathogenic process
 +
|gastric cancer
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0022477 HSALNT0022477]
 +
|[[LINC02474]]
 +
|long intergenic non-protein coding RNA 2474, RP11-400N13.2
 +
|transcriptional regulation
 +
|pathogenic process
 +
|gastric cancer
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030809 HSALNT0030809]
 +
|[[LINC02590]]
 +
|long intergenic non-protein coding RNA 2590, AC016735.2
 +
|transcriptional regulation
 +
|pathogenic process
 +
|gastric cancer
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0170966 HSALNT0170966]
 +
|[[MUC5B-AS1]]
 +
|MUC5B antisense RNA 1
 +
|transcriptional regulation
 +
|pathogenic process
 +
| lung adenocarcinoma
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275151 HSALNT0275151]
 +
|[[FAM230D]]
 +
|family with sequence similarity 230 member D, LINC02592: long intergenic non-protein coding RNA 2592, AC008079.1
 +
|_
 +
|_
 +
|_
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275163  HSALNT0275163 ]
 +
|[[FAM230E]]
 +
|family with sequence similarity 230 member E, LINC01662: long intergenic non-protein coding RNA 1662
 +
|_
 +
|_
 +
|_
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275179  HSALNT0275179 ]
 +
|[[FAM230F]]
 +
|family with sequence similarity 230 member F, LINC01663: long intergenic non-protein coding RNA 1663
 +
|_
 +
|_
 +
|_
 +
|_
 +
|-
 +
|NA
 +
|[[FAM230G]]
 +
|family with sequence similarity 230 member G, AC007731.1
 +
|_
 +
|_
 +
|_
 +
|_
 +
|-
 +
|NA
 +
|[[FAM230H]]
 +
|family with sequence similarity 230 member H, AP000552.1
 +
|_
 +
|_
 +
|Papillary thyroid carcinoma
 +
|_
 +
|-
 +
|NA
 +
|[[FAM230I]]
 +
|family with sequence similarity 230 member I, LINC01658: long intergenic non-protein coding RNA 1658
 +
|_
 +
|_
 +
|_
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275150 HSALNT0275150]
 +
|[[FAM230J]]
 +
|family with sequence similarity 230 member J, LINC01660: long intergenic non-protein coding RNA 1660
 +
|_
 +
|_
 +
|_
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0103387 HSALNT0103387]
 +
|[[HCG14]]
 +
|HLA complex group 14, dJ111M5.4
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Celiac disease,  Nutritional and Metabolic Diseases
 +
|_
 +
|-
 +
|NA
 +
|[[LINC01510]]
 +
|long intergenic non-protein coding RNA 1510
 +
|transcriptional regulation, ceRNA
 +
|pathogenic process
 +
|Colorectal cancer, Non-small cell lung cancer
 +
|_
 +
|-
 +
|NA
 +
|[[LNCOC1]]
 +
|lncRNA associated with ovarian cancer 1, Lnc-OC1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Ovarian cancer
 +
|_
 +
|-
 +
|NA
 +
|[[LGALSL-DT]]
 +
|LGALSL divergent transcript, LOC105374771
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Postmenopausal osteoporosis (PMOP)
 +
|_
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002862 HSALNT0002862]
 +
|[[LINC02596]]
 +
|long intergenic non-protein coding RNA 2596, LOC105376834
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Postmenopausal osteoporosis (PMOP)
 +
|_
 +
|-
 +
|NA
 +
|[[DEC1]]
 +
|deleted in esophageal cancer 1, CTS9, Candidate Tumor Suppressor CTS9
 +
|NA
 +
|pathogenic process
 +
|esophageal squamous cell carcinoma
 +
|Neoplasms
 +
|-
 +
|NA
 +
|[[MYOPARR]]
 +
|myogenin promoter-associated myogenic regulatory antisense long non-coding RNA
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[PCED1B-AS1]]
 +
|PCED1B antisense RNA 1
 +
|ceRNA
 +
|pathogenic process
 +
|Tuberculosis
 +
|Bacterial Infections and Mycoses
 +
|-
 +
|NA
 +
|[[UMLILO]]
 +
|upstream master lncRNA of the inflammatory chemokine locus
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LINC02631]]
 +
|long intergenic non-protein coding RNA 2631, AC092620.3
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[BMNCR]]
 +
|bone marrow associated non-coding RNA
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[ZEBTR]]
 +
|ZEB1 transcriptional regulator RNA, LncRNA-BX111
 +
|NA
 +
|pathogenic process
 +
|Pancreatic cancer
 +
|Neoplasms
 +
|-
 +
|NA
 +
|[[SNHG31]]
 +
|small nucleolar RNA host gene 31
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LINC00574]]
 +
|long intergenic non-protein coding RNA 574, C6orf208, FLJ13162, dJ182D15.1, CRALA
 +
|NA
 +
|pathogenic process
 +
|Primary breast cance
 +
|Neoplasms
 +
|-
 +
|NA
 +
|[[RCC2-AS1]]
 +
|RCC2 antisense RNA 1
 +
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 +
|Neoplasms
 +
|-
 +
|NA
 +
|[[PRDM16-DT]]
 +
|lnc-dPrdm16
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[BCL6-AS1]]
 +
|BCL6 antisense RNA 1, lnc-RP11-211G3.3.1-1
 +
|NA
 +
|pathogenic process
 +
|diffuse large B-cell lymphoma
 +
|Neoplasms; Immune System Diseases
 +
|-
 +
|NA
 +
|[[C1orf220]]
 +
|chromosome 1 open reading frame 220, FLJ35530
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[MIR122HG]]
 +
|lnc-pri-miR-122
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[PANTR1]]
 +
|linc-POU3F3, linc-Brn1a, LINC01158
 +
|NA
 +
|developmental process
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[C11orf72]]
 +
|FLJ90834, chromosome 11 open reading frame 72
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[CT66]]
 +
|cancer/testis antigen 66, cancer/testis associated transcript 66
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[CT75]]
 +
|cancer/testis antigen 75
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[MIR9-3HG]]
 +
|MIR9-3 host gene, LINC00925, long intergenic non-protein coding RNA 925
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[RN7SL2]]
 +
|RNA component of signal recognition particle 7SL2, RNA7SL, cytoplasmic 2,  7SL1c, 7L30.1, RNSRP2
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[RN7SL3]]
 +
|RNA component of signal recognition particle 7SL3, RN7SL631P, (RNA,7SL, cytoplasmic 631, pseudogene), (RNA, 7SL, cytoplasmic 3)
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[CT70]]
 +
|cancer/testis associated transcript 70, cancer/testis antigen 70, LeXis
 +
|ceRNA,  transcriptional regulation
 +
|pathogenic process
 +
|osteosarcoma, colon adenocarcinoma
 +
|Neoplasms
 +
|-
 +
|NA
 +
|[[CT69]]
 +
|cancer/testis associated transcript 69, cancer/testis associated transcript 69
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[C10orf91]]
 +
|chromosome 10 open reading frame 91 (putative), chromosome 10 open reading frame 91, bA432J24.4
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[CTBP1-DT]]
 +
|CTBP1 divergent transcript, C4orf42, CTBP1-AS1, CTBP1-AS2, chromosome 4 open reading frame 42, CTBP1 antisense RNA 1 (head to head), CTBP1 antisense RNA 2 (head to head)
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[FAM201B]]
 +
|family with sequence similarity 201 member B,
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[MAFG-DT]]
 +
|MAFG divergent transcript, MAFG antisense RNA 1 (non-protein coding), MAFG antisense RNA 1, MAFG antisense RNA 1 (head to head)
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[RPP38-DT]]
 +
|RPP38 divergent transcript, C10orf111, chromosome 10 open reading frame 111,  MGC35468, bA455B2.4
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[CDRT3]]
 +
|CMT1A duplicated region transcript 3
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[DLEU2L]]
 +
|deleted in lymphocytic leukemia 2 like, BCMS upstream neighbor-like, BCMSUNL
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[ARHGAP42-AS1]]
 +
|AK124326
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0116707 HSALNG0116707]
 +
|[[ASB16-AS1]]
 +
|DKFZp762C2414,C17orf65
 +
CeRNA
 +
|NA
 +
Osteosarcoma
 +
|NA
 +
|-
 +
|NA
 +
|[[BAIAP2-DT]]
 +
|lnc-BAIAP2,BAIAP2-AS1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/transcript?transid=HSALNT0289434 HSALNT0289434]
 +
|[[BASP1-AS1]]
 +
|LOC285696
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[BCAN-AS1]]
 +
|RP11-284F21.9
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[C2ORF27A]]
 +
|C2orf27
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[CALHM6-AS1]]
 +
|RP1-93H18.6
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[CAVIN2-AS1]]
 +
|LOC105373813
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0108275 HSALNG0108275]
 +
|[[CHASERR]]
 +
|LINC01578
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[CHROMR]]
 +
|CHROME,PRKRA-AS1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0119714 HSALNG0119714]
 +
|[[DLGAP1-AS1]]
 +
|HsT914,FLJ35776
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0119716 HSALNG0119716]
 +
|[[DLGAP1-AS2]]
 +
|MGC11082
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[EGILA]]
 +
|Lnc-EGFR
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[ELDR]]
 +
|Fabl,LINC01156
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[EMSLR]]
 +
|EMS
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[EPCART]]
 +
|TPCAT-2-180961,PRCAT122,PCAT-2-180961
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[EVA1A-AS]]
 +
|EVA1A-AS1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0082135 HSALNG0082135]
 +
|[[FAM99A]]
 +
|FLJ42833
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0082137 HSALNG0082137]
 +
|[[FAM99B]]
 +
|DKFZp781M09150
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[FAM218A]]
 +
|FLJ31659,TRIM61-AS1,C4orf39
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0099631 HSALNG0099631]
 +
|[[GAS6-DT]]
 +
|FLJ44054,GAS6-AS2
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/transcript?transid=HSALNT0048545 HSALNT0048545]
 +
|[[GCSIR]]
 +
|Lnc-ITM2C-1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0047439 HSALNG0047439]
 +
|[[GMDS-DT]]
 +
|GMDS-AS1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/transcript?transid=HSALNT0026700 HSALNT0026700]
 +
|[[GRASLND]]
 +
|RNF144A-AS1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[HOXC13-AS]]
 +
|HOXC-AS5
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[IGFL2-AS1]]
 +
|AC006262.5
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0082653 HSALNG0082653]
 +
|[[IRAG1-AS1]]
 +
|MRVI1-AS1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/transcript?transid=HSALNT0129814 HSALNT0129814]
 +
|[[KDM7A-DT]]
 +
|JHDM1D-AS1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/transcript?transid=HSALNT0025249 HSALNT0025249]
 +
|[[KIF26B-AS1]]
 +
|RP11-62I21.1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[KLRK1-AS1]]
 +
|LOC101928100
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LASTR]]
 +
|LINC02657
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0069631 HSALNG0069631]
 +
|[[LDLR-AS1]]
 +
|BM450697
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0131739 HSALNG0131739]
 +
|[[LINC00266-1]]
 +
|bA476I15.3,RBRP,C20orf69,NCRNA00266,NCRNA00266-1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0097328 HSALNG0097328]
 +
|[[LINC00458]]
 +
|LncRNA-ES3,ES3
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LINC00515]]
 +
|PRED21,C21orf71
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0104041 HSALNG0104041]
 +
|[[LINC00637]]
 +
|HITT
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0122571 HSALNG0122571]
 +
|[[LINC00908]]
 +
|ASRPS
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0112089 HSALNG0112089]
 +
|[[LINC00920]]
 +
|CALIC
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0035402 HSALNG0035402]
 +
|[[LINC01094]]
 +
|CTEPHA1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/transcript?transid=HSALNT0131038 HSALNT0131038]
 +
|[[LINC01287]]
 +
|TCONS_l2_00027522
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LINC01551]]
 +
|C14orf23
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0004816 HSALNG0004816]
 +
|[[LINC01555]]
 +
|FLJ35487,C1orf180
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LINC02145]]
 +
|FLJ33360
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LINC02250]]
 +
|TCONS_00023273
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LINC02303]]
 +
|TRMP
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LINC02476]]
 +
|LVCAT5,lnc-TSPAN12
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/transcript?transid=HSALNT0006451 HSALNT0006451]
 +
|[[LINC02605]]
 +
|RP11-79H23.3,IL-7,AS
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LINC02620]]
 +
|BCRT1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LINC02682]]
 +
|TCONS_00019584,lnc-SOX6-1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LINC02835]]
 +
|lncMER52A
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LINC02859]]
 +
|LncRNA-LOC101928316
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LINC02861]]
 +
|RP11-462G12.2
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LINC02862]]
 +
|AC073284.4
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LINC02864]]
 +
|RP11-169F17.1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LINC02867]]
 +
|LA16c-313D11.9
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LINC02882]]
 +
|RP11-81H3.2
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LINC02883]]
 +
|KMU15
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LINC02886]]
 +
|RP11-697M17.1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LINC02891]]
 +
|lnc-RTN4R-1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LINCADL]]
 +
|linc-ADAL
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LNC-LBCS]]
 +
|LBCS
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LNCDAT]]
 +
|YYLNCT
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LNCNEF]]
 +
|lncRNA-NEF,LINC01384
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[LNCTAM34A]]
 +
|GUARDIN,LINC01759
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0047822 HSALNG0047822]
 +
|[[LY86-AS1]]
 +
|FLJ33708,LY86AS,LY86-AS
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0067477 HSALNG0067477]
 +
|[[MAILR]]
 +
|MAIL1,AZIN1-AS1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[MIR9-1HG]]
 +
|CROC4,C1orf61
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[MIR23AHG]]
 +
|LOC284454
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/transcript?transid=HSALNT0159828 HSALNT0159828]
 +
|[[MIR1915HG]]
 +
|bA418C1.3,C10orf114,CASC10
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[NR4A1AS]]
 +
|NR4A1-AS1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[NRAD1]]
 +
|NCRNA00284,LINC00284
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/transcript?transid=HSALNT0140217 HSALNT0140217]
 +
|[[OTUD6B-AS1]]
 +
|GS1-251I9.4
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0041428 HSALNG0041428]
 +
|[[OXCT1-AS1]]
 +
|SARRAH
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[PCSEAT]]
 +
|PRCAT38
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/transcript?transid=HSALNT0268592 HSALNT0268592]
 +
|[[PELATON]]
 +
|GCRL1,LINC01272,SMIM25
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0069519 HSALNG0069519]
 +
|[[PGM5P3-AS1]]
 +
|FAM233B
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/transcript?transid=HSALNT0180290 HSALNT0180290]
 +
|[[PGR-AS1]]
 +
|AT1,AT2,AT3
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/transcript?transid=HSALNT0114603 HSALNT0114603]
 +
|[[PHACTR2-AS1]]
 +
|NR027113,lncIHS
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0092289 HSALNG0092289]
 +
|[[PRANCR]]
 +
|LINC01481,CNOT2-DT
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[PSLNR]]
 +
|LA16c-83F12.6
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0049455 HSALNG0049455]
 +
|[[PSMB8-AS1]]
 +
|XXbac-BPG246D15.8,TAP1-AS1,TAPSAR1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0055664 HSALNG0055664]
 +
|[[PSMG3-AS1]]
 +
|KIAA1908
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0094500 HSALNG0094500]
 +
|[[PXN-AS1]]
 +
|EyeLinc4
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/transcript?transid=HSALNT0289231 HSALNT0289231]
 +
|[[RCAN3AS]]
 +
|TCONS_00001428
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://ngdc.cncb.ac.cn/lncbook/transcript?transid=HSALNT0289236 HSALNT0289236]
 +
|[[ROCR]]
 +
|LINC02095
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|NA
 +
|[[SAP30-DT]]
 +
|ENST00000608794
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''STK32A-AS1''
+
|NA
−
|[[STK32A-AS1]]
+
|[[SCP2D1-AS1]]
−
|CTC-255N20
+
|dJ1068E13.1,C20orf78
−
|STK32A antisense RNA 1
+
|NA
−
|Osteosarcoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SVIL-AS1''
+
|NA
−
|[[SVIL-AS1]]
+
|[[SFTA1P]]
−
|RP11-534G20.3
+
|SFTPF
−
|SVIL antisense RNA 1
+
|NA
−
|rheumatoid arthritis
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TGFB2-AS1''
+
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0108960 HSALNG0108960]
−
|[[TGFB2-AS1]]
+
|[[SNHG9]]
−
|NR_046268
+
|DKFZp686N06141,NCRNA00062
−
|TGFB2 antisense RNA 1 (head to head)
+
|NA
−
|early-onset preeclampsia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TGFB3-AS1''
+
|[https://ngdc.cncb.ac.cn/lncbook/transcript?transid=HSALNT0104616 HSALNT0104616]
−
|[[TGFB3-AS1]]
+
|[[SNHG32]]
−
|ENST00000553732
+
|D6S57,G8,C6orf48
−
|TGFB3 antisense RNA 1
+
|NA
−
|early-onset preeclampsia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TDRKH-AS1''
+
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0118528 HSALNG0118528]
−
|[[TDRKH-AS1]]
+
|[[SOX9-AS1]]
−
|RP11-98D18
+
|FLJ37644
−
|TDRKH antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TFAP2A-AS2''
+
|NA
−
|[[TFAP2A-AS2]]
+
|[[SPATA8]]
−
|HIPSTR
+
|MGC44294,SRG8
−
|TFAP2A antisense RNA 2
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TRAM2-AS1''
+
|NA
−
|[[TRAM2-AS1]]
+
|[[THY1-AS1]]
−
|N/A
+
|RP11-334E6.12
−
|TRAM2 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TMEM132D-AS1''
+
|NA
−
|[[TMEM132D-AS1]]
+
|[[TMEM18-DT]]
−
|LOC283352
+
|AC092159.2
−
|TMEM132D antisense RNA 1
+
|NA
−
|Botulinum Toxin Type A
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TNFRSF10A-AS1''
+
|NA
−
|[[TNFRSF10A-AS1]]
+
|[[TNRC17]]
−
|RP11-1149O23.2
+
|CAGL234
−
|TNFRSF10A antisense RNA 1
+
|NA
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TNFRSF14-AS1''
+
|NA
−
|[[TNFRSF14-AS1]]
+
|[[TP73-AS2]]
−
|ENST00000416860.2
+
|RP5-1092A11.2
−
|TNFRSF14 antisense RNA 1
+
|NA
−
|Acute myocardial infarction
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TPT1-AS1''
+
|[https://ngdc.cncb.ac.cn/lncbook/transcript?transid=HSALNT0289424 HSALNT0289424]
−
|[[TPT1-AS1]]
+
|[[TTTY22]]
−
|N/A
+
|NCRNA00147
−
|TPT1 antisense RNA 1
+
|NA
−
|anaplastic gliomas
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TRIM52-AS1''
+
|NA
−
|[[TRIM52-AS1]]
+
|[[UICLM]]
−
|N/A
+
|CROCC2-AS1
−
|TRIM52 antisense RNA 1 (head to head)
+
|NA
−
|renal cell carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''VPS9D1-AS1''
+
|[https://ngdc.cncb.ac.cn/lncbook/gene?geneid=HSALNG0078695 HSALNG0078695]
−
|[[VPS9D1-AS1]]
+
|[[UNC5B-AS1]]
−
|MYU
+
|UASR1
−
|VPS9D1 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''WWOX-AS1''
+
|NA
−
|[[WWOX-AS1]]
+
|[[VPS13B-DT]]
−
|RP11-190D6.2
+
|OLC8
−
|WWOX antisense RNA 1
+
|NA
−
|Epithelial ovarian cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ZNF674-AS1''
+
|NA
−
|[[ZNF674-AS1]]
+
|[[WAKMAR2]]
−
|N/A
+
|Lnc-TNFAIP3
−
|ZNF674 antisense RNA 1 (head to head)
+
|NA
−
|hepatocellular carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ZNF710-AS1''
+
|NA
−
|[[ZNF710-AS1]]
+
|[[ZKSCAN2-DT]]
−
|ENST00000558334
+
|CTD-2547G23.4
−
|ZNF710 antisense RNA 1
+
|NA
−
|early-onset preeclampsia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ZFHX2-AS1''
 
−
|[[ZFHX2-AS1]]
 
−
|N/A
 
−
|ZFHX2 antisense RNA 1
 
−
|_
 
 
|}
 
|}

Latest revision as of 13:55, 12 June 2021

LncBook ID Symbol Synonyms Functional Mechanism Biological Process Disease Mesh Ontology
HSALNT0289501 HPVC1 PE5L,HPV18E5L NA pathogenic process NA NA
HSALNT0289605 NONHSAT104559 lnc-C9orf53-2:1 NA NA NA NA
HSALNT0199632 N4BP2L2-IT2 CG030 NA NA NA NA
HSALNT0171094 LINC01150 2G7,TCONS_00019134 NA pathogenic process Wilms' tumor Neoplasms
HSALNT0289115 LINC01587 C4orf6,aC1 NA pathogenic process neuroblastoma Neoplasms
HSALNT0290105 NONHSAT115106 NONHSAT115106 NA NA NA NA
HSALNT0289234 RNF217-AS1 STL NA pathogenic process acute lymphoblastic leukemia Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
HSALNT0280481 INE2 NCRNA00011 NA NA NA NA
HSALNT0289485 INE1 NCRNA00010 NA NA NA NA
HSALNT0289511 LINC01565 C3orf27,GR6 NA pathogenic process leukemia Neoplasms
HSALNT0289068 LINC00869 KIAA0493 NA NA NA NA
HSALNT0289430 ERC2-IT1 C1orf1,C3orf51,Po42 NA pathogenic process NA NA
HSALNT0290394 Lnc-PDIA4-1:1 lnc-PDIA4-1:1 NA NA NA NA
HSALNT0289195 NOP14-AS1 C4orf10,RES4-24 NA NA NA NA
HSALNT0290309 NONHSAT022116 NONHSAT022116,AF080092,TSU NA developmental process NA NA
HSALNT0289243 SMAD5-AS1 SMAD5O,DAMS NA pathogenic process malignant hematopoietic Cell Physiological Phenomena
HSALNT0289025 LINC00244 C7orf4,NCRNA00244 NA pathogenic process preaxial polydactyly NA
HSALNT0289017 KIF25-AS1 C6orf54,NCRNA00300,HGC6.1.1 NA pathogenic process ovarian cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289332 LINC01558 C6orf123,LINC01557,HGC6.2,dJ431P23.4 NA pathogenic process ovarian cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289438 AFDN-AS1 C6orf124,MLLT4-AS1,HGC6.4,dJ431P23.3 NA pathogenic process NA NA
HSALNT0289232 RFPL3S RFPL3-AS1,RFPL3-A, NCRNA00005 NA pathogenic process opitz syndrome NA
HSALNT0289393 RFPL1S RFPL1-AS1,RFPL1-A, NCRNA00006 NA pathogenic process NA NA
HSALNT0289500 HCG4B HCG4P6,HCGIV-6,HCGIV.5,HCGIV-06,bCX67J3.3,Em:AB023056.16,bPG309N1.1,bQB90C11.3 NA NA NA NA
HSALNT0289894 LINC00294 NA NA NA NA NA
HSALNT0289345 LINC00893 NA NA pathogenic process hunter syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities
HSALNT0290133 PCBP3-OT1 PCBP3-OT1,FLJ44028 NA NA NA NA
HSALNT0289488 ENST00000418282.1 NCRNA00187 NA pathogenic process blepharophimosis syndrome Eye Diseases
HSALNT0289712 COPG2IT1 CIT1,NCRNA00170,COPG2AS NA NA NA NA
HSALNT0265040 LINC00652 HSPC072 NA developmental process NA NA
HSALNT0289282 WASIR2 NCRNA00286A NA NA NA NA
HSALNT0246856 LINC00470 C18orf2 NA pathogenic process age-related macular degeneration Eye Diseases
HSALNT0289507 LINC00588 C8orf71,DKFZP434F122 NA NA NA NA
HSALNT0276604 TTC28-AS1 TTC28AS,TTC28-AS,KIAA1648 NA NA NA NA
HSALNT0237577 CDRT7 NCRNA00025,LINC00025 NA NA NA NA
HSALNT0288912 CDRT8 NA NA NA NA NA
HSALNT0275048 CECR3 NA NA pathogenic process cat eye syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities
HSALNT0288915 CECR9 NA NA pathogenic process cat eye syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities
HSALNT0288998 HDHD5-AS1 CECR4,CECR5-AS1,NCRNA00017 NA pathogenic process cat eye syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities
HSALNT0288914 CECR5-AS1 NCRNA00017 NA pathogenic process cat eye syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities
HSALNT0288919 CLRN1-AS1 CLRN1O,UCRP NA pathogenic process usher syndrome type 3 NA
HSALNT0289271 TMEM9B-AS1 C11orf18 NA NA NA NA
HSALNT0289324 LINC01547 C21orf69,C21orf67 NA pathogenic process Down syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0270409 LINC00029 C20orf51,NCRNA00029,bA305P22.4 NA NA NA NA
HSALNT0289336 LINC00529 C8orf8 NA pathogenic process keratolytic winter erythema NA
HSALNT0288978 FLVCR1-AS1 FLVCR1-DT,LQK1 NA NA NA NA
HSALNT0238050 SMCR2 NA NA pathogenic process Smith-Magenis syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0289401 SMCR5 NCRNA00034 NA pathogenic process Smith-Magenis syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0290246 SMCR6 NA NA pathogenic process Smith-Magenis syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0274626 LINC00205 C21orf86,NCRNA00205, NA pathogenic process NA NA
HSALNT0271512 C21orf91-OT1 NCRNA00285,D21S2089E NA NA NA NA
HSALNT0272596 LINC00307 NCRNA00307,D21S2091E NA NA NA NA
HSALNT0274502 TSPEAR-AS2 C21orf90 NA NA NA NA
HSALNT0274807 MCM3AP-AS1 C21orf85,MCM3APAS,MCM3AP-AS,FLJ10508,NCRNA00031 NA NA NA NA
HSALNT0288888 B3GALT5-AS1 C21orf88 NA NA NA NA
HSALNT0288898 BRWD1-AS2 C21orf87,NCRNA00257,BRWD1-IT2 NA NA NA NA
HSALNT0289031 LINC00315 C21orf93,NCRNA00315 NA NA NA NA
HSALNT0289033 LINC00334 C21orf89,NCRNA00334 NA NA NA NA
HSALNT0289322 LINC00314 C21orf94,NCRNA00314 NA NA NA NA
HSALNT0271821 LINC00308 C21orf74,NCRNA00308,PRED16 NA pathogenic process NA NA
HSALNT0289023 LINC00189 C21orf109,NCRNA00189 NA pathogenic process NA NA
HSALNT0289375 NCRUPAR ncR-uPAR,ncRuPAR,NCRNA00193 transcriptional regulation developmental process NA NA
HSALNT0273467 DSCR10 NA NA NA NA NA
HSALNT0289480 DSCR9 NCRNA00038 NA NA NA NA
HSALNT0290051 MDS2 NA NA pathogenic process myelodysplastic syndrome Hemic and Lymphatic Diseases
HSALNT0127810 ST7-AS2 ST7OT2,ST7AS2 NA pathogenic process autism Mental Disorders
HSALNT0127813 ST7-OT3 ST7OT3,NCRNA00026 NA pathogenic process autism Mental Disorders
HSALNT0290258 ST7-OT4 NA NA pathogenic process autism Mental Disorders
HSALNT0290257 NONHSAT122926 NONHSAT122926 NA NA NA NA
HSALNT0289372 MIR600HG C9orf45,NCRNA00287,GL012,FLJ22161 NA NA NA NA
HSALNT0013239 ATP1A1-AS1 C1orf203,ATP1A1OS,MGC16179 NA NA NA NA
HSALNT0048563 SPATA3-AS1 NA NA NA NA NA
HSALNT0050859 LINC00852 C3orf42,GHRLOS2,NAG73,GHRL-AS2 NA NA NA NA
HSALNT0069395 LINC01096 NA NA NA NA NA
HSALNT0072367 LINC02260 NA NA NA NA NA
HSALNT0077259 LINC01091 NA NA NA NA NA
HSALNT0096480 SAP30L-AS1 FLJ38109,GALNT10-AS1 NA NA NA NA
HSALNT0098558 PRR7-AS1 NA NA NA NA NA
HSALNT0099356 LINC01622 TCONS_00011202 NA NA NA NA
HSALNT0113415 LINC01312 MGC34034 NA NA NA NA
HSALNT0134652 EXTL3-AS1 C8orf50 NA NA NA NA
HSALNT0138253 C8orf34-AS1 NA NA NA NA NA
HSALNT0154876 PSMD5-AS1 NA NA NA NA NA
HSALNT0163228 LINC01553 C10orf40,AC023904.2 NA NA NA NA
HSALNT0175689 LINC00301 C11orf64,NCRNA00301,MGC39681 NA NA NA NA
HSALNT0247235 DLGAP1-AS3 NA NA NA NA NA
HSALNT0254200 CIRBP-AS1 C19orf23,MGC39338 NA NA NA NA
HSALNT0257335 LINC01785 NA NA NA NA NA
HSALNT0261582 LINC01869 MGC45922 NA NA NA NA
HSALNT0269743 LINC01711 MGC4294 NA NA NA NA
HSALNT0288468 FAM41AY1 FAM41AY NA NA NA NA
HSALNT0288899 C5orf66-AS2 NA NA NA NA NA
HSALNT0288922 CSTF3-AS1 CSTF3-DT NA NA NA NA
HSALNT0288923 CYP1B1-AS1 C2orf58,MGC34824 NA NA NA NA
HSALNT0288957 ENTPD3-AS1 FLJ36665 NA NA NA NA
HSALNT0288970 FAM27E3 MGC42630 NA NA NA NA
HSALNT0288972 FAM41C NA NA NA NA NA
HSALNT0288977 FLG-AS1 NA NA NA NA NA
HSALNT0288983 GABPB1-IT1 FLJ10038 NA NA NA NA
HSALNT0289010 ILF3-AS1 ILF3-DT NA NA NA NA
HSALNT0289034 LINC00347 NA NA NA NA NA
HSALNT0289039 LINC00466 NA NA NA NA NA
HSALNT0289040 LINC00471 C2orf52,MGC43122 NA NA NA NA
HSALNT0289044 LINC00526 C18orf18,MGC17515,HsT959 NA NA NA NA
HSALNT0289048 LINC00593 C15orf50,MGC42951 NA NA NA NA
HSALNT0289050 LINC00608 NA NA NA NA NA
HSALNT0289054 LINC00638 MGC23270 NA NA NA NA
HSALNT0289056 LINC00661 NA NA NA NA NA
HSALNT0289057 LINC00662 NA NA NA NA NA
HSALNT0289062 LINC00692 NA NA NA NA NA
HSALNT0289064 LINC00705 NA NA NA NA NA
HSALNT0289067 LINC00868 C17orf52 NA NA NA NA
HSALNT0130693 LINC00996 NA NA NA NA NA
HSALNT0289101 LINC01252 NA NA NA NA NA
HSALNT0289131 LINC02135 NA NA NA NA NA
HSALNT0289193 NIFK-AS1 NA NA NA NA NA
HSALNT0289244 SMG7-AS1 DKFZP564C196 NA NA NA NA
HSALNT0235326 SNAI3-AS1 MGC23284 NA NA NA NA
HSALNT0215205 SNHG10 C14orf62,FLJ40557,NCRNA00063,LINC00063 NA NA NA NA
HSALNT0289290 ZNF205-AS1 MGC3771 NA NA NA NA
HSALNT0289294 LINC00260 C1orf217,NCRNA00260,MGC5457 NA NA NA NA
HSALNT0289295 LINC00337 C1orf211,NCRNA00337,MGC40168 NA NA NA NA
HSALNT0289298 WAC-AS1 NA NA NA NA NA
HSALNT0289299 LINC00839 NA NA NA NA NA
HSALNT0289303 LINC00612 C12orf33,MGC40170,FLJ41814 NA NA NA NA
HSALNT0289312 LINC00663 MGC39821 NA NA NA NA
HSALNT0289320 LINC00494 NA NA NA NA NA
HSALNT0289330 LINC01019 NA NA NA NA NA
HSALNT0289333 LINC00265 NCRNA00265,NCRNA00265-1 NA NA NA NA
HSALNT0289334 LINC00689 NA NA NA NA NA
HSALNT0289337 LINC01591 NA NA NA NA NA
HSALNT0289340 LINC01501 NA NA NA NA NA
HSALNT0289346 LINC01560 CXorf24 NA NA NA NA
HSALNT0289352 LINC01959 NA NA NA NA NA
HSALNT0289353 LINC02175 NA NA NA NA NA
HSALNT0289354 LINC02209 FAM183CP NA NA NA NA
HSALNT0289359 LINGO1-AS1 NA NA NA NA NA
HSALNT0289362 MAFG-AS1 MAFG-DT NA NA NA NA
HSALNT0289373 MORF4L2-AS1 NA NA NA NA NA
HSALNT0289381 NPHP3-AS1 NCRNA00119 NA NA NA NA
HSALNT0289385 PAXIP1-AS1 NA NA NA NA NA
HSALNT0289413 TOLLIP-AS1 NA NA NA NA NA
HSALNT0289416 LINC00311 TMEM148,NCRNA00311,MGC22001 NA NA NA NA
HSALNT0289422 ZNF252P-AS1 C8orf77 NA NA NA NA
HSALNT0289423 ZNF436-AS1 C1orf213,FLJ90508 NA NA NA NA
HSALNT0289429 BFSP2-AS1 MGC2848 NA NA NA NA
HSALNT0289432 CTBP1-DT C4orf42,CTBP1-AS1,CTBP1-DT,MGC21675 NA NA NA NA
HSALNT0289436 EXOC3-AS1 C5orf55 NA NA NA NA
HSALNT0289441 HCG27 bPG299F13.9,bCX101P6.9,bQB115I13.2,FLJ40123 NA NA NA NA
HSALNT0289450 BAALC-AS2 C8orf56,BAALCOS,MGC39526 NA NA NA NA
HSALNT0289453 FAM87A NA NA NA NA NA
HSALNT0289459 JMJD1C-AS1 NA NA NA NA NA
HSALNT0289465 ATP2B1-AS1 LINC00936 NA NA NA NA
HSALNT0289466 CEP83-AS1 CEP83-DT NA NA NA NA
HSALNT0289470 HEXA-AS1 C15orf34,FLJ13315 NA NA NA NA
HSALNT0289487 BIN3-IT1 FLJ14107 NA NA NA NA
HSALNT0289490 CSNK1G2-AS1 C19orf34,MGC39696 NA NA NA NA
HSALNT0289508 LINC00634 NA NA NA NA NA
HSALNT0289510 LINC00685 CXYorf10,NCRNA00107,PPP2R3B-AS1,OTTHUMT00000055574 NA NA NA NA
HSALNT0289515 SHANK2-AS3 C11orf76 NA NA NA NA
HSALNT0290073 NCBP2-AS2 NA NA NA NA NA
HSALNT0289502 NONHSAT095745 NCRNA00099,UM9-5 NA NA NA NA
HSALNT0289856 GTSCR1 NA NA pathogenic process Gilles de la Tourette syndrome Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0289325 LINC00272 C1orf120,NCRNA00272,RP1-223H12.3 NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0288512 TTTY9B NCRNA00132 NA NA NA NA
HSALNT0290155 Prion-associated RNAs NA NA pathogenic process prion disease Nervous System Diseases
HSALNT0289444 BLACE NA NA pathogenic process acute B lymphoblastic leukemias Hemic and Lymphatic Diseases
HSALNT0060411 H1FX-AS1 C3orf47,FLJ34151 NA NA NA NA
HSALNT0186668 LINC00477 C12orf67,FLJ32894,FAM191B NA NA NA NA
HSALNT0275096 LINC00528 C22orf37,FLJ40542 NA NA NA NA
HSALNT0287824 ASMTL-AS1 CXYorf2,NCRNA00105,ASMTLAS,ASMTL-AS,FLJ13330 NA NA NA NA
HSALNT0288887 ANP32A-IT1 C15orf28,NCRNA00321,FLJ11722,HsT18971 NA NA NA NA
HSALNT0289396 RUSC1-AS1 C1orf104,FLJ35976 NA NA NA NA
HSALNT0084628 LINC01194 CT49,TAG NA pathogenic process melanoma Neoplasms
HSALNT0289468 NONHSAT040032 C14orf134,NCRNA00041,DIO3-AS1,NONHSAT040032,NONHSAT040039,BC111049 NA NA NA NA
HSALNT0121060 NPSR1-AS1 AAA1,IMAGE:4827585 NA NA NA NA
HSALNT0074370 LINC00575 C4orf11 NA pathogenic process NA NA
HSALNT0137345 LINC01602 T1560 NA pathogenic process NA NA
HSALNT0289433 FAM13A-AS1 FAM13A1OS,FAM13AOS,NCRNA00039 NA NA NA NA
HSALNT0289186 MIRLET7DHG NA NA NA NA NA
HSALNT0155254 MIR181A2HG NA NA NA NA NA
HSALNT0289283 WDFY3-AS2 C4orf12,NCRNA00247,FBI4 NA NA NA NA
HSALNT0154555 PAPPA-AS1 PAPPAS,PAPPA-AS,DIPAS,TAF4B,TAF2C2,TAFII105,NCRNA00156 NA NA NA NA
HSALNT0136307 LINC00293 BEYLA NA developmental process NA NA
HSALNT0030983 SIX3-AS1 SIX3OS NA developmental process NA NA
HSALNT0211503 Lnc-C14orf101-5:1 OTX2OS1 NA developmental process NA NA
HSALNT0063422 LINC01192 CT64 NA NA NA NA
HSALNT0217123 LINC01193 CT60,LOC348120 NA NA NA NA
HSALNT0289664 C1QTNF9B-AS1 PCOTH NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0289623 ATP6V1G2-DDX39B NA NA pathogenic process dilated cardiomyopathy Cardiovascular Diseases
HSALNT0289498 FAM226B CXorf50B,NCRNA00246B,LINC00246B NA NA NA NA
HSALNT0289321 LINC00163 C21orf134,NCRNA00163,NLC1-A,NLC1A NA pathogenic process narcolepsy Mental Disorders;Nervous System Diseases
HSALNT0289505 LINC00165 C21orf135,NCRNA00165,NLC1-B NA NA NA NA
HSALNT0290297 NONHSAT035776 ENSG00000251002 NA NA NA NA
HSALNT0274212 LINC00322 C21orf136,NCRNA00322,FLJ16545 NA NA NA NA
HSALNT0289741 NONHSAT102417 DHFR minor transcript 5'-UTR,ENSG00000228716,NONHSAT102417 transcriptional regulation NA NA NA
HSALNT0289527 NONHSAT128494 ncRNA 21A,NONHSAT128494 NA NA NA NA
HSALNT0289409 TLX1NB TD1,TDI,APT-B7 NA pathogenic process leukemogenesis Hemic and Lymphatic Diseases
HSALNT0289662 C15orf2 NA NA pathogenic process Angelman syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0290097 NPAP1 NA NA pathogenic process Angelman syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0217406 NONHSAT040875 NCRNA00199 NA pathogenic process Prader-Willi syndrome Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0289227 NONHSAT040920 NCRNA00198 NA pathogenic process Prader-Willi syndrome Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0262816 MIMT1 MIM1,NCRNA00067,LINC00067 NA NA NA NA
HSALNT0289180 MIR34AHG NA NA NA NA NA
HSALNT0289357 LINC02570 XXbac-BPG27H4.8 NA pathogenic process MHC-associated diseases Immune System Diseases
HSALNT0290177 RNY1 NA NA pathogenic process cervix cancer;prostate cancer;colorectal cancer;bladder cancer;kidney cancer;lung cancer Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
HSALNT0289378 NKX2-2-AS1 NKX2-2AS transcriptional regulation pathogenic process NA NA
HSALNT0290151 NONHSAT023851 FJ515872.1,NONHSAT023851 transcriptional regulation NA NA NA
HSALNT0289607 Anti-NOS2A NA NA pathogenic process meningioma;glioblastoma Neoplasms;Nervous System Diseases
HSALNT0289687 CDKN1A-AS1 p21NAT transcriptional regulation NA NA NA
HSALNT0116668 RPS6KA2-AS1 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289384 PAPPA-AS2 AGU1 NA NA NA NA
HSALNT0262802 ZIM2-AS1 ZIM2as NA NA NA NA
HSALNT0289824 Lnc-DLX5-3:1 Evf-2,Dlx6as1,Dlx6os1,ENSG00000231764, ENST00000430027.2,lnc-DLX5-3:1 transcriptional regulation NA NA NA
HSALNT0289481 ADORA2A-AS1 C22orf45,FLJ34651 NA NA NA NA
HSALNT0290146 POU5F1P4 NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0290033 LSINCT1 NA NA pathogenic process lung cancer;breast cancer Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290034 LSINCT10 NA NA pathogenic process lung cancer;breast cancer Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290035 LSINCT11 NA NA pathogenic process lung cancer;breast cancer Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290036 LSINCT12 NA NA pathogenic process lung cancer;breast cancer Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290037 LSINCT2 NA NA pathogenic process lung cancer;breast cancer Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290038 LSINCT3 NA NA pathogenic process lung cancer;breast cancer Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290039 LSINCT4 NA NA pathogenic process lung cancer;breast cancer Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290041 LSINCT6 NA NA pathogenic process lung cancer;breast cancer Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290042 LSINCT7 NA NA pathogenic process lung cancer;breast cancer Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290043 LSINCT8 NA NA pathogenic process lung cancer;breast cancer Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290044 LSINCT9 NA NA pathogenic process lung cancer;breast cancer Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289676 NONHSAT016928 FLJ31066,NONHSAT016928,lnc-FANK1-3:1 transcriptional regulation NA NA NA
HSALNT0290032 LRRC3DN C21orf30,DKFZP434C128 transcriptional regulation NA NA NA
HSALNT0266984 SNHG11 C20orf198,LINC00101,NCRNA00101 NA pathogenic process obesity Nutritional and Metabolic Diseases
HSALNT0289880 NONHSAT113225 NONHSAT113225,ENSG00000220635 ceRNA NA NA NA
HSALNT0006368 ENST00000444042.2 ncRNA-a3 transcriptional regulation NA NA NA
HSALNT0027470 ENST00000417473.2 ncRNA-a5 transcriptional regulation NA NA NA
HSALNT0289066 ENST00000429328.2 PDZK1IP1-AS1,ncRNA-a4 transcriptional regulation NA NA NA
HSALNT0289936 NONHSAT059436 ROR,lincRNA-ST8SIA3,ENSG00000258609,NONHSAT059436 NA NA NA NA
HSALNT0289705 CHL1-AS2 NA NA pathogenic process adolescent idiopathic scoliosis Musculoskeletal Diseases
HSALNT0076084 SEC24B-AS1 1/2-SBSRNA4 siRNA NA NA NA
HSALNT0290137 PDZRN3-AS1 NA NA pathogenic process type 2 diabetes Nutritional and Metabolic Diseases;Endocrine System Diseases
HSALNT0290237 SCAANT1 ATXN7-AS1 transcriptional regulation pathogenic process spinocerebellar ataxia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0289594 AK123790 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0289911 LINC01451 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290401 ZNF350-AS1 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0289845 GADD45G NA NA pathogenic process pituitary adenoma Endocrine System Diseases;Neoplasms;Nervous System Diseases
HSALNT0289410 Lnc-RASA1-3:23 AK082072,linc-POLR3G-8,ENSG00000247828 NA NA NA NA
HSALNT0289736 DAPK1 NA NA pathogenic process Pancreatic ductal adenocarcinoma Neoplasms
HSALNT0290048 MAP3K14 MAP3K14 NA pathogenic process Pancreatic ductal adenocarcinoma Neoplasms
HSALNT0290150 PPP3CB NA NA pathogenic process Pancreatic ductal adenocarcinoma Neoplasms
HSALNT0151531 DAPK1-IT1 NA NA pathogenic process NA NA
HSALNT0288990 GDNF-AS1 GDNFOS transcriptional regulation pathogenic process Alzheimer's disease Mental Disorders;Nervous System Diseases
HSALNT0029702 BIRC6-AS2 megamind NA developmental process NA NA
HSALNT0029692 BIRC6-AS1 NA NA NA NA NA
HSALNT0289310 LINC00854 NA NA NA NA NA
HSALNT0290332 Uc.73 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289841 FR0257520 NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0290104 NRG1 NA NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289689 CDKN2B-AS11 NA NA pathogenic process;developmental process stroke Cardiovascular Diseases;Nervous System Diseases
HSALNT0289690 CDKN2B-AS12 NA NA pathogenic process glioma Neoplasms
HSALNT0289691 CDKN2B-AS13 NA NA pathogenic process plexiform neurofibroma Neoplasms;Nervous System Diseases
HSALNT0289697 CDKN2B-AS7 NA NA pathogenic process acute lymphoblastic leukemia Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
HSALNT0289826 FADS1 NA NA pathogenic process lipid metabolism disorder Nutritional and Metabolic Diseases
HSALNT0289698 CDKN2B-AS8 NA NA pathogenic process melanoma Neoplasms
HSALNT0289696 CDKN2B-AS6 NA NA pathogenic process neuroblastoma Neoplasms
HSALNT0289699 CDKN2B-AS9 NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0289688 CDKN2B-AS10 NA NA pathogenic process stroke Cardiovascular Diseases;Nervous System Diseases
HSALNT0288950 ENST00000456816 NA NA pathogenic process clear cell renal cell cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290021 LOC389332 NA NA pathogenic process clear cell renal cell cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290306 TMEM72 NA NA pathogenic process clear cell renal cell cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289641 BC029135 NA NA pathogenic process renal clear cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0290374 X91348 NA NA pathogenic process renal clear cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0289694 CDKN2B-AS4 NA NA pathogenic process cancer Neoplasms
HSALNT0289692 CDKN2B-AS2 NA NA pathogenic process coronary heart disease Cardiovascular Diseases
HSALNT0289693 CDKN2B-AS3 NA NA pathogenic process intracranial aneurysm Cardiovascular Diseases;Nervous System Diseases
HSALNT0289695 CDKN2B-AS5 NA NA pathogenic process type 2 diabetes Nutritional and Metabolic Diseases;Endocrine System Diseases
HSALNT0290319 T-UCRs NA NA pathogenic process neuroblastoma Neoplasms
HSALNT0289530 51A NA splicing regulation pathogenic process Alzheimer's disease Mental Disorders;Nervous System Diseases
HSALNT0290163 RAB4B-EGLN2 NA NA pathogenic process cancer Neoplasms
HSALNT0290167 RERT NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0265263 LINC00237 NCRNA00237 NA pathogenic process macrocephaly;obesity Musculoskeletal Diseases;Pathological Conditions, Signs and Symptoms;Nutritional and Metabolic Diseases;Physiological Phenomena
HSALNT0267186 LINC01370 HI-LNC25,HILNC25 NA pathogenic process type 2 diabetes Nutritional and Metabolic Diseases;Endocrine System Diseases
HSALNT0289114 LINC01574 HI-LNC12,TCONS_00009551 NA pathogenic process type 2 diabetes Nutritional and Metabolic Diseases;Endocrine System Diseases
HSALNT0290159 PTHLH NA NA pathogenic process brachydactyly Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
HSALNT0189394 NONHSAT028496 CISTR-ACT,CISTRACT,re52431 transcriptional regulation pathogenic process brachydactyly Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
HSALNT0289862 HELLPAR LINC-HELLP NA pathogenic process HELLP syndrome Female Urogenital Diseases and Pregnancy Complications
HSALNT0289904 LINC01125 NA NA pathogenic process uremia Male Urogenital Diseases
HSALNT0289544 AC002511.1 LINC01531 NA pathogenic process enterovirus 71 infection Virus Diseases
HSALNT0289609 AP000688.29 AP000688.2 NA pathogenic process enterovirus 71 infection Virus Diseases
HSALNT0289832 FFAR2 NA NA pathogenic process enterovirus 71 infection Virus Diseases
HSALNT0290222 RP4-620F22.3 AC099063.2 NA pathogenic process enterovirus 71 infection Virus Diseases
HSALNT0290227 RP5-843L14.1 LINC01716 NA pathogenic process enterovirus 71 infection Virus Diseases
HSALNT0287285 MAGEA8-AS1 RP5-869M20.2 NA NA NA NA
HSALNT0289019 LHX5-AS1 locus4010 NA NA NA NA
HSALNT0288902 CAPN10-AS1 CAPN10-DT,locus959 NA NA NA NA
HSALNT0289404 STAM-AS1 locus3182 NA NA NA NA
HSALNT0148276 PTENP1-AS PTENpg1-asRNA transcriptional regulation NA NA NA
HSALNT0289562 AF116616 NA NA pathogenic process osteosarcoma Neoplasms
HSALNT0289589 AK094838 NA NA pathogenic process osteosarcoma Neoplasms
HSALNT0289620 ASLNC00339 NA NA pathogenic process osteosarcoma Neoplasms
HSALNT0289629 BC002350 NA NA pathogenic process osteosarcoma Neoplasms
HSALNT0289651 BC091525 NA NA pathogenic process osteosarcoma Neoplasms
HSALNT0289652 BE503655 NA NA pathogenic process osteosarcoma Neoplasms
HSALNT0289753 ENO1 NA NA pathogenic process osteosarcoma Neoplasms
HSALNT0289835 FKBP10 NA NA pathogenic process osteosarcoma Neoplasms
HSALNT0290064 MYHAS NA NA pathogenic process osteosarcoma Neoplasms
HSALNT0289985 LncRNA-LALR1 NA transcriptional regulation pathogenic process liver cancer Neoplasms;Digestive System Diseases
HSALNT0091577 NR2F1-AS1 FLJ42709 NA NA NA NA
HSALNT0289709 CK19 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289943 Llme23 NA NA pathogenic process melanoma Neoplasms
HSALNT0289553 AC096655.1 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289178 ENST00000602507.1 Lnc-Ang362 NA pathogenic process Ang II-associated cardiovascular disease Cardiovascular Diseases
HSALNT0289261 STX18-AS1 LOC100507266 NA pathogenic process atrial septal defect Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289849 GHSR NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289210 ENST00000452148.2 PCAN-R2 NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0289702 CES1P1 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289892 LINC00210 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0290006 LOC100506974 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0290219 RP3-508I15.14 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0290243 SLC6A6 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0290342 Uc003bgl.1 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289075 LINC00970 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0211868 SALRNA1 SAL-RNA1,XLOC_023166 NA developmental process NA NA
HSALNT0222267 SALRNA3 SAL-RNA3,XLOC_025918 NA developmental process NA NA
HSALNT0222274 SALRNA2 SAL-RNA2,XLOC_025931 NA developmental process NA NA
HSALNT0289428 NONHSAT076558 GPR1-AS1,GPR1AS transcriptional regulation NA NA NA
HSALNT0226207 LINC00235 NA NA pathogenic process anorexia nervosa Mental Disorders
HSALNT0289526 1B FGF-antisense transcripts NA NA pathogenic process endometriosis Female Urogenital Diseases and Pregnancy Complications
HSALNT0290171 RNA polymerase III-dependent lncRNAs NA NA pathogenic process diffuse cerebral hypomyelination NA
HSALNT0290168 REST/CoREST-regulated lncRNAs NA NA pathogenic process Huntington disease Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0289606 Alu lncRNAs NA NA pathogenic process macular degeneration Eye Diseases
HSALNT0290358 UCH1LAS NA NA pathogenic process Parkinson's disease Nervous System Diseases
HSALNT0290244 SLC7A2-IT1A/B NA NA pathogenic process progressive encephalopathy with severe infantile anorexia Nervous System Diseases
HSALNT0289877 Kcna2-AS NA NA pathogenic process neuropathic pain Nervous System Diseases
HSALNT0289191 NCOA7-AS1 NA NA pathogenic process NA NA
HSALNT0290020 LOC389023 NA transcriptional regulation pathogenic process psychiatric disease Nervous System Diseases
HSALNT0175124 PTPRJ-AS1 NA transcriptional regulation NA NA NA
HSALNT0289654 BM742401 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289331 LINC00951 lincRNA-uc003opf.1,FLJ41649 NA pathogenic process esophageal squamous cell cancer Neoplasms
HSALNT0290130 PAWR NA NA pathogenic process acute lymphoblastic leukemia Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
HSALNT0290264 T-ALL-R-LncR1 NA NA pathogenic process acute lymphoblastic leukemia Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
HSALNT0289599 AK130977 NA NA pathogenic process malignant pleural mesothelioma Neoplasms
HSALNT0289625 AX746718 NA NA pathogenic process malignant pleural mesothelioma Neoplasms
HSALNT0289738 DDR2 NA NA pathogenic process malignant pleural mesothelioma Neoplasms
HSALNT0290003 LOC100131831 NA NA pathogenic process malignant pleural mesothelioma Neoplasms
HSALNT0290144 POT1-AS1 NA NA pathogenic process malignant pleural mesothelioma Neoplasms
HSALNT0290253 SNORA17B NA NA pathogenic process malignant pleural mesothelioma Neoplasms
HSALNT0207421 GAS6-AS1 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289838 FMR5 NA NA pathogenic process fragile X syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0208907 FOXG1-AS1 FOXG1-AS NA pathogenic process autism spectrum disorder Mental Disorders
HSALNT0290263 SYNGAP1-AS1 SYNGAP1-AS NA pathogenic process autism spectrum disorder Mental Disorders
HSALNT0290176 RNase MRP NA NA pathogenic process cartilage hair hypoplaisia Cardiovascular Diseases
HSALNT0289469 GABPB1-AS1 NA NA pathogenic process NA NA
HSALNT0289009 IDI2-AS1 C10orf110,IDI2-A,HT009,Em:AC022536.4 NA NA NA NA
HSALNT0289093 LINC01184 FLJ33630 NA NA NA NA
HSALNT0290108 OGT NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0290077 NcNRFR NA transcriptional regulation pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0290337 Uc001lsz NA NA pathogenic process gastric cancer;prostate cancer;liver cancer;lung cancer Respiratory Tract Diseases;Male Urogenital Diseases;Neoplasms;Digestive System Diseases
HSALNT0289087 LINC01090 NA NA pathogenic process post-traumatic stress disorder Mental Disorders
HSALNT0289981 LncRNA-DQ786227 NA NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289876 JADRR LINC00915,lncRNA-JADE transcriptional regulation pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290254 SOX2OT-S1 NA NA pathogenic process esophageal squamous cell cancer Neoplasms
HSALNT0289870 HOXA13 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0078946 SMAD1-AS1 ENST00000513542 NA pathogenic process ventricular septal defects Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0087329 FGF10-AS1 RP11-473L15.2 transcriptional regulation pathogenic process ventricular septal defects Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0290318 TUC339 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289819 Lnc-CHRAC1-2:1 LINC01130,TCONS_00014875,ERIC transcriptional regulation pathogenic process retinoblastoma Neoplasms
HSALNT0289615 ARA NA NA pathogenic process cancer Neoplasms
HSALNT0289822 ESCCAL-5 NA NA pathogenic process esophageal squamous cell cancer Neoplasms
HSALNT0290074 NcC11orf49 NA NA pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0290076 NcHDAC5 NA NA pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0290078 NcRAB31 NA NA pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0290080 NcSRPK1 NA NA pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0018253 ENST00000442621.1 LINC01131,OVAL NA pathogenic process ovarian cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289884 LALR NA transcriptional regulation pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0289701 CEACAMP8 CEACAMP8 NA pathogenic process pre-eclampsia Female Urogenital Diseases and Pregnancy Complications
HSALNT0290018 LOC284100 NA NA pathogenic process pre-eclampsia Female Urogenital Diseases and Pregnancy Complications
HSALNT0290023 LOC391533 NA NA pathogenic process pre-eclampsia Female Urogenital Diseases and Pregnancy Complications
HSALNT0189558 LINC01154 NA NA NA NA NA
HSALNT0196616 Lnc-DHX37-1:1 BRI3BP-AS1,BRI3BPAS1,Linc1992,TCONS_00020260 transcriptional regulation pathogenic process Kawasaki disease Cardiovascular Diseases
HSALNT0289235 RNF219-AS1 NA NA pathogenic process blood pressure Cardiovascular Diseases
HSALNT0289561 AF086415 NA NA pathogenic process nasopharyngeal cancer Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
HSALNT0289583 AK056098 NA NA pathogenic process nasopharyngeal cancer Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
HSALNT0289590 AK095147 NA NA pathogenic process nasopharyngeal cancer Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
HSALNT0289600 AK294004 NA transcriptional regulation pathogenic process nasopharyngeal cancer Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
HSALNT0289612 AP5M1 NA NA pathogenic process nasopharyngeal cancer Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
HSALNT0290110 ORAOV1 NA NA pathogenic process nasopharyngeal cancer Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
HSALNT0290210 RP1-179N16.3 Z95152.1 NA pathogenic process nasopharyngeal cancer Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
HSALNT0037026 LINC01159 linc-Brn1b NA developmental process NA NA
HSALNT0289014 ENST00000604849.1 KDM5C adjacent non-coding transcript NA developmental process NA NA
HSALNT0289905 LINC01157 TCONS_00010378,linc-Enc1 NA developmental process NA NA
HSALNT0289460 ENST00000444200.1 NA transcriptional regulation NA NA NA
HSALNT0290400 ZNF300P1 ZNF300P1 NA pathogenic process ovarian cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289750 EEF1A1P9 NA NA pathogenic process gastric cardia adenocarcinoma Neoplasms
HSALNT0289796 ENST00000318333 NA NA pathogenic process gastric cardia adenocarcinoma Neoplasms
HSALNT0289797 ENST00000374520 NA NA pathogenic process gastric cardia adenocarcinoma Neoplasms
HSALNT0289800 ENST00000422362 NA NA pathogenic process gastric cardia adenocarcinoma Neoplasms
HSALNT0289808 ENST00000455912 NA NA pathogenic process gastric cardia adenocarcinoma Neoplasms
HSALNT0289809 ENST00000456007 NA NA pathogenic process gastric cardia adenocarcinoma Neoplasms
HSALNT0289810 ENST00000456185 NA NA pathogenic process gastric cardia adenocarcinoma Neoplasms
HSALNT0289817 EPOR NA NA pathogenic process gastric cardia adenocarcinoma Neoplasms
HSALNT0289913 LINC01550 NA NA pathogenic process gastric cardia adenocarcinoma Neoplasms
HSALNT0290142 PMS2P5 NA NA pathogenic process gastric cardia adenocarcinoma Neoplasms
HSALNT0290269 TCF7 NA NA pathogenic process gastric cardia adenocarcinoma Neoplasms
HSALNT0290345 Uc003jfz.2 NA NA pathogenic process gastric cardia adenocarcinoma Neoplasms
HSALNT0289095 ENST00000412690.1 VIN,lnc-ACTR3 transcriptional regulation pathogenic process influenza A virus Virus Diseases
HSALNT0288976 ENST00000427391.1 LINC01200 transcriptional regulation NA NA NA
HSALNT0289097 LINC01202 NA NA NA NA NA
HSALNT0290271 TCONS_00014512 NA NA pathogenic process hepatoblastoma Neoplasms
HSALNT0290272 TCONS_00014978 NA NA pathogenic process hepatoblastoma Neoplasms
HSALNT0290274 TCONS_00024647 NA NA pathogenic process hepatoblastoma Neoplasms
HSALNT0290279 TCONS_00090092_MEG3 NA NA pathogenic process hepatoblastoma Neoplasms
HSALNT0290280 TCONS_l2_00000179 NA NA pathogenic process hepatoblastoma Neoplasms
HSALNT0290283 TCONS_l2_00004424 NA NA pathogenic process hepatoblastoma Neoplasms
HSALNT0290284 TCONS_l2_00006843 NA NA pathogenic process hepatoblastoma Neoplasms
HSALNT0290289 TCONS_l2_00014091 NA NA pathogenic process hepatoblastoma Neoplasms
HSALNT0290291 TCONS_l2_00018070 NA NA pathogenic process hepatoblastoma Neoplasms
HSALNT0290292 TCONS_l2_00020565 NA NA pathogenic process hepatoblastoma Neoplasms
HSALNT0290293 TCONS_l2_00021262 NA NA pathogenic process hepatoblastoma Neoplasms
HSALNT0290296 TCONS_l2_00030560 NA NA pathogenic process hepatoblastoma Neoplasms
HSALNT0289927 LincRNA1611 NA NA pathogenic process Pancreatic ductal adenocarcinoma Neoplasms
HSALNT0290149 Ppp3ca NA NA pathogenic process Pancreatic ductal adenocarcinoma Neoplasms
HSALNT0290265 TC0100223 NA NA pathogenic process epithelial ovarian cancer Neoplasms
HSALNT0290267 TC0101686 NA NA pathogenic process epithelial ovarian cancer Neoplasms
HSALNT0290268 TC1500845 NA NA pathogenic process ovarian cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289318 LAMP5-AS1 NA NA pathogenic process acute lymphoblastic leukemia Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
HSALNT0234022 LINC01228 lincRNA-DYNLRB2-2 NA pathogenic process NA NA
HSALNT0162654 SGMS1-AS1 NA NA pathogenic process NA NA
HSALNT0289206 PCAT19 LOC100505495,LINC01190 NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0289521 ABHD15-AS1 linc-TP53I13,lnc-TP53I13 NA pathogenic process cardiometabolic disease Cardiovascular Diseases
HSALNT0289100 LINC01230 linc-DMRT2,lnc-DRMT2,TCONS_00015639 NA pathogenic process cardiometabolic disease Cardiovascular Diseases
HSALNT0249183 PCAT18 LINC01092 NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0290029 LOC728606 NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0288956 ENST00000547963.1 NA NA pathogenic process esophageal squamous cell cancer Neoplasms
HSALNT0289802 ENST00000435885 NA NA pathogenic process oesophageal squamous cell cancer Neoplasms
HSALNT0205898 LINC01232 FLJ41590,TCONS_00021520 NA pathogenic process NA NA
HSALNT0257311 LINC01233 XLOC_013014 NA pathogenic process NA NA
HSALNT0183247 ENST00000526269.2 FLI1-AS1 NA pathogenic process vascular SMC phenotype Cardiovascular Diseases
HSALNT0289296 LINC00467 C1orf97,MGC14801 NA pathogenic process neuroblastoma Neoplasms
HSALNT0143586 CASC21 LINC01244,CARLo-2 NA pathogenic process NA NA
HSALNT0288906 CASC19 LINC01245,CARLo-6 NA pathogenic process NA NA
HSALNT0289754 ENSG00000135253.9 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289755 ENSG00000147753.5 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289756 ENSG00000196096 AC079610.1 NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289757 ENSG00000197251.3 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289758 ENSG00000203325 AL445248.1 NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289759 ENSG00000206129 AC006305.1 NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289760 ENSG00000215231.3 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289761 ENSG00000215374.4 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289762 ENSG00000215808.2 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289763 ENSG00000226496.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289764 ENSG00000229563.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289765 ENSG00000230133.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289766 ENSG00000230544.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289767 ENSG00000231133.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289768 ENSG00000231185 AC010317.1 NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289769 ENSG00000232021.2 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289770 ENSG00000232046.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289771 ENSG00000232956.3 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289772 ENSG00000233154.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289773 ENSG00000233251 AC007743.1 NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289774 ENSG00000235285.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289775 ENSG00000237036.3 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289776 ENSG00000237548.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289777 ENSG00000240453.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289778 ENSG00000241269.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289779 ENSG00000245910.3 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289780 ENSG00000248176 AC109349.1 NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289781 ENSG00000249364 AC112206.2 NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289782 ENSG00000249772 AC026427.1 NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289783 ENSG00000250195 AC109927.1 NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289784 ENSG00000250608 AC010210.1 NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289785 ENSG00000254154 AL359075.2 NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289786 ENSG00000255471 AP001528.2 NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289787 ENSG00000256218 AC007848.2 NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289788 ENSG00000259150.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289789 ENSG00000259334.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289790 ENSG00000259484.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289791 ENSG00000259758.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289793 ENSG00000263753.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289794 ENSG00000264772 AC016876.2 NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289795 ENSG00000266952.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289828 FAM66B FAM66E NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289895 LINC00336 C6orf227,NCRNA00336 NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289899 LINC00929 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289906 LINC01204 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289912 LINC01538 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289915 LINC01721 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289916 LINC01762 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289917 LINC01798 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0290247 SMIM2-IT1 C13orf44-IT1 NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0290316 TTTY7 CLONE795723,LINC00129,NCRNA00129A,TTTY7B,TTY7,TTTY7 NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0290175 RNA-a NA transcriptional regulation pathogenic process Opitz-Kaveggia syndrome NA
HSALNT0289525 116HG NA transcriptional regulation pathogenic process Prader-Willi syndrome Nervous System Diseases
HSALNT0290320 U1 spliceosomal lncRNA NA NA pathogenic process Parkinson's disease Nervous System Diseases
HSALNT0289102 LINC01262 TCONS_l2_00021807,RP11-462G22.1 ceRNA pathogenic process Parkinson's disease Nervous System Diseases
HSALNT0289681 CCAT1-L NA transcriptional regulation pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0290062 MT-LIPCAR uc022bqs.1,LIPCAR NA pathogenic process heart disease Cardiovascular Diseases
HSALNT0289941 LIPCAR NA NA pathogenic process heart failure Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
HSALNT0200965 TUSC8 LINC01071,XLOC_010588 NA pathogenic process cervical cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0161787 LINC01264 RP11-124O11.2 NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289733 D4Z4 NA NA pathogenic process;developmental process facioscapulohumeral muscular dystrophy Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0289678 CARL NA ceRNA pathogenic process myocardial infarction Cardiovascular Diseases
HSALNT0289923 Linc-CBR1-2 NA NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0243354 Lnc-HEATR6-1:4 WAP four-disulfide core domain 21,pseudogene transcriptional regulation pathogenic process DC dysfunction NA
HSALNT0290232 RUNX1 NA NA pathogenic process acute myeloid leukemia Neoplasms
HSALNT0290234 RUNXOR NA NA pathogenic process hematopoietic malignancies Neoplasms;Hemic and Lymphatic Diseases
HSALNT0289979 LncRNA-CIR NA NA pathogenic process osteoarthritis Musculoskeletal Diseases
HSALNT0290368 VIM2P NA NA pathogenic process osteoarthritis Musculoskeletal Diseases
HSALNT0289879 KRAS1P NA NA pathogenic process cancer Neoplasms
HSALNT0290054 MINA NA NA pathogenic process esophageal squamous cell cancer;gastric cancer;lung cancer;hepatocelluar cancer Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
HSALNT0289270 TMEM92-AS1 RP11-893F2.9,lncRNA-508851,TCONS_00025237 NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0288900 ENST00000604200.1 LINC00468 NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289593 AK123657 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289659 BX648207 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289660 BX649059 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289846 GAS2L3 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289633 BC011663 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289867 HIV1230 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290045 M14574 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290245 SLCO5A1 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290326 Uc.341 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290344 Uc003iqu NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290346 Uc003tfx NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289950 Lnc-AL355149.1-1 NA NA pathogenic process nasopharyngeal cancer Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
HSALNT0290001 Lnc-ZNF674-1 NA NA pathogenic process nasopharyngeal cancer Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
HSALNT0286909 LINC00632 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289105 LINC01317 NA NA NA NA NA
HSALNT0234804 LINC01081 TCONS_00024764 transcriptional regulation pathogenic process alveolar capillary dysplasia Respiratory Tract Diseases
HSALNT0289840 FOSB NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0289587 AK093543 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289732 D16366 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289814 ENST00000501583 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289907 LINC01374 TCONS_00018278 NA pathogenic process NA NA
HSALNT0231106 CASC22 LINC01373,TCONS_00024290,LincRNA-ENST00000515084 NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0058246 LINC00882 NA ceRNA pathogenic process airway diseases Respiratory Tract Diseases
HSALNT0018288 KIAA1614-AS1 RP11-46A10.4 ceRNA pathogenic process airway smooth muscle (ASM) disease Respiratory Tract Diseases
HSALNT0142310 LINC00536 NA NA pathogenic process trichorhinophalangeal syndrome NA
HSALNT0034200 LBX2-AS1 NA NA pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0149799 ENST00000414223 NA NA pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0290012 LOC105374631 NA NA pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0290305 TMEM179 NA NA pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0290315 TSPAN8 NA NA pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0290334 Uc001aka.2 NA NA pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0290339 Uc001vjj.1 NA NA pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0290343 Uc003erl.1 NA NA pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0290354 Uc009wkz.1 NA NA pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0027893 ENST00000433810.1 MYCNUN,lncUSMycN NA pathogenic process neuroblastoma Neoplasms
HSALNT0273205 LINC01436 AP000688.8 NA pathogenic process Down syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0266116 MIR663AHG RP3-410C9.1 NA pathogenic process turner syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases
HSALNT0289108 LINC01435 RP11-215N21.1,TCONS_00018040 NA pathogenic process NA NA
HSALNT0289674 CADM3-AS1 NA NA pathogenic process bladder cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289882 KRT19P3 NA NA pathogenic process bladder cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290310 TNXA NA NA pathogenic process bladder cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0008750 ZRANB2-AS2 NA NA NA NA NA
HSALNT0289745 DMTF1 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290059 MRUL NA transcriptional regulation pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0185163 FAM66C NA NA NA NA NA
HSALNT0289476 ENST00000357401.3 NA NA NA NA NA
HSALNT0289535 AA174084 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0266298 ABALON INXS splicing regulation pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0290370 VTRNA2-1 CBL-3,CBL3,MIR886,MIRN886,VTRNA2,hsa-mir-886,hvg-5,nc886,svtRNA2-1a NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289619 ASK00420 NA NA pathogenic process cervical cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289749 EBIC NA transcriptional regulation pathogenic process cervical cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290299 TI09485 NA NA pathogenic process cervical cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290300 TI10124 NA NA pathogenic process cervical cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290301 TI13831 NA NA pathogenic process cervical cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290302 TI18318 NA NA pathogenic process cervical cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290303 TI21327 NA NA pathogenic process cervical cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290304 TI22687 NA NA pathogenic process cervical cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290307 TMPOP2 NA transcriptional regulation pathogenic process cervical cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289570 AK021444 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289601 AK307796 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289801 ENST00000425785 SEC63P1 NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289871 HOXB-AS3 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0290367 URHC NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289085 LINC01080 TCONS_00021856 NA pathogenic process Alzheimer's disease Mental Disorders;Nervous System Diseases
HSALNT0289751 EFNA3 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289798 ENST00000395084 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0289829 FAM83A-AS1 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290164 RAD1 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0289585 AK056988 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289638 BC017743 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0290156 PRR26 C10orf108 NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0290349 Uc003yqb.1 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289675 CAI2 NA NA pathogenic process neuroblastoma Neoplasms
HSALNT0290313 TSLC1-AS1 NA NA pathogenic process glioma Neoplasms
HSALNT0013359 LINC01525 lnc-MAN1A2-1 NA pathogenic process squamous cell cancer Neoplasms
HSALNT0109106 LINC01526 Lnc-FAM46A-1 NA pathogenic process squamous cell cancer Neoplasms
HSALNT0162774 LINC01468 lnc-MBL2-4 NA pathogenic process squamous cell cancer Neoplasms
HSALNT0289110 LINC01503 lnc-PPP2R4-5 NA pathogenic process tongue squamous cell cancer Neoplasms
HSALNT0289968 Lnc-MBL2-4:3 NA NA pathogenic process tongue squamous cell cancer Neoplasms
HSALNT0289993 Lnc-STXBP5-1 NA NA pathogenic process tongue squamous cell cancer Neoplasms
HSALNT0289563 AF118081 NA NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289597 AK124939 NA NA pathogenic process pulmonary adenocarcinoma Neoplasms
HSALNT0290153 PRAS NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0290249 SNAR-A1 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289929 LincRNA-BC2 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289930 LincRNA-BC4 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289931 LincRNA-BC5 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289932 LincRNA-BC8 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0083190 LINC01511 RP11-325I22.2 NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0290026 LOC440905 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0289552 AC079776.2 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0289720 CTA-363E6.2 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0289901 LINC00987 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0290185 RP11-1C1.7 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0290197 RP11-445K13.2 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0290199 RP11-473M20.11 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0290213 RP11-893F2.6 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0290217 RP13-514E23.1 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0290218 RP1-90D4.3 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0290220 RP4-575N6.5 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0290226 RP5-826L7.1 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0290378 XLOC_003286 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0290379 XLOC_003405 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0290389 XLOC_012255 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0290056 MIR21 NA NA pathogenic process laryngeal squamous cell cancer Neoplasms
HSALNT0289621 ASncmtRNAs NA transcriptional regulation pathogenic process cancer Neoplasms
HSALNT0289316 LINC01614 LCAL4,TCONS_00003105 NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289982 LncRNA-FER1L4 NA ceRNA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290016 LOC283177 NA NA pathogenic process diffuse large B-cell lymphoma Hemic and Lymphatic Diseases
HSALNT0289003 HORMAD2-AS1 MTMR3-AS1,NONHSAG033653 NA pathogenic process type 1 diabetes;bowel disease Nutritional and Metabolic Diseases;Endocrine System Diseases;Digestive System Diseases
HSALNT0290372 WNT4 NA NA pathogenic process endometriosis Female Urogenital Diseases and Pregnancy Complications
HSALNT0289540 AB074278 NA NA pathogenic process bladder cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290166 RCCRT1 NA NA pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0289043 LINC00491 BC008363 NA pathogenic process pancreatic ductal adenocarcinoma Neoplasms
HSALNT0289858 H1.3 NA NA pathogenic process ovarian cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289896 LINC00582 NA NA pathogenic process endometrial cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289301 LINC01537 RP11-169D4.1-001 NA pathogenic process laryngeal squamous cell cancer Neoplasms
HSALNT0289551 AC026166.2 MTCO1P5 NA pathogenic process laryngeal squamous cell cancer Neoplasms
HSALNT0290184 RP11-169D4.1-001 NA NA pathogenic process laryngeal squamous cell cancer Neoplasms
HSALNT0289545 AC006050.3 NA NA pathogenic process lung squamous cell cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289556 AC138128.1 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289818 ERCC1 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290061 MT1DP MT1DP NA pathogenic process liver cancer Neoplasms;Digestive System Diseases
HSALNT0289578 AK023096 NA NA pathogenic process Wilms’ tumor;uterine leiomyomas Neoplasms
HSALNT0289112 LINC01562 RP11-296A18.3 transcriptional regulation pathogenic process intervertebral disc degeneration Musculoskeletal Diseases
HSALNT0289567 AK000974 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289579 AK024118 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289645 BC040204 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290321 U79277 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289869 HOST2 NA ceRNA pathogenic process epithelial ovarian cancer Neoplasms
HSALNT0289368 MGAT3-AS1 TapSAKI NA pathogenic process acute kidney injury Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications
HSALNT0289624 ATXN7L3B NA NA pathogenic process spinocerebellar ataxia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0289990 Lnc-SCA7 NA ceRNA pathogenic process spinocerebellar ataxia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0290004 LOC100287482 NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0290383 XLOC_007697 NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0290384 XLOC_008559 NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0290385 XLOC_009911 NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0289813 ENST00000480739 RPL13AP23 NA pathogenic process Pancreatic ductal adenocarcinoma Neoplasms
HSALNT0290111 OS9 NA NA pathogenic process Pancreatic ductal adenocarcinoma Neoplasms
HSALNT0290324 Uc.283-plus NA NA pathogenic process glioma Neoplasms
HSALNT0289117 LINC01611 RP1-90L14.1,TCONS_l2_00025430 NA pathogenic process diabetic retinopathy Endocrine System Diseases;Male Urogenital Diseases;Cardiovascular Diseases
HSALNT0289529 2900055J20Rik 2900055J20Rik NA pathogenic process left ventricular hypertrophy Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
HSALNT0289792 ENSG00000261777 AC012184.3 NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0289618 Asb3 NA NA pathogenic process cardiovascular and renal disease Cardiovascular Diseases
HSALNT0289703 Chac2 NA NA pathogenic process cardiovascular and renal disease Cardiovascular Diseases
HSALNT0290139 Pex11b NA NA pathogenic process cardiovascular and renal disease Cardiovascular Diseases
HSALNT0290255 Sp5 NA NA pathogenic process cardiovascular and renal disease Cardiovascular Diseases
HSALNT0211639 PSMA3-AS1 FLJ31306 NA pathogenic process NA NA
HSALNT0289319 LINC00493 LOC388789 NA pathogenic process NA NA
HSALNT0288903 CARD8-AS1 LOC100505812 transcriptional regulation pathogenic process leukemia and neuroblastoma Neoplasms
HSALNT0064729 KCNMB2-AS1 RP11-385J1.2 NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289548 AC013264.2 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289857 GUCY1B2 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0290190 RP11-385J1.2 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0290216 RP1-317E23.3 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0290317 TUBA4B NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0290375 XLOC_000371 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0290397 Z82214.3 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289735 DALIR DALI transcriptional regulation NA NA NA
HSALNT0290376 XLOC_000620 NA NA pathogenic process H. pylori-related diseases Bacterial Infections and Mycoses
HSALNT0290380 XLOC_004122 NA NA pathogenic process H. pylori-related diseases Bacterial Infections and Mycoses
HSALNT0290381 XLOC_004562 NA NA pathogenic process H. pylori-related diseases Bacterial Infections and Mycoses
HSALNT0290382 XLOC_005912 NA NA pathogenic process H. pylori-related diseases Bacterial Infections and Mycoses
HSALNT0290391 XLOC_014388 NA NA pathogenic process H. pylori-related diseases Bacterial Infections and Mycoses
HSALNT0290028 LOC652276 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0290162 R05532 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0098175 LINC01411 RP11-267A15.1 NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0290025 LOC401317 NA NA pathogenic process nasopharyngeal cancer Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
HSALNT0289726 CTD-2574D22.4 AC120114.2 NA pathogenic process osteoarthritis Musculoskeletal Diseases
HSALNT0290141 PMS2L2 NA NA pathogenic process osteoarthritis Musculoskeletal Diseases
HSALNT0289974 LncRNA-422 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289520 AATBC NA NA pathogenic process bladder cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289311 LINC00974 NA ceRNA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0089943 ZBED3-AS1 NA NA developmental process NA NA
HSALNT0289116 LINC01589 CTA-941F9.9,TCONS_00029353 NA pathogenic process NA NA
HSALNT0289910 LINC01426 NA NA pathogenic process esophageal squamous cell cancer Neoplasms
HSALNT0290341 Uc002yug.2 NA splicing regulation pathogenic process esophageal squamous cell cancer Neoplasms
HSALNT0290250 SNCG NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289996 Lnc-uc003wbd NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0289559 AF085935 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0290347 Uc003wbd NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0290098 NR_001284 TNXA NA pathogenic process chronic thromboembolic pulmonary hypertension Cardiovascular Diseases
HSALNT0290327 Uc.343 NA NA pathogenic process osteoarthritis Musculoskeletal Diseases
HSALNT0289196 NRAV DYNLL1-AS1 transcriptional regulation pathogenic process influenza A virus Virus Diseases
HSALNT0290140 PLEC NA NA pathogenic process chronic obstructive pulmonary disease Respiratory Tract Diseases
HSALNT0290172 RNA44121 NA NA pathogenic process chronic obstructive pulmonary disease Respiratory Tract Diseases
HSALNT0290173 RNA50010 NA NA pathogenic process chronic obstructive pulmonary disease Respiratory Tract Diseases
HSALNT0290174 RNA58351 NA NA pathogenic process chronic obstructive pulmonary disease Respiratory Tract Diseases
HSALNT0289714 CR613944 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0289933 LincRNA-CALCA NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290200 RP11-501G6.1 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290208 RP11-672F9.1 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290405 C14orf132 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0289937 LincRNA-TSPAN8 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0290225 RP5-1014O16.1 AC244098.1 NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0290275 TCONS_00026102 NA NA pathogenic process atrial fibrillation Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
HSALNT0290277 TCONS_00032546 NA NA pathogenic process atrial fibrillation Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
HSALNT0289037 LINC00441 RB1-DT,ncRNA-RB1 NA pathogenic process NA NA
HSALNT0289661 C1401f132 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289141 LINC02365 LVCAT8 NA pathogenic process NA NA
HSALNT0288885 ADGRD1-AS1 LACAT8 NA NA NA NA
HSALNT0289142 LINC02475 LVCAT1 NA NA NA NA
HSALNT0289542 Abhd11os NA NA pathogenic process neurodegenerative diseases Nervous System Diseases
HSALNT0288895 BISPR NA NA pathogenic process virus infection Virus Diseases
HSALNT0233975 MAFTRR linc-MAF-4 transcriptional regulation NA NA NA
HSALNT0290058 MRAK052686 NA NA pathogenic process nonalcoholic fatty liver disease Digestive System Diseases
HSALNT0290221 RP4-583P15.10 AL121845.1 NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0211341 KTN1-AS1 C14orf33,MYCLo-3 NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0266752 DLGAP4-AS1 CCAT7 NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289682 CCAT3 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289684 CCAT8 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289898 LINC00659 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289627 BALR-2 NA NA pathogenic process B cell acute lymphoblastic leukemia Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
HSALNT0289948 Lnc-ACACA-1 NA NA pathogenic process clear cell renal cell cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289953 Lnc-BMP2-2 NA NA pathogenic process clear cell renal cell cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289955 Lnc-CPN2-1 NA NA pathogenic process clear cell renal cell cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289958 Lnc-FOXG1-2 NA NA pathogenic process clear cell renal cell cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289960 Lnc-FZD1-2 NA NA pathogenic process clear cell renal cell cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289962 Lnc-ITPR2-3 NA NA pathogenic process clear cell renal cell cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289965 Lnc-LCP2-2 NA NA pathogenic process clear cell renal cell cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289988 Lnc-RP3-368B9 NA NA pathogenic process clear cell renal cell cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289991 Lnc-SLC30A4-1 NA NA pathogenic process clear cell renal cell cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289992 Lnc-SPAM1-6 NA NA pathogenic process clear cell renal cell cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289995 Lnc-TTC34-3 NA NA pathogenic process clear cell renal cell cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0222064 DRAIC NA NA pathogenic process prostate cancer;glioma;cancer;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
HSALNT0290390 XLOC_014172 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290014 LOC149086 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0290183 RP11-160H22.5 AL121983.2 NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289945 LNC00964-3 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289616 Arid2-IR NA NA pathogenic process renal inflammation NA
HSALNT0289716 CR619813 NA NA pathogenic process pancreatic cancer Endocrine System Diseases;Neoplasms;Digestive System Diseases
HSALNT0289739 DDX6P1 NA NA pathogenic process pancreatic cancer Endocrine System Diseases;Neoplasms;Digestive System Diseases
HSALNT0289938 LincRNA-ZNF532 NA NA pathogenic process pancreatic cancer Endocrine System Diseases;Neoplasms;Digestive System Diseases
HSALNT0290011 LOC105372753 NA NA pathogenic process pancreatic cancer Endocrine System Diseases;Neoplasms;Digestive System Diseases
HSALNT0290013 LOC105377769 NA NA pathogenic process pancreatic cancer Endocrine System Diseases;Neoplasms;Digestive System Diseases
HSALNT0290205 RP11-58D2.1 NA NA pathogenic process pancreatic cancer Endocrine System Diseases;Neoplasms;Digestive System Diseases
HSALNT0288946 ENST00000434223 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0288947 ENST00000442037 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0288953 ENST00000540136 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0290103 NR_038125 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0290136 PDLIM3 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0290335 Uc001gch.1 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0290336 Uc001gzl.3 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0290351 Uc004bbl.1 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0290369 VNN2 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0289577 AK022798 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289663 C1orf74 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289602 AKR7L NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289711 COL3A1 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289878 KCNE2 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289636 BC015134 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289713 CR594506 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289928 LincRNA-BBOX1-2 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0271719 LINC00320 PRED14,FLJ37539 NA pathogenic process;developmental process cortical white matter Nervous System Diseases
HSALNT0289823 EVADR NA NA pathogenic process pancreatic cancer;lung cancer;colorectal cancer;rectal cancer Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases
HSALNT0289952 Lnc-bc060912 NA NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289613 APF NA ceRNA pathogenic process myocardial infarction Cardiovascular Diseases
HSALNT0289617 AS Uchl1 NA NA pathogenic process Parkinson's disease Nervous System Diseases
HSALNT0289104 LINC01296 FLJ39632 NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0290403 ZXF2 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0290113 P14695 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290114 P16984 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290115 P19780 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290116 P23099 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290117 P24363 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290118 P28210 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290120 P33863 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290121 P4091 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290122 P6391 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290123 P6488 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290124 P700 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290125 P8611 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290126 P8725 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290127 P8860 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290128 P9745 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0289269 TH2LCRR TH2-LCR transcriptional regulation pathogenic process allergic asthma Respiratory Tract Diseases;Immune System Diseases
HSALNT0289964 Lnc-LCE5A-1 NA NA pathogenic process laryngeal cancer;head and neck squamous cell cancer Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Neoplasms
HSALNT0055198 FAM3D-AS1 lnc-KCTD6-3 NA pathogenic process tongue cancer;pharyngeal cancer;head and neck squamous cell cancer;laryngeal cancer Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
HSALNT0289843 FRLnc1 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0242005 ENST00000575202 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0288952 ENST00000539009 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0288954 ENST00000544591 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289752 EHHADH-AS1 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289812 ENST00000468960 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0290276 TCONS_00026506 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0189952 LRP1-AS NA transcriptional regulation pathogenic process Alzheimer's disease Mental Disorders;Nervous System Diseases
HSALNT0032045 LINC01122 FLJ30838,AC007092.1 NA NA NA NA
HSALNT0289565 AI364715 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289921 LINC0949 NA NA pathogenic process systemic lupus erythematosus Immune System Diseases;Skin and Connective Tissue Diseases
HSALNT0289680 CCAL NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289079 LINC00993 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289811 ENST00000460164 NA NA pathogenic process triple-negative breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290282 TCONS_l2_00003938 NA NA pathogenic process triple-negative breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289888 LGALS3 NA NA pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0289963 Lnc-KCMF1-2:1 NA NA pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0289967 Lnc-LLPH-2:1 NA NA pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0289971 Lnc-PLA2R1-1:1 NA NA pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0289972 Lnc-PSD4-1:14 NA NA pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0290066 N335550 NA NA pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0290070 N340790 NA NA pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0290072 N386477 NA NA pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0290286 TCONS_l2_00010365 NA NA pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0289118 LINC01612 RP11-789C1.1,TCONS_00008319 NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289610 AP001439.2 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289671 CACNAICAS3 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289853 GS1-5L10.1 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290065 MYLK-AS1 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290157 PRSS21 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290202 RP11-528G1.2 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290207 RP11-643M14.1 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290209 RP11-789C1.1 LINC01612 NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290314 TSNAX-DISC1 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290386 XLOC_010235 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289558 AF075041 NA NA pathogenic process pancreatic cancer Endocrine System Diseases;Neoplasms;Digestive System Diseases
HSALNT0289564 AF339813 NA NA pathogenic process pancreatic cancer Endocrine System Diseases;Neoplasms;Digestive System Diseases
HSALNT0289575 AK022029 NA NA pathogenic process pancreatic cancer Endocrine System Diseases;Neoplasms;Digestive System Diseases
HSALNT0289576 AK022159 NA NA pathogenic process pancreatic cancer Endocrine System Diseases;Neoplasms;Digestive System Diseases
HSALNT0289604 AL389956 NA NA pathogenic process pancreatic cancer Endocrine System Diseases;Neoplasms;Digestive System Diseases
HSALNT0289640 BC023629 NA NA pathogenic process pancreatic cancer Endocrine System Diseases;Neoplasms;Digestive System Diseases
HSALNT0290096 NONHSAT125629 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290393 XR_250621.1 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0288951 ENST00000503938 NA NA pathogenic process triple-negative breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290085 NONHSAT012762 NA NA pathogenic process triple-negative breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289151 LMCD1-AS1 NA NA pathogenic process acute kidney injury Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications
HSALNT0289926 Linc-PXN-1 NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0290281 TCONS_l2_00001418 NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0290285 TCONS_l2_00008237 NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0290287 TCONS_l2_00011130 NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0290288 TCONS_l2_00013175 NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0290294 TCONS_l2_00022611 NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0290295 TCONS_l2_00022670 NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0290352 Uc004bdv.3 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290363 ULK4P2 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0289942 LK4P2 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289538 AB019562 NA NA pathogenic process hypopharyngeal squamous cell cancer Neoplasms
HSALNT0091661 ENST00000503710 NA NA pathogenic process endometrial cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289806 ENST00000445734 NA NA pathogenic process endometrial cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289807 ENST00000448093 NA NA pathogenic process endometrial cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289815 ENST00000502941 NA NA pathogenic process endometrial cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290340 Uc002nbr.3 NA NA pathogenic process endometrial cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290356 Uc021re1.1 NA NA pathogenic process endometrial cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289549 AC016745.3 AC016745.1 NA pathogenic process glioma Neoplasms
HSALNT0290180 RP11-128A17.1 AC078909.1 NA pathogenic process glioma Neoplasms
HSALNT0290377 XLOC_001711 NA NA pathogenic process glioma Neoplasms
HSALNT0289975 LncRNA-AK058003 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289061 LINC00682 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289305 LINC01559 FLJ33810 NA pathogenic process Huntington disease Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0289854 GSTT1-AS1 NA transcriptional regulation pathogenic process mycobacterium tuberculosis infection Bacterial Infections and Mycoses
HSALNT0289978 LncRNA-CD244 NA transcriptional regulation pathogenic process tuberculosis infection Bacterial Infections and Mycoses
HSALNT0289237 SAMD12-AS1 NA NA pathogenic process neuroblastoma Neoplasms
HSALNT0290179 RP11-119F7.4 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290278 TCONS_00068220 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0285573 DANT1 NA transcriptional regulation NA NA NA
HSALNT0288926 DANT2 NA transcriptional regulation NA NA NA
HSALNT0290399 ZMAT1 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289554 AC100865.1 NA NA pathogenic process coronary artery disease Cardiovascular Diseases
HSALNT0289228 RAD51-AS1 TODRA transcriptional regulation pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289743 DKFZP434K028 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289630 BC002811 NA NA pathogenic process astrocytoma Neoplasms
HSALNT0290387 XLOC_010967 NA NA pathogenic process astrocytoma Neoplasms
HSALNT0288955 ENST00000545440 NA NA pathogenic process pediatric acute myeloid leukemia Hemic and Lymphatic Diseases
HSALNT0288981 FRGCA LncRNA-AP001631.9 NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289976 LncRNA-AP001631.9 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289686 CD99P1 NA ceRNA pathogenic process idiopathic pulmonary fibrosis Respiratory Tract Diseases
HSALNT0289119 LINC01613 n341773 NA pathogenic process idiopathic pulmonary fibrosis Respiratory Tract Diseases
HSALNT0289844 FTH1P3 FTH1P3 NA pathogenic process oral squamous cell cancer Neoplasms
HSALNT0289855 GTF2IRD2P1 GTF2IRD2P1 NA pathogenic process oral squamous cell cancer Neoplasms
HSALNT0290135 PDIA3F NA NA pathogenic process oral squamous cell cancer Neoplasms
HSALNT0289329 LINC00994 NA NA pathogenic process inflammatory bowel disease Digestive System Diseases
HSALNT0289208 PCAT5 LINC01452,TPCAT-10-36067 NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0114870 LUADT1 NA transcriptional regulation pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0289154 LOXL1-AS1 NA NA pathogenic process exfoliation syndrome Eye Diseases
HSALNT0289734 DACOR1 TCONS_00023265 transcriptional regulation pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289060 LINC00675 NA NA pathogenic process Pancreatic ductal adenocarcinoma Neoplasms
HSALNT0288889 B4GALT1-AS1 NA transcriptional regulation pathogenic process NA NA
HSALNT0289348 LINC01616 n341006 NA pathogenic process Alzheimer's disease Mental Disorders;Nervous System Diseases
HSALNT0290068 N336934 NA NA pathogenic process Alzheimer's disease Mental Disorders;Nervous System Diseases
HSALNT0290240 SIRT1-AS NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0290198 RP11-457M11.2 NA ceRNA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0150768 LINC01507 XLOC_000303 NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289903 LINC01057 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289914 LINC01617 C8orf23,NCRNA00249,XLOC_006844 NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0290015 LOC152578 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0072252 LINC01618 LOC152578 NA pathogenic process NA NA
HSALNT0156870 NALT1 MIR4674HG,LINC01573,TCONS_l2_00029132 transcriptional regulation pathogenic process acute lymphoblastic leukemia Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
HSALNT0289083 MALINC1 LINC01024,MA-linc1 NA pathogenic process human breast and lung cancer Neoplasms
HSALNT0289902 LINC01024 MA-linc1 NA pathogenic process osteosarcoma;lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289120 LINC01627 RP11-397D12.4 NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289121 LINC01628 AC007403.1 NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289820 ERICH1-AS1 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0290193 RP11-397D12.4 LINC01627 NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289122 LINC01629 linc-KIAA1737-2 transcriptional regulation pathogenic process hypoxic and inflammatory renal epithelial injury NA
HSALNT0290161 PTPRG-AS1 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289980 LncRNA-DLEU1 NA ceRNA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289983 LncRNA-Hh NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0288986 GAS1RR LncRNA-Hh NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0288908 CCDC18-AS1 ENST00000440778.1 NA pathogenic process adolescent idiopathic scoliosis Musculoskeletal Diseases
HSALNT0289055 LINC00649 TCONS_00028768 NA pathogenic process adolescent idiopathic scoliosis Musculoskeletal Diseases
HSALNT0289219 PRKCQ-AS1 ENST00000414894.1 NA pathogenic process adolescent idiopathic scoliosis Musculoskeletal Diseases
HSALNT0290203 RP11-567G11.1 LINC02041 NA pathogenic process pancreatic cancer Endocrine System Diseases;Neoplasms;Digestive System Diseases
HSALNT0289805 ENST00000438550 RPS24P1 NA pathogenic process nasopharyngeal cancer Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
HSALNT0290083 NONHSAG011351 NA NA pathogenic process type 1 diabetes Nutritional and Metabolic Diseases;Endocrine System Diseases
HSALNT0290049 MCHR2-AS1 NA NA pathogenic process psychiatric disease Nervous System Diseases
HSALNT0289799 ENST00000414355 NA NA pathogenic process cadmium toxicology Disorders of Environmental Origin
HSALNT0290241 SKP2 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289837 FLJ90757 NA ceRNA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0290017 LOC283663 NA ceRNA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0290019 LOC338651 NA ceRNA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0290132 PCATs NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0086786 EGFLAM-AS1 lncRNA-LOWEG NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290031 LOWEG NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289635 BC014579 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0289721 CTB-167B5.2 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0289863 HELLS NA NA pathogenic process leukemia Neoplasms
HSALNT0290195 RP11-401P9.4 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290252 SNHG19 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0289557 AF070632 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289569 AK021443 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289728 CTD-3080P12.3 NA ceRNA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289987 LncRNA-n336928 NA NA pathogenic process bladder cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289723 CTC-523E23.5 AC008555.2 NA pathogenic process intervertebral disc degeneration Musculoskeletal Diseases
HSALNT0289724 CTD-2246P4.1 NA NA pathogenic process intervertebral disc degeneration Musculoskeletal Diseases
HSALNT0290055 MIR132 MIRN132,miRNA132,mir-132 NA pathogenic process intervertebral disc degeneration Musculoskeletal Diseases
HSALNT0290189 RP11-363G2.4 NA NA pathogenic process intervertebral disc degeneration Musculoskeletal Diseases
HSALNT0290191 RP11-38F22.1 LINC02424 NA pathogenic process intervertebral disc degeneration Musculoskeletal Diseases
HSALNT0290223 RP4-639J15.1 AC006967.2 NA pathogenic process intervertebral disc degeneration Musculoskeletal Diseases
HSALNT0290233 RUNX1-IT1 C21orf96 NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0288943 ENST00000415964 NA NA pathogenic process pediatric acute myeloid leukemia Hemic and Lymphatic Diseases
HSALNT0290009 LOC101927497 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289956 Lnc-CYP4A22-2/3 NA NA pathogenic process clear cell renal cell cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289999 Lnc-ZNF180-2 NA NA pathogenic process renal clear cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0290086 NONHSAT037832 NA NA pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0289658 BX647187 NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0289584 AK056155 NA NA pathogenic process Loeys-Dietz syndrome Musculoskeletal Diseases
HSALNT0290057 MR1 NA NA pathogenic process Loeys-Dietz syndrome Musculoskeletal Diseases
HSALNT0289543 AC002454.1 AC002454.1 NA pathogenic process endometriosis Female Urogenital Diseases and Pregnancy Complications
HSALNT0289909 LINC01420 NA NA pathogenic process systemic lupus erythematosus Immune System Diseases;Skin and Connective Tissue Diseases
HSALNT0289531 53BP1 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290101 NR_024118 NA NA pathogenic process rheumatoid arthritis Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
HSALNT0290239 SGO1-AS1 SGOL1-AS1 NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289293 ZNF667-AS1 MORT NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289984 LncRNA-HIF2PUT NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0288945 ENST00000433673 AC068282.1 NA pathogenic process polycystic ovary syndrome Female Urogenital Diseases and Pregnancy Complications
HSALNT0288948 ENST00000454271 AL021940.1 NA pathogenic process polycystic ovary syndrome Female Urogenital Diseases and Pregnancy Complications
HSALNT0289495 ENST00000432431 AC023128.1 NA pathogenic process polycystic ovary syndrome Female Urogenital Diseases and Pregnancy Complications
HSALNT0289918 LINC01828 NA NA pathogenic process polycystic ovary syndrome Female Urogenital Diseases and Pregnancy Complications
HSALNT0290388 XLOC_011402 NA NA pathogenic process polycystic ovary syndrome Female Urogenital Diseases and Pregnancy Complications
HSALNT0289873 ICAM-1 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289666 C5-OT1 C5T1lncRNA NA pathogenic process rheumatoid arthritis Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
HSALNT0289626 AX800134 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0290338 Uc001ncr NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0290330 Uc.48+ NA NA pathogenic process diabetic neuropathic pain Male Urogenital Diseases
HSALNT0289098 LINC01207 NA transcriptional regulation pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0289628 BALR-6 NA transcriptional regulation pathogenic process B-lymphoblastic leukemia Hemic and Lymphatic Diseases
HSALNT0290022 LOC389641 NA NA pathogenic process Pancreatic ductal adenocarcinoma Neoplasms
HSALNT0289725 CTD-2541M15 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289940 LINK-A NA NA pathogenic process triple-negative breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290107 NUTF2P3 NUTF2P3 NA pathogenic process pancreatic cancer Endocrine System Diseases;Neoplasms;Digestive System Diseases
HSALNT0290095 NONHSAT123350 NA NA pathogenic process renal clear cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0290362 UHRF1 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0290366 UPAT NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289307 LINC00324 FLJ34790,MGC104931 NA pathogenic process NA NA
HSALNT0289969 Lnc-MX1-1 NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0290024 LOC400891 NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0289883 LA16c-313D11.11 NA ceRNA pathogenic process endometrial cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290192 RP11-395G23.3 AC027031.2 NA pathogenic process endometrial cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289581 AK027294 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0290371 WISP1 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0206117 FGF14-AS2 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290131 PCAT2 CARLo-4,PCA2,TCONS_00015167 NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0289528 2700086A05Rik 2700086A05Rik NA pathogenic process idiopathic pulmonary fibrosis Respiratory Tract Diseases
HSALNT0290251 SNED1 NA NA pathogenic process Idiopathic pulmonary fibrosis Respiratory Tract Diseases
HSALNT0290333 Uc.77 NA NA pathogenic process idiopathic pulmonary fibrosis Respiratory Tract Diseases
HSALNT0289816 ENST00000537266 NA NA pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0289860 HAGLROS NA NA pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0289881 KRT18P55 KRT18P55 NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0229266 IL21R-AS1 NA NA pathogenic process coronary artery disease Cardiovascular Diseases
HSALNT0290112 OTTHUMT00000387022 NA NA pathogenic process coronary artery disease Cardiovascular Diseases
HSALNT0000551 PRKCZ-AS1 RP11-181G12.2 NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0030981 LINC01833 RP11-89,K21.1 NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0290214 RP11-89K21 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0165271 LINC00857 NA NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0290109 OR3A4 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290046 MAGI1-IT1 NA ceRNA pathogenic process cardiac hypertrophy Cardiovascular Diseases
HSALNT0290242 SLC26A4-AS1 NA ceRNA pathogenic process cardiac hypertrophy Cardiovascular Diseases
HSALNT0289302 KRT7-AS NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0218672 LINC01852 ENST00000434223 NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0290178 RP11-1008C21.2 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289592 AK123072 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289573 AK021954 NA NA pathogenic process atherosclerosis Cardiovascular Diseases
HSALNT0288916 CERNA1 LOC100129973 ceRNA pathogenic process cardiovascular disease Cardiovascular Diseases
HSALNT0018525 LAMC1-AS1 lnc-LAMC2-1:1 NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0290087 NONHSAT040387 NA NA pathogenic process atrial fibrillation Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
HSALNT0290092 NONHSAT098586 NA NA pathogenic process atrial fibrillation Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
HSALNT0289213 PCSK6-AS1 NA NA NA NA NA
HSALNT0289637 BC016831 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289874 IGKV NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290196 RP11-434D9.1 AC112206.2 NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289885 LCAL6 NA NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0289650 BC088254 NA NA pathogenic process myocardial hypertrophy Cardiovascular Diseases
HSALNT0289596 AK124454 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289731 CYP4B1-PS1 NA NA pathogenic process diabetic nephropathy Endocrine System Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications
HSALNT0289106 LINC01405 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290259 ST8SIA6-AS1 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289278 TRIM52-AS1 NA NA pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0289634 BC012900 NA NA pathogenic process ulcerative colitis Digestive System Diseases
HSALNT0274011 UMODL1-AS1 FLJ33471 NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289454 ARRDC1-AS1 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289456 FAM74A3 OTTHUMG00000067149 NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289834 FH NA NA pathogenic process Fumarase deficiency Respiratory Tract Diseases;Neoplasms
HSALNT0289961 Lnc-HOXC4-3:1 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289994 Lnc-TEAD4-1:1 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290270 TCONS_00003876 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290235 SARCC NA NA pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0290360 Ucoo2kmd.1 NA ceRNA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289015 KAZN-AS1 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289722 CTB-89H12.4 AC021078.1 ceRNA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0289496 EPB41L4A-AS2 FLJ11235 NA pathogenic process lung cancer;breast cancer;kidney cancer Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications
HSALNT0289146 LINC02567 ENST00000427806 NA pathogenic process attention deficit hyperactivity disorder Mental Disorders
HSALNT0289833 FGFR3-AS1 NA NA pathogenic process osteosarcoma Neoplasms
HSALNT0289707 CILinc01 NA NA pathogenic process osteoarthritis Musculoskeletal Diseases
HSALNT0289708 CILinc02 NA NA pathogenic process osteoarthritis Musculoskeletal Diseases
HSALNT0286597 LINC00629 LINC00629AB,LINC00629C,LINC00629D,LINC00629 NA pathogenic process choriocarcinoma Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289665 C2dat1 NA NA pathogenic process ischemic brain injury Cardiovascular Diseases
HSALNT0289217 POU6F2-AS2 FLJ12971 protein localization pathogenic process oesophageal squamous cell cancer Neoplasms
HSALNT0289946 Lnc13 NA NA pathogenic process celiac disease Nutritional and Metabolic Diseases;Digestive System Diseases
HSALNT0289729 CTD903 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0290093 NONHSAT104436 NA NA pathogenic process esophageal squamous cell cancer Neoplasms
HSALNT0289550 AC024560.2 AC024560.1 NA pathogenic process cervical cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289483 ENST00000436681 AP000552.1 NA pathogenic process congenital heart defect Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289536 AA584040 NA NA pathogenic process congenital heart defect Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289537 AA709223 NA NA pathogenic process congenital heart defect Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289657 BX478947 NA NA pathogenic process congenital heart defect Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0247515 LINC00668 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289719 CRNDE-h NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0142879 SMILR NA NA pathogenic process vascular pathologies Cardiovascular Diseases
HSALNT0290396 Z38 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0197213 LINC00507 NA NA developmental process NA NA
HSALNT0289086 LINC01082 TCONSNA00024492 NA pathogenic process alveolar capillary dysplasia with misalignment of pulmonary veins Cardiovascular Diseases
HSALNT0289094 LINC01185 FLJ16341 NA pathogenic process NA NA
HSALNT0290160 PTPRD-AS1 NA NA pathogenic process ovarian cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290186 RP11-254I22.1 MIR583HG NA pathogenic process ovarian cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290204 RP11-57P19.1 AC009432.1 NA pathogenic process ovarian cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290211 RP11-80H5.7 AL157400.4 NA pathogenic process ovarian cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290215 RP1-223E5.4 AL441883.1 NA pathogenic process ovarian cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290224 RP4-799P18.3 AL122008.4 NA pathogenic process ovarian cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289126 LINC01844 LOC101926975 NA pathogenic process hirschsprung disease Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
HSALNT0289947 Lnc34a NA transcriptional regulation pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289150 LINP1 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289951 LncARSR NA ceRNA pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0289392 RBM15-AS1 AS-RBM15 translational control pathogenic process acute megakaryocytic leukemia Neoplasms
HSALNT0290089 NONHSAT073641 NA NA pathogenic process vascular diseases Cardiovascular Diseases
HSALNT0290027 LOC572558 NA NA pathogenic process bladder cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289582 AK033210 NA NA pathogenic process;developmental process bronchopulmonary dysplasia Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
HSALNT0289848 GClnc1 NA transcriptional regulation pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289572 AK021630 NA NA pathogenic process Parkinson's disease Nervous System Diseases
HSALNT0289603 AL049437 NA NA pathogenic process Parkinson's disease Nervous System Diseases
HSALNT0290007 LOC100507661 NA NA pathogenic process thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0289084 LINC01029 NA NA pathogenic process cognitive functions and neuronal plasticity Nervous System Diseases
HSALNT0290169 RMEL3 NA NA pathogenic process melanoma Neoplasms
HSALNT0289959 Lnc-FRG2C-3 NA NA pathogenic process ankylosing spondylitis Musculoskeletal Diseases
HSALNT0289966 Lnc-LIN54-1 NA NA pathogenic process ankylosing spondylitis Musculoskeletal Diseases
HSALNT0289997 Lnc-USP50-2 NA NA pathogenic process ankylosing spondylitis Musculoskeletal Diseases
HSALNT0290000 Lnc-ZNF354A-1 NA NA pathogenic process ankylosing spondylitis Musculoskeletal Diseases
HSALNT0288949 ENST00000455309 NA NA pathogenic process primary Sjögren's syndrome Immune System Diseases
HSALNT0289920 LINC02384 NA NA pathogenic process primary Sjögren's syndrome Immune System Diseases
HSALNT0289998 Lnc-UTS2D-1:1 NA NA pathogenic process primary Sjögren's syndrome Immune System Diseases
HSALNT0290067 N336161 NA NA pathogenic process primary Sjögren's syndrome Immune System Diseases
HSALNT0290069 N340599 NA NA pathogenic process primary Sjögren's syndrome Immune System Diseases
HSALNT0290099 NR_002712 NA NA pathogenic process primary Sjögren's syndrome Immune System Diseases
HSALNT0290290 TCONS_l2_00014794 NA NA pathogenic process primary Sjögren's syndrome Immune System Diseases
HSALNT0290170 RMRP CHH,NME1R,RRP2,RMRP ceRNA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289900 LINC00961 NA NA pathogenic process ovarian cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289077 LINC00977 NA NA pathogenic process primary spontaneous pneumothorax Respiratory Tract Diseases
HSALNT0289560 AF085995 NA NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289566 AK000053 NA NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289571 AK021595 NA NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289574 AK022024 NA NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289595 AK124307 NA NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289639 BC020384 NA NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289642 BC030759 NA NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289715 CR615992 NA NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289954 Lnc-CC3 NA NA pathogenic process cervical cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289614 APOC1P1-3 NA transcriptional regulation pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290365 UNMIBC NA transcriptional regulation pathogenic process bladder cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290323 Uc.167 NA NA pathogenic process ventricular septal defects Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0290212 RP11-838N2.4 GAPLINC ceRNA pathogenic process glioblastoma Neoplasms
HSALNT0289109 LINC01478 NA NA pathogenic process blood pressure Cardiovascular Diseases
HSALNT0289313 LINC00342 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289677 CAR10 NA NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289365 MAPT-AS1 NA transcriptional regulation pathogenic process Parkinson's disease Nervous System Diseases
HSALNT0289679 CAT104 NA ceRNA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290260 STXBP5-AS1 NA ceRNA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289861 HAR1 NA NA pathogenic process Huntington disease Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0290359 UCHL1-AS1 NA translational control pathogenic process Parkinson's disease Nervous System Diseases
HSALNT0290238 SCAANT1-AS NA NA pathogenic process spinocerebellar ataxia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0289648 BC041488 NA transcriptional regulation pathogenic process bladder cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290188 RP11-359E19.2 AC022733.1 transcriptional regulation pathogenic process bladder cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289851 GIHCG NA transcriptional regulation pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289649 BC087858 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0290353 Uc004cov.4 NA NA pathogenic process hypertrophic cardiomyopathy Cardiovascular Diseases
HSALNT0290357 Uc022bqu.1 NA NA pathogenic process hypertrophic cardiomyopathy Cardiovascular Diseases
HSALNT0127837 CFTR-AS1 BGas transcriptional regulation pathogenic process cystic fibrosis Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
HSALNT0046367 MYOSLID NA NA pathogenic process vascular smooth muscle cell (VSMC) contractile phenotype Cardiovascular Diseases
HSALNT0290331 Uc.63 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290106 Numb NA NA pathogenic process uveal melanoma Neoplasms
HSALNT0289847 GCASPC TCONS_00011605,RP1-56L9.7-001,lnc-SOD2-1 NA pathogenic process gallbladder cancer Neoplasms;Digestive System Diseases
HSALNT0289568 AK001094 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289588 AK093735 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289631 BC003519 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290100 NR_003573 ANXA2P2 NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290119 P2RX7-V3 NA NA pathogenic process uveal melanoma Neoplasms
HSALNT0290308 TMSB4 NA ceRNA pathogenic process osteoarthritis Musculoskeletal Diseases
HSALNT0288928 DDX11-AS1 CONCR NA pathogenic process NA NA
HSALNT0290052 MELOE NA NA pathogenic process melanoma Neoplasms
HSALNT0290231 RSU1P2 RSU1P2 ceRNA pathogenic process cervical cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290165 RBMY2FP RBMY2FP NA NA hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0290071 N375709 NA NA pathogenic process nasopharyngeal cancer Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
HSALNT0289748 DUXAP8 DUXAP8 NA NA gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290030 LOC729966 NA NA pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0290143 POIR NA ceRNA pathogenic process periodontitis Stomatognathic Diseases
HSALNT0067481 MELTF-AS1 MFI2-AS1,AC068302.3 NA pathogenic process osteosarcoma Neoplasms
HSALNT0290053 MFI2 NA NA pathogenic process osteosarcoma Neoplasms
HSALNT0289922 Linc-223 NA ceRNA pathogenic process acute myeloid leukemia Neoplasms
HSALNT0014603 LINC01138 LINC00875,FLJ39739 NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0290262 SUZ12P1 SUZ12P1 NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0290005 LOC100505976 NA NA pathogenic process laryngeal squamous cell cancer Neoplasms
HSALNT0290392 XLOC_l2_010636 NA NA pathogenic process laryngeal squamous cell cancer Neoplasms
HSALNT0090295 RASGRF2-AS1 CTC-459I6.1 NA pathogenic process sepsis-induced endothelial dysfunction Bacterial Infections and Mycoses
HSALNT0289852 GPC3-AS1 NA transcriptional regulation pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0189472 HOXC-AS1 NA transcriptional regulation pathogenic process atherosclerosis Cardiovascular Diseases
HSALNT0289157 LUARIS lncRNA#32 transcriptional regulation NA NA NA
HSALNT0289371 MIR3936HG LOC553103,SLC22A5-AS1 NA pathogenic process gastric cancer;nasopharyngeal cancer Otorhinolaryngologic Diseases;Stomatognathic Diseases;Neoplasms;Digestive System Diseases
HSALNT0290148 Ppp1r1b NA transcriptional regulation pathogenic process congenital heart defect Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289038 LINC00460 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0290194 RP1-13P20.6 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0290364 Unigene56159 NA ceRNA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0290355 Uc009yby.1 NA NA pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0289406 TFAP2A-AS2 HIPSTR NA developmental process NA NA
HSALNT0289704 Chaer NA transcriptional regulation pathogenic process cardiac hypertrophy Cardiovascular Diseases
HSALNT0211378 LINC00520 C14orf34 NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0087374 MRPS30-DT BRCAT54 NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289388 PPP1R12A-AS1 R12A-AS1 translational control NA NA NA
HSALNT0289013 ITFG2-AS1 NA NA NA NA NA
HSALNT0290088 NONHSAT041499 NA NA pathogenic process schizophrenia Mental Disorders
HSALNT0290091 NONHSAT089447 NA NA pathogenic process schizophrenia Mental Disorders
HSALNT0289970 Lnc-NKX2-3-1 NA transcriptional regulation pathogenic process acute lymphoblastic leukemia Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
HSALNT0289989 Lnc-RTN4R-1 NA transcriptional regulation pathogenic process acute lymphoblastic leukemia Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
HSALNT0289821 ERL NA NA pathogenic process Marek's disease Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases
HSALNT0192459 LINC02258 RP11-248E9.5 NA pathogenic process pneumonia Respiratory Tract Diseases
HSALNT0241871 SKAP1-AS1 RP11-456D7.1 NA pathogenic process pneumonia Respiratory Tract Diseases
HSALNT0289439 DINOL DINO NA NA NA NA
HSALNT0288901 CAMTA1-DT lncCAMTA1 transcriptional regulation pathogenic process liver cancer Neoplasms;Digestive System Diseases
HSALNT0290328 Uc.345 NA transcriptional regulation pathogenic process pancreatic cancer Endocrine System Diseases;Neoplasms;Digestive System Diseases
HSALNT0290060 MSNP1AS NA translational control pathogenic process autism spectrum disorder Mental Disorders
HSALNT0289376 NEXN-AS1 C1orf118,FLJ90637 NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0183194 LINC02098 RP11-702B10.1 NA pathogenic process esophageal cancer Neoplasms
HSALNT0198055 PSPC1-AS2 RP11-523H24.3 NA pathogenic process esophageal cancer Neoplasms
HSALNT0289155 LRRC75A-AS1 C17orf45,NCRNA00188,C17orf76-AS1,FAM211A-AS1,MGC40157 NA pathogenic process rheumatoid arthritis Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
HSALNT0289220 PRKG1-AS1 RP11-573I11.2 NA pathogenic process rheumatoid arthritis Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
HSALNT0289262 SVIL-AS1 RP11-534G20.3 NA pathogenic process rheumatoid arthritis Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
HSALNT0289281 VPS33B-DT NA NA pathogenic process rheumatoid arthritis Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
HSALNT0289804 ENST00000438399 NA NA pathogenic process rheumatoid arthritis Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
HSALNT0290228 RPKG1-AS1 NA NA pathogenic process rheumatoid arthritis Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
HSALNT0290350 Uc004afb.1 NA NA pathogenic process rheumatoid arthritis Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
HSALNT0289398 SLC5A4-AS1 RP1-90G24.10 NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289411 TNFRSF10A-AS1 RP11-1149O23.2 NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289727 CTD-2616J11.14 AC008750.7 NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290182 RP11-150O12.3 AC124067.4 NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289730 CXCL1P1 CXCL1P1 NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289803 ENST00000438347 CCND3P1 NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289897 LINC00601 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289503 KIAA0087 NA NA pathogenic process endometrial cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289827 FAM212B-AS1 NA NA pathogenic process endometrial cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290010 LOC102723552 NA NA pathogenic process endometrial cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290181 RP11-140I24 LINC01568 NA pathogenic process endometrial cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290201 RP11-501O2 LINC02046 NA pathogenic process endometrial cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290206 RP11-600K151 NA NA pathogenic process endometrial cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290084 NONHSAG051968 NA NA pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0290090 NONHSAT076747 NA NA pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0290094 NONHSAT122730 NA NA pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0138768 MIR2052HG NA transcriptional regulation pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289096 LINC01198 NA NA pathogenic process glioma Neoplasms
HSALNT0289274 TPT1-AS1 NA NA pathogenic process glioma Neoplasms
HSALNT0289924 Linc-cdh4-2 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0144641 LINC02055 RP1130-1 NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289737 DBCCR1 NA transcriptional regulation pathogenic process bladder cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289547 AC012065.7 NA NA pathogenic process chronic lymphocytic leukemia Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
HSALNT0289229 RAMP2-AS1 NA NA pathogenic process glioblastoma Neoplasms
HSALNT0289591 AK098081 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289644 BC037331 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289646 BC040303 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289717 CR749831 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289250 SNHG18 NA NA pathogenic process glioma Neoplasms
HSALNT0106140 FOXP4-AS1 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0026202 RNASEH1-AS1 LOC100506054 NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0288993 GSEC ST3GAL4-AS1,DCPS-AS1,FLJ39051 NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0060264 DNAJB8-AS1 NA NA NA NA NA
HSALNT0248137 CHMP1B-AS1 NA NA NA NA NA
HSALNT0021970 TGFB2-AS1 NR_046268 NA pathogenic process early-onset preeclampsia Female Urogenital Diseases and Pregnancy Complications
HSALNT0078323 SLC7A11-AS1 NA NA pathogenic process early-onset preeclampsia Female Urogenital Diseases and Pregnancy Complications
HSALNT0134663 INTS9-AS1 ENST00000520055 NA pathogenic process early-onset preeclampsia Female Urogenital Diseases and Pregnancy Complications
HSALNT0231572 MMP2-AS1 NA NA pathogenic process early-onset preeclampsia Female Urogenital Diseases and Pregnancy Complications
HSALNT0267869 SLC12A5-AS1 RP11-465L10.10 NA pathogenic process early-onset preeclampsia Female Urogenital Diseases and Pregnancy Complications
HSALNT0288921 CSMD2-AS1 ENST00000434181 NA pathogenic process early-onset preeclampsia Female Urogenital Diseases and Pregnancy Complications
HSALNT0288997 HDAC2-AS2 ENST00000421891 NA pathogenic process early-onset preeclampsia Female Urogenital Diseases and Pregnancy Complications
HSALNT0289012 INO80-AS1 NA NA pathogenic process early-onset preeclampsia Female Urogenital Diseases and Pregnancy Complications
HSALNT0289140 LINC02247 NA NA pathogenic process early-onset preeclampsia Female Urogenital Diseases and Pregnancy Complications
HSALNT0289161 MAGI2-AS3 NA NA pathogenic process early-onset preeclampsia Female Urogenital Diseases and Pregnancy Complications
HSALNT0289188 MNX1-AS2 NA NA pathogenic process early-onset preeclampsia Female Urogenital Diseases and Pregnancy Complications
HSALNT0289245 SMIM10L2B-AS1 NA NA pathogenic process early-onset preeclampsia Female Urogenital Diseases and Pregnancy Complications
HSALNT0289407 TGFB3-AS1 NA NA pathogenic process early-onset preeclampsia Female Urogenital Diseases and Pregnancy Complications
HSALNT0289457 HSD17B3-AS1 NA NA pathogenic process early-onset preeclampsia Female Urogenital Diseases and Pregnancy Complications
HSALNT0289919 LINC02246 NA NA pathogenic process early-onset preeclampsia Female Urogenital Diseases and Pregnancy Complications
HSALNT0289288 ZNF710-AS1 ENST00000558334 NA pathogenic process early-onset preeclampsia Female Urogenital Diseases and Pregnancy Complications
HSALNT0289266 TDRKH-AS1 RP11-98D18.9 NA pathogenic process NA NA
HSALNT0289128 LINC01952 AC004854.4 NA pathogenic process recurrent miscarriage Female Urogenital Diseases and Pregnancy Complications
HSALNT0290075 NCF4-AS1 CTA-833B7.2 NA pathogenic process recurrent miscarriage Female Urogenital Diseases and Pregnancy Complications
HSALNT0289360 LNCSRLR lncRNA-SRLR transcriptional regulation pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0288918 CFLAR-AS1 ALS2CR10 NA pathogenic process esophageal squamous cell cancer Neoplasms
HSALNT0289710 COL1A2-AS1 TCONS_00013888,lncRNA8975-1 transcriptional regulation pathogenic process hypertrophic scar Skin and Connective Tissue Diseases
HSALNT0075075 LNCPRESS2 lncPRESS2 transcriptional regulation NA NA NA
HSALNT0011289 LINC01930 EU358092 NA pathogenic process schizophrenia Mental Disorders
HSALNT0097120 HMMR-AS1 NA NA pathogenic process basal-like breast cancer Neoplasms
HSALNT0184498 CCND2-AS1 CCND2-AS2 NA pathogenic process glioma Neoplasms
HSALNT0289045 LINC00578 NA NA pathogenic process major depression disorder Behavior and Behavior Mechanisms
HSALNT0288884 ADAMTS9-AS1 NA NA pathogenic process epithelial ovarian cancer Neoplasms
HSALNT0080041 FAM198B-AS1 NA NA pathogenic process NA NA
HSALNT0103007 LINC00240 C6orf41,NCRNA00240,bA373D17.1 ceRNA pathogenic process esophageal squamous cell cancer Neoplasms
HSALNT0289071 LINC00909 NA NA NA NA NA
HSALNT0289509 LINC00680 NA NA NA NA NA
HSALNT0129070 LINC00513 AC016831.7 NA NA NA NA
HSALNT0289129 LINC02001 RP11-1094M14.11 NA NA NA NA
HSALNT0289215 POC1B-AS1 RP11-734K2.4 NA NA NA NA
HSALNT0289241 SLC12A9-AS1 RP11-126L15.4 NA NA NA NA
HSALNT0289275 TRAM2-AS1 NA NA NA NA NA
HSALNT0002243 ENST00000457898.1 ENSG00000226029 ceRNA pathogenic process oesophageal cancer Neoplasms
HSALNT0288941 ELF3-AS1 ENST00000415582 NA pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0289134 LINC02158 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289350 LINC01671 BC041455 NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289124 LINC01684 lnc-JAM2-6 NA pathogenic process nonalcoholic fatty liver disease Digestive System Diseases
HSALNT0289036 LINC00365 NA NA pathogenic process esophageal cancer Neoplasms
HSALNT0289111 LINC01554 C5orf27,FLJ38821,FIS NA pathogenic process esophageal cancer Neoplasms
HSALNT0289132 LINC02154 GS1-600G8.5 NA pathogenic process esophageal cancer Neoplasms
HSALNT0137721 LINC02155 RP11-705O24.1 NA pathogenic process esophageal cancer Neoplasms
HSALNT0225363 LINC02157 RP11-327J17.1 NA pathogenic process esophageal cancer Neoplasms
HSALNT0289133 LINC02156 RP1-90J4.1 NA pathogenic process esophageal cancer Neoplasms
HSALNT0133924 LINC02153 NA NA pathogenic process major depression disorder Behavior and Behavior Mechanisms
HSALNT0181656 LINC02151 TCONS_00019174 NA pathogenic process major depression disorder Behavior and Behavior Mechanisms
HSALNT0227367 LINC02152 NA NA pathogenic process major depression disorder Behavior and Behavior Mechanisms
HSALNT0029246 BRE-AS1 NA NA NA NA NA
HSALNT0289251 SNHG26 AC005682.5 NA pathogenic process bladder urothelial cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0252719 LIVAR lnc18q22.2 NA pathogenic process nonalcoholic steatohepatiti Digestive System Diseases
HSALNT0289074 LINC00969 ENST00000453324 NA pathogenic process lung squamous cell cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289138 LINC02243 ENST00000441841 NA pathogenic process lung squamous cell cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289399 SLC9A3-AS1 UC011CLY.2 NA pathogenic process lung squamous cell cancer Respiratory Tract Diseases;Neoplasms
HSALNT0288934 DM1-AS NA NA pathogenic process myotonic dystrophy type 1 Musculoskeletal Diseases;Nervous System Diseases
HSALNT0009014 LINC02238 RP4-788P17.1 NA pathogenic process B cell lymphoma Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
HSALNT0289163 MEF2C-AS2 CTC-467M3.1 NA pathogenic process diffuse large B-cell lymphoma Hemic and Lymphatic Diseases
HSALNT0289181 MIR4422HG RP11-101C11.1 NA pathogenic process diffuse large B-cell lymphoma Hemic and Lymphatic Diseases
HSALNT0289403 SPON1-AS1 RP11-21,L19.1 NA pathogenic process diffuse large B-cell lymphoma Hemic and Lymphatic Diseases
HSALNT0289461 CD44-AS1 RP1-68D18.4 NA pathogenic process diffuse large B-cell lymphoma Hemic and Lymphatic Diseases
HSALNT0262277 LILRB1-AS1 AC009892.10 NA pathogenic process NA NA
HSALNT0282241 LINC01186 NA NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289168 MHENCR NA ceRNA pathogenic process melanoma Neoplasms
HSALNT0072994 LINC02232 RP11-707A18.1 NA pathogenic process NA NA
HSALNT0080161 LINC02233 RP11-6C14.1 NA pathogenic process NA NA
HSALNT0084027 LINC02236 RP11-332J15.1 NA pathogenic process NA NA
HSALNT0091870 LINC02234 RP11-455B3.1 NA pathogenic process NA NA
HSALNT0139521 LINC02235 RP11-354A14.1 NA pathogenic process NA NA
HSALNT0142040 LINC02237 RP11-1101K5.1 NA pathogenic process NA NA
HSALNT0289135 LINC02179 RP11-189E14.4 NA pathogenic process NA NA
HSALNT0289351 LINC01689 AP000469.2 NA pathogenic process NA NA
HSALNT0289137 LINC02231 RP11-766N7.4 NA pathogenic process Esophageal squamous cell cancer Neoplasms
HSALNT0220239 MIR4713HG RP11-108K3.1 NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0288967 FAM160A1-DT RP11-610P16.1 NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289239 SATB2-AS1 NA translational control pathogenic process osteosarcoma Neoplasms
HSALNT0289512 LINC01826 lnc-MKI67IP-3 ceRNA pathogenic process atherosclerosis Cardiovascular Diseases
HSALNT0289024 LINC00226 C14orf97,NCRNA00226 NA pathogenic process pancreatic ductaladenocarcinoma Neoplasms
HSALNT0082192 F11-AS1 NA NA NA NA NA
HSALNT0219108 SPINT1-AS1 RP11-532F12.5 NA pathogenic process melanoma Neoplasms
HSALNT0289177 MIR200CHG U47924.27 NA pathogenic process melanoma Neoplasms
HSALNT0289328 LINC00888 NA NA pathogenic process melanoma Neoplasms
HSALNT0289309 LINC00672 NA transcriptional regulation pathogenic process endometrial cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289198 P4HA3-AS1 NA NA pathogenic process parkinson's disease Nervous System Diseases
HSALNT0197312 TMEM132D-AS1 LOC283352 NA pathogenic process human dermal fibroblasts Cell Physiological Phenomena
HSALNT0289472 ATP2C2-AS1 RP11-517C16.2-001 NA NA NA NA
HSALNT0233849 WWOX-AS1 RP11-190D6.2 NA pathogenic process epithelial ovarian cancer Neoplasms
HSALNT0128829 FLNC-AS1 NA NA pathogenic process cervical squamous cancer Neoplasms
HSALNT0289889 LIF-AS1 Lnc-LIF-AS NA pathogenic process cervical squamous cancer Neoplasms
HSALNT0011283 DPYD-AS2 NA NA pathogenic process cervical squamous cancer Neoplasms
HSALNT0289836 FLICR NA transcriptional regulation pathogenic process autoimmune diabete Immune System Diseases
HSALNT0289356 LINC02402 ENST00000550337.1 NA pathogenic process diabetes Endocrine System Diseases
HSALNT0137118 CERNA3 CTA ceRNA pathogenic process osteosarcoma Neoplasms
HSALNT0090838 LINC02488 CTD-2316B1 NA pathogenic process NA NA
HSALNT0174947 LINC02489 CTD-2589M5 NA pathogenic process NA NA
HSALNT0220441 LINC02490 RP11-209E8 NA pathogenic process NA NA
HSALNT0289260 STK32A-AS1 CTC-255N20 NA pathogenic process NA NA
HSALNT0289143 LINC02487 NA NA pathogenic process squamous cell cancer Neoplasms
HSALNT0095585 SPRY4-AS1 THCAT68 NA pathogenic process bladder cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0288927 DDN-AS1 CAT1507 NA pathogenic process bladder cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0012862 SLC16A1-AS1 NA NA pathogenic process acute myocardial infarction Cardiovascular Diseases
HSALNT0289412 TNFRSF14-AS1 ENST00000416860.2 NA pathogenic process acute myocardial infarction Cardiovascular Diseases
HSALNT0259139 LINC00665 NA NA NA NA NA
HSALNT0040268 DARS-AS1 NA NA pathogenic process renal disease NA
HSALNT0288913 CEBPA-AS1 CEBPA-DT NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289011 INHBA-AS1 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0288988 GASAL1 GASL1 NA pathogenic process liver cancer Neoplasms;Digestive System Diseases
HSALNT0289127 LINC01857 AC079767.4 NA pathogenic process tuberculosis Bacterial Infections and Mycoses
HSALNT0289091 LINC01140 FLJ41676 NA NA NA NA
HSALNT0281957 PINCR NA transcriptional regulation pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289344 LINC00890 NA NA pathogenic process leiomyoma Neoplasms
HSALNT0019828 LINC00862 C1orf98,SMIM16 NA pathogenic process cystic fibrosis Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
HSALNT0073790 LINC02562 RP11-44F21.5 NA pathogenic process cystic fibrosis Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
HSALNT0263101 LINC02560 CTD-2619J13.13 NA pathogenic process cystic fibrosis Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
HSALNT0289144 LINC02551 RP11-890B15.2 NA pathogenic process cystic fibrosis Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
HSALNT0289458 DDIT4-AS1 RP11-442H21.2 NA pathogenic process cystic Fibrosis Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
HSALNT0288992 GPRC5D-AS1 RP11-392P7.6 NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289386 PCBP1-AS1 NA NA pathogenic process NA NA
HSALNT0289405 STARD4-AS1 NA NA pathogenic process NA NA
HSALNT0201547 LINC00462 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0207103 SOX1-OT LINC00403 NA pathogenic process NA NA
HSALNT0002131 SLC25A34-AS1 RP11-169K16.4 NA NA NA NA
HSALNT0289218 PPP1R26-AS1 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289047 LINC00589 C8orf75,TSLNC8 NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289516 TPM1-AS TPM1-AS1 splicing regulation pathogenic process esophageal cancer Neoplasms
HSALNT0289314 LINC01101 FLJ14816 NA pathogenic process HPV-induced cervical neoplasia Neoplasms
HSALNT0289147 LINC02572 AC079776.2 NA pathogenic process epithelial ovarian cancer Neoplasms
HSALNT0096804 LINC02202 NA NA NA NA NA
HSALNT0289076 LINC00973 CTD-2021J15.2 NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0288625 TTTY10 NCRNA00133 NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289323 LINC00319 C21orf125,NCRNA00319,PRED49,FLJ38036 ceRNA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0015533 IL6R-AS1 RP11-350G8.5 NA NA NA NA
HSALNT0090330 CKMT2-AS1 NA NA NA NA NA
HSALNT0012995 HIPK1-AS1 NA NA NA NA NA
HSALNT0289216 POLH-AS1 RP3-337H4.8 NA NA NA NA
HSALNT0289276 TRDN-AS1 HRAT13 NA NA NA NA
HSALNT0289159 LY6E-DT LOC100133669 NA pathogenic process ovarian cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0288991 GLIS3-AS1 C9orf70,MGC16153 NA NA NA NA
HSALNT0288896 BNC2-AS1 RP11-62F24.2 NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289292 ZNF503-AS1 NA NA pathogenic process age-related macular degeneration Eye Diseases
HSALNT0159506 VIM-AS1 NA NA pathogenic process endometrial cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0288882 ACBD3-AS1 RP11-275I14.4 NA pathogenic process endometrial cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289156 LRRC8C-DT FLJ27354 NA pathogenic process endometrial cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289447 ELN-AS1 CTB-51J22.1 NA pathogenic process endometrial cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0076712 LINC02264 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0093666 LINC02201 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0271685 LINC02573 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289125 LINC01816 LOC100133985 NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289355 LINC02381 LOC400043 NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289366 MBNL1-AS1 LOC401093 NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289513 MIR4697HG LINC00947,LOC283174 NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289073 LINC00968 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0114453 NMBR-AS1 RP11-137J7.2 NA pathogenic process non-melanoma skin cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289300 LINC01518 NA NA pathogenic process non-melanoma skin cancer Respiratory Tract Diseases;Neoplasms
HSALNT0003783 LINC02574 RP11-288L9.1 transcriptional regulation pathogenic process UVB-irradiated KC & non-melanoma skin cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0030828 LINC02580 AC093609.1 NA pathogenic process UVB-irradiated KC & non-melanoma skin cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0127022 LINC02577 NA NA pathogenic process UVB-irradiated KC & non-melanoma skin cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0154722 LINC02578 RP11-127L21.1 NA pathogenic process UVB-irradiated KC & non-melanoma skin cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0288962 FAM111A-DT NA NA pathogenic process UVB-irradiated KC & non-melanoma skin cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289148 LINC02575 AP001065.15 transcriptional regulation pathogenic process UVB-irradiated KC & non-melanoma skin cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0177212 RPS6KB2-AS1 AP003419.16 NA pathogenic process aging‑associated idiopathic pulmonary fibrosis Physiological Phenomena
HSALNT0289072 LINC00941 lncRNA-MUF ceRNA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289338 LINC00094 FLJ35348,bA374P20.3 NA pathogenic process lung squamous cell cancer Respiratory Tract Diseases;Neoplasms
HSALNT0114192 FILNC1 NA translational control pathogenic process renal tumor Neoplasms
HSALNT0289199 PARAL1 NA ceRNA pathogenic process obesity Pathological Conditions, Signs and Symptoms;Nutritional and Metabolic Diseases;Physiological Phenomena
HSALNT0056667 LINC02027 LOC728290 NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289069 LINC00880 NA NA NA NA NA
HSALNT0252974 LINC02582 CTD-2354A18.1 NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289035 LINC00364 LncRNA00364 NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0060981 NCK1-DT NCK1-AS1,SLC35G2-AS1 ceRNA pathogenic process cervical cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0288890 BAALC-AS1 lncFZD6,FZD6-DT transcriptional regulation pathogenic process liver cancer Neoplasms;Digestive System Diseases
HSALNT0046602 CPS1-IT1 CPS1-IT,CPS1IT,CPS1IT1,PRO0132 NA pathogenic process hepatocellular cancer;lung cancer;intrahepatic cholangiocarcinoma Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
HSALNT0289445 DLX6-AS1 DLX6-A, DLX6A, Evf-2,NCRNA00212,NCRNA00212,FLJ34048 transcriptional regulation pathogenic process split hand/split foot malformation disorder;lung adenocarcinoma Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms
HSALNT0289891 LINC00114 NA NA NA NA NA
HSALNT0289415 TSIX LINC00013,NCRNA00013,XIST-A, XIST-AS1,XISTAS transcriptional regulation pathogenic process systemic sclerosis Skin and Connective Tissue Diseases
HSALNT0217334 MKRN3-AS1 ZNF127A, MKRN3A, MKRN3-A,FNZ127,NCRNA00009,ZNF127-AS NA pathogenic process Prader-Willi syndrome Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0290256 Lnc-SRA1-1:1 lnc-SRA1-1:1,SRA1,ENSG00000213523 transcriptional regulation pathogenic process nonalcoholic fatty liver disease;polycystic ovary syndrome;ovarian cancer;dilated cardiomyopathy;cardiomyopathy;breast cancer;laryngeal squamous cell cancer;uterus cancer Skin and Connective Tissue Diseases;Neoplasms;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
HSALNT0289442 HCP5 6S2650E,D6S2650E,P5-1 NA pathogenic process AIDS Immune System Diseases;Virus Diseases
HSALNT0289284 Lnc-EIF3M-1:1 WIT1,WIT-1,WT1A, WT1-AS1 transcriptional regulation pathogenic process gastric cancer;primary myelofibrosis;hepatocellular cancer;Wilms' tumor;acute myeloid leukemia Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
HSALNT0289421 NONHSAT017524 KCNQ1-AS2,KCNQ10T1,Kncq1,KvDMR1,KvLQT1-A, LIT1,NCRNA00012 transcriptional regulation pathogenic process prostate cancer;colorectal cancer;hepatocelluar cancer;acute myocardial infarction;kidney cancer;Beckwith-Wiedemann syndrome;breast cancer Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Digestive System Diseases
HSALNT0263784 PCNA-AS1 PCNAA, PCNA-AS transcriptional regulation pathogenic process gastric cancer;hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0289524 HCG9 PERB11,HCGIX,HCGIX4,HCGIX-4 NA NA NA NA
HSALNT0289264 TCL6 TCL6e1,TNG2,TNG1 NA pathogenic process;developmental process renal cell cancer;leukemia Male Urogenital Diseases;Neoplasms
HSALNT0289203 ENST00000412654.1 DD3,NCRNA00019,PCAT3 transcriptional regulation;ceRNA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0289462 NONHSAT017465 ASM,ASM1,BW, D11S813E,LINC00008,NCRNA00008,WT2 transcriptional regulation;ceRNA developmental process;pathogenic process prostate cancer;glioma;cancer;breast cancer;ovarian cancer;Marek's disease;gestational trophoblastic diseases;glioblastoma;non-small cell lung cancer;hyperhomocysteinemia;congenital heart defect;congenital hyperinsulinism;pancreatic cancer;Beckwith-Wiedemann syndrome;endometriosis;trophoblastic tumor;adrenocortical cancer;coronary artery disease;Wiedemann-Beckwith syndrome;bladder cancer;melanoma;myeloproliferative polycythaemia vera;hepatocelluar cancer;meningioma;breast adenocarcinoma;neuroblastoma;embryonal cancer;osteosarcoma;esophageal cancer;kidney cancer;malignant digestive cancer;chronic myeloid leukemia;mullerian aplasia;malignant hematopoiesis;gastric cardia adenocarcinoma;cervical cancer;gallbladder cancer;pheochromocytoma;germ cell tumor;colorectal cancer;hydatidiform mole;Pancreatic ductal adenocarcinoma;pre-eclampsia;atherosclerosis;esophageal squamous cell cancer;calcific aortic valve disease;gastric cancer;osteoarthritis;choriocarcinoma;chronic myeloproliferative disorders;neural tube defects;skin cancer;ulcerative colitis;type 2 diabetes;thyroid cancer;pneumoconiosis;infertility;liver cancer;heart failure;medulloblastoma;laryngeal squamous cell cancer;Silver-Russell syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;growth restriction;Prader-Willi syndrome;diabetic cardiomyopathy;obesity;lung cancer;Parkinson's disease;renal cell cancer;Wilms' tumor Nutritional and Metabolic Diseases;Cell Physiological Phenomena;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Physiological Phenomena;Neoplasms;Male Urogenital Diseases;Endocrine System Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Immune System Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Nervous System Diseases;Digestive System Diseases;Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Respiratory Tract Diseases;Occupational Diseases;Otorhinolaryngologic Diseases;Stomatognathic Diseases
HSALNT0288932 NONHSAT033797 BCM, BCMS1,DLB1,LEU1,LEU2,LINC00021,NCRNA00021,XTP6 transcriptional regulation;ceRNA pathogenic process lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;hematopoietic and solid tumors;chronic lymphocytic leukemia;inherited bone marrow failure disorder;lymphoma;breast cancer;head and neck squamous cell cancer Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases
HSALNT0289493 DBH-AS1 NCRNA00118,BPR NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0088415 ENST00000506884.1 DKFZP586D0823,NCRNA00206 NA pathogenic process prostate cancer;glioblastoma Male Urogenital Diseases;Neoplasms
HSALNT0289463 IGF2-AS IGF2A,PEG8,IGF2-AS1 transcriptional regulation pathogenic process liver cancer;type 1 diabetes;prostate cancer;Wilms' tumor;hepatocelluar cancer Neoplasms;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases
HSALNT0269786 Lnc-CTSZ-5:1 GNASA, GNAS-A,SANG,NESP-A, NESPA, GNAS1A, NCRNA00075 transcriptional regulation pathogenic process non-small cell lung cancer;pseudohypoparathyroidism type Ib Musculoskeletal Diseases;Respiratory Tract Diseases;Neoplasms
HSALNT0289252 NONHSAT054526 C6orf160,MGC16362,bA33E24.2,U50HG,NCRNA00044,LINC00044 NA pathogenic process gastric cancer;lymphoma;melanoma Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
HSALNT0023827 NONHSAT010191 DISC1-AS1,DISC1O, NCRNA00015 transcriptional regulation pathogenic process bipolar disorder;affective disorder;major depressive affective disorder;schizophrenia;autism spectrum disorder;depression Bacterial Infections and Mycoses;Mental Disorders;Behavior and Behavior Mechanisms
HSALNT0203415 NONHSAT034251 SCA8,KLHL1A,NCRNA00003 transcriptional regulation pathogenic process spinocerebellar ataxia;spinocerebellar ataxia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0290312 TRAF3IP2-AS1 C6UA, C6orf3,NCRNA00248,TRAF3IP2-AS2 transcriptional regulation pathogenic process schizophrenia;cocaine abuse Chemically-Induced Disorders;Mental Disorders
HSALNT0289008 HYMAI NCRNA00020 NA pathogenic process transient neonatal diabetes Nutritional and Metabolic Diseases
HSALNT0288968 FAM201A C9orf122 NA pathogenic process leukemia Neoplasms
HSALNT0288969 FAM222A-AS1 NA NA pathogenic process NA NA
HSALNT0289484 FAM226A CXorf50,NCRNA00246,NCRNA00246A,LINC00246A,MGC34827 NA pathogenic process NA NA
HSALNT0289497 FAM215A C17orf88,APR-2,LINC00530 NA pathogenic process ovarian cancer;leukemia Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289230 NONHSAT089783 LUST transcriptional regulation pathogenic process tumor Neoplasms
HSALNT0002923 LINC00339 NCRNA00339,HSPC157 NA pathogenic process;developmental process Pancreatic ductal adenocarcinoma Neoplasms
HSALNT0144027 ASAP1-IT1 ASAP1-IT,ASAP1IT,ASAP1IT1,DDEF1IT1,HSPC054,NCRNA00050 NA pathogenic process ovarian cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289212 NONHSAT076153 NCRNA00071,LINC00071,PCAT9 transcriptional regulation;ceRNA pathogenic process osteoarthritis;prostate cancer;glioma Musculoskeletal Diseases;Male Urogenital Diseases;Neoplasms
HSALNT0289016 KCNQ1DN BWRT,HSA404617 NA pathogenic process aging;Wilms' tumor Physiological Phenomena;Neoplasms
HSALNT0288933 NONHSAT033821 DLB2,BCMSUN,RFP2O,LEU2,TRIM13O, NCRNA00022,LINC00022,MIR15AHG transcriptional regulation pathogenic process lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;chronic lymphocytic leukemia;non-small cell lung cancer Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases
HSALNT0217624 PWAR4 PAR4,PAR-4 NA pathogenic process Prader-Willi syndrome and Angelman syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0289165 ENST00000553584.1 SNHG23,SNHG24,NCRNA00024,Irm,Rian,Bsr,LINC00024,AL132709.8,lnc-MGC NA pathogenic process Prader-Willi syndrome and Angelman syndrome;temple syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0289482 CECR7 SAHL1 NA pathogenic process hepatocellular cancer;cat eye syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases
HSALNT0074223 ENST00000504263.1 GDEP,PCAN1,PCA4 NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0061175 PISRT1 NCRNA00195 transcriptional regulation developmental process;pathogenic process blepharophimosis syndrome Eye Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
HSALNT0190912 ENST00000538665.1 Tmevpg1,LincR-Ifng-3'A, NEST transcriptional regulation pathogenic process Hashimoto's thyroiditis;primary immune thrombocytopenia;multiple sclerosis;Sjögren syndrome Immune System Diseases ;Immune System Diseases;Endocrine System Diseases;Nervous System Diseases
HSALNT0038178 FAM138B F379 NA NA NA NA
HSALNT0145703 FAM138C F379 NA NA NA NA
HSALNT0288963 FAM138A F379 NA NA NA NA
HSALNT0183947 FAM138D F379 NA NA NA NA
HSALNT0226092 FAM138E F379 NA NA NA NA
HSALNT0253925 FAM138F F379 NA NA NA NA
HSALNT0289326 NONHSAT087716 LOH3CR2A,NCRNA00312,NAG7,NAG-7,ERR10,ERR-10,LMCD1DN transcriptional regulation pathogenic process nasopharyngeal cancer;bladder cancer;non-small cell lung cancer Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Stomatognathic Diseases
HSALNT0288886 ENST00000609176.1 AIR,NCRNA00088,IGF2RA, IGF2R-AS1 transcriptional regulation pathogenic process NA NA
HSALNT0254857 MIR7-3HG C19orf30,NCRNA00306,LINC00306,PGSF1,PGSF1a,PGSF1b,Huh7,uc002mbe.2 NA pathogenic process liver cancer;hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0185751 LOH12CR2 LOH2CR12 NA pathogenic process pre-B acute lymphoblastic leukaemia Hemic and Lymphatic Diseases
HSALNT0289479 DSCR8 C21orf65,MTAG2,CT25.1a,CT25.1b,MMA-1a,MMA-1b NA pathogenic process Down syndrome;melanoma Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases
HSALNT0289030 LINC00313 C21orf84,NCRNA00313, NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289029 LINC00310 C21orf82,NCRNA00310 NA pathogenic process NA NA
HSALNT0272435 LINC00161 C21orf100,NCRNA00161 ceRNA pathogenic process osteosarcoma Neoplasms
HSALNT0289184 ENST00000602580.1 C21orf35,FLJ38295,C21orf34,LINC00478,MONC NA pathogenic process myeloid leukemia Hemic and Lymphatic Diseases
HSALNT0289005 HOXA11-AS HOXA11A,HOXA11-AS1,HOXA11, HOXA-AS5,NCRNA00076 ceRNA pathogenic process uterine cervix cancer;ovarian cancer;glioma;cervical cancer;gastric cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
HSALNT0193654 RMST NCRM, NCRNA00054,LINC00054 transcriptional regulation developmental process;pathogenic process breast cancer;rhabdomyosarcoma Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290079 NONHSAT102247 NCRUPAR,ENSG00000225407 transcriptional regulation developmental process;pathogenic process gastric cancer;colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289167 MESTIT1 MEST-AS1,MEST-IT,MEST-IT1,NCRNA00040,PEG1-AS NA pathogenic process Silver-Russell syndrome Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
HSALNT0273791 DSCAM-AS1 M41 NA pathogenic process adolescent idiopathic scoliosis;breast cancer Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289391 PWARSN PAR-SN,PARSN NA pathogenic process NA NA
HSALNT0127791 ST7-AS1 ST7OT1,ST7AS1 NA pathogenic process glioma;autism Mental Disorders;Neoplasms
HSALNT0206298 DAOA-AS1 DAOAA, DAOA-A,G30 NA pathogenic process panic disorder;schizophrenia;bipolar disorder Mental Disorders
HSALNT0167060 OLMALINC C10orf75,NCRNA00263,LINC00263,bA34D15.5,FLJ12974,HI-LNC80 NA pathogenic process type 2 diabetes Nutritional and Metabolic Diseases;Endocrine System Diseases
HSALNT0026878 LINC00299 C2orf46,NCRNA00299,FLJ45673 NA pathogenic process;developmental process intellectual and developmental disability;neurodevelopmental disabilities Mental Disorders;Nervous System Diseases
HSALNT0289081 LINC01020 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0101186 LINC00518 C6orf218,MGC40222 NA pathogenic process NA NA
HSALNT0083960 LINC01018 SRHC NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289361 LPP-AS2 MYCLo-5,MYCLo-6 NA NA NA NA
HSALNT0143233 LINC00964 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289364 MAPKAPK5-AS1 C12orf47,FLJ39616 NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289053 LINC00635 NA NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289327 LINC00636 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0262657 ZNF582-AS1 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289020 LINC00115 NCRNA00115,FLJ22639 ceRNA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0289254 SNHG7 MGC16037,NCRNA00061 NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289162 MAP3K20-AS1 MLK7-AS1 NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0145357 RHPN1-AS1 C8orf51,MGC3113 NA NA NA NA
HSALNT0289343 NONHSAT137541 DXS399E,NCRNA00001,DXS1089,swd66,LINC00001 transcriptional regulation;ceRNA pathogenic process non-small cell lung cancer;B-cell acute lymphoblastic leukemia;bladder cancer;testicular germ cell tumor;colorectal cancer;cancer;ovarian cancer;female cancers;renal collecting duct cancer;membranous nephropathy;Trisomy 21;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;Klinefelter's syndrome;glioblastoma;breast cancer;cystic fibrosis Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases
HSALNT0289389 PRNT M8 NA pathogenic process NA NA
HSALNT0288942 Lnc-PDZD8-3:1 NCRNA00045,EMX2-AS1 transcriptional regulation pathogenic process NA NA
HSALNT0200443 LINC00598 TTL NA pathogenic process NA NA
HSALNT0289517 TTTY17A NCRNA00140 NA NA NA NA
HSALNT0027901 MYCNOS NCYM,N-CYM,MYCN-AS1 transcriptional regulation pathogenic process neuroblastoma Neoplasms
HSALNT0047175 DIRC3 FLJ14199 NA pathogenic process familial renal cell cancer;breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289363 ENST00000534336.1 PRO1073,MALAT-1,NCRNA00047,HCN,NEAT2,LINC00047,mascRNA splicing regulation;;translational control;transcriptional regulation;protein localization;ceRNA pathogenic process prostate cancer;glioma;cancer;breast cancer;ovarian cancer;amyotrophic lateral sclerosis;proliferative vitreoretinopathy;glioblastoma;endometrial stromal sarcoma;oral squamous cell cancer;acute myocardial infarction;hemangioma;pancreatic cancer;endometrioid endometrial cancer;melanoma;tongue squamous cell cancer;HIV;hepatocelluar cancer;bladder cancer;neuroblastoma;lung cancer;nasopharyngeal cancer;osteosarcoma;esophageal cancer;kidney cancer;hepatic steatosis;urothelial cancer;diabetes;triple-negative breast cancer;liver fibrosis;cervical cancer;uterus cancer;gallbladder cancer;decreased myogenesis;esophageal squamous cell cancer;fibrosarcoma;colorectal cancer;Pancreatic ductal adenocarcinoma;pre-eclampsia;retinal neurodegeneration;small cell lung cancer;multiple myeloma;gastric cancer;lung adenocarcinoma;uveal melanoma;epithelial ovarian cancer;TDP-43-associated pathological states;thyroid cancer;congenital microtia;liver cancer;renal clear cell cancer;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;non-small cell lung cancer;pulmonary arterial hypertension;diabetic cardiomyopathy;vulvar squamous cell cancer;hyperglycaemia;papillary thyroid cancer;Parkinson's disease;renal cell cancer;lung cancer brain metastasis Eye Diseases;Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Cell Physiological Phenomena;Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Stomatognathic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases
HSALNT0289744 DLG2-AS1 DLG2A, DLG2-A,PSZA11q14,SZ-1 NA pathogenic process schizophrenia;myotonic dystrophy type 1;heart failure Pathological Conditions, Signs and Symptoms;Musculoskeletal Diseases;Mental Disorders;Cardiovascular Diseases;Nervous System Diseases
HSALNT0289164 NONHSAT039745 FP504,GTL2,LINC00023,NCRNA00023,PRO0518,PRO2160,onco-lncRNA-83,prebp1 translational control;transcriptional regulation;ceRNA pathogenic process oral squamous cell cancer;phaeochromocytoma;prostate cancer;testicular germ cell tumor;glioma;cancer;osteosarcoma;non-functioning pituitary adenoma;heroin abuse;stroke;non-small cell lung cancer;thrombocytopenic purpura;acute myeloid leukemia;pancreatic cancer;bladder cancer;tongue squamous cell cancer;hepatocelluar cancer;meningioma;drug abuse;liver fibrosis;pancreatic neuroendocrine tumor;esophageal squamous cell cancer;myelodysplastic syndrome;retinoblastoma;chronic myeloid leukemia;type 1 diabetes;breast cancer;cervical cancer;kidney cancer;gallbladder cancer;cholestatic liver injury;colorectal cancer;neuroblastoma;multiple myeloma;gastric cancer;osteoarthritis;lung adenocarcinoma;endometrial cancer;Huntington disease;diabetes;type 2 diabetes;lung cancer;epithelial ovarian cancer;primary myelofibrosis;metabolic syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;vulvar squamous cell cancer;papillary thyroid cancer;renal cell cancer;Wilms' tumor Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Immune System Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Chemically-Induced Disorders;Musculoskeletal Diseases;Mental Disorders;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases
HSALNT0290298 TERC DKCA1,PFBMFT2,SCARNA19,TR,TRC3,hTR NA pathogenic process prostate cancer;dyskeratosis congenita;lung squamous cell cancer Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases
HSALNT0288907 CASC2 NA ceRNA pathogenic process colorectal cancer;gastric cancer;endometrial cancer;lung cancer;renal cell cancer;glioma Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
HSALNT0205332 MIR17HG C13orf25,MIRHG1,FLJ14178,MIRH1,MIHG1,NCRNA00048,miR-17-92,LINC00048 NA pathogenic process diffuse large B-cell lymphoma;syndromic developmental defect;cancer Neoplasms;Hemic and Lymphatic Diseases
HSALNT0288716 TTTY6 TTY6,TTTY6A,LINC00127 NA NA NA NA
HSALNT0288731 TTTY4 TTY4,TTTY4A,LINC00123 NA NA NA NA
HSALNT0288815 TTTY3 TTY3,TTTY3A,LINC00121 NA NA NA NA
HSALNT0288703 TTTY5 TTY5,LINC00126 NA NA NA NA
HSALNT0289255 SNHG8 NCRNA00060,LINC00060 NA pathogenic process gastric cancer;malignant pleural mesothelioma Neoplasms;Digestive System Diseases
HSALNT0289486 Lnc-EPCAM-1:2 BC200,BC200a,NCRNA00004,LINC00004 splicing regulation;translational control pathogenic process aging;lung cancer;glioma;ovarian cancer;esophageal squamous cell cancer;non-small cell lung cancer;esophageal cancer;Alzheimer's disease;tongue cancer;parotid cancer;breast cancer;cervical cancer Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Mental Disorders;Female Urogenital Diseases and Pregnancy Complications;Physiological Phenomena;Endocrine System Diseases;Nervous System Diseases
HSALNT0144426 ZFAT-AS1 ZFATAS,ZFAT-AS,SAS-ZFAT,NCRNA00070 NA pathogenic process autoimmune disease Immune System Diseases
HSALNT0289285 ZEB1-AS1 NA NA pathogenic process esophageal squamous cell cancer;autoimmune thyroid disease;hepatocelluar cancer Immune System Diseases;Neoplasms;Digestive System Diseases
HSALNT0289185 MIRLET7BHG linc-Ppara NA developmental process NA NA
HSALNT0289374 NBR2 NCRNA00192 transcriptional regulation pathogenic process gastric cancer;breast cancer;cancer Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
HSALNT0289417 NONHSAT084827 FLJ20618,NCRNA00080,LINC00080 transcriptional regulation;ceRNA pathogenic process osteosarcoma;prostate cancer;glioma;ovarian cancer;glioblastoma;non-small cell lung cancer;B-cell neoplasms;chronic kidney disease;melanoma;bladder cancer;urothelial cancer of the bladder;esophageal squamous cell cancer;multiple sclerosis;breast cancer;hepatoblastoma;colorectal cancer;multiple myeloma;gastric cancer;Huntington disease;hepatocellular cancer;oesophageal squamous cell cancer;renal cell cancer Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases
HSALNT0288973 FAS-AS1 FASA, FAS-A,SAF transcriptional regulation pathogenic process ataxia telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Immune System Diseases;Nutritional and Metabolic Diseases;Cardiovascular Diseases;Nervous System Diseases
HSALNT0288996 HAS2-AS1 HAS2A, HAS2-A,HASNT,NCRNA00077 transcriptional regulation NA NA NA
HSALNT0289390 PSORS1C3 NCRNA00196 NA pathogenic process rheumatoid arthritis;psoriasis Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
HSALNT0289868 HLA-AS1 NA NA pathogenic process psoriasis;liver injury;multiple sclerosis;AIDS Skin and Connective Tissue Diseases;Immune System Diseases;Virus Diseases;Digestive System Diseases;Nervous System Diseases
HSALNT0290154 NONHSAT011777 NCRNA00074 transcriptional regulation pathogenic process psoriasis;prostate cancer Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms
HSALNT0262809 PEG3-AS1 PEG3AS,PEG3-AS,APEG3,NCRNA00155 NA NA NA NA
HSALNT0289533 Lnc-LRR1-1:1 7S RNA,SRP RNA,4.5S SRP RNA,4.5S RNA,RN7SL1 RNA,ENSG00000258486,lnc-LRR1-1:1 protein localization pathogenic process AIDS;Leishmaniasis;dermatomyositis;polymyositis Skin and Connective Tissue Diseases;Immune System Diseases;Virus Diseases;Musculoskeletal Diseases;Parasitic Diseases;Nervous System Diseases
HSALNT0290081 Lnc-C11orf16-1:1 29A,lnc-C11orf16-1:1 NA pathogenic process neuroblastoma Neoplasms
HSALNT0289382 NONHSAT134764 NCRNA00194 NA pathogenic process AIDS;Down syndrome;HIV Immune System Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases;Virus Diseases
HSALNT0289253 Lnc-TCF24-2:3 U87HG,HBII-276HG,NCRNA00058 translational control;ceRNA pathogenic process hepatocellular cancer;hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases
HSALNT0289653 NONHSAT017676 AY195961.1,NONHSAT017674,AY034469.1,NONHSAT017675,AY034470.1 NA NA NA NA
HSALNT0290398 ENST00000554403.1 Zfh-5AS,ENSG00000157306,ENST00000554403.1 NA NA NA NA
HSALNT0011306 MIR137HG NA NA pathogenic process schizophrenia;lung cancer;malignant lymphoma Respiratory Tract Diseases;Mental Disorders;Neoplasms
HSALNT0289449 Lnc-EVX1-9:1 HOXA6as NA pathogenic process glioma Neoplasms
HSALNT0289451 CCDC26 MGC27434,RAM transcriptional regulation pathogenic process hematological malignancies;glioma;acute myeloid leukemia;leukemia;pancreatic cancer;breast cancer Skin and Connective Tissue Diseases;Neoplasms;Hemic and Lymphatic Diseases;Endocrine System Diseases;Digestive System Diseases
HSALNT0289893 LINC00271 C6orf217,NCRNA00271 NA pathogenic process type 2 diabetes;schizophrenia Nutritional and Metabolic Diseases;Mental Disorders;Endocrine System Diseases
HSALNT0288892 BCAR4 NA transcriptional regulation pathogenic process osteosarcoma;breast cancer;colorectal cancer Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
HSALNT0289890 LINC00032 C9orf14,NCRNA00032 NA pathogenic process narcolepsy;melanoma Mental Disorders;Neoplasms;Nervous System Diseases
HSALNT0274572 PICSAR C21orf113,LINC00162,NCRNA00162,NLC1-C,NLC1C,PRED74 transcriptional regulation pathogenic process testicular embryonal cancer;narcolepsy;cutaneous squamous cell cancer Male Urogenital Diseases;Mental Disorders;Neoplasms;Nervous System Diseases
HSALNT0256354 Lnc-OR10H5-1:1 CUDR,LINC00178,NCRNA00178,UCAT1,onco-lncRNA-36 transcriptional regulation;ceRNA developmental process;pathogenic process oral squamous cell cancer;osteosarcoma;prostate cancer;ovarian cancer;non-small cell lung cancer;acute myocardial infarction;pancreaticobiliary maljunction;pancreatic cancer;melanoma;tongue squamous cell cancer;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;esophageal squamous cell cancer;esophageal cancer;liver cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;urinary bladder;gastric cancer;endometrial cancer;breast cancer;hepatocellular cancer;squamous cell cancer;lung cancer;renal cell cancer Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases;Digestive System Diseases
HSALNT0289475 Lnc-BIRC7-2:1 HAR1F,NCRNA00064,LINC00064 transcriptional regulation pathogenic process Huntington disease;Alzheimer's disease Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Mental Disorders;Nervous System Diseases
HSALNT0288995 ENST00000447910.2 HAR1R,NCRNA00065,LINC00065 transcriptional regulation pathogenic process Huntington disease;hereditary haemorrhagic telangiectasia;Alzheimer's disease Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Nervous System Diseases
HSALNT0288958 EPB41L4A-AS1 C5orf26,NCRNA00219,TIGA1 NA pathogenic process lung cancer;cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289170 Lnc-CRYBA4-2:1 C22orf35,FLJ25967,Rncr2,gomafu,NCRNA00066,LINC00066,lncRNA-MIAT splicing regulation;ceRNA pathogenic process prostate cancer;chronic lymphocytic leukemia;cancer;drug abuse;diabetes-induced microvascular dysfunction;schizophrenia;acute myocardial infarction;dilated cardiomyopathy;lung adenocarcinoma;diabetic retinopathy;myocardial infarction;Alzheimer's disease Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Chemically-Induced Disorders;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Mental Disorders;Endocrine System Diseases;Nervous System Diseases
HSALNT0289007 NONHSAT107640 NCRNA00078,LINC00078,HCCAT1 transcriptional regulation;ceRNA pathogenic process prostate cancer;glioma;hepatocelluar cancer;osteosarcoma;atherosclerosis;gastric cancer;hepatocellular cancer;esophageal cancer;liver cirrhosis;diffuse large B-cell lymphoma;pancreatic cancer;papillary thyroid cancer;liver cancer;cervical cancer;colorectal cancer Neoplasms;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
HSALNT0288940 NONHSAT087635 EGO,NCRNA00190 NA pathogenic process;developmental process prostate cancer;breast cancer Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms
HSALNT0289387 PINK1-AS PINK1-AS1,FLJ00387,PINK1A, naPINK1 transcriptional regulation pathogenic process glucose metabolism disorder;Parkinson's disease;diabetes Nutritional and Metabolic Diseases;Endocrine System Diseases;Nervous System Diseases
HSALNT0289225 ENST00000513868.2 NCRNA00079,LINC00079,onco-lncRNA-100,MIR1204HG,PVT transcriptional regulation;translational control pathogenic process murine plasmacytomas;prostate cancer;cancer;ovarian cancer;renal cancer;B-cell lymphoma;non-small cell lung cancer;pancreatic cancer;Hodgkin's lymphoma;asthma;hepatocelluar cancer;bladder cancer;plasmacytoma;cleft lip;acute promyelocytic leukemia;diabetic nephropathy;esophageal cancer;kidney cancer;type 1 diabetes;breast cancer;cervical cancer;diabetic kidney disease;hematological malignancies;colorectal cancer;neuroblastoma;cardiac hypertrophy;multiple myeloma;gastric cancer;lymphoma;type 2 diabetes;thyroid cancer;pleural mesothelioma;lung squamous cell cancer;Burkitt lymphoma;hepatocellular cancer;renal cell cancer Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Immune System Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases;Digestive System Diseases
HSALNT0289189 ENST00000604258.1 NA NA pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0246525 NARF-AS1 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0147433 NONHSAT130421 CDKN2BA,ANRIL,RP11-145E5.4,NCRNA00089,p15A, CDKN2B-A, PCAT12 siRNA;transcriptional regulation;ceRNA pathogenic process glaucoma;prostate cancer;glioma;cancer;osteosarcoma;neurofibromatosis;ischemic heart failure;stroke;non-small cell lung cancer;hypertension;intracranial aneurysm;aortic aneurysm;periodontitis;acute lymphoblastic leukemia;Alzheimer's disease;coronary artery disease;melanoma;bladder cancer;abdominal aortic aneurysm;ovarian cancer;esophageal cancer;basal cell cancer;breast cancer;cervical cancer;coronary heart disease;gallbladder cancer;acute myocardial infarction;colorectal cancer;neuroblastoma;peripheral artery disease;esophageal squamous cell cancer;atherosclerosis;leukemia;hereditary cutaneous malignant melanoma;gastric cancer;cardiovascular disease;coronary disease;frailty;diabetes;type 2 diabetes;thyroid cancer;primary open-angle glaucoma;ischemic stroke;plexiform neurofibroma;laryngeal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;myocardial infarction;lung cancer;endometriosis;primary myelofibrosis Eye Diseases;Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Mental Disorders;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases
HSALNT0050854 NONHSAT087920 NCRNA00068,GHRL-AS1 transcriptional regulation NA NA NA
HSALNT0288959 ENST00000583516.1 HESRG NA pathogenic process embryonal cancer Neoplasms
HSALNT0287173 FMR1-AS1 FMR1A, FMR1-A,ASFMR1,FMR4 transcriptional regulation pathogenic process fragile X syndrome;neurological disorder Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0289499 HCG4 HCGIV-10,HCGIV.9 NA pathogenic process NA NA
HSALNT0288994 HAND2-AS1 DEIN,NBLA00301,FLJ11539 NA pathogenic process neuroblastoma Neoplasms
HSALNT0289286 NONHSAT074775 ZEB2A, ZEB2-A,ZEB2NAT splicing regulation pathogenic process bladder cancer;hepatocellular cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
HSALNT0017702 NONHSAT007663 SNHG2,NCRNA00030 transcriptional regulation;ceRNA pathogenic process varicose great saphenous veins;prostate cancer;glioma;cancer;ovarian cancer;non-small cell lung cancer;hypertension;pancreatic cancer;B-cell neoplasms;melanoma;head and neck cancer;hepatocelluar cancer;bladder cancer;autoimmune disease;liver fibrosis;kidney cancer;breast cancer;cervical cancer;colorectal cancer;multiple myeloma;gastric cancer;osteoarthritis;endometrial cancer;lymphoma;type 2 diabetes;pleural mesothelioma;hepatocellular cancer;lung adenocarcinoma;lung cancer;renal cell cancer Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Nutritional and Metabolic Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
HSALNT0288891 NONHSAT024403 BACE1A,FJ573250,NCRNA00177,BACE1-AS1 translational control;transcriptional regulation pathogenic process ovarian cancer;colorectal cancer;Alzheimer's disease Neoplasms;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Nervous System Diseases;Endocrine System Diseases;Digestive System Diseases
HSALNT0289414 TRPM2-AS TRPM2-AS1 NA pathogenic process melanoma;prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0288935 DNM3OS DNM3-AS1,MIR199A2HG NA pathogenic process epithelial ovarian cancer Neoplasms
HSALNT0288930 DGCR5 NCRNA00037,LINC00037 transcriptional regulation pathogenic process Huntington disease;DiGeorge syndrome;velocardiofacial syndrome;clear cell renal cell cancer Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Nervous System Diseases
HSALNT0288893 ENST00000499008.3 BDNFO,BT2A,BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1,BDNFAS siRNA;transcriptional regulation developmental process;pathogenic process Huntington disease;schizophrenia;psychiatric disease;obesity Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nutritional and Metabolic Diseases;Mental Disorders;Physiological Phenomena;Nervous System Diseases
HSALNT0120317 Lnc-EVX1-12:1 HOXA-AS1,NCRNA00179,HOXA1-AS1 transcriptional regulation pathogenic process;developmental process colorectal cancer;Pancreatic ductal adenocarcinoma;promyelocytic leukemia;acute myeloid leukemia;infiltrating ductal cancers ;acute promyelocytic leukemia;leukemia;glioma Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
HSALNT0290158 NONHSAT129210 PTCSC,AK023948,NCRNA00197 NA pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0289004 NONHSAT028508 HOXC-AS4,HOXC11-AS1,NCRNA00072 siRNA;transcriptional regulation;ceRNA pathogenic process oral squamous cell cancer;prostate cancer;glioma;cancer;breast cancer;osteosarcoma;renal cancer;glioblastoma;non-small cell lung cancer;sarcoma;pancreatic cancer;large B-Cell lymphoma;bladder transitional cell cancer;B-cell neoplasms;melanoma;asthenozoospermia;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;aortic valve calcification;infiltrating ductal cancers ;ovarian cancer;diffuse large B-cell lymphoma;gastrointestinal stromal tumor;atypical teratoid rhabdoid tumor;urothelial cancer;triple-negative breast cancer;gastric cardia adenocarcinoma;cervical cancer;temporomandibular joint osteoarthritis;gallbladder cancer;esophageal squamous cell cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;rheumatoid arthritis;gastric cancer ;pre-eclampsia;acute leukemia;small cell lung cancer;multiple myeloma;gastric cancer;osteoarthritis;LPS-induced sepsis;endometrial cancer;head and neck squamous cell cancer;gastric adenocarcinoma;lung cancer;liver cancer;ischemic stroke;ischemic heart failure;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;papillary thyroid cancer;Parkinson's disease;renal cell cancer;gastrointestinal cancer Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Musculoskeletal Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases
HSALNT0289192 ENST00000501122.2 NCRNA00084,TncRNA,MENepsilon/beta,LINC00084,VINC transcriptional regulation;ceRNA pathogenic process oral squamous cell cancer;glioma;ovarian cancer;amyotrophic lateral sclerosis;paraspeckle disintegration;nasopharyngeal cancer;AIDS;frontotemporal lobar degeneration;prostate cancer;systemic lupus erythematosus;renal syndrome;TDP-43-associated pathological states;HIV;Huntington disease;chronic lymphocytic leukemia;acute promyelocytic leukemia;esophageal squamous cell cancer;multiple sclerosis;breast cancer;intrauterine growth restriction;colorectal cancer;leukemia;gastric cancer;malignant pleural mesothelioma;endometrial cancer;gastric adenocarcinoma;papillary thyroid cancer;infertility;bladder cancer;hepatocellular cancer;non-small cell lung cancer;obesity;lung cancer;Parkinson's disease;laryngeal squamous cell cancer Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Nutritional and Metabolic Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Physiological Phenomena;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases
HSALNT0095094 NONHSAT104072 U19H,NCRNA00059 NA pathogenic process myelodysplastic syndrome Hemic and Lymphatic Diseases
HSALNT0245443 NONHSAT056039 ncRAN,Nbla12061,Nbla10727 NA pathogenic process bladder cancer;bladder cancer;colorectal cancer;neuroblastoma Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
HSALNT0288897 BOK-AS1 BOKA,NCRNA00151,NAToB NA pathogenic process esophageal squamous cell cancer;testicular cancer;cancer Male Urogenital Diseases;Neoplasms
HSALNT0289532 NONHSAT113149 7-3 RNA,K-RNA,7SK-RNA,7SK snRNA,RN7SK,ENSG00000202198,NONHSAT113149 transcriptional regulation developmental process;pathogenic process cancer;cardiac hypertrophy;gastric cancer;AIDS;multiple sclerosis;colorectal adenocarcinoma Neoplasms;Immune System Diseases;Virus Diseases;Cardiovascular Diseases;Digestive System Diseases;Nervous System Diseases
HSALNT0289182 MIR4435-2HG MIR4435-1HG,LINC00978,AGD2,AK001796,lncRNA-AWPPH,MORRBID NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289200 PARTICL PARTICLE transcriptional regulation pathogenic process low-dose irradiation Disorders of Environmental Origin
HSALNT0289172 ENST00000517411.1 LINC01604,TCONS_00015189 transcriptional regulation;ceRNA pathogenic process gallbladder cancer;Burkitt lymphoma Neoplasms;Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Digestive System Diseases
HSALNT0001792 NPPA-AS1 NPPAA, NPPA-AS splicing regulation pathogenic process cardiovascular disease Cardiovascular Diseases
HSALNT0290230 RRP1B NA transcriptional regulation pathogenic process spinocerebellar ataxia;laryngeal squamous cell cancer;cancer Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases
HSALNT0289467 CLLU1 NA NA NA NA NA
HSALNT0289173 ENST00000531381.1 AGD1,lncRNA-N2,linc-NeD125 NA developmental process;pathogenic process myeloid leukemia;myopia;cervical cancer;neuroblastoma Eye Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Hemic and Lymphatic Diseases
HSALNT0059175 NONHSAT091315 LINC00902,LSAMP-AS1,LSAMP-AS3,LSAMPAS3,NCRNA00295 transcriptional regulation;ceRNA pathogenic process glioma;Pancreatic ductal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;ischemic heart failure;gastric cancer;hepatocellular cancer;non-small cell lung cancer;acute myeloid leukemia;colorectal cancer Respiratory Tract Diseases;Cardiovascular Diseases;Neoplasms;Digestive System Diseases
HSALNT0289647 BC040587 NA NA pathogenic process osteosarcoma;breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0059186 LINC00901 LSAMP-AS4,TCONS_00005428,BC040587 NA pathogenic process osteosarcoma;gastric cancer;breast cancer Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
HSALNT0233366 HCCAT5 HTA,FJ222407 NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0290040 LSINCT5 NA NA pathogenic process chronic heart failure;colorectal cancer;ovarian cancer;gastric cancer;lung cancer;breast cancer Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
HSALNT0179611 DISC1FP1 Boymaw transcriptional regulation pathogenic process schizophrenia Mental Disorders
HSALNT0217643 SNHG14 115HG,IC-SNURF-SNRPN,LNCAT,NCRNA00214,U-UBE3A-AT, UBE3A-A, UBE3A-AS1,UBE3AATS ceRNA pathogenic process Angelman syndrome;cerebral infarction;Prader-Willi syndrome Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Nervous System Diseases
HSALNT0289273 TP73-AS1 KIAA0495,PDAM NA pathogenic process esophageal squamous cell cancer;oligodendroglial tumors;non-small cell lung cancer;glioblastoma;multiple myeloma Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases
HSALNT0290311 TP53COR1 Trp53cor1 transcriptional regulation pathogenic process prostate cancer;colorectal cancer;hepatocelluar cancer;atherosclerosis;Burkitt lymphoma;chronic lymphocytic leukemia;B cell lymphoma;lung cancer;cervical cancer Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
HSALNT0289221 NONHSAT129019 CARLo-3,PCAT8 transcriptional regulation pathogenic process gastric cancer;prostate cancer;glioma;colorectal cancer Male Urogenital Diseases;Neoplasms;Digestive System Diseases
HSALNT0020131 PCAT6 KDM5B-AS1,ncRNA-a2,PCAN-R1,KDM5BAS1,onco-lncRNA-96 transcriptional regulation pathogenic process prostate cancer;triple-negative breast cancer;lung cancer Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms
HSALNT0289277 TRERNA1 LINC00651,ncRNA-a7,treRNA transcriptional regulation NA NA NA
HSALNT0014972 ENST00000416894.1 LINC00568,ncRNA-a1,FAL1 transcriptional regulation pathogenic process ovarian cancer;thyroid cancer Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Neoplasms
HSALNT0290008 Lnc-SNAI1-1:1 Noncoding RNA activating7: ncRNA-a7,ENST00000431460.1,ENSG00000231265,TRERNA1 transcriptional regulation pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0290248 Lnc-BSPH1-1:1 EU035784.1,lnc-BSPH1-1:1 transcriptional regulation NA NA NA
HSALNT0289342 Lnc-ZCCHC13-1:1 NCRNA00183,ENOX,LINC00183,DCBALD06 transcriptional regulation pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289280 VLDLR-AS1 lincRNA-VLDLR NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0288982 ENST00000602812.1 NCRNA00182,MIR374AHG,LINC00182,FLJ33139 transcriptional regulation pathogenic process hepatocellular cancer;breast cancer;colorectal cancer;hepatocelluar cancer Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
HSALNT0091079 MEF2C-AS1 NA NA pathogenic process gastric cancer;Prader-Willi syndrome and Angelman syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases;Nervous System Diseases
HSALNT0189341 PCBP2-OT1 TUC338 NA pathogenic process hepatocellular cancer;tongue squamous cell cancer Neoplasms;Digestive System Diseases
HSALNT0290373 WRAP53 NA NA pathogenic process hepatocellular cancer;cancer;dyskeratosis congenita Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases
HSALNT0289265 NONHSAT112472 LINC00532,lincRNA-NRNA024015 NA pathogenic process esophageal squamous cell cancer;gastric cancer;testicular cancer;aplastic anemia Male Urogenital Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
HSALNT0289175 NONHSAT081499 MIRHG2,BIC,NCRNA00172 NA pathogenic process B-cell chronic lymphocytic leukemia;chronic lymphocytic leukemia;breast cancer;glioma Immune System Diseases;Skin and Connective Tissue Diseases;Neoplasms;Hemic and Lymphatic Diseases
HSALNT0289051 LINC00620 NA NA pathogenic process cervical cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0120390 NONHSAT119717 NCRNA00213,HOXA-AS6,RP1-170O19.3,HOXA13-AS1 transcriptional regulation pathogenic process hirschsprung disease;colorectal cancer;prostate cancer;tongue squamous cell cancer;Pancreatic ductal adenocarcinoma;osteosarcoma;hepatocelluar cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;pancreatic cancer;lung cancer;glioma Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases
HSALNT0289287 NONHSAT080206 C20orf199,NCRNA00275,ZNFX1-AS1,HSUP1,HSUP2 transcriptional regulation;ceRNA pathogenic process gastric cancer;hepatocellular cancer;ductal cancer;colorectal cancer;breast cancer Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
HSALNT0289259 Lnc-NDFIP1-3:1 SPRIGHTLY transcriptional regulation pathogenic process prostate cancer;melanoma;glioma;esophageal squamous cell cancer;pre-eclampsia;bladder cancer;renal clear cell cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung cancer;breast cancer;cervical cancer;colorectal cancer Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
HSALNT0105595 Lnc-CDKN1A-1:1 PANDA transcriptional regulation pathogenic process colorectal cancer;cancer;bladder cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;p53-associated pathological states;breast cancer;renal cell cancer Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
HSALNT0068185 HTT-AS HTT-AS1,HTTAS NA pathogenic process Huntington disease Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0099036 HEIH LINC-HEIH,lncRNA-HEIH,LINC00848,HCCAT2 NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0222533 NPTN-IT1 lncRNA-LET NA pathogenic process gallbladder cancer;colorectal cancer;hepatocelluar cancer;esophageal squamous cell cancer;lung squamous cell cancer;nasopharyngeal cancer;gastric cancer;hypoxia;squamous cell lung cancer;cervical cancer Pathological Conditions, Signs and Symptoms;Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Digestive System Diseases
HSALNT0289747 DQ786243 NA transcriptional regulation pathogenic process crohn's disease;colorectal cancer;hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0289204 ENST00000561978.1 PCAT-1,PCA1 transcriptional regulation;ceRNA pathogenic process prostate cancer;colorectal cancer;esophageal squamous cell cancer;bladder cancer;hepatocellular cancer;lung cancer Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
HSALNT0275894 PCAT14 NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0211999 HIF1A-AS2 3'aHIF-1A,aHIF translational control pathogenic process bladder cancer;osteosarcoma;renal cancer;glioblastoma;gastric cancer;acute myocardial infarction;kidney cancer;breast cancer Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
HSALNT0288999 HIF1A-AS1 5'aHIF-1A,5'aHIF1alpha NA pathogenic process acute myocardial infarction;non-small cell lung cancer;cardiovascular disease;aortic aneurysm;thoracoabdominal aorta aneurysm;kidney cancer Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications
HSALNT0289258 SOX2-OT SOX2OT,DKFZp761J1324,NCRNA00043 transcriptional regulation pathogenic process colorectal cancer;esophageal squamous cell cancer;lung squamous cell cancer;retinal neurodegeneration;neurodevelopmental syndromes associated with the SOX2 locus;hepatocellular cancer;lung cancer;breast cancer;Alzheimer's disease Eye Diseases;Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Mental Disorders;Digestive System Diseases;Nervous System Diseases
HSALNT0289700 CDR1-AS CDR1NAT,ciRS-7,CDR1as ceRNA NA NA NA
HSALNT0289149 LINCMD1 MIR133BHG,LINC-MD1 ceRNA developmental process;pathogenic process Duchenne muscular dystrophy Musculoskeletal Diseases
HSALNT0288894 BGLT3 LINC01083,BGL3,lncRNA-BGL3 ceRNA pathogenic process chronic myeloid leukemia Neoplasms;Hemic and Lymphatic Diseases
HSALNT0289042 LINC00473 C6orf176,bA142J11.1 transcriptional regulation pathogenic process non-small cell lung cancer;renal cell cancer Respiratory Tract Diseases;Male Urogenital Diseases;Neoplasms
HSALNT0101681 LINC01108 LncRNA-ES1 NA developmental process NA NA
HSALNT0289418 TUNAR LINC00617,TUNA,HI-LNC78 transcriptional regulation developmental process;pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289197 ENST00000500949.2 cyrano,linc-OIP5 NA developmental process NA NA
HSALNT0289046 Lnc-PRL-6:2 NA NA pathogenic process West Syndrome;West syndrome Nervous System Diseases
HSALNT0289656 BX118339 NA NA pathogenic process West syndrome Nervous System Diseases
HSALNT0021726 LINC00538 Yiya,PROX1UT NA pathogenic process colorectal cancer;cancer Neoplasms;Digestive System Diseases
HSALNT0273249 CBR3-AS1 PlncRNA-1,PlncRNA1 ceRNA pathogenic process esophageal squamous cell cancer;hepatocellular cancer;prostate cancer Male Urogenital Diseases;Neoplasms;Digestive System Diseases
HSALNT0289179 NONHSAT130385 LOC554202,hsa-lnc-31,LncHIFCAR ceRNA pathogenic process bladder cancer;gastric cancer;breast cancer;colorectal cancer;Pancreatic ductal adenocarcinoma Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
HSALNT0288925 NONHSAT096369 KIAA0114,SNHG13,ANCR,AGU2,lncRNA-ANCR transcriptional regulation developmental process;pathogenic process prostate cancer;colorectal cancer;osteosarcoma;bone diseases;postmenopausal osteoporosis;hepatocellular cancer;breast cancer Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Musculoskeletal Diseases;Digestive System Diseases
HSALNT0290329 Uc.388 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289842 FR0348383 NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0289279 TTTY15 DKFZP434I143,NCRNA00138 NA pathogenic process NA NA
HSALNT0289718 Lnc-IRX3-4:2 LOC643911,LINC00180,CRNDEP transcriptional regulation;ceRNA pathogenic process gallbladder cancer;colorectal cancer;ovarian cancer;medulloblastoma;chronic lymphocytic leukemia;renal cell cancer;glioma Neoplasms;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
HSALNT0289685 CCND1 NA NA pathogenic process tumor;cervical cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289935 LincRNA-p21 NA transcriptional regulation pathogenic process lung cancer;cancer Respiratory Tract Diseases;Neoplasms
HSALNT0290134 PCNCR1 NA NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0289492 NONHSAT099821 DBE-T,DUX4L30 transcriptional regulation developmental process;pathogenic process facioscapulohumeral muscular dystrophy Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0289455 BANCR LINC00586 transcriptional regulation pathogenic process osteosarcoma ;lung cancer;melanoma;colorectal cancer;osteosarcoma;esophageal squamous cell cancer;bladder cancer;eosinophilic esophagitis;gastric cancer;hepatocellular cancer;non-small cell lung cancer;retinoblastoma;papillary thyroid cancer Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
HSALNT0209589 ENST00000556013.2 NA ceRNA pathogenic process papillary thyroid cancer;thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0289103 LINC01268 LOC285758 NA pathogenic process NA NA
HSALNT0289070 LINC00887 linc-ATP13A4-8,HEIRCC transcriptional regulation pathogenic process hypoxic and inflammatory renal epithelial injury;renal clear cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0288931 NONHSAT035954 C14orf167,PRO1488,AS1DHRS4 transcriptional regulation NA NA NA
HSALNT0288974 FENDRR FOXF1-AS1,TCONS_00024240,lincFOXF1,onco-lncRNA-21 transcriptional regulation developmental process;pathogenic process osteosarcoma;gastric cancer;non-small cell lung cancer;lung cancer Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
HSALNT0106473 LINC01512 LOC100132354,TCONS_00011120,HI-LNC77 NA pathogenic process lung adenocarcinoma;type 2 diabetes Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Endocrine System Diseases;Neoplasms
HSALNT0289059 LINC00673 HI-LNC75,HILNC75,LUCAIR1,SLNCR,SLNCR1 transcriptional regulation pathogenic process pancreatic cancer;type 2 diabetes;non-small cell lung cancer;melanoma;Pancreatic ductal adenocarcinoma Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Endocrine System Diseases;Digestive System Diseases
HSALNT0289107 LINC01433 LOC728228 NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0143571 NONHSAT129017 CARLo-5,onco-lncRNA-40 ceRNA pathogenic process gallbladder cancer;glioma;hepatocelluar cancer;ovarian cancer;acute myeloid leukemia;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung adenocarcinoma;endometrial cancer;lung cancer;breast cancer;colorectal cancer Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
HSALNT0289408 ENST00000448587.1 ENST00000448587.1,FLJ90734,NCRNA00036,LINC00036,onco-lncRNA-16 translational control pathogenic process;developmental process bladder cancer;colorectal cancer;esophageal squamous cell cancer;gastric cancer;skin desease;squamous cell cancer Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
HSALNT0289152 LNCPRESS1 lncPRESS1 translational control NA NA NA
HSALNT0289145 LINC02561 RP11-445P17.8 NA pathogenic process cystic fibrosis Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
HSALNT0289065 LINC00850 KUCG1 NA pathogenic process Duchenne muscular dystrophy Musculoskeletal Diseases
HSALNT0289431 AFAP1-AS1 AFAP1A, AFAP1-A,MGC10981 NA pathogenic process non-small cell lung cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;esophageal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;pancreatic cancer;Barrett's Esophagus;lung cancer Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases
HSALNT0289519 XACT NA NA NA NA NA
HSALNT0248684 GATA6-AS1 locus5689,BM742401 NA pathogenic process gastric cancer;chronic lymphocytic leukemia Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
HSALNT0289222 ENST00000430058.1 NA transcriptional regulation pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0289655 BTG3-AS1 ASBEL translational control pathogenic process ovarian cancer;colorectal cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
HSALNT0289224 NONHSAT130775 NONHSAT130775,PTENpg1,PTEN2,ENSG00000237984 transcriptional regulation;ceRNA pathogenic process gastric cancer;prostate cancer;renal cell cancer;cancer;hepatocelluar cancer Male Urogenital Diseases;Neoplasms;Digestive System Diseases
HSALNT0290129 PAN NA transcriptional regulation pathogenic process Kaposi's sarcoma Neoplasms;Virus Diseases
HSALNT0289939 LINC-ROR lincRNA-RoR,lincRNA-ST8SIA3,ROR transcriptional regulation;ceRNA pathogenic process gallbladder cancer;liver cancer;glioma;malignant melanoma;unveal melanoma;breast cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;pancreatic cancer;endometrial cancer;triple-negative breast cancer;colorectal cancer Skin and Connective Tissue Diseases;Neoplasms;Stomatognathic Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases
HSALNT0290322 UBE3A-ATS NA NA pathogenic process Angelman syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0091004 LINC00461 EyeLinc1,Visc-1a,Visc-1b,Visc-2,LOC645323 NA pathogenic process;developmental process retinal and visual function Eye Diseases
HSALNT0289491 CTBP1-AS PCAT10 transcriptional regulation pathogenic process chronic hepatitis C;prostate cancer;polycystic ovary syndrome Neoplasms;Male Urogenital Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
HSALNT0037401 ENST00000441383.1 LINC00876,AC096655.1-002 NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0120344 NONHSAT119676 HOXA3as transcriptional regulation pathogenic process promyelocytic leukemia;gastric cancer Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
HSALNT0091313 ENST00000511918.1 SCAL1 transcriptional regulation pathogenic process non-small cell lung cancer;lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289425 BLACAT1 linc-UBC1,LINC00912,onco-lncRNA-30 transcriptional regulation pathogenic process bladder cancer;gastric cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
HSALNT0149012 GLIDR LINC01172,MGC21881,TCONS_00015562 NA pathogenic process glioblastoma Neoplasms
HSALNT0217561 PWAR5 PAR5,PAR-5 NA pathogenic process glioblastoma;Prader-Willi syndrome and Angelman syndrome;Prader-Willi syndrome Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases
HSALNT0289272 TP53TG1 TP53AP1,H_RG012D21.9,LINC00096 NA pathogenic process non-small cell lung cancer;ataxia telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Nutritional and Metabolic Diseases;Cardiovascular Diseases;Nervous System Diseases
HSALNT0289598 AK126698 NA NA pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0217598 NONHSAT041063 NCRNA00002 transcriptional regulation pathogenic process Prader-Willi syndrome Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0143633 CCAT2 NCCP1,LINC00873 transcriptional regulation pathogenic process non-small cell lung cancer;oral squamous cell cancer;colorectal cancer;ovarian cancer;esophageal squamous cell cancer;bladder cancer;small cell lung cancer;gastric cancer;hepatocellular cancer;prostate cancer;cervical squamous cell cancer;lung cancer;breast cancer;cervical cancer Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
HSALNT0289026 LINC00261 C20orf56,NCRNA00261,bA216C10.1,HCCDR1,TCONS_00027846,ALIEN,DEANR1,onco-lncRNA-17 NA pathogenic process pancreatic cancer;non-small cell lung cancer;gastric cancer Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases
HSALNT0289078 LINC00982 FLJ42875 NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0290082 NEAT1_2 NEAT1_2 protein localization pathogenic process amyotrophic lateral sclerosis Nutritional and Metabolic Diseases;Nervous System Diseases
HSALNT0288989 GATA3-AS1 NA transcriptional regulation pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0289427 GNG12-AS1 NA transcriptional regulation NA NA NA
HSALNT0290395 YAM1 Yam-1 transcriptional regulation pathogenic process;developmental process skeletal myogenesis Musculoskeletal Diseases
HSALNT0289202 PAX8-AS1 NA NA pathogenic process malignant pleural mesothelioma;cervical cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0054469 RASSF1-AS1 ANRASSF1 transcriptional regulation pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0290261 SUMO1P3 SUMO1P3 NA pathogenic process bladder cancer;gastric cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
HSALNT0289002 HNF1A-AS1 C12orf27,NCRNA00262,FLJ38690,HAS1 ceRNA pathogenic process esophageal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;adenocarcinoma;lung adenocarcinoma;pancreatic cancer Neoplasms;Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Stomatognathic Diseases
HSALNT0289377 NIPBL-AS1 NIPBL-DT,NIPBL-AS NA pathogenic process autism spectrum disorder Mental Disorders
HSALNT0289249 SNHG15 C7orf40,FLJ38860,MYO1GUT,Linc-Myo1g NA pathogenic process gastric cancer;hepatocellular cancer;hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases
HSALNT0235898 ENST00000574306.1 C17orf91,MGC14376,DKFZp686O06159 NA pathogenic process ovarian cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0235898 ENST00000574306.1 C17orf91,MGC14376,DKFZp686O06159 NA NA NA NA
HSALNT0288984 ENST00000579368.1 MTCL1-AS1,HMlincRNA717 NA pathogenic process pancreatic cancer;non-small cell lung cancer;gastric cancer Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases
HSALNT0289369 MIF-AS1 LOC284889,MIF-AS transcriptional regulation pathogenic process malaria;nephrolithiasis Skin and Connective Tissue Diseases;Male Urogenital Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Parasitic Diseases
HSALNT0129086 NONHSAT123382 MKLN1-AS1,FLJ43663,PINT,LincRNA-Pint transcriptional regulation pathogenic process colorectal cancer;heart failure Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases;Neoplasms;Digestive System Diseases
HSALNT0289240 NONHSAT075852 LINC00913,SChLAP1,PCAT11 transcriptional regulation pathogenic process bladder cancer;prostate cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0193241 SOCS2-AS1 NA transcriptional regulation pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0138824 CASC9 ESCCAL-1,ESSCAL1,LINC00981 NA pathogenic process esophageal squamous cell cancer;esophageal cancer Neoplasms
HSALNT0267627 HNF4A-AS1 uc002xlx NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0289194 NKILA NA NA pathogenic process nasopharyngeal cancer;breast cancer;tongue squamous cell cancer Skin and Connective Tissue Diseases;Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
HSALNT0289304 LINC00942 NA NA pathogenic process ovarian cancer;autism spectrum disorder Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Mental Disorders;Neoplasms
HSALNT0289187 MNX1-AS1 CCAT5,LOC645249 NA pathogenic process ovarian cancer;colorectal cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
HSALNT0289518 VPS9D1-AS1 MYU NA pathogenic process ovarian cancer;colorectal cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
HSALNT0290266 TC0101441 NA NA pathogenic process epithelial ovarian cancer Neoplasms
HSALNT0289426 ERLNC1 TC0101441,ElncRNA1 NA pathogenic process ovarian cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290050 ENST00000416928.2 NA NA NA NA NA
HSALNT0043560 ENST00000416928.2 HOXD-AS1,Mdgt NA pathogenic process bladder cancer;neuroblastoma Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289092 LINC01158 PANTR1,linc-Brn1a,linc-POU3F3 transcriptional regulation pathogenic process;developmental process esophageal squamous cell cancer;gastric cancer;glioma Neoplasms;Digestive System Diseases
HSALNT0289448 GHET1 lncRNA-GHET1 NA pathogenic process bladder cancer;gastric cancer;colorectal cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
HSALNT0289514 PEG13 NA transcriptional regulation pathogenic process intellectual disabilities Behavior and Behavior Mechanisms;Pathological Conditions, Signs and Symptoms;Mental Disorders;Nervous System Diseases
HSALNT0289183 ENST00000414769.1 MGC16121,H19X NA pathogenic process choriocarcinoma Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289201 NONHSAT018635 NA transcriptional regulation pathogenic process;developmental process uveal melanoma Neoplasms
HSALNT0288956 LINC01234 LCAL84,onco-lncRNA-32 ceRNA pathogenic process oesophageal squamous cell cancer;breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289021 CYTOR C2orf59,NCRNA00152,MGC4677 transcriptional regulation;ceRNA pathogenic process colorectal cancer;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;renal cell cancer Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases
HSALNT0289706 CHRF NA ceRNA pathogenic process cardiac hypertrophy;silicosis Respiratory Tract Diseases;Occupational Diseases;Cardiovascular Diseases
HSALNT0143635 ENST00000502056.1 LINC00860,CARLo-1 NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0143672 CASC11 TCONS_00014535,LINC00990,CARLo-7,ENST00000518376 transcriptional regulation pathogenic process hepatocellular cancer;colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289032 LINC00323 PRED42,FLJ37173 NA pathogenic process breast cancer;hereditary haemorrhagic telangiectasia Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms
HSALNT0024655 LINC01139 LINK-A,TCONS_00000027 NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0289018 LEF1-AS1 NA NA pathogenic process hereditary haemorrhagic telangiectasia;colorectal cancer Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases
HSALNT0247326 LINC00667 NA NA pathogenic process hereditary haemorrhagic telangiectasia Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
HSALNT0290145 POU3F3 NA transcriptional regulation pathogenic process esophageal squamous cell cancer;glioma Neoplasms
HSALNT0199349 LINC00426 NA NA pathogenic process primary Sjögren's syndrome Immune System Diseases
HSALNT0155974 LINC00963 MetaLnc9 NA pathogenic process prostate cancer;renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0289211 PCF11-AS1 NA NA pathogenic process hepatocellular cancer;adolescent idiopathic scoliosis Musculoskeletal Diseases;Neoplasms;Digestive System Diseases
HSALNT0289534 91H NA transcriptional regulation pathogenic process osteosarcoma;esophageal squamous cell cancer;breast cancer;colorectal cancer Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
HSALNT0289446 ELFN1-AS1 MYCLo-2 transcriptional regulation pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0288883 ACTA2-AS1 uc001kfo.1,ZXF1 NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0289443 NONHSAT121673 RSBN1L-AS1 transcriptional regulation pathogenic process liver fibrosis;glioblastoma Neoplasms;Digestive System Diseases
HSALNT0289986 LncRNA-MVIH NA NA pathogenic process hepatocellular cancer;non-small cell lung cancer Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
HSALNT0289977 LncRNA-ATB NA ceRNA pathogenic process colorectal cancer;hepatocelluar cancer;gastric cancer;pancreatic cancer;renal cell cancer;pneumoconiosis Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Occupational Diseases;Endocrine System Diseases;Digestive System Diseases
HSALNT0289622 ATB NA ceRNA pathogenic process prostate cancer;glioma;keloid;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;colorectal cancer Pathological Conditions, Signs and Symptoms;Skin and Connective Tissue Diseases;Neoplasms;Tissues;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases
HSALNT0289586 AK057054 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0278370 LINC01315 lnc-C22orf32-1,C22orf32-1 NA pathogenic process nasopharyngeal cancer Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
HSALNT0055601 ADAMTS9-AS2 NA NA pathogenic process non-small cell lung cancer;glioma Respiratory Tract Diseases;Neoplasms
HSALNT0289383 ENST00000608917.1 PACER,PTGS2-AS1 transcriptional regulation pathogenic process osteosarcoma;osteoarthritis;inflammation and cancer Musculoskeletal Diseases;Neoplasms
HSALNT0289268 TGFB2-OT1 FLJ11812 ceRNA NA NA NA
HSALNT0288938 DUBR LINC00883 ceRNA pathogenic process asthma and chronic obstructive pulmonary disease Respiratory Tract Diseases
HSALNT0289440 Lnc-FOXC1-1:1 LINC01379,TCONS_00011636 transcriptional regulation pathogenic process esophageal squamous cell cancer;basal-like breast cancer;oral squamous cell cancer Neoplasms
HSALNT0288924 CYP51A1-AS1 ENST00000453068,LRRD1-AS1 NA pathogenic process renal cell cancer Male Urogenital Diseases;Neoplasms
HSALNT0289395 RPL34-AS1 FLJ37673,RP11-462C24.1 NA pathogenic process gastric cancer;colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289435 C5orf66-AS1 CTC-276P9.1,Epist NA pathogenic process esophageal squamous cell cancer;bladder cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289052 LINC00623 NA NA pathogenic process nasopharyngeal cancer Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
HSALNT0289831 FER1L4 FER1L4 ceRNA pathogenic process gastric cancer;endometrial cancer;colorectal cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
HSALNT0288985 ENST00000426539.1 LINC01458,lncRNA-AC130710 NA pathogenic process ovarian cancer;gastric cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
HSALNT0288881 ABHD11-AS1 WBSCR26,LINC00035,NCRNA00035 NA pathogenic process gastric cancer;mutant huntingtin Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases
HSALNT0282263 ZNF674-AS1 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289207 PCAT29 NA NA pathogenic process prostate cancer;glioma;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
HSALNT0289672 CADM1 NA NA NA NA NA
HSALNT0289297 LINC01527 lnc-SPRR2D-1,RP1-13P20.6 NA pathogenic process squamous cell cancer Neoplasms
HSALNT0289158 LUNAR1 NA transcriptional regulation pathogenic process diffuse large B-cell lymphoma;T cell acute lymphoblastic leukemia Hemic and Lymphatic Diseases
HSALNT0289830 FAR2P-1 NA NA pathogenic process lung adenocarcinoma;non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289263 ENST00000607033.1 EYA4-AS1 transcriptional regulation pathogenic process kidney clear cell sarcoma Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0145373 MAFA-AS1 RP11-909N17.3,TCONS_00014882 NA pathogenic process lung adenocarcinoma;non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0290229 RPLP0P2 RPLP0P2 NA pathogenic process lung adenocarcinoma Respiratory Tract Diseases;Neoplasms
HSALNT0289291 ZNF295-AS1 C21orf121,NCRNA00318,PRED87 NA pathogenic process lung adenocarcinoma;epithelial ovarian cancer Respiratory Tract Diseases;Neoplasms
HSALNT0084473 LINC01513 RP11-1C1.7,TCONS_00009352 NA pathogenic process NA NA
HSALNT0289471 IRAIN IGF1R-AS transcriptional regulation pathogenic process pancreatic cancer;acute myeloid leukemia;non-small cell lung cancer;breast cancer Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Endocrine System Diseases;Digestive System Diseases
HSALNT0290402 ZNRD1-AS1 NA NA pathogenic process hepatocellular cancer;lung cancer;cervical cancer Respiratory Tract Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
HSALNT0289504 LCAL1 onco-lncRNA-27 NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289169 MHRT Myheart transcriptional regulation pathogenic process heart hypertrophy;acute myocardial infarction Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
HSALNT0289859 HA117 NA NA pathogenic process hirschsprung disease Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
HSALNT0026673 ENST00000414795.1 lncRNA-CMPK2 transcriptional regulation pathogenic process chronic hepatitis C;HCV Digestive System Diseases;Virus Diseases
HSALNT0289887 LET NA NA pathogenic process gallbladder cancer;esophageal squamous cell cancer;gastric cancer;nasopharyngeal cancer;renal cell cancer;cervical cancer Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Digestive System Diseases;Stomatognathic Diseases
HSALNT0007921 NFIA-AS1 RP5-833A20.1 transcriptional regulation pathogenic process atherosclerosis;glioma Cardiovascular Diseases;Neoplasms
HSALNT0247156 GAPLINC LINC01540,TCONS_00026238,lncRNA-uc002kmd.1 siRNA pathogenic process gastric cancer;colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0288917 CERNA2 HOST2,lncRNA-HOST2 ceRNA pathogenic process hepatocellular cancer;epithelial ovarian cancer Neoplasms;Digestive System Diseases
HSALNT0289113 LINC01564 TCONS_00011314 NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0289088 LINC01105 FLJ30594,LOC150622 NA pathogenic process gastric cancer;leukemia and neuroblastoma Neoplasms;Digestive System Diseases
HSALNT0289464 AGAP2-AS1 LOC100130776,PUNISHER transcriptional regulation pathogenic process non-small cell lung cancer;glioma;leukemia and neuroblastoma Respiratory Tract Diseases;Neoplasms
HSALNT0288960 EWSAT1 TMEM84,NCRNA00277,LINC00277,FLJ33768 transcriptional regulation pathogenic process Ewing sarcoma Neoplasms
HSALNT0289242 SLC25A25-AS1 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289317 KCNK15-AS1 RP11-445H22.4 NA pathogenic process osteoarthritis;breast cancer Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289864 HIF2PUT NA NA pathogenic process osteosarcoma;colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289267 TEX41 DKFZp686O1327,LINC00953 transcriptional regulation NA NA NA
HSALNT0290361 UFC1 NA transcriptional regulation;ceRNA pathogenic process osteoarthritis;hepatocellular cancer Musculoskeletal Diseases;Neoplasms;Digestive System Diseases
HSALNT0289886 LEIGC NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289367 MDC1-AS1 MDC1-AS NA pathogenic process bladder cancer;glioma Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289190 NBAT1 CASC14,NBAT-1 transcriptional regulation pathogenic process breast cancer;renal clear cell cancer;neuroblastoma Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms
HSALNT0234826 LINC00917 NA NA pathogenic process intervertebral disc degeneration;breast cancer Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289419 LINC00173 NCRNA00173,FLJ42957 NA pathogenic process HIV-1-infected;hepatocelluar cancer Virus Diseases;Neoplasms;Digestive System Diseases
HSALNT0290138 PEG10 NA NA pathogenic process diffuse large B-cell lymphoma;esophageal cancer Neoplasms;Hemic and Lymphatic Diseases
HSALNT0289136 LINC02224 BRCAT107,ENST00000505706 NA pathogenic process active tuberculosis Bacterial Infections and Mycoses
HSALNT0289866 HIT NA transcriptional regulation pathogenic process non-small cell lung cancer;breast cancer Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
HSALNT0003927 SNHG12 ASLNC04080,C1orf79,LINC00100,NCRNA00100,PNAS-123 NA pathogenic process osteosarcoma;endometrial cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289099 LINC01225 NA NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0290047 MALAT2 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0176345 NONHSAT021826 LINC00057,NCRNA00057,U22HG,UHG,lncRNA16 NA pathogenic process astrocytoma;hepatocellular cancer;non-small cell lung cancer;Parkinson's disease;neuroblastoma Respiratory Tract Diseases;Neoplasms;Digestive System Diseases;Nervous System Diseases
HSALNT0094592 WSPAR TCONS_00009511-XLOC_004555,lncTCF7 transcriptional regulation pathogenic process hepatocellular cancer;liver cancer Neoplasms;Digestive System Diseases
HSALNT0289308 LINC00511 onco-lncRNA-12 NA pathogenic process lung adenocarcinoma;breast cancer Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
HSALNT0289452 FAM83H-AS1 onco-lncRNA-3 NA pathogenic process NA NA
HSALNT0289041 LINC00472 C6orf155,dJ288M22.3,FLJ13189 NA pathogenic process ovarian cancer;breast cancer Skin and Connective Tissue Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Endocrine System Diseases
HSALNT0289925 Linc-ITGB1 NA NA pathogenic process gallbladder cancer;breast cancer Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
HSALNT0016239 LINC01133 lncRNA-PAGBC transcriptional regulation pathogenic process non-small cell lung cancer;colorectal cancer;lung squamous cell cancer Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
HSALNT0289489 CCEPR CCHE1,lncRNA-CCHE1 transcriptional regulation pathogenic process hepatocellular cancer;cervical cancer Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
HSALNT0289402 SOX21-AS1 NA NA pathogenic process lung adenocarcinoma;oral squamous cell cancer Respiratory Tract Diseases;Neoplasms
HSALNT0288905 CASC15 LINC00340,lnc-SOX4-1 NA pathogenic process basal cell cancer;melanoma;neuroblastoma Neoplasms
HSALNT0289555 AC104699.1 NA NA pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0096322 CLMAT3 SPARC-AS1 NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0289233 RGMB-AS1 NA NA pathogenic process lung adenocarcinoma;non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0289908 LINC01419 LVCAT7,TCONS_00014497 NA pathogenic process hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0289541 AB209630 NA NA pathogenic process hypopharyngeal squamous cell cancer Neoplasms
HSALNT0289608 AOC4P AOC4P NA pathogenic process colorectal cancer;hepatocelluar cancer Neoplasms;Digestive System Diseases
HSALNT0289082 LINC01021 LINC01021,LOC643401,RP11-46C20.1 NA pathogenic process NA NA
HSALNT0196121 LINC01089 LIMT NA pathogenic process breast cancer;astrocytoma Skin and Connective Tissue Diseases;Neoplasms
HSALNT0123080 EGFR-AS1 NA NA pathogenic process hepatocellular cancer Neoplasms;Digestive System Diseases
HSALNT0289539 AB073614 NA NA pathogenic process ovarian cancer;glioma Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0242418 CACNA1G-AS1 NA NA pathogenic process keloid Pathological Conditions, Signs and Symptoms;Skin and Connective Tissue Diseases;Tissues
HSALNT0170814 MIR210HG NA transcriptional regulation pathogenic process hypoxic and inflammatory stress NA
HSALNT0288979 FOXC2-AS1 ODRUL NA pathogenic process osteosarcoma Neoplasms
HSALNT0289022 LINC00160 C21orf52,NCRNA00160 NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0105274 LINC01016 NA NA pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0288904 CARMN MIR143HG,CARMEN transcriptional regulation pathogenic process cardiac differentiation Cardiovascular Diseases
HSALNT0289123 LINC01630 LOC100287225 NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0288971 FAM30A C14orf110,KIAA0125,HSPC053 NA pathogenic process gallbladder cancer Neoplasms;Digestive System Diseases
HSALNT0289506 LINC00346 C13orf29,NCRNA00346 NA pathogenic process hepatocellular cancer;breast cancer Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
HSALNT0289643 BC032469 NA ceRNA pathogenic process esophageal squamous cell cancer;gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289580 AK024171 NA NA pathogenic process intervertebral disc degeneration;gastric cancer Musculoskeletal Diseases;Neoplasms;Digestive System Diseases
HSALNT0290187 RP11-284N8.3.1 NA NA pathogenic process ovarian cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289839 FMR6 NA NA pathogenic process fragile X syndrome;fragile X-associated premature ovarian insufficiency Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Female Urogenital Diseases and Pregnancy Complications;Nervous System Diseases
HSALNT0290152 PRAL lncRNA-PRAL NA pathogenic process hepatocellular cancer;lung cancer Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
HSALNT0289380 NORAD LINC00657 transcriptional regulation;translational control pathogenic process breast cancer Skin and Connective Tissue Diseases;Neoplasms
HSALNT0086803 LIFR-AS1 NA NA pathogenic process preterm Female Urogenital Diseases and Pregnancy Complications
HSALNT0076183 PANCR NA NA pathogenic process atrial fibrillation Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
HSALNT0288975 FEZF1-AS1 NA transcriptional regulation pathogenic process gastric cancer;colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0238475 CCDC144NL-AS1 NA ceRNA pathogenic process ovarian cancer;cardiac hypertrophy Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Cardiovascular Diseases;Neoplasms
HSALNT0290102 NR_026689 NA NA pathogenic process ovarian cancer;lung cancer Respiratory Tract Diseases;Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289522 ADARB2-AS1 C10orf109,NCRNA00168,bA466B20.1 NA pathogenic process breast cancer;pancreatic ductal adenocarcinoma Skin and Connective Tissue Diseases;Neoplasms
HSALNT0288936 DPP10-AS1 BC032913 NA pathogenic process breast cancer;colorectal cancer Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
HSALNT0289474 GAS8-AS1 C16orf3 NA pathogenic process papillary thyroid cancer;breast cancer Skin and Connective Tissue Diseases;Endocrine System Diseases;Neoplasms
HSALNT0289063 LINC00704 LINC00704 NA pathogenic process NA NA
HSALNT0289238 SAMMSON LINC01212 NA pathogenic process melanoma Neoplasms
HSALNT0289027 LINC00302 C1orf46,NCRNA00302,XP33 NA developmental process NA NA
HSALNT0245543 SNHG20 C17orf86,NCRNA00338,LINC00338,PRO0872,FLJ25582,DKFZp686L05235,SCARNA16HG transcriptional regulation pathogenic process hepatocellular cancer;colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0015631 DCST1-AS1 RP11-307C12.11 NA pathogenic process ovarian cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0149810 PGM5-AS1 FAM233A,LOC572558 NA pathogenic process bladder cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0290236 SBF2-AS1 NA transcriptional regulation pathogenic process non-small cell lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0290325 Uc.338 NA transcriptional regulation pathogenic process hepatocellular cancer;lung cancer Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
HSALNT0290002 LOC100130476 NA NA pathogenic process esophageal squamous cell cancer;gastric cardia adenocarcinoma Neoplasms
HSALNT0289049 Lnc-TNKS-1:1 Rncr3 NA pathogenic process diabetes Endocrine System Diseases
HSALNT0020406 LINC00628 NA transcriptional regulation pathogenic process gastric cancer Neoplasms;Digestive System Diseases
HSALNT0289478 DSCR4 DCRB NA pathogenic process Down syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0017675 GAS5-AS1 NA NA pathogenic process oral submucous fibrosis;non-small cell lung cancer Respiratory Tract Diseases;Neoplasms;Stomatognathic Diseases
HSALNT0289523 HCG11 bK14H9.3,FLJ14049,FLJ30357 NA pathogenic process prostate cancer Male Urogenital Diseases;Neoplasms
HSALNT0134828 LINC02099 AC145110.1 NA pathogenic process rheumatoid arthritis;breast cancer Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms
HSALNT0209098 G2E3-AS1 CAT1647 NA pathogenic process bladder cancer Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0289139 LINC02245 lnc-SERTAD2-3,AC007386.2 NA pathogenic process ovarian cancer Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
HSALNT0008167 FOXD3-AS1 pasFOXD3 transcriptional regulation pathogenic process glioma Neoplasms
HSALNT0289335 LINC00998 NA NA pathogenic process major depression disorder Behavior and Behavior Mechanisms
HSALNT0289379 NNT-AS1 NA NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0055497 PSMD6-AS1 ENST00000462717,lnc00462717 NA pathogenic process papillary thyroid cancer;glioma Endocrine System Diseases;Neoplasms
HSALNT0289130 LINC02081 CTD-2357A8.3,XLOC_012582 NA pathogenic process esophageal cancer Neoplasms
HSALNT0289306 LINC00052 TMEM83,NCRNA00052,FLJ31461 ceRNA pathogenic process hepatocellular cancer;breast cancer Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
HSALNT0199070 PLUT PDX1-AS1,PLUTO,HI-LNC71 transcriptional regulation pathogenic process type 2 diabetes Nutritional and Metabolic Diseases;Endocrine System Diseases
HSALNT0289341 LINC01505 RP11-308N19.1 NA pathogenic process NA NA
HSALNT0289315 LINC01116 TALNEC2 transcriptional regulation pathogenic process prostate cancer;glioblastoma Male Urogenital Diseases;Neoplasms
HSALNT0006439 FOXD2-AS1 MGC12982 NA pathogenic process lung cancer Respiratory Tract Diseases;Neoplasms
HSALNT0252387 LINC00305 C18orf20,NCRNA00305,MGC39571,HsT1235 NA NA NA NA
HSALNT0289473 FBXL19-AS1 NCRNA00095,MGC125469,MGC125470,MGC125472 NA pathogenic process colorectal cancer Neoplasms;Digestive System Diseases
HSALNT0187807 LINC02555 AC079630.2 NA pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0251493 LINC01929 CTD-2171N6.1 NA pathogenic process papillary thyroid cancer Endocrine System Diseases;Neoplasms
HSALNT0244776 LINC01152 TCONS_00025128,CMPD NA pathogenic process NA NA
HSALNT0284591 DIAPH2-AS1 NA NA pathogenic process Hodgkin's disease Neoplasms
HSALNT0289226 PWAR1 PAR1,PAR-1 NA pathogenic process Prader-Willi syndrome and Angelman syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
HSALNT0289339 LINC00950 FP588 NA NA NA NA
HSALNT0289740 DGCR12 DGS-E NA pathogenic process;developmental process DiGeorge syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Endocrine System Diseases
HSALNT0275220 DGCR9 DGS-A,POM121L5P NA pathogenic process DiGeorge syndrome Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Endocrine System Diseases
HSALNT0288929 DGCR10 DGS-B NA pathogenic process NA NA
HSALNT0289494 DGCR11 DGS-D NA pathogenic process NA NA
HSALNT0267755 LINC02597 Long intergenic non-protein coding RNA 2597, LOC101929866 Transcriptional regulation Pathogenic process Postmenopausal osteoporosis (PMOP) Musculoskeletal Diseases
HSALNT0178412 UVRAG-DT UVRAG divergent transcript, LOC100506113 Transcriptional regulation Pathogenic process Postmenopausal osteoporosis (PMOP) Musculoskeletal Diseases
HSALNT0185540 LINC02598 Long intergenic non-protein coding RNA 2598, RP11-277P12.9 _ Pathogenic process Lung squamous cell carcinoma (LUSC) Neoplasms; Respiratory Tract Diseases
HSALNT0278274 SREBF2-AS1 SREBF2 antisense RNA 1, RP5-821D11.7 _ Pathogenic process Lung squamous cell carcinoma (LUSC) Neoplasms; Respiratory Tract Diseases
HSALNT0021177 LINC02602 Long intergenic non-protein coding RNA 2602, TCONS_00001798 _ Pathogenic process Non-small cell lung cancer (NSCLC)  Neoplasms; Respiratory Tract Diseases
HSALNT0021052 MIR205HG MIR205 host gene, LINC00510 CeRNA Pathogenic process Head & neck squamous cell carcinoma (HNSCC) Neoplasms
HSALNT0107588 ZNF451-AS1 ZNF451 regulatory antisense RNA 1, BC032020 Transcriptional regulation Pathogenic process Pancreatic ductal adenocarcinoma (PDAC) Neoplasms
HSALNT0189537 SCAT2 S-phase cancer associated transcript 2, CBX5-AS1 _ Pathogenic process Kidney clear cell carcinoma (KIRC) Neoplasm
HSALNT0107867 SCAT8 S-phase cancer associated transcript 8, EYS-AS1 _ Pathogenic process Kidney clear cell carcinoma (KIRC) Neoplasm
HSALNT0158500 LINC00707 long intergenic non-protein coding RNA 707 Transcriptional regulation Pathogenic process Lung cancer (LC)  Neoplasms; Respiratory Tract Diseases
HSALNT0185476 LINC02470 long intergenic non-protein coding RNA 2470, AC091814.2 _ Pathogenic process Non-small cell lung cancer (NSCLC) and overian cancer Neoplasm
HSALNT0068302 LINC02600 long intergenic non-protein coding RNA 2600, AC141928.1 _ Pathogenic process Non-small cell lung cancer (NSCLC) and overian cancer Neoplasm
HSALNT0123915 LINC02604 long intergenic non-protein coding RNA 2604, lncHERG CeRNA Pathogenic process Glioblastoma Neoplasms
HSALNT0160932 MACORIS macrophage enriched lincRNA repressor of IFN-gamma signaling, MacORIS Transcriptional regulation _ Cardiometabolic Diseases Cardiovascular Diseases
HSALNT0171022 KRTAP5-AS1 KRTAP5-1/KRTAP5-2 antisense RNA 1 CeRNA Pathogenic process Gastric Cancer Neoplasms; Digestive System Diseases
HSALNT0215076 GSC-DT GSC divergent transcript, DIGIT _  Developmental process _ _
HSALNT0072605 CHAER1 Cardiac hypertrophy associated epigenetic regulator 1, Chaer Translational control Pathogenic process Cardiac hypertrophy Cardiovascular Diseases
HSALNT0027291 ODC1-DT ODC1 divergent transcript, lncRNA-MIF CeRNA Pathogenic process Head and neck carcinoma  Neoplasm
HSALNT0039409 MAP3K2-DT MAP3K2 divergent transcript, ENST00000433673 _ Pathogenic process Polycystic ovary syndrome (PCOS) Female Urogenital Diseases and Pregnancy Complications
HSALNT0208284 ZFHX2-AS1 ZFHX2 antisense RNA 1 Transcriptional regulation Developmental process _ _
HSALNT0152349 LINC02603 long intergenic non-protein coding RNA 2603, MIRLET7DHG _ _ _ _
HSALNT0081596 TENM3-AS1 TENM3 antisense RNA 1 _ _ _ _
HSALNT0165522 LINC00858 long intergenic non-protein coding RNA 858, LOC170425, CRCAL-2 _ _ non-small cell lung cancer  Respiratory Tract Diseases
HSALNT0281930 SCAT1 S-phase cancer associated transcript 1 LINC02081, CTD-2357A8.3, XLOC_012582 _ _ esophagal cancer Digestive system Diseases
HSALNT0191750 LNCOG lncRNA osteogenesis associated, LINC02407, RP11-54A9.1, lncRNA-OG _ _ osteogenic differenciation Musculoskeletal Diseases
HSALNT0246388 DCXR-DT DCXR divergent transcript RP13-650J16.1 _ _ prostate cancer Male Urogenital Diseases
HSALNT0209659 NKX2-1-AS1 NKX2-1 antisense RNA 1 _ _ lung cancer  Respiratory Tract Diseases
HSALNT0038250 ACTR3-AS1 ACTR3 antisense RNA 1, AC104653.1 _ _ glioblastoma Nervous system diseases
HSALNT0043145 ITGA6-AS1 ITGA6 antisense RNA 1, AC078883.3 _ _ glioblastoma Nervous system diseases
HSALNT0281822 LINC02601 long intergenic non-protein coding RNA 2601, RP5-1172N10.2 _ _ glioblastoma Nervous system diseases
NA ZKSCAN7-AS1 ZKSCAN7 ZNF cluster antisense RNA 1, RP11-944L7.4, FLJ12738, ZFP, ZNF167, ZNF448, ZNF64, ZSCAN39 _ _ glioblastoma Nervous system diseases
HSALNT0120721 GARS-DT GARS divergent transcript, AC005154.6, AC005154.1 _ _ heroine addiction Nervous system diseases
NA GPRACR GPR107 adjacent cis regulating lncRNA, LncGPR107 _ _ liver cancer Digestive system Diseases
HSALNT0082561 LINC01060 long intergenic non-protein coding RNA 1060 _ _ pancreatic cancer Digestive system Diseases
HSALNT0058704 TBILA TGF-beta induced lncRNA, RP11-757F18.5 _ _ non-small cell lung cancer  Respiratory Tract Diseases
NA UGDH-AS1 UGDH antisense RNA 1 _ _ invertebral disc degeneration Musculoskeletal Diseases
HSALNT0245777 TNRC6C-AS1 NA _ _ Thyroid cancer Endocrine system Disease
HSALNT0225753 LINC02244 long intergenic non-protein coding RNA 2244, RP11-20G13.3 _ _ obesity Digestive system Diseases
NA NKAIN3-IT1 NKAIN3 intronic transcript, LOC643763 _ _ glioblastoma Nervous system diseases
HSALNT0013113 NGF-AS1 NA _ _ dysmenorhea Female Urogenital Diseases
HSALNT0031057 LINC01121 long intergenic non-protein coding RNA 1121, UNQ6975 _ _ pancreatic cancer Digestive system Diseases
HSALNT0234176 ARLNC1 androgen receptor regulated long noncoding RNA 1, LINC02170, PRCAT47 _ _ prostate cancer Male Urogenital Diseases
NA MPPED2-AS1 MPPED2 antisense RNA 1, RP5-1024C24.1 _ _ thyroid neoplasias Endocrine system Disease
NA LINC01703 NA _ _ Hepatocellular carcinoma Digestive system Diseases
HSALNT0144162 HPYR1 Helicobacter pylori responsive 1, LINC00027 _ pathogenic process H. pylori infection _
HSALNT0172266 LINC00958 long intergenic non-protein coding RNA 958, protein localization,transcriptional regulation pathogenic process bladder cancer, glioma _
HSALNT0167574 SH3PXD2A-AS1 SH3PXD2A antisense RNA 1 transcriptional regulation pathogenic process colorectal cancer _
NA SSTR5-AS1 SSTR5 antisense RNA 1 transcriptional regulation pathogenic process neuroendocrine prostate cancer _
NA TSPOAP1-AS1 TSPOAP1, SUPT4H1 and RNF43 antisense RNA 1 _ pathogenic process breast cancer _
NA LINC00174 long intergenic non-protein coding RNA 174 ceRNA pathogenic process colorectal carcinoma _
HSALNT0169064 LINC01561 long intergenic non-protein coding RNA 1561 ceRNA pathogenic process breast cancer _
NA LINC00514 long intergenic non-protein coding RNA 514 transcriptional regulation pathogenic process neuroendocrine prostate cancer _
HSALNT0282164 LINC02595 long intergenic non-protein coding RNA 2595, AK098783 _ pathogenic process colorectal cancer _
HSALNT0197396 FZD10-AS1 FZD10 antisense divergent transcript _ _ _ _
NA LINC01567 long intergenic non-protein coding RNA 1567, LOCCS transcriptional regulation pathogenic process colon cancer _
NA ADPGK-AS1 ADPGK antisense RNA 1 transcriptional regulation pathogenic process pancreatic cancer _
HSALNT0255381 RAB11B-AS1 RAB11B antisense RNA 1 transcriptional regulation pathogenic process osteosarcoma _
HSALNT0237805 SNHG29 Small nucleolar RNA host gene 29, LRRC75A-AS1, C17orf76-AS1 transcriptional regulation pathogenic process acute myeloid leukemia, rheumatoid arthritis _
NA SNHG17 small nucleolar RNA host gene 17 transcriptional regulation pathogenic process colorectal cancer _
HSALNT0215138 DICER1-AS1 DICER1 antisense RNA 1 transcriptional regulation pathogenic process osteosarcoma _
HSALNT0043929 TTN-AS1 TTN antisense RNA 1 transcriptional regulation pathogenic process esophageal squamous cell carcinoma _
HSALNT0152594 LINC00092 long intergenic non-protein coding RNA 92 transcriptional regulation pathogenic process ovarian cancer _
HSALNT0050704 THUMPD3-AS1 THUMPD3 antisense RNA 1, SETD5-AS1 transcriptional regulation pathogenic process Neuron death in stroke _
HSALNT0205980 LINC00554 long intergenic non-protein coding RNA 554, lncZic2 transcriptional regulation pathogenic process liver cancer _
HSALNT0141703 ZFPM2-AS1 ZFPM2 antisense RNA 1, SCAT3 transcriptional regulation pathogenic process multiple cancers, gastric carcinogenesis _
NA HOXB-AS1 HOXB cluster antisense RNA 1 transcriptional regulation pathogenic process autosomal dominant polycistic kidney disease _
HSALNT0167650 CFAP58-DT CFAP58 divergent transcript, ITPRIP-1 transcriptional regulation pathogenic process innate immune response to viral infection _
NA FAM230A family with sequence similarity 230 member A _ _ _ _
NA CPNE8-AS1 CPNE8 antisense RNA 1, RP11-396F22.1 transcriptional regulation pathogenic process cervical cancer _
NA THORLNC testis associated oncogenic lncRNA transcriptional regulation pathogenic process melanoma, skin squamous cell carcinoma,osteosarcoma, renal cell carcinoma _
NA IATPR ITGB1 adjacent tumor promoting lncRNA transcriptional regulation pathogenic process breast cancer, gallbladder cancer _
HSALNT0242280 PICART1 p53 inducible cancer associated RNA transcript 1, AC009720.1, NR_038230, LOC84080 transcriptional regulation pathogenic process breast cancer, colorectal cancer, lung cancer _
NA LINC02599 long intergenic non-protein coding RNA 2599, AC026904.1 transcriptional regulation pathogenic process breast cancer _
HSALNT0183231 ETS1-AS1 ETS1 antisense RNA 1, pancEts-1, Ets-1 promoter-associated noncoding RNA transcriptional regulation pathogenic process gastric cancer, neuroblastoma _
NA MAPK6-DT MAPK6 divergent transcript, lncMAPK6 transcriptional regulation pathogenic process liver cancer _
HSALNT0036655 IL1R1-AS1 IL1R1 antisense RNA 1, AC007271.3 transcriptional regulation pathogenic process Oral squamous cell carcinoma, breast cancer _
HSALNT0001134 LINC01672 long intergenic non-protein coding RNA 1672, long intergenic non-protein coding RNA 1672 transcriptional regulation pathogenic process Esophageal squamous cell carcinoma _
HSALNT0135857 SIRLNT SIRT1 regulating lncRNA tumor promoter, SIRT1 regulating lncRNA tumor promoter, ceRNA pathogenic process Breast cancer _
HSALNT0135484 LINC01605 long intergenic non-protein coding RNA 1605, TCONS_00014973, LincDUSP transcriptional regulation pathogenic process Colon Cancer, Bladder cancer _
HSALNT0184552 GAU1 GALNT8 antisense upstream 1, GALNT8 divergent transcript transcriptional regulation pathogenic process Neuroblastoma and retinoblastoma _
HSALNT0287294 LINC00894 long intergenic non-protein coding RNA 894 transcriptional regulation pathogenic process Lung adenocarcinoma _
HSALNT0000250 LINC02593 long intergenic non-protein coding RNA 2593, AL645608.1 _ pathogenic process breast cancer, hepatocellular carcinoma _
HSALNT0241060 LINC02594 long intergenic non-protein coding RNA 2594, CTC‐501O10.1 _ _ gastric cancer _
HSALNT0022481 LINC01705 long intergenic non-protein coding RNA 1705, RP11-400N13.3 transcriptional regulation pathogenic process gastric cancer _
HSALNT0022477 LINC02474 long intergenic non-protein coding RNA 2474, RP11-400N13.2 transcriptional regulation pathogenic process gastric cancer _
HSALNT0030809 LINC02590 long intergenic non-protein coding RNA 2590, AC016735.2 transcriptional regulation pathogenic process gastric cancer _
HSALNT0170966 MUC5B-AS1 MUC5B antisense RNA 1 transcriptional regulation pathogenic process lung adenocarcinoma _
HSALNT0275151 FAM230D family with sequence similarity 230 member D, LINC02592: long intergenic non-protein coding RNA 2592, AC008079.1 _ _ _ _
HSALNT0275163 FAM230E family with sequence similarity 230 member E, LINC01662: long intergenic non-protein coding RNA 1662 _ _ _ _
HSALNT0275179 FAM230F family with sequence similarity 230 member F, LINC01663: long intergenic non-protein coding RNA 1663 _ _ _ _
NA FAM230G family with sequence similarity 230 member G, AC007731.1 _ _ _ _
NA FAM230H family with sequence similarity 230 member H, AP000552.1 _ _ Papillary thyroid carcinoma _
NA FAM230I family with sequence similarity 230 member I, LINC01658: long intergenic non-protein coding RNA 1658 _ _ _ _
HSALNT0275150 FAM230J family with sequence similarity 230 member J, LINC01660: long intergenic non-protein coding RNA 1660 _ _ _ _
HSALNT0103387 HCG14 HLA complex group 14, dJ111M5.4 transcriptional regulation pathogenic process Celiac disease, Nutritional and Metabolic Diseases _
NA LINC01510 long intergenic non-protein coding RNA 1510 transcriptional regulation, ceRNA pathogenic process Colorectal cancer, Non-small cell lung cancer _
NA LNCOC1 lncRNA associated with ovarian cancer 1, Lnc-OC1 transcriptional regulation pathogenic process Ovarian cancer _
NA LGALSL-DT LGALSL divergent transcript, LOC105374771 transcriptional regulation pathogenic process Postmenopausal osteoporosis (PMOP) _
HSALNT0002862 LINC02596 long intergenic non-protein coding RNA 2596, LOC105376834 transcriptional regulation pathogenic process Postmenopausal osteoporosis (PMOP) _
NA DEC1 deleted in esophageal cancer 1, CTS9, Candidate Tumor Suppressor CTS9 NA pathogenic process esophageal squamous cell carcinoma Neoplasms
NA MYOPARR myogenin promoter-associated myogenic regulatory antisense long non-coding RNA transcriptional regulation NA NA NA
NA PCED1B-AS1 PCED1B antisense RNA 1 ceRNA pathogenic process Tuberculosis Bacterial Infections and Mycoses
NA UMLILO upstream master lncRNA of the inflammatory chemokine locus transcriptional regulation NA NA NA
NA LINC02631 long intergenic non-protein coding RNA 2631, AC092620.3 NA NA NA NA
NA BMNCR bone marrow associated non-coding RNA transcriptional regulation NA NA NA
NA ZEBTR ZEB1 transcriptional regulator RNA, LncRNA-BX111 NA pathogenic process Pancreatic cancer Neoplasms
NA SNHG31 small nucleolar RNA host gene 31 NA NA NA NA
NA LINC00574 long intergenic non-protein coding RNA 574, C6orf208, FLJ13162, dJ182D15.1, CRALA NA pathogenic process Primary breast cance Neoplasms
NA RCC2-AS1 RCC2 antisense RNA 1 NA pathogenic process non-small cell lung cancer Neoplasms
NA PRDM16-DT lnc-dPrdm16 NA NA NA NA
NA BCL6-AS1 BCL6 antisense RNA 1, lnc-RP11-211G3.3.1-1 NA pathogenic process diffuse large B-cell lymphoma Neoplasms; Immune System Diseases
NA C1orf220 chromosome 1 open reading frame 220, FLJ35530 NA NA NA NA
NA MIR122HG lnc-pri-miR-122 NA NA NA NA
NA PANTR1 linc-POU3F3, linc-Brn1a, LINC01158 NA developmental process NA NA
NA C11orf72 FLJ90834, chromosome 11 open reading frame 72 NA NA NA NA
NA CT66 cancer/testis antigen 66, cancer/testis associated transcript 66 NA NA NA NA
NA CT75 cancer/testis antigen 75 NA NA NA NA
NA MIR9-3HG MIR9-3 host gene, LINC00925, long intergenic non-protein coding RNA 925 NA NA NA NA
NA RN7SL2 RNA component of signal recognition particle 7SL2, RNA7SL, cytoplasmic 2, 7SL1c, 7L30.1, RNSRP2 NA NA NA NA
NA RN7SL3 RNA component of signal recognition particle 7SL3, RN7SL631P, (RNA,7SL, cytoplasmic 631, pseudogene), (RNA, 7SL, cytoplasmic 3) NA NA NA NA
NA CT70 cancer/testis associated transcript 70, cancer/testis antigen 70, LeXis ceRNA, transcriptional regulation pathogenic process osteosarcoma, colon adenocarcinoma Neoplasms
NA CT69 cancer/testis associated transcript 69, cancer/testis associated transcript 69 NA NA NA NA
NA C10orf91 chromosome 10 open reading frame 91 (putative), chromosome 10 open reading frame 91, bA432J24.4 NA NA NA NA
NA CTBP1-DT CTBP1 divergent transcript, C4orf42, CTBP1-AS1, CTBP1-AS2, chromosome 4 open reading frame 42, CTBP1 antisense RNA 1 (head to head), CTBP1 antisense RNA 2 (head to head) NA NA NA NA
NA FAM201B family with sequence similarity 201 member B, NA NA NA NA
NA MAFG-DT MAFG divergent transcript, MAFG antisense RNA 1 (non-protein coding), MAFG antisense RNA 1, MAFG antisense RNA 1 (head to head) NA NA NA NA
NA RPP38-DT RPP38 divergent transcript, C10orf111, chromosome 10 open reading frame 111, MGC35468, bA455B2.4 NA NA NA NA
NA CDRT3 CMT1A duplicated region transcript 3 NA NA NA NA
NA DLEU2L deleted in lymphocytic leukemia 2 like, BCMS upstream neighbor-like, BCMSUNL NA NA NA NA
NA ARHGAP42-AS1 AK124326 NA NA NA NA
HSALNG0116707 ASB16-AS1 DKFZp762C2414,C17orf65

CeRNA

NA

Osteosarcoma

NA
NA BAIAP2-DT lnc-BAIAP2,BAIAP2-AS1 NA NA NA NA
HSALNT0289434 BASP1-AS1 LOC285696 NA NA NA NA
NA BCAN-AS1 RP11-284F21.9 NA NA NA NA
NA C2ORF27A C2orf27 NA NA NA NA
NA CALHM6-AS1 RP1-93H18.6 NA NA NA NA
NA CAVIN2-AS1 LOC105373813 NA NA NA NA
HSALNG0108275 CHASERR LINC01578 NA NA NA NA
NA CHROMR CHROME,PRKRA-AS1 NA NA NA NA
HSALNG0119714 DLGAP1-AS1 HsT914,FLJ35776 NA NA NA NA
HSALNG0119716 DLGAP1-AS2 MGC11082 NA NA NA NA
NA EGILA Lnc-EGFR NA NA NA NA
NA ELDR Fabl,LINC01156 NA NA NA NA
NA EMSLR EMS NA NA NA NA
NA EPCART TPCAT-2-180961,PRCAT122,PCAT-2-180961 NA NA NA NA
NA EVA1A-AS EVA1A-AS1 NA NA NA NA
HSALNG0082135 FAM99A FLJ42833 NA NA NA NA
HSALNG0082137 FAM99B DKFZp781M09150 NA NA NA NA
NA FAM218A FLJ31659,TRIM61-AS1,C4orf39 NA NA NA NA
HSALNG0099631 GAS6-DT FLJ44054,GAS6-AS2 NA NA NA NA
HSALNT0048545 GCSIR Lnc-ITM2C-1 NA NA NA NA
HSALNG0047439 GMDS-DT GMDS-AS1 NA NA NA NA
HSALNT0026700 GRASLND RNF144A-AS1 NA NA NA NA
NA HOXC13-AS HOXC-AS5 NA NA NA NA
NA IGFL2-AS1 AC006262.5 NA NA NA NA
HSALNG0082653 IRAG1-AS1 MRVI1-AS1 NA NA NA NA
HSALNT0129814 KDM7A-DT JHDM1D-AS1 NA NA NA NA
HSALNT0025249 KIF26B-AS1 RP11-62I21.1 NA NA NA NA
NA KLRK1-AS1 LOC101928100 NA NA NA NA
NA LASTR LINC02657 NA NA NA NA
HSALNG0069631 LDLR-AS1 BM450697 NA NA NA NA
HSALNG0131739 LINC00266-1 bA476I15.3,RBRP,C20orf69,NCRNA00266,NCRNA00266-1 NA NA NA NA
HSALNG0097328 LINC00458 LncRNA-ES3,ES3 NA NA NA NA
NA LINC00515 PRED21,C21orf71 NA NA NA NA
HSALNG0104041 LINC00637 HITT NA NA NA NA
HSALNG0122571 LINC00908 ASRPS NA NA NA NA
HSALNG0112089 LINC00920 CALIC NA NA NA NA
HSALNG0035402 LINC01094 CTEPHA1 NA NA NA NA
HSALNT0131038 LINC01287 TCONS_l2_00027522 NA NA NA NA
NA LINC01551 C14orf23 NA NA NA NA
HSALNG0004816 LINC01555 FLJ35487,C1orf180 NA NA NA NA
NA LINC02145 FLJ33360 NA NA NA NA
NA LINC02250 TCONS_00023273 NA NA NA NA
NA LINC02303 TRMP NA NA NA NA
NA LINC02476 LVCAT5,lnc-TSPAN12 NA NA NA NA
HSALNT0006451 LINC02605 RP11-79H23.3,IL-7,AS NA NA NA NA
NA LINC02620 BCRT1 NA NA NA NA
NA LINC02682 TCONS_00019584,lnc-SOX6-1 NA NA NA NA
NA LINC02835 lncMER52A NA NA NA NA
NA LINC02859 LncRNA-LOC101928316 NA NA NA NA
NA LINC02861 RP11-462G12.2 NA NA NA NA
NA LINC02862 AC073284.4 NA NA NA NA
NA LINC02864 RP11-169F17.1 NA NA NA NA
NA LINC02867 LA16c-313D11.9 NA NA NA NA
NA LINC02882 RP11-81H3.2 NA NA NA NA
NA LINC02883 KMU15 NA NA NA NA
NA LINC02886 RP11-697M17.1 NA NA NA NA
NA LINC02891 lnc-RTN4R-1 NA NA NA NA
NA LINCADL linc-ADAL NA NA NA NA
NA LNC-LBCS LBCS NA NA NA NA
NA LNCDAT YYLNCT NA NA NA NA
NA LNCNEF lncRNA-NEF,LINC01384 NA NA NA NA
NA LNCTAM34A GUARDIN,LINC01759 NA NA NA NA
HSALNG0047822 LY86-AS1 FLJ33708,LY86AS,LY86-AS NA NA NA NA
HSALNG0067477 MAILR MAIL1,AZIN1-AS1 NA NA NA NA
NA MIR9-1HG CROC4,C1orf61 NA NA NA NA
NA MIR23AHG LOC284454 NA NA NA NA
HSALNT0159828 MIR1915HG bA418C1.3,C10orf114,CASC10 NA NA NA NA
NA NR4A1AS NR4A1-AS1 NA NA NA NA
NA NRAD1 NCRNA00284,LINC00284 NA NA NA NA
HSALNT0140217 OTUD6B-AS1 GS1-251I9.4 NA NA NA NA
HSALNG0041428 OXCT1-AS1 SARRAH NA NA NA NA
NA PCSEAT PRCAT38 NA NA NA NA
HSALNT0268592 PELATON GCRL1,LINC01272,SMIM25 NA NA NA NA
HSALNG0069519 PGM5P3-AS1 FAM233B NA NA NA NA
HSALNT0180290 PGR-AS1 AT1,AT2,AT3 NA NA NA NA
HSALNT0114603 PHACTR2-AS1 NR027113,lncIHS NA NA NA NA
HSALNG0092289 PRANCR LINC01481,CNOT2-DT NA NA NA NA
NA PSLNR LA16c-83F12.6 NA NA NA NA
HSALNG0049455 PSMB8-AS1 XXbac-BPG246D15.8,TAP1-AS1,TAPSAR1 NA NA NA NA
HSALNG0055664 PSMG3-AS1 KIAA1908 NA NA NA NA
HSALNG0094500 PXN-AS1 EyeLinc4 NA NA NA NA
HSALNT0289231 RCAN3AS TCONS_00001428 NA NA NA NA
HSALNT0289236 ROCR LINC02095 NA NA NA NA
NA SAP30-DT ENST00000608794 NA NA NA NA
NA SCP2D1-AS1 dJ1068E13.1,C20orf78 NA NA NA NA
NA SFTA1P SFTPF NA NA NA NA
HSALNG0108960 SNHG9 DKFZp686N06141,NCRNA00062 NA NA NA NA
HSALNT0104616 SNHG32 D6S57,G8,C6orf48 NA NA NA NA
HSALNG0118528 SOX9-AS1 FLJ37644 NA NA NA NA
NA SPATA8 MGC44294,SRG8 NA NA NA NA
NA THY1-AS1 RP11-334E6.12 NA NA NA NA
NA TMEM18-DT AC092159.2 NA NA NA NA
NA TNRC17 CAGL234 NA NA NA NA
NA TP73-AS2 RP5-1092A11.2 NA NA NA NA
HSALNT0289424 TTTY22 NCRNA00147 NA NA NA NA
NA UICLM CROCC2-AS1 NA NA NA NA
HSALNG0078695 UNC5B-AS1 UASR1 NA NA NA NA
NA VPS13B-DT OLC8 NA NA NA NA
NA WAKMAR2 Lnc-TNFAIP3 NA NA NA NA
NA ZKSCAN2-DT CTD-2547G23.4 NA NA NA NA
Retrieved from "https://ngdc.cncb.ac.cn/lncrnawiki1/index.php?title=LncRNAWiki:Featured&oldid=1277598"